

















Prenatal exposure to non-persistent 
chemicals and child neurodevelopment: 
an epidemiological study
Michiel Arjen van den Dries
UITNODIGING
Voor het volgen van de openbare 
verdediging van het proefschrift
 
Prenatal exposure to non-
persistent chemicals and 
child neurodevelopment:  
an epidemiological study 
Dinsdag 02-02-2021  
15:30 uur 
U kunt de openbare verdediging 
volgen via een livestream.  
De link voor de livestream 
ontvangt u via e-mail.  
Michiel van den Dries 
Generaal Vetterstraat 2-H  
1059BV Amsterdam  
michielvddries@gmail.com 
Paranimfen 
Jeanne Leerssen  
Yllza Xerxa  
michielsparanimfen@gmail.com
Prenatal Exposure to Non-persistent Chemicals and 
Child neurodevelopment: an Epidemiological Study
Prenatale blootstelling aan niet-persistente 
chemicaliën en neurologische ontwikkeling van het 
kind: een epidemiologische studie
Prenatal Exposure to Non-persistent Chemicals and Child neurodevelopment: an Epidemiological 
Study
Author: M.A. van den Dries 
ISBN: 978-94-6423-096-3  
Cover design: Elisabeth Leerssen en Michiel van den Dries
Layout: Marian Sloot || www.proefschriftmaken.nl
Printing: ProefschriftMaken || www.proefschriftmaken.nl
© copyright M. A. van den Dries, 2020 
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or 
transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, 
without prior permission of the author or the copyright-owning journals for previous published chapters.
Prenatal Exposure to Non-persistent Chemicals and 
Child neurodevelopment: an Epidemiological Study
Prenatale blootstelling aan niet-persistente 
chemicaliën en neurologische ontwikkeling van het 
kind: een epidemiologische studie
Thesis
to obtain the degree of Doctor from the
Erasmus University Rotterdam
by command of the
rector magnificus
Prof. dr. F.A. van der Duijn Schouten
and in accordance with the decision of the Doctorate Board.
The public defence shall be held on
Tuesday 2 February 2021 at 15.30hrs
by
Michiel Arjen van den Dries
born in Bilthoven, the Netherlands.
Doctoral Committee:
Promotor: Prof. dr. H.W. Tiemeier
Other members: Prof. dr. ir. A. Burdorf
 Prof. dr. S.M. Engel
 Prof. dr. ir. R.C.H. Vermeulen
Copromotors: Dr. M. Guxens
 Dr. ir. A Pronk
Paranymphs: Jeanne Leerssen
 Yllza Xerxa
Manuscripts that form the basis of  this 
thesis
van den Dries, M. A., Pronk, A., Guxens, M., Spaan, S., Voortman, T., Jaddoe, V.W.V., 
Jusko, T. A., Longnecker, M. P., & Tiemeier, H. (2018). Determinants of organophosphate 
pesticide exposure in pregnant women: A population-based cohort study in the Netherlands. 
International journal of hygiene and environmental health, 221(3), 489–501. (Chapter 2).
van den Dries, M. A., Guxens, M., Spaan, S., Ferguson, K. K., Philips, E., Santos, S., 
Jaddoe, V.W.V., Ghassabian, A., Trasande, L., Tiemeier, H., & Pronk, A. (2020). Phthalate 
and Bisphenol Exposure during Pregnancy and Offspring Nonverbal IQ. Environmental 
health perspectives, 128(7), 77009. (Chapter 3)
Jusko, T. A., van den Dries, M. A., Pronk, A., Shaw, P. A., Guxens, M., Spaan, S., 
Jaddoe, V.W.V., Tiemeier, H., & Longnecker, M. P. (2019). Organophosphate Pesticide 
Metabolite Concentrations in Urine during Pregnancy and Offspring Nonverbal IQ at 
Age 6 Years. Environmental health perspectives, 127(1), 17007. (Chapter 4)
van den Dries, M. A., Guxens, M., Pronk, A., Spaan, S., El Marroun, H., Jusko, T. 
A., Longnecker, M. P., Ferguson, K. K., & Tiemeier, H. (2019). Organophosphate 
pesticide metabolite concentrations in urine during pregnancy and offspring attention-
deficit hyperactivity disorder and autistic traits. Environment international, 131, 105002. 
(Chapter 5)
Mulder, T. A., van den Dries, M. A., Korevaar, T., Ferguson, K. K., Peeters, R. P., & 
Tiemeier, H. (2019). Organophosphate pesticide exposure in pregnant women and 
maternal and cord blood thyroid hormone concentrations. Environment international, 
132, 105124. (Chapter 6)
Ghassabian, A.*, van den Dries M. A.*, Trasande, L., Lamballais, S., Spaan, S., 
Asimakopoulos, A. G., Martinez-Moral, M. P., Kannan, K., Engel, S. M., Pronk, A., 
White, T., Tiemeier, H., & Guxens, M. Prenatal exposure to phthalates: A follow-up study 
of brain morphology and white matter microstructure in preadolescence. Manuscript to 
be submitted for publication. (Chapter 7)
van den Dries, M. A., Lamballais, S., El Marroun, H., Pronk, A., Spaan, S., Ferguson, 
K. K., Longnecker, M. P., Tiemeier, H., & Guxens, M. (2020). Prenatal exposure to 
organophosphate pesticides and brain morphology and white matter microstructure in 
preadolescents. Environmental research, 191, 110047. (Chapter 8)
Ferguson, K. K., van den Dries, M. A., Gaillard, R., Pronk, A., Spaan, S., Tiemeier, 
H., & Jaddoe, V.W.V. (2019). Organophosphate Pesticide Exposure in Pregnancy in 
Association with Ultrasound and Delivery Measures of Fetal Growth. Environmental 
health perspectives, 127(8), 87005. (Chapter 9)
van den Dries, M. A., Keil, A. P., Tiemeier, H., Pronk, A., Spaan, S., Santos, S., 
Asimakopoulos, A. G., Kannan, K., Gaillard, R., Guxens, M., Trasande, L., Jaddoe, 
V.W.V., & Ferguson, K. K. Prenatal exposure to non-persistent chemical mixtures and 
fetal growth. Manuscript to be submitted for publication (Chapter 10).
* These authors contributed equally
 
Table of  contents
Part I  9
Chapter 1 General introduction 11
Part II Determinants of  exposure to non-persistent chemicals during pregnancy 23
Chapter 2 Determinants of  organophosphate pesticide exposure in pregnant women: 
A population-based cohort study in the Netherlands 25
Part III Prenatal exposure to non-persistent chemicals and neurodevelopment in children 75
Chapter 3 Phthalate and bisphenol exposure during pregnancy and offspring nonverbal IQ 77
Chapter 4 Organophosphate pesticide metabolite concentrations in urine during 
pregnancy and offspring nonverbal IQ at age 6 years 119
Chapter 5 Organophosphate pesticide metabolite concentrations in urine during 
pregnancy and offspring attention-deficit hyperactivity disorder and autistic 
 traits 171
Part IV The effect of  exposure to non-persistent chemicals on potential mediators of  
the association with neurodevelopment 217
Chapter 6 Organophosphate pesticides exposure in pregnant women and maternal and 
cord blood thyroid hormone concentrations 219
Chapter 7 Prenatal exposure to phthalates: A follow-up study of  brain morphology 
and white matter microstructure in preadolescence 247
Chapter 8 Prenatal exposure to organophosphate pesticides and brain morphology and 
white matter microstructure in preadolescents 277
Chapter 9 Organophosphate pesticide exposure in pregnancy in association with 
ultrasound and delivery measures of  fetal growth 311
Chapter 10 Prenatal exposure to non-persistent chemical mixtures and fetal growth 353
Part V  385
Chapter 11 General discussion 387
Chapter 12 Summary / Samenvatting 419
Appendix Acknowledgements 431
 Author affiliations 432
 List of  publications not part of  this thesis 435
 PhD Portfolio 436
 Words of  gratitude / Dankwoord 438














Exposure to chemical pollutants is a great and rising worldwide problem. The human 
health consequences of chemical pollution are poorly understood and almost inevitability 
underestimated.1,2 Over 100.000 new chemicals have been introduced since 1950, and 
of those approximately 5000 are produced on an extensive scale.2,3 This comprehensive 
production has led to a broad diffusion of chemicals in the environment and resulted 
in a universal human exposure from fetal life onwards. Further, only in the past decades 
pre-market safety assessments have been required in few developed countries.1,2 The 
consequence is that chemicals whose safety and toxicity have never been thoroughly tested 
have repetitively affected human health and the environment in the past century.1,2 Lead, 
dichlorodiphenyltrichloroethane (DDT), and asbestos are such examples. In the past 
decades, novel chemicals with little pre-market safety assessment have been introduced 
on a global scale resulting in a ubiquitous exposure.1,2,4 Three of these chemical groups are 
phthalates, bisphenols and organophosphate (OP) pesticides and are commonly found 
in variety of consumer products and food items.5,6
Phthalates are chemicals exert as plasticizers and as solvents in numerous consumer goods.7 
The annual worldwide production of phthalates is estimated to be 5 billion kg.8 There are 
several different sorts of phthalates with diverse usages and chemical characteristics. For 
example, Di-(2-ethylhexyl) and benzyl butyl phthalates are typically used as plasticizers 
for polyvinyl chloride (PVC) and exist in products such as food packaging materials, floor 
materials, clothing, toys, and medical devices. Whereas diethyl and dibutyl phthalates 
are generally used as solvent and fixative in products such as cosmetics, paints, and 
glues.7,9-11 Because phthalates are weakly bound to their product, they easily leach into 
the environment and therefore are present in a variety of consumer goods and food items. 
Phthalates are also commonly detected in indoor air and house dust.7,12-15 Consequently, 
the exposure to phthalates most likely happens through inhalation of air from the indoor 
environment, diet, and the use of consumer goods such as personal care products, and 
products containing PVC.
Bisphenol A and its replacements (such as bisphenol F and bisphenol S) are among the 
most widely used group of synthetic compounds around the globe. These chemicals are 
mainly applied in the production of polycarbonate plastics and epoxy resins and therefore 
present in water bottles, storage containers, and in the lining of food and beverage 
containers. Further, bisphenols are present on thermal paper receipts.16,17 Similar to 
phthalates, bisphenols are weakly bound and leach from their product into its contents.18-21 
Therefore, diet is the main source of bisphenol exposure.
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1Pesticides are extensively used in both developed and developing countries as a result of an 
intensification in agriculture largely for export purposes.22 For instance, the Netherlands 
is one of the world’s leading exporter of agricultural products with an estimated export 
value of 90.3 billion euros in 2018.23 As a consequence, more than half of the total surface 
area of the Netherlands is being utilized for agricultural purposes and more pesticides and 
fertilizers per square km of farmland are being applied as compared to most other western 
countries.24,25 At present, 2.3 billion kg of pesticides are used worldwide of which one 
third consist of OP pesticides.26 OP pesticides are insecticides and particularly used in 
agriculture for crop protection. After harvesting, residues of OP pesticides may remain 
on or in the agricultural product.27 Therefore, the exposure to OP pesticides in urban 
settings mainly occurs through the consumption of food.28
Biomonitoring studies have shown that concentrations of phthalates, bisphenols, and 
OP pesticides are commonly detected in biospecimens of the general population.29 These 
chemicals are non-persistent and therefore after ingestion, absorption, or inhalation are 
rapidly metabolized and excreted.22,30,31 Concern exists about the long-term health effects 
of these non-persistent chemicals because the exposure through consumer products 
is ubiquitous, across the lifespan, and occurs in many different combinations and 
concentrations. Because these chemicals are coming from industry and are non-persistent, 
their contribution to adverse health effects is potentially preventable.
Prenatal exposure to these chemicals can occur because they have the ability to surpass the 
placenta and blood brain barrier.32-38 The brain is particularly susceptible to neurotoxicity 
during fetal life. To ensure normal brain development, many vital biological actions occur 
during the fetal period.39 Therefore, interference by chemical insults during these precisely 
timed processes may result in adverse neurodevelopmental health outcomes.39-41 Animal 
studies have shown that low-dose exposure to phthalates, bisphenols, and OP pesticides 
impairs neurodevelopment and behaviour.42-56
In humans, few epidemiological studies have examined the association of fetal exposure 
and neurodevelopment, including cognition and behavioral outcomes such as autism and 
attention-deficit hyperactivity disorder. The results of these studies have been suggestive, 
but overall are inconclusive.40,57-60 For example, one study found prenatal OP pesticide 
exposure measured at the 13 weeks and 26 weeks of gestation to be inversely associated 
with IQ,61 whereas two other studies found no association between early, mid, and late 
pregnancy exposure.62,63 Further, much uncertainty exists about which mechanisms underlie 
the observed associations between non-persistent chemicals and neurodevelopment.
The heterogeneity in epidemiological results may be explained by the fact that most of 
these studies had modest sample sizes. This may have reduced the statistical power to 
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consistently observe poor health outcomes. Further, most studies measured prenatal exposure 
to these chemicals at one, or at most two, time points during pregnancy. However, several 
potentially susceptible periods of fetal neurodevelopment to chemical exposure may exist 
during pregnancy.41,64,65 A susceptible period is a specific developmental moment during 
which chemical exposure results in a greater effect on health than the exposure to the same 
chemical at another moment.66 It is conceivable that some studies using a single exposure 
measurement during pregnancy might have missed the susceptible period, potentially 
resulting in diluted effects (i.e., estimates closer to the null). Moreover, the short half-life, 
i.e. fast metabolization and excretion of non-persistent chemicals, results in within-person 
variability in biomarker concentrations as a result of variation in contact with exposure 
sources (e.g., changing dietary patterns or use of different type of personal care products). 
Therefore, the use of a biomarker measurement at a single time point to assess pregnancy 
exposure to non-persistent chemicals may have resulted in exposure misclassification, also 
resulting in a regression of the exposure-response estimates towards the null.60,67 Finally, 
the exposures to these non-persistent chemicals do not occur in isolation but coincide 
(as a mixture) on a daily basis across the lifespan. Most epidemiological studies on these 
chemicals in relation to neurodevelopment have been restricted to the investigation of 
associations between single pollutants and neurodevelopmental outcomes. Restricting 
analyses to single pollutants may ignore health effects which would be detected if the 
joint chemical exposure is assessed. For example, the additive effect of the exposure to 
multiple chemicals acting on the same biological pathways may be harmful even when 
individual exposures are below practically meaningful thresholds. Further, co-exposures 
may act together in different ways to produce unexpected synergistic health effects.68-71 
Other limitations of single-chemical models are the potential biased effect estimates in 
the presence of co-pollutant confounding, and inflated false discoveries when correlated 
exposures are modelled separately.60,72 Concentrating on the mixture as a whole can provide 
effect estimates that more closely correspond to real-world exposures. Taken together, 
much uncertainty still exists about the relationship between prenatal non-persistent 
chemical exposure and neurodevelopment.
Aims
The present thesis examined the relationship between prenatal exposure to phthalates, 
bisphenols, and OP pesticides and neurodevelopment in children by studying (i) the 
determinants of exposure to non-persistent chemicals during pregnancy, (ii) exploring the 
association of prenatal exposure to non-persistent chemicals with neurodevelopment in 
children, and (iii) investigating the effect of exposure to these non-persistent chemicals on 
the potential mediators—such as thyroid function, brain structure, and fetal growth—of 




These aims were explored using data from the Generation R Study, a prospective 
population-based cohort designed to detect early environmental and genetic determinants 
of development from fetal life onward in a multi-ethnic urban population.73 The Generation 
R Study is characterized by a large sample size, detailed follow-up information of prenatal 
and postnatal development of the fetus or child, repeated measurements (early, mid, 
and late pregnancy) of non-persistent chemical exposure, and the availability of detailed 
demographic information. Every women who was pregnant and lived in the research 
district Rotterdam, the Netherlands, and was expected to give birth between 2002 and 
2006 were eligible.73
In total, 8,879 women were enrolled during pregnancy. Between 2004 and 2006, women 
were asked to provide biospecimens at the time of routine ultrasound examinations 
during early, mid, and late pregnancy. A total of 2,083 women provided a urine sample 
at each visit. When children turned 6 and 9 years of age, mother-child pairs were asked 
to visit the research center in order to collect sociodemographic data and biospecimens, 
and to measure health outcomes including neurodevelopment. Of the 2,083 women 
who provided a urine sample at each prenatal visit, 1,405 mother-child pairs provided 
data at the follow-up visits. The availability of follow-up data was a requirement to allow 
studies of the associations between prenatal non-persistent chemical exposure and child 
health including neurodevelopment. This subset is the basis of the majority of the studies 
presented in this thesis. Mothers provided written informed consent for themselves 
and their children. The Medical Ethical Committee of the University Medical Center 
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Background: In the Netherlands organophosphate (OP) pesticides are frequently used for 
pest control in agricultural settings. Despite concerns about the potential health impacts of 
low-level OP pesticide exposure, particularly in vulnerable populations, the primary sources 
of exposure remain unclear. The present study was designed to investigate the levels of OP 
metabolite concentrations across pregnancy and to examine various determinants of OP 
metabolite concentrations among an urban population of women in the Netherlands.
Method: Urinary concentrations of six dialkyl phosphate (DAP) metabolites, the main urinary 
metabolites of OP pesticides, were determined at <18, 18–25, and >25 weeks of pregnancy in 
784 pregnant women participating in the Generation R Study (between 2004 and 2006), a large 
population-based birth cohort in Rotterdam, the Netherlands. Questionnaires administered 
prenatally assessed demographic and lifestyle characteristics and maternal diet. Linear mixed 
models, with adjustment for relevant covariates, were used to estimate associations between 
the potential exposure determinants and DAP metabolite concentrations expressed as molar 
concentrations divided by creatinine levels.
Results: The median DAP metabolite concentration was 311 nmol/g creatinine for the first 
trimester, 317 nmol/g creatinine for the second trimester, and 310 nmol/g creatinine for the 
third trimester. Higher maternal age, married/living with a partner, underweight or normal 
weight (BMI of <18.5 and 18.5–<25), high education, high income, and non-smoking were 
associated with higher DAP metabolite concentrations, and DAP metabolite concentrations 
tended to be higher during the summer. Furthermore, fruit intake was associated with increased 
DAP metabolite concentrations. Each 100 g/d difference in fruit consumption was associated 
with a 7% higher total DAP metabolite concentration across pregnancy. Other food groups 
were not associated with higher DAP metabolite concentrations.
Conclusions: The DAP metabolite concentrations measured in urine of pregnant women 
in the Netherlands were higher than those in most other studies previously conducted. Fruit 
intake was the main dietary source of exposure to OP pesticides in young urban women in 
the Netherlands. The extent to which DAP metabolite concentrations reflect exposure to 
the active parent pesticide rather than to the less toxic metabolites remains unclear. Further 
research will be undertaken to investigate the possible effects of this relatively high-level OP 
pesticide exposure on offspring health.




In the Netherlands more than 50% of the total surface area is used for agriculture purposes.1 
Organophosphate (OP) pesticides are a class of insecticides that are commonly used in 
agriculture. Between 1998 and 2008, approximately 35% of the insecticides used in the 
Netherlands were OP pesticides,2 which may lead to high background exposure.
For non-occupationally exposed individuals, the exposure occurs most likely through the 
ingestion of food.3 Further, residential exposure can occur through the use of insecticides 
in and around the house.4-7 Exposures to high doses of OP pesticides are known to be 
neurotoxic in humans and animals.8-10 Nevertheless, results obtained from both animal 
and human studies raise concerns about the potential health impact of low-level OP 
pesticide exposure in the general population.11
Animal studies have demonstrated that OP pesticide exposure levels even below the 
threshold for acetylcholinesterase inhibition can alter psychological disorder related gene 
expression,12 induce changes in behavior and neurochemistry,13 and result in cognitive 
impairments.14,15 Moreover, low level OP pesticide exposure can change neuronal cell 
development,16 induce oxidative stress,17,18 and influence the thyroid hormone levels and 
the reproductive system.19-21
Fetuses and children are more susceptible to neurotoxic effects than adults as the human 
brain is particularly vulnerable during maturational and developmental processes.22 Prenatal 
exposure to OP pesticides is potentially harmful because OP pesticides are able to cross the 
blood-brain barrier. Also, OP pesticides can cross the placental barrier, as they have been 
found in human amniotic fluid samples.23 Further, epidemiological studies suggest that 
prenatal exposure to OP pesticides may be associated with adverse neurodevelopmental 
and birth outcomes,24,25 although results are not conclusive.26
After absorption, most OP pesticides undergo bioactivation, during which the toxic oxon 
form is formed, followed by detoxification, which produces up to six dialkyl phosphate 
(DAP) metabolites.27,28 These DAP metabolites have a short half-life and are mostly 
excreted in urine within 24 h.29 As these DAP metabolites can stem from more than one 
OP pesticide, DAP metabolites are non-specific biomarkers of OP pesticides. Therefore, 
urinary DAP metabolite concentrations provide information about the total exposure 
to several parent OP pesticides.30
Several studies investigating prenatal OP pesticide exposure have observed that maternal 
characteristics, such as education, smoking, social economic status (SES), body mass index 
(BMI), and diet (especially the consumption of fruits and vegetables) are associated with 
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DAP metabolite concentrations in urine.31-34 This was confirmed in two pilot studies in 
the Netherlands, both embedded in the Generation R Study. Moreover, the reported DAP 
metabolite concentrations were relatively high as compare to other birth cohort studies.35,36
Although several studies investigated the possible determinants of prenatal DAP metabolite 
concentrations in non-occupationally exposed individuals, several gaps remain. To the best 
of our knowledge only one study with a large sample size have jointly tested the different 
determinants of DAP metabolite concentrations to investigate what the main source of 
OP pesticide exposure in pregnant women is.32 In contrast, most other studies relating 
dietary intake and other determinants to DAP metabolite concentrations used bivariate 
models wherein each possible predictor was tested separately.31,33,34 Moreover, several 
studies, including our pilot study, investigated only broad food group categories34,35 while 
few studies explored specific food items (e.g., apples).32,33 The sample size of most studies 
limited the ability to test specific determinants of DAP metabolite concentrations.31,34,35 
It therefore remains unclear which determinants, food groups, and corresponding food 
items contribute most to the exposure. Large biomonitoring studies with detailed exposure 
history are needed to address this since such information is important for public health 
measures.
The Generation R cohort provides suitable data to determine the levels of prenatal DAP 
metabolite concentrations because of the large sample size, availability of three repeated 
urinary specimens across pregnancy, and the availability of detailed information of 
potential environmental determinants. Therefore, the objectives of the present study 
were to investigate the levels of DAP metabolites concentrations across pregnancy and 
to examine various determinants of DAP metabolite concentrations.
Methods
Study population and follow-up
The Generation R Study is a prospective population-based birth cohort designed to identify 
early environmental and genetic determinants of normal and abnormal development and 
health from fetal life onwards.37 Mothers, who had a delivery date from April 2002 to 
January 2006 and lived in the study area in Rotterdam, the Netherlands, were qualified for 
inclusion and enrolled during pregnancy. The study protocol underwent human subjects 
review at Erasmus Medical Center, Rotterdam, the Netherlands and all participants 
provided written informed consent.
In total, 8879 mothers were enrolled during pregnancy. Of those, 4918 were enrolled 
during pregnancy from February 2004 to January 2006, when up to three spot urine 
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specimens were collected at the time of routine ultrasound examinations (<18, 18–25, 
>25 weeks of gestational age, respectively). A complete set of three urine specimens was 
available for 2083 pregnant women. We selected samples based on available follow-up 
data, which was obtained in 1449 children of these women. The availability of follow-up 
data was a priority for future studies on the possible associations between prenatal OP 
pesticide exposure and health related outcomes in children. In total, 800 women were 
randomly selected to determine the DAP metabolite concentrations in the maternal 
urine samples. Due to insufficient urine specimens, maternal DAP results were available 
for 778 complete urine sets and 6 incomplete urine sets (5 women with 2 samples and 
1 woman with 1 sample).
Urine collection and analysis of  DAP metabolites
Details of maternal urine specimen collection have been described elsewhere.38 Briefly, 
all urine samples were collected between 8 am and 8 pm in 100 mL polypropylene urine 
collection containers that were kept for a maximum of 20 h in a cold room (4 °C) before 
being frozen at −20 °C in 20 mL portions in polypropylene vials. Measurements of six 
non-specific DAP metabolites of OP pesticides were conducted at Institut National de 
Santé Publique in Quebec (INSPQ), Canada, using gas chromatography coupled with 
tandem mass spectrometry (GC–MS/MS).39
Three dimethyl (DM) metabolites (dimethylphosphate (DMP), dimethylthiophosphate 
(DMTP), and dimethyldithiophosphate (DMDTP)) and three diethyl (DE) metabolites 
(diethylphosphate (DEP), diethylthiophosphate (DETP), and diethyldithiophosphate 
(DEDTP)) were determined. DM metabolites are only generated by dimethyl OP pesticides, 
whereas DE metabolites are only generated by diethyl OP pesticides. The molar sum 
of DE and DM metabolite concentrations represents the total urinary DAP metabolite 
concentrations. Most OP pesticides degrade to form DAP metabolites. However, several 
OP pesticides do not degrade to form a DAP metabolite (e.g., Acephate). Therefore, the 
total DAP metabolite concentrations provide information about the total exposure to 
OP pesticides that generate DAP metabolites.30
The limits of quantification (LOQ) were 0.87 μg/l for DMP, 1.33 for DMTP, 0.30 for 
DMDTP, 1.67 for DEP, 0.40 for DETP, and 0.20 for DEDTP. The limit of detection 
(LOD) was 0.26 μg/l for DMP, 0.40 for DMTP, 0.09 for DMDTP, 0.50 for DEP, 0.12 for 
DETP, and 0.06 for DEDTP. The inter-day precision of the method during this project, 
expressed as the coefficient of variation (CV) and measured with the inclusion of the 
values <LOD, varied between 4.2–8.8% for DEDTP, 4.1–7.2% for DEP, 5.0–9.1% for 
DETP, 5.5–7.1% for DMDTP, 5.3–8.0% for DMP, and 5.5–7.7% for DMTP based on 
reference materials (clinical check-urine level II 637 E-495 and MRM E-459).
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Molar concentrations were used to facilitate comparison of our results with those from 
other studies, based on the following molecular weights: DMP 126.0, DMTP 142.1, 
DMDTP 158.2, DEP 154.1, DETP 170.2, and DEDTP 186.2 g/mol. To account for 
urine dilution, the level of creatinine was determined in each sample based on the Jaffe 
reaction,40 with a limit of detection of 0.28 mmol/l. The day-to-day precision for creatinine 
varied between 3.0 and 3.3 CV%.
To evaluate reliability of DAP metabolite measures, we made use of 45 participants included 
in the present study, which were also included in the pilot study,35,36 resulting in two 
available DAP concentrations per sample. DAP metabolite concentrations in urine were, 
however, determined in two different laboratories, at the INSPQ in the present study and 
at the Institute for Prevention and Occupational Medicine of the German Social Accident 
Insurance, Germany in the pilot study. Intra class correlations (ICC) were calculated for 
the creatinine (g/l) and total DAP metabolite concentrations in nmol/L. The creatinine 
concentrations for the three trimesters had excellent ICC values (0.90–0.98) and the total 
DAP metabolite concentrations in nmol/L varied between good and excellent ICC values 
(0.81–0.95).41 The median total DAP metabolite concentrations of the 45 overlapping 
participants from the current study tended to be slightly higher (median differences; <18 
weeks = 65 nmol/L, 18–25 weeks = 50 nmol/L, and >25 weeks = 40 nmol/L).
Further, Pearson correlation coefficients were calculated to investigate whether the time 
elapsed between the date of sampling and the date of the analytical measurement had 
any influence on the DAP metabolite concentrations. The correlations were negligible 
and varied for the three measurements between −0.14 and 0.05.42
Determinants of  OP pesticide exposure
Maternal demographic and lifestyle data were assessed by questionnaire or direct 
measurement during pregnancy. During early visits, data on maternal height and weight 
were measured and were used to calculate early BMI. Prenatal questionnaires were used to 
collect information about maternal age, parity, smoking (no smoking during pregnancy, 
smoked until pregnancy recognized, and continued smoking during pregnancy), alcohol 
intake during pregnancy (no alcohol consumption during pregnancy, alcohol consumption 
until pregnancy recognized, continued occasionally (<1 glass/week), and continued 
frequently (1+ glass/week)), marital status, highest completed education level (low: only 
lower vocational training, or <3 years at general secondary school; intermediate: 3+ years 
of secondary education, intermediate vocational training; high: university degree or higher 
vocational training), ethnicity (Dutch, other-western, and non-western), and household 
total net income (<1200 euro per month (i.e., below the Dutch social security level), 
1200–2000 euro per month, and >2000 euro per month).
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Data on potential occupational exposure to pesticides and pet ownership were also 
prenatally assessed by questionnaires. Pesticide exposure through pet ownership (dog, cat, 
or no pet) in the home might occur because flea treatments for cats and dogs (such as flea 
collars) may contain OP pesticides (e.g., Diazinon). Maternal occupational exposure to 
pesticides and partner’s exposure to pesticides were prenatally determined by means of a 
questionnaire. To measure possible occupational exposure, the questions “do you work 
with pesticides?” and “does your partner work with pesticides?” were asked.
Maternal dietary intake in the first trimester was assessed using a modified version of 
a validated semi-quantitative food frequency questionnaire (FFQ).43 The FFQ was 
administered at a median gestational age of 13.5 weeks (95% range 10.1–21.8 weeks) and 
covered the past three months. The FFQ includes questions on consumption frequency, 
portion sizes, and preparation methods of 293 food items and is structured according to 
meal patterns. The 293 food items were reduced to 24 predefined food groups (such as 
meat, grains, vegetables, fruits, etc.) according to the European Prospective Investigation 
into Cancer and Nutrition (EPIC)-soft classification, based on origin, culinary usage, 
and nutrient profiles.44 Average daily energy intake was calculated using the Dutch 
food composition Table 2006. More details about the assessment of dietary intake are 
described elsewhere.43 All food items were adjusted for energy intake (varying between 
619 and 3452 kcal). Except for household income (13%), owning a dog (11%), owning 
a cat (11%), occupational exposure to pesticides (14%), partner’s exposure to pesticides 
(31%), and maternal dietary determinants (22%), the percentage of missing values of 
these variables did not exceed 10%.
Statistical analysis
Urinary DAP concentrations were expressed on a volume (nmol/L) and creatinine basis 
(nmol/g creatinine). The three DM metabolites were summed as total DM and the three 
DE metabolites were summed as total DE. Total DAP concentrations were calculated by 
summing the six metabolites. Next, total DAP, DE, and DM metabolite concentrations 
were log10 transformed to achieve normal distributions.
Missing DAP metabolite (nmol/L) values at a specific time point were imputed 10 times 
with a multiple imputation method using other metabolite levels (nmol/L) from the same 
time point as predictors. Also, concentrations below the LOD were randomly assigned 
10 imputed values below their LOD thresholds using a multiple imputation method.45 
Concentrations between LOQ and LOD were not imputed and kept for the analyses. To 
avoid loss of precision and power, missing values of potential confounding factors were 
also 10 times imputed with the use of a multiple imputation procedure.
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We first provided descriptive statistics of the DAP metabolite concentrations in our study 
sample and compared those values with the values of several other studies that measured 
prenatal DAP metabolite concentrations. We then compared the median (P25, P75) 
maternal DAP metabolite concentrations by category of maternal characteristics and 
examined the association between these potential determinants and maternal urinary 
DAP metabolite concentrations with linear mixed model (LMM) analyses. LMM analyses 
allowed us to account for the repeated DAP metabolite concentrations within the same 
subject and to fit a correlation matrix on these repeated measurements. To explore the 
most important maternal characteristics of urinary DAP metabolite concentrations, we 
fitted a single LMM that included the maternal demographic and lifestyle determinants 
and season of urine collection as predictors and DAP metabolite concentrations across 
pregnancy as the outcome. We then used a stepwise variable selection procedure using 
the Akaike’s information criterion (AIC) to identify the optimal model fit.
We also fitted a LMM to identify the most meaningful dietary intake predictors of 
maternal urinary DAP metabolite concentrations. We estimated the association between 
the various dietary intake categories and maternal urinary DAP concentrations across 
pregnancy for each food group separately. These associations were adjusted for the 
determinants identified by the AIC stepwise selection procedure. The food groups that had 
a statistically significant association (P < 0.05) with maternal urinary DAP concentrations 
across pregnancy were further examined by testing associations with specific food items 
from this group. Frequently consumed food items were expressed in 100 g/d. The food 
items that were not consumed by 20% of the participants were dichotomized (0 = no 
intake, 1 = intake).
Several sensitivity analyses were conducted. First, as the replacement of values below 
LOD with LOD/√2 is another common substitution method in environmental exposure 
studies,46 we substituted values below LOD with LOD/√2 instead of using the MI method. 
Second, we reanalyzed the association between food group intake and DAP metabolite 
concentrations using only DAP concentrations from the <18 weeks of gestation period as 
the outcome because the FFQ was administered in the first trimester. Third, we reanalyzed 
the association between food groups and DAP metabolite concentrations including all 
food group variables in one model, thereby mutually adjusting the food groups for each 
other. Fourth, we modeled the most meaningful food intake predictors categorically (<50, 
50–99, 100–149,150–199, and ≥200 g) instead of continuously to demonstrate the dose-
response relationship. Fifth, we fitted models with metabolite concentrations expressed as 
nmol/L urine adjusted for creatinine concentration as a separate covariate.47 Finally, we 
investigated whether the results were the same if missing confounder values were excluded 
rather than imputed. A p-value of <0.05 was defined as statistically significant. Statistical 
analyses were performed using SPSS (version 21) and R (version 3.2.3).48





Most women were within the age category 30–<35 years (45.9%), had an early pregnancy 
BMI between 18.5 and <25 (65.9%), were nulliparous (62.3%), had a Dutch ethnic 
background (57.5%), and had a high educational background (54.9%) (Table 1). 
Moreover, most women were married or lived with a partner (89.7%), did not smoke 
during pregnancy (77.0%), and drank alcohol occasionally (less than 1 glass/week) during 
pregnancy (39.4%). Few women participating in this study worked with pesticides (0.6%) 
or had a partner that worked with pesticides (0.9%). A total of 7.4% of the women had 
a dog and 23.5% had a cat in their home. Selected participants in this study tended to 
be older, more frequently Dutch, more highly educated, from a household with higher 
income, and less likely to smoke during pregnancy than the overall cohort. The median 
DAP metabolite concentration in nmol/g creatinine across pregnancy was higher among 
those who were older, had a lower BMI, had a high income, higher education, did not 
smoke, and had partners (Table 1). Moreover, the median DAP metabolite concentrations 
in nmol/g creatinine across pregnancy was higher in the urine samples collected during 
the summer and among those who did not own a dog or a cat.
DAP metabolite levels in urine
Figure 1 presents descriptive statistics of the DAP metabolite concentrations in nmol/g 
creatinine by gestational period. Maternal urine specimens were collected on average 
(±SD) at 13.2 ± 1.8, 20.4 ± 0.9, and 30.4 ± 0.8 weeks of gestation. The median total 
DAP metabolite concentrations for <18, 18–25, and >25 weeks of gestation were 311, 
317, and 310 nmol/g creatinine, respectively. The median DE metabolite concentrations 
measured at 18, 18–25, and >25 weeks of gestation (44, 43, and 42 nmol/g creatinine, 
respectively) were lower as compared to the median DM metabolite concentrations 
measured during the same gestational periods (245, 269, and 249 nmol/g creatinine, 
respectively). The DEDTP metabolite had a high percentage of values below the LOD 
in the three consecutive gestational periods (81%, 85%, and 85%, respectively). For the 
other five metabolites (DETP, DEP, DMDTP, DMP, and DETP) 80% or more of the 
concentrations were above the LOD.
The temporal variability of DAP concentrations in urine samples collected across pregnancy 
has been described in detail elsewhere.35 Briefly, the total DAP metabolite concentrations 
across pregnancy showed weak to moderate correlations. The total DAP metabolites in 
nmol/L had an ICC of 0.43 (95%CI: 0.36–0.50) and the total DAP metabolites in 
nmol/g creatinine had an ICC of 0.51 (95%CI: 0.42–0.54).41 Moreover, in accordance 
with the Pearson correlation coefficients, both the total DAP metabolite concentrations 
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Table 1. Demographic and lifestyle characteristics and residential and occupational exposure 
characteristics of  784 pregnant women from the Netherlands participating in the Generation R 









Demographic and lifestyle 
characteristics at time of enrollment
Age in years
< 20 4.2 % 1.8% 292 (231, 382)
20-< 25 15.9 % 10.1% 329 (237, 453)
25-< 30 26.4 % 26.5% 323 (245, 481)
30-< 35 36.9 % 45.9% 381 (265, 517)
≥ 35 16.6 % 15.7% 382 (262, 484)
Missing, n 2 -
BMI
< 18.5 2.1 % 2.3% 371 (299, 561)
18.5-< 25 57.9 % 65.9% 375 (267, 507)
25-< 30 26.3 % 23.5% 342 (253, 449)
≥ 30 13.8 % 8.3% 263 (196, 432)
Missing, n 899 4
Height in cm (quartiles)
< 161 23.6 % 18.0% 341 (257, 499)
161 – < 168 27.4 % 35.8% 348 (246, 483)
168 – < 173 24.6 % 24.3% 366 (239, 492)
≥ 173 24.4 % 22.0% 365 (278, 503)
Missing, n 934 1
Parity (Previous births)
0 55.1 % 62.3% 362 (256, 502)
1 30.2 % 26.7% 376 (267, 502)
≥ 2 14.7 % 11.0% 280 (204, 426)
Missing, n 378 4
Ethnicity
Non-Western 38.4 % 29.8% 340 (243, 519)
Other Western 11.6 % 12.6% 334 (258, 484)
Dutch 50.0 % 57.5% 369 (256, 484)
Missing, n 694 -
Education
Low 26.5 % 14.9% 290 (199, 436)
Intermediate 30.7 % 30.2% 334 (242, 483)
High 42.8 % 54.9% 382 (279, 436)
Missing, n 1221 25
Household income in euro’s
<1200 per month 20.7 % 12.6% 304 (219, 465)
1200–2000 per month 18.5 % 16.6% 319 (246, 465)
> 2000 per month 60.8 % 70.8% 379 (272, 497)
Missing, n 3066 102
Continue












Married/ living with partner 85.5 % 89.7% 368 (266, 503)
No partner 14.5 % 10.3% 256 (187, 386)
Missing, n 1213 29
Smoking
No smoking during pregnancy 73.4 % 77.0% 372 (266, 506)
Until pregnancy recognized 8.6 % 8.9% 338 (258, 499)
Continued during pregnancy 18.0 % 14.1% 274 (181, 434)
Missing, n 1534 63
Alcohol consumption
No consumption during pregnancy 48.0 % 36.7% 328 (243, 484)
Until pregnancy recognized 13.2 % 17.5% 372 (266, 499)
Continued occasionally 31.6 % 39.4% 380 (255, 507) 
Continued frequently 7.2 % 6.5% 346 (293, 435)
Missing, n 1870 40
Season of urine collection
Fall - 22.1% 302 (186, 457)
Winter - 21.2% 315 (198, 491)
Spring - 29.0% 311 (199, 497)
Summer - 27.8% 318 (205, 532)
Missing, n - 7
Work with pesticides 
Do not know 1.9% 2.1% 337 (242, 635)
No 97.4% 97.3% 363 (258, 495)
Yes 0.7% 0.6% 203 (167, 278)
Missing, n 3295 106
Partner works with pesticides
No 98.6% 99.1% 372 (263, 495)
Yes 1.4% 0.9% 243 (219, 596)
Missing, n 4952 243
Owning a dog
No, due to allergy 12.8% 11.9% 315 (249, 495)
No 77.9% 80.7% 375 (259, 503)
Yes 9.3% 7.4% 283 (191, 394)
Missing, n 2366 85
Owning a cat
No, due to allergy 14.0% 13.3% 342 (262, 483)
No 64.2% 63.2% 371 (260, 509)
Yes 21.8% 23.5% 329 (240, 478)
Missing, n 2404 83
a. Median (P25, P75) DAP metabolite exposure concentrations are based on the averaged DAP metabolite concen-




Figure 1. Descriptive statistics of DAP metabolite concentrations in nmol/g creatinine from 784 pregnant 
women from the Netherlands participating in the Generation R cohort. 
Note. N=784. Concentrations below the limit of detection (LOD) were randomly assigned imputed values 
below their LOD thresholds using a multiplicative lognormal imputation method (Palarea-Albaladejo & 
Martin-Fernandez, 2015).
a. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
b. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
c. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
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in nmol/L (r = 0.14–0.24) and in nmol/g creatinine (r = 0.17–0.34) across pregnancy, 
showed weak correlations.42
Predictors of  urinary OP pesticide metabolite levels
Maternal demographic and lifestyle characteristics
Table 3 presents the maternal demographic and lifestyle determinants of total DAP, DM, 
and DE metabolite concentrations. Maternal age was positively associated with total 
DAP and DE urinary metabolite concentrations. A one year higher maternal age was 
associated with a 1% (95%CI: 0–2%) increase in total DAP and a 1% (95%CI: 0–2%) 
increase in DE urinary metabolite concentrations. Women with a BMI of 25–< 30 had 
10% (95%CI: 1–20%) lower total DAP, 9% (95%CI: 1–19%) lower DM, and 14% 
(95%CI: 3–26%) lower DE metabolite concentrations as compared to women with a 
BMI 18.5–< 25. Also, women with a BMI of ≥30 had 24% (95%CI: 9–41%) lower 
total DAP, 23% (95%CI: 7–40%) lower DM, and 45% (95%CI: 24–70%) lower DE 
metabolite concentrations as compared to women with a BMI 18.5–< 25.
Further, women with a high maternal educational attainment had 15% (95%CI: 2–30%) 
higher total DAP and 17% (95%CI: 4–33%) higher DM metabolite concentrations than 
women with a low educational attainment. Compared to women with a low household 
income, women with a high household income had 29% (95%CI: 9–52%) higher 
DE metabolite concentrations. Next, women with a non-western ethnicity had 10% 
(95%CI: 1–21%) higher total DAP and 15% (95%CI: 5–26%) higher DM metabolite 
concentrations compared to Dutch women.
Moreover, women who did not smoke during pregnancy had 23% (95%CI: 10–38%) 
higher total DAP, 21% (95%CI: 8–36%) higher DM, and 37% (95%CI: 20–57%) 
higher DE metabolite concentrations than women who continued smoking during their 
pregnancy. Similarly, women who smoked only until the pregnancy was recognized had 
26% (95%CI: 9–47%) higher total DAP, 24% (95%CI: 7–45%) higher DM, and 38% 
(95%CI: 16–65%) higher DE metabolite concentrations than women who continued 
smoking during their pregnancy. Differences in total DAP, DM, and DE metabolite 
concentrations were observed between the seasons of urine collection. The urine samples 
collected during the summer contained 11% (95%CI: 3–20%) more DAP and 16% 
(95%CI: 7–26%) more DM metabolite concentrations than the urine samples collected 
during the fall. Urine samples collected during the winter had 11% (95%CI: 2–21%) 
lower DM metabolite concentrations than the concentrations collected during the summer, 
but 14% (95%CI: 3–25%) higher DE metabolite concentrations than the urine samples 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































No consistent associations between pet ownership (cat and dog) and DAP metabolite 
concentrations were observed. For example, we observed that participants who did not 
own a dog had 16% (95%CI: 0 to 33%) higher DAP and 20% (95%CI:1–42%) higher 
DE metabolite concentrations.
Maternal dietary determinants
Table 4 presents the adjusted associations between consumption of food groups and total 
DAP, DM, and DE metabolite concentrations. The consumption of fruit was associated with 
total DAP metabolite concentrations, DM metabolite concentrations, and DE metabolite 
concentrations. A 100 g/d increase in consumption of fruits was associated with a 7% 
(95%CI: 4–11%) increase in DAP metabolite concentrations, a 7% (95%CI: 4–11%) 
increase in DM metabolite concentrations, and a 7% (95%CI: 3–12%) increase in DE 
metabolite concentrations. There were no statistically significant associations between 
the consumption of vegetables, nuts, dairy, fish, grain, and meat with total DAP, DM, 
and DE metabolite concentrations (P > 0.05).
Table 5 presents the adjusted associations between the consumption of different fruit types 
and total DAP, DM, and DE metabolite concentrations. The consumption of oranges/
grapefruits and apples were associated with total DAP metabolite concentrations and 
DM metabolite concentrations. A 100 g/d higher consumption of oranges/grapefruits 
was related to a 13% (95%CI: 3–24%) higher total DAP metabolite concentration and 
a 14% higher DM metabolite concentration (95%CI: 3–26%). A 100 g/d higher apple 
consumption was associated with a 14% (95%CI: 4–26%) higher total DAP metabolite 
concentration and a 16% (95%CI: 5–29%) higher DM metabolite concentration. Further, 
women who consumed apricots and grapes/cherries also had significantly higher DAP 
metabolite and DM metabolite concentrations compared to women who did not consume 
these fruits. Consumers of lemons/limes, apricots, kiwis, strawberries/raspberries, mangos 
and pineapples/melons had higher DE metabolite concentrations than women who did 
not consume these fruits.
Sensitivity analysis
The results were consistent when the LOD/√2 substitution method was used (see Tables 
S1, S2, and S3). As part of the sensitivity analysis, we tested the association between food 
groups (and fruit types) and DAP metabolite concentrations, only using the measurement 
from the <18 weeks of gestation period as an outcome (see Tables S4 and S5). The results 
were similar to the results presented earlier (see Table 4, Table 5), the consumption of 
fruits was significantly associated with total DAP, DM, and DE metabolite concentrations. 
Within fruit types, again apples, oranges/grapefruits, and apricots were significantly 
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2
associations of food groups with DAP metabolite concentrations were mutually adjusted 
(see Table S6). Other sensitivity analyses also supported the consistency of the results. 
when modeled categorically, higher intake of fruit was associated with increased DAP 
metabolite concentrations (see Table S7). When the models were fitted with metabolite 
concentrations expressed as nmol/L and adjusted for creatinine by including creatinine as 
a covariate, results compared to Table 3 were mostly similar but slightly weaker. Moreover, 
BMI, maternal age, parity, and dog ownership no longer predicted total DAP metabolite 
concentrations (see Table S8). The results of this sensitivity analyses were similar with 
the primary analyses for the food groups, but slightly different for fruit types (see Table 
S9 and S10). When we fitted the models with metabolite concentrations expressed as 
nmol/L and adjusted for creatinine with the total DAP metabolite measurement from <18 
weeks of gestation period as the outcome (see Tables S11 and S12), both food group and 
fruit type results with creatinine adjustment were similar to the results presented in Table 
4, Table 5. But, the associations between fruit types and DE metabolite concentrations 
were weaker. Finally, the results were similar when we examined the association between 
possible determinants and DAP metabolite concentrations without participants with 
imputed covariate data (see Tables S13, S14, and S15).
Discussion
In this study we reported prenatal levels of DAP metabolite concentrations across 
pregnancy and identified determinants of prenatal exposure to OP pesticides (or their 
degradation products) in an urban population of Dutch pregnant women. Our results 
suggest that fruit intake was the main source of exposure. Furthermore, we observed 
seasonal variation in total DAP metabolite concentrations with the highest concentrations 
during the summer. Higher maternal age, married/living with a partner, underweight or 
normal weight (BMI of <18.5 and 18.5–<25), high education, high income, and non-
smoking were associated with higher DAP metabolite concentrations. Pet ownership did 
not contribute to increased DAP metabolite concentrations.
These results extend those of Spaan et al. (2015) and Ye et al. (2008), who also 
observed relatively high levels of DAP metabolite concentrations among a subset of the 
Generation R Study population as compared to other American and European studies 
(Fig. 2). The median total DAP metabolite concentrations in this study (311 nmol/g 
creatinine, 224 nmol/L) was slightly higher than in two previous pilot studies of 
the Generation R cohort (215 nmol/g creatinine, 129 nmol/L). The median DAP 
metabolite concentrations in this study were approximately 3 times higher compared 
to the urinary DAP metabolite concentrations in pregnant women from the Canadian 
MIREC cohort (Median = 78 nmol/L), which used the same analytical lab (INSPQ, 
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Figure 2. Comparison of total dialkyl phosphates (DAP) metabolite concentrations on a creatinine-basis 
(nmol/g creatinine) and a wet-weight metabolite basis (nmol/L) in maternal urine of various birth cohorts.
*Geometric mean instead of the median DAP concentrations is presented.
a. Mother-infant pair cohort study from the Sheyang County, China. One spot urine sample collected prior 
to delivery from 310 mothers.55
b. Pregnant women sampled in hospitals from the Amnatchareon Province, Nakhonsawan Province and the 
Kanchanaburi Province of Thailand. One spot urine sample collected at 28 weeks of gestation from 86 women.54
c. Prospective cohort study in Mount Sinai Children’s Environmental health center, New York City. Spot 
urine collected at mean gestational age 31.2 weeks from 285 to 297 women.51
d. Prospective cohort study in Salinas Valley, California. Two spot urine samples collected at baseline and 26 
weeks of gestation. The geometric mean value represents the average of the two DAP metabolite concentrations.49
e. National Health and Nutrition Examination Survey study. A study representing the US population of all 
ages. One spot urine sample collected of 126 women during pregnancy.50
f. Prospective birth cohort in Cincinnati metropolitan area. Two spot urine samples collected at 16 and 26 
of gestation from 344 women. The geometric mean value represents the average of the two DAP metabolite 
concentrations.52
g. Maternal-Infant Research on Environmental Chemicals study. One spot urine sample collected during 
the first trimester from 1884 women.33
h. A pregnancy cohort in Norway. Ten pools of one 1-ml urine samples from 11 women at 17 weeks of 
gestation.50
i. Mother child cohort in Brittany, France. One spot urine sample collected at <19 weeks of gestation from 
231 women.53
j. INfancia y Medio Ambiente project (Environment and Childhood), to investigate the effects of environmental 
exposure, diet and genetics on fetal and child development. One spot urine sample collected at the third 
trimester from 573 women (mean = 32.2 weeks of gestagion).32
k. A prospective population-based birth cohort in Rotterdam, the Netherlands. Designed to identify the early 
environmental and genetic determinants of normal and abnormal development and health from fetal life 
onwards. Data combined from two previous small pilot studies. One to three spot urine samples collected 
at <18 weeks, 18–25 weeks and >25 weeks of gestation from 168 women. The values represent the average 
of the three median DAP metabolite concentrations.35,36
l. Δ Current study. Three spot urine samples collected at <18 weeks, 18–25 weeks, and >25 weeks of gestation 
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Quebec) as this study.33 Moreover, the DAP metabolite concentrations were higher than 
the urinary DAP metabolite concentrations from pregnant women of several American 
studies (CHAMACOS cohort: median = 115 nmol/L, NHANES study: median = 72 
nmol/g creatinine, 52 nmol/L, Mount Sinai cohort: 82 nmol/L, and HOME cohort: 
median = 81 nmol/L),49-52 European studies (France PELAGIE cohort: median = 44 nmol/L, 
Norwegian MoBa cohort: GM = 145 nmol/g creatinine, 87 nmol/L, and Spanish INMA 
cohort: GM = 107 nmol/g creatinine, 96 nmol/L),32,50,53 and compared to a study from 
Thailand (median = 161 nmol/g creatinine, 90 nmol/L.54 In contrast, the DAP metabolite 
concentrations from our study were considerably lower than those observed in China 
(median = 296 nmol/L).55
The results of our study suggest that the relatively high-level exposure to OP pesticides 
or their degradation products among this general population cohort in the Netherlands 
may be related to the high consumption of fruits. Although results must be compared 
carefully since different methods were used to measure diet, the fruit and vegetable intake 
of our study sample in the Dutch population (median of 295 g/day) was higher compared 
to the fruit and vegetable intake of NHANES subjects (median of 167 g/day), who were 
women of reproductive age.56,57
Another reason that might explain the differences in DAP metabolite concentrations 
between the various studies of pregnant women are differences in population characteristics. 
Our study population consisted mainly of well-educated women with a relatively high 
family income. Compared to our study, in both the CHAMACOS and the Mount Sinai 
Hospital birth cohorts lower levels of DAP metabolite concentrations were measured among 
their populations, which both include mainly participants of ethnic minorities and low 
SES. SES is known to be positively related with the consumption fruit and vegetables,58 
an important source of OP pesticide exposure.3 This could also explain why SES-related 
population characteristics in our study, such as BMI, parity, marital status, and smoking 
status, were associated with DAP metabolite concentrations. However, when we controlled 
for fruit intake, the associations remained essentially unchanged. Married women in general 
make healthier food choices compared to non-married women59,60 and dietary patterns 
are strongly related to SES, ethnic differences, and BMI.58,61-63 However, compared to 
the Generation R cohort, both the MIREC and the PELAGIE cohort also comprised 
populations with high SES, yet considerably lower DAP metabolite concentrations were 
measured. Most likely the differences in DAP metabolite concentrations between cohorts 
cannot fully be explained by differences in SES.
In addition to the consumption of fruits, the dose of OP pesticides present in or on the 
fruits also determines the exposure levels. Possibly, the higher DAP metabolite levels in 
pregnant women are also due to the farming practices in the Netherlands. The Netherlands 
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uses more pesticides and fertilizers per square km of farmland than most other Organization 
for Economic Co-operation and Development (OECD) countries, such as the United 
States and Canada.64 Whether these intense farming activities increase the level of OP 
exposure through consumption of domestic fruits is unclear. However, between 1998 and 
2008 approximately 1/3 of all insecticides used in the Netherlands were OP pesticides, with 
DM metabolite generating OP pesticides being the most frequently used. For example, 
in 2004 of all insecticides used in the Netherlands 32% were OP pesticides that generate 
DM metabolites (Dimethoate = 30%, Malathion = 0.9%, Parathion-methyl = 1.2% 
and pirimiphos-methyl = 0.4%) and only 0.075% were OP pesticides that generate DE 
metabolites (chlorpyrifos = 0.25% chlorfenvinphos = 0.5%).2 This may also explain why 
in our study sample the DM metabolite concentrations were much more present in urine 
than the DE metabolite concentrations. Similarly, many previous studies also reported 
higher DM metabolite concentrations than DE metabolite concentrations.32
The DAP metabolite concentrations measured in our study however, were considerably 
lower compared to the levels observed in China and Taiwan.55,65,66 This may be explained 
by China’s heavy use of OP pesticides in agricultural activities.67 The pesticide residues, 
often from OP pesticides, on agricultural products in Chinese markets are easily detected, 
with some of these products showing high levels of residues exceeding the safe standard.68
Our results are in agreement with findings obtained by Bradman et al. (2003), Llop et al. 
(2017), Lu et al. (2008), Sokoloff et al. (2016), and Yolton et al. (2013) who concluded 
that DAP metabolite levels in urine vary between seasons, and that diet, especially fruit, 
was associated with OP pesticide exposure. More specifically, Sokoloff et al. (2016) found 
citrus fruits and apple juice intake to be related to higher DAP metabolite concentrations 
and Llop et al. (2017) found that apples/pears and stone fruits intake were associated 
with increased DAP metabolite concentrations. Our result in which the total DAP and 
DM metabolite concentrations were higher in summer than in other seasons might 
be explained by the increased fruit consumption during the summer. Although not 
statistically significant, in our study women consumed more fruit during the summer 
than during other seasons.
The observation that dietary intake of fruits was the main source of exposure is in line 
with the observation that a large fraction of fruits have detectable OP pesticide residue 
levels.69,70 Specific information on the presence of OP pesticide residues on fruit can be 
retrieved from the Quality Programme for Agricultural Products (KAP) database in the 
Netherlands.69 Detectable residues from 18 different OP pesticides were found on fruit 
samples tested between 2004 and 2006 for pesticides. For example, 45 (35%) out of 
the 130 apples tested positive for azinphos-methyl residues. Whether OP pesticides that 
generate DM metabolites are more commonly applied to certain fruits and OP pesticides 
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that generate DE metabolites to other fruits is unclear. However, out of all the samples 
that tested positive for OP pesticide residues in the KAP database, the OP pesticides that 
generate DM metabolites (e.g., Dimethoate, Azinphos-methyl, and Malathion) were more 
frequently detected on apples (68%), oranges/grapefruits (64%), and grapes/cherries 
(61%) than OP pesticides that generate DE metabolites (e.g., Chlorpyrifos, Diazinon, 
and Ethion).69 This is in line with our observation that the intake of these fruits were 
positively associated with DM metabolite concentrations and not with DE metabolite 
concentrations. Caution is needed here since the intake of lemons/limes was positively 
associated with DE metabolite concentration, but residues of DM metabolite generating 
OP pesticides were more frequently detected on lemons/limes (55%). Moreover, only 
few residues of both DM and DE metabolite generating OP pesticides were detected on 
kiwis, strawberries, and pineapples/melons.69
Although we did not measure the residential use of pest control items, it has been 
suggested that pet ownership might result in increased DAP metabolite concentrations 
because flea control items may contain OP pesticides.5 For example, in the Netherlands 
flea collars for both cats and dogs from the brand Beaphar contain the OP pesticide 
Diazinon. However, no increased DAP metabolite concentrations were observed in our 
study in participants with cats or dogs.
Our finding of a lower DAP metabolite concentration in smokers could be explained by 
reduced fruit intake. Women who smoked during pregnancy had significantly lower fruit 
intake than those who did not smoke during pregnancy. However, It has also been suggested 
that nicotine intake may influence the metabolism and toxicity of OP pesticides.71 An 
animal study showed that nicotine exposure could alter OP metabolism and that the extent 
of brain acetylcholinesterase (AChE) inhibition was reduced due to the co-exposure of 
OP pesticides and nicotine.71 The observed differences in DAP metabolite concentrations 
across BMI categories could also be explained by diet and SES although we adjusted 
for these variables. Yet, it may also be that women with higher BMI will excrete more 
creatinine,72 and thus their DAP concentrations on a nmol/g creatinine basis will appear 
lower. Some support for this explanation comes from the sensitivity analyses. When we 
fitted the models with metabolite concentrations expressed as nmol/L and adjusted for 
creatinine, the effect of BMI on total DAP and DM metabolites concentrations were 
attenuated.
Our study has a few limitations that need to be considered. DAP metabolites can also 
be found in food products and the environment due to environmental degradation.73,74 
The extent to which DAP metabolite concentrations reflect exposure to the active parent 
pesticide rather than to less toxic metabolites remains therefore unclear.75 Nevertheless, the 
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measurement of DAP concentrations is scientifically accepted as a useful tool to identify 
and compare degrees of OP pesticide exposure in diverse populations.76
Further, our results suggest that the main route of exposure was through the ingestion 
of fruits. Rather than only rely on DAP metabolites, which reflect the total exposure 
to most OP pesticides30 through all exposure routes (dermal, inhalation, ingestion) in 
combination with questionnaire information, it would also have been interesting to verify 
exposure by taking environmental and dietary samples such as fruit.
Additionally, we did not have information whether our participants consumed organic 
food products. Several studies have shown that individuals following an organic diet 
have significantly lower DAP metabolite concentrations in their urine than individuals 
with a non-organic diet.77-79 It would have been informative to have data on the type of 
diet (organic or non-organic) to test whether organic food consumption could act as an 
effect modifier of the relation between fruit intake and DAP metabolite concentrations.
Moreover, we were not able to assess residential exposure to OP pesticides in detail. Besides 
the question about pet ownership, we did not have any information about possible other 
residential pesticide use in and around the home by the participant, another household 
member, or a professional exterminator. It would have been informative to investigate 
whether participants used residential products, which may contain OP pesticides such 
as insecticides for the lawn and garden (e.g., emulsifiable concentrate), insecticides for 
house plants, and residential pest products (e.g., fly control insecticides and moth killer 
cassettes). Also, it would have been informative to ask participants who owned a cat or 
a dog, whether they treated their pet with flea products.
Next, since dietary intake was not examined over time, we were not able to capture 
possible changes in diet as the pregnancy progressed. Therefore, the assumption was 
made that dietary intake during the first trimester of pregnancy reflects the dietary intake 
over the whole pregnancy period. Nevertheless, the associations between dietary intake 
and metabolite levels that were collected during the first trimester were similar to the 
associations between dietary intake and metabolite levels across pregnancy, which suggests 
that the observed associations are stable across weeks.
Another limitation of this study is the absence of information about the exact time of 
spot urine sampling. Because the urine spot samples were collected between 8am and 
8pm, there may have been a combination of first morning and random spot samples. 
Concentrations of chemicals, urine volume and the rate of excretion vary with fluid 
intake, time of day, and other factors.80-82 Although time of sample collection is unlikely 
to confound the association between possible determinants of OP pesticide exposure 
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and DAP metabolite concentrations, the difference in DAP metabolite concentrations 
between morning and random spot urine samples could have been tested as a predictor 
of DAP metabolite concentrations.
Moreover, this study was limited by the absence of information about the urine samples 
storage time in the 4 °C cold room as it might be plausible that OP pesticides degrade 
into DAP metabolites during such storage. It would have been informative to analyze 
whether storage time was associated with DAP metabolite concentrations to exclude the 
possibility that the samples had degraded during this period.
Furthermore, DAP metabolites are known to have a short half-life and are mostly excreted 
in urine within 24 h, which can result in day-to-day variability in exposure within subjects.83 
Ideally, many urine specimens need to be sampled during pregnancy. Our study includes 
three measures of DAP metabolite concentrations across pregnancy among a large sample 
which is more frequent than most other previous studies of prenatal OP exposure24,32,33 
and a key strength of this study.
Another strength of the study was the availability of urinary creatinine levels, which 
allowed us to adjust for urinary dilution. During pregnancy urine volumes can increase by 
25%,84 and by expressing DAP metabolites on a creatinine basis we were able to account 
for this. Another advantage of our study is that it is a large population-based prospective 
cohort study, which comprises a broad range of contextual information. Therefore, we 
were able to investigate many potential sources of OP pesticide exposure and were able 
to account for various confounding variables.
We should, however, be cautious when generalizing the factors associated with increased 
OP pesticide exposure in pregnant women in the Netherlands. The Generation R Study 
is representative of an urban population with varying ethnicities, SES, and educational 
level and not generalizable to semi-urban and rural areas in the Netherlands where the 
source of OP pesticide exposure could be different.
Overall, this study strengthens the hypothesis that dietary intake plays an important 
role in prenatal OP pesticide exposure among women living in an urban environment. 
Previous epidemiological studies have suggested that prenatal exposure to OP pesticides 
is associated with adverse neurodevelopmental and birth outcomes among children, but 
overall were inconclusive.24-26 Considerably higher DAP metabolite concentrations were 
found in the Generation R population compared to other cohorts. Further research will 
be undertaken to investigate the possible health effects of this relatively high level of OP 
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Prenatal exposure to non-persistent 






Phthalate and bisphenol exposure during 
pregnancy and offspring nonverbal IQ
van den Dries, M. A., Guxens, M., Spaan, S., Ferguson, K. K., Philips, E., 
Santos, S., Jaddoe, V.W.V., Ghassabian, A., Trasande, L., Tiemeier, H., &  
Pronk, A. (2020). 




Background: Prenatal exposures to phthalates and bisphenols are associated with impaired 
brain development in animals. However, epidemiological studies investigating the association 
between prenatal phthalate or bisphenol exposure and cognition have produced mixed findings 
and mostly had modest sample sizes and measured the exposure during the third trimester. 
We examined the association between pregnancy maternal urinary biomarkers of phthalate 
or bisphenol exposure and nonverbal intelligence quotient (IQ) in children 6 years of age.
Method: The study sample consisted of 1,282 mother–child pairs participating in the 
Generation R Study, a population-based birth cohort in Rotterdam, Netherlands (enrollment 
2002–2006). We measured maternal urinary concentrations of 18 phthalate metabolites and 
8 bisphenols at <18, 18–25, and >25 wks of gestation. Child nonverbal IQ was measured at 6 
years of age using the Snijders-Oomen Nonverbal Intelligence Test–Revised. Linear regression 
models were fit for each of the three collection phases separately, the three collection phases 
jointly, and for the averaged prenatal exposure across pregnancy.
Results: Higher urinary concentrations of phthalate metabolites during early pregnancy 
were associated with lower child nonverbal IQ score [e.g., B per 10-fold increase in summed 
low-molecular weight phthalates=−1.7 (95% CI: −3.1, −0.3)]. This association remained 
unchanged when adjusted for mid and late pregnancy exposures. We also observed an inverse 
association between late pregnancy di-n-octyl phthalate (DNOP) exposure and nonverbal 
IQ. Maternal urinary concentrations of bisphenols were not associated with child nonverbal 
IQ. There was no effect estimate modification by sex.
Conclusions: We did not observe that maternal biomarkers of bisphenol exposure are 
associated with nonverbal IQ. We found that phthalate exposure in early pregnancy and 
DNOP exposure in late pregnancy are associated with lower nonverbal IQ scores in children. 
Our results might suggest that particularly early pregnancy is a sensitive window of phthalate 
exposure, but future studies are needed to replicate our findings




Phthalates and bisphenols are synthetic compounds incorporated in many products. 
For example, phthalates such as di-(2-ethylhexyl) phthalate (DEHP), dibutyl phthalate 
(DBP), di-n-octyl phthalate (DNOP), and benzyl butyl phthalate (BBP) are primarily 
used as plasticizers for polyvinyl chloride and exist in food packaging materials, floor 
materials, clothing, toys, and medical devices. DBPs are also used as solvents and fixatives 
in paint and cosmetics.1-3 Bisphenol A (BPA) or common replacements such as bisphenol 
S (BPS) and bisphenol F (BPF) exist in products such as epoxy resin coatings of canned 
food containers, water bottles, storage containers, thermal paper, and baby bottles.4,5
Phthalates and bisphenols are omnipresent in the environment, and these compounds 
have been detected in urine samples of mothers and their offspring.6 Prenatal exposure 
to these chemicals can occur because of their ability to cross the placental and blood–
brain barriers.7-10 Studies suggest that prenatal phthalate and bisphenol exposure both 
interfere with the thyroid hormone system,11-16 which is crucial for normal fetal brain 
development.17 In addition, neurotoxic effects of phthalates and bisphenols may be 
mediated by anti-androgenic activity,18-21 disruption of brain dopaminergic activity,22-24 
and interaction with peroxisome proliferator-activated receptors.15,16,25
Studies in animals have shown that prenatal phthalate and bisphenol exposure impairs 
neurodevelopment in the offspring.21,24,26-34 With respect to phthalates, animal studies 
find inverse associations between prenatal exposure to DEHP and DBP and learning, 
memory, and brain development in the offspring.24,26-29 Also, prenatal exposure to DEHP 
can affect developmental plasticity of the hippocampus.30 Regarding bisphenols, animal 
studies have shown that gestational exposure to BPA was associated with alterations in 
brain morphology and brain function.21 Further, BPA-exposed rats and mice exhibit 
persistent learning and memory impairments31,33,35 and low-dose BPA exposure disrupts 
hippocampal CA1 neuronal morphology, which is believed to persist into adulthood.33-35
However, epidemiological studies investigating the associations between prenatal phthalate 
or bisphenol exposure and cognitive functioning in children are limited and the findings are 
inconclusive. One study using mother–child pairs from inner-city New York reported that 
higher metabolite concentrations of DBP and di-isobutyl phthalate metabolites measured 
in the third trimester were associated with lower intelligent quotient (IQ) score in 328 
children at 7 years.36 Similarly, other studies (n=150–417) found that higher levels of DEHP 
metabolites during the third trimester were associated with a lower score on the mental 
development index (MDI) of the Bayley Scales of Infant Development at 0.5–2 years.37,38 
Two studies found that third-trimester concentrations of DBP and mono(3-carboxypropyl) 
phthalate (mCPP) metabolites were inversely associated with the MDI at child age 2–3 
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y, but only in girls.39,40 Another study found the averaged sum of high-molecular weight 
phthalates (HMWPs) and DEHP exposure across pregnancy to be inversely associated 
with IQ, but only in boys.41 Yet, five other studies did not find any association between 
prenatal exposure to phthalates and cognition during the second42,43 and third trimester,43-46 
using data from 100–452 mother–child pairs. Research on bisphenol exposure mostly 
found little evidence of an association between prenatal exposure and child cognition. 
One study found an inverse association between prenatal BPA exposure measured in cord 
blood and offspring IQ at 7 years of age in 148 children.47 However, most other studies 
using maternal urine concentrations to determine exposure did not show an association 
between prenatal BPA exposure and cognitive functioning in 239–812 children at 1–8 
years of age.45,48-52 Further, a recent study found first trimester exposure to a mixture of 26 
endocrine-disrupting chemicals to be associated with lower IQ among boys.53 Among a 
broad range of chemical biomarkers, the present study included phthalate metabolites and 
BPA, BPF, and BPS and identified BPF as the primary chemical of concern. In addition, 
concentrations of BPA, mono-ethyl phthalate (mEP), and monobenzyl phthalate (mBzP) 
had a considerable contribution to the overall mixture effect.53
The heterogeneity in epidemiological results may be explained by the fact that most of 
these studies had modest sample sizes, which may have limited the statistical power to 
consistently detect adverse associations. In addition, most studies measured prenatal 
exposure only during the third trimester, whereas other windows of susceptibility may 
exist.54 Finally, only one previous study investigated the association between prenatal 
exposure to BPS and BPF with IQ. To address these limitations, we studied a large cohort 
from the Generation R Study, which is characterized by detailed follow-up information 
of the child and three repeated measurements (early, mid, and late pregnancy) of urinary 
phthalate and bisphenol biomarkers, including BPF and BPS. We investigated the extent 
to which maternal exposure to phthalates or bisphenols during pregnancy are associated 
with offspring’s nonverbal IQ at 6 years of age.
Methods
Study participants and follow-up
Generation R is a prospective population-based birth cohort designed to identify early 
environmental and genetic determinants of growth and development.55 Briefly, all pregnant 
women who resided in the study area in Rotterdam, Netherlands, and had a delivery 
date between April 2002 and January 2006 were eligible. All eligible pregnant women 
who visited a midwife or obstetrician in Rotterdam were contacted by the Generation R 
Study staff for recruitment. The study staff were able to communicate with the pregnant 
women in Dutch, English, French, Portuguese, and Turkish. Among the 9,778 mothers 
Prenatal phthalate and bisphenol exposure and nonverbal IQ
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who participated in the study, 8,879 (91%) were enrolled during pregnancy and the 
rest were enrolled during routine visits of the newborn to the child health centers. The 
enrollment procedure has been previously described in detail.56-60 Between February 
2004 and January 2006, women provided spot urine specimens at the time of routine 
ultrasound examinations during early, mid, and late pregnancy. A total of 2,083 women 
provided a complete set of three urine specimens.
When the children turned 6 years of age, the families were invited to participate in an in-
person follow-up visit to collect neurobehavioral data, biospecimens, and sociodemographic 
and health data. Of the 2,083 mother–child pairs with three urinary samples, 1,405 provided 
data at 6 years of age of the child. The availability of follow-up data was a requirement 
to allow studies of the associations between prenatal phthalate and bisphenol exposure 
and child health, including cognition. Of these 1,405 mother–child pairs, 1,282 had 
complete data on nonverbal IQ and comprised the study sample. Women in this subset 
had higher education and income levels, were slightly older, and were more likely to be 
of Dutch national origin than the broader Generation R cohort.55
The study protocol underwent human subjects review at Erasmus Medical Center, 
Rotterdam, Netherlands (MEC 198.782.2001.31, MEC-2007-413). Mothers provided 
written informed consent for themselves and their children.
Bisphenol and phthalate measurements in urine
Maternal spot urine specimens were collected during early (mean=13.3 wks of gestation, 
range=6.5–17.9 wks), mid (mean=20.4 wks of gestation, range=18.1–24.9 wks), and late 
pregnancy (mean=30.3 wks of gestation, range=27.4–34.5 wks). Details on urine specimen 
collection have been described elsewhere.61 Briefly, all urine samples were collected (at 
0800–1000 hours) in 100-mL polypropylene urine collection containers that were kept for 
a maximum of 20 h in a cold room (4°C) before being frozen at −20°C in 20-mL aliquots 
in 25-mL polypropylene vials. The urine specimens were shipped on dry ice in 4-mL 
polypropylene vials to the Wadsworth Center, New York State Department of Health, 
Albany, New York, for analysis of phthalate metabolite and bisphenol concentrations.
A detailed description of the analytical procedure is given elsewhere.62 Briefly, quantitative 
detection of phthalate metabolites was achieved by using a solid-phase extraction method 
followed by enzymatic deconjugation of the glucuronidated phthalate monoesters 
coupled with high performance liquid chromatography electrospray ionization–tandem 
mass spectrometry (HPLC-ESI-MS/MS),63 which allowed for the rapid detection of 18 
metabolites of phthalates with limits of detection (LODs) in the range of 0.008–0.89 ng/
mL. Quantitative detection of bisphenols was realized using a liquid–liquid extraction 
method followed by enzymatic deconjugation of the glucuronidated bisphenols coupled 
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with HPLC-ESI-MS/MS, which permitted the detection of eight biomarkers of bisphenols 
(including BPA, BPF, and BPS) with an LOD range of 0.03–0.79 ng/mL. Similarly, samples 
were analyzed for creatinine using HPLC-ESI-MS/MS. Quantification of calibration 
check standards resulted in an LOD of 0.30 ng/mL.
Exposure biomarkers were excluded from further statistical analyses if more than 80% 
of the study population had concentrations below the LOD. Urinary biomarkers for 
exposure to phthalates were grouped according to their parent compound, biologic 
activity, and source of exposure in order to limit multiple comparisons. Phthalate groups 
included low-molecular weight phthalates (LMWPs), HMWPs, DEHP, DNOP, and 
phthalic acid (PA). For the LMWP group, we summed mono-methyl phthalate (mMP), 
mEP, mono-n-butyl phthalate (mBP), and mono-isobutyl phthalate (mIBP) metabolite 
concentrations. For the HMWP group, we summed mono-(2-ethyl-5-carboxypentyl) 
phthalate (mECPP), mono-(2-ethyl-5-hydroxyhexyl) phthalate (mEHHP), mono-(2-ethyl-
5-oxohexyl) phthalate (mEOHP), mono-[(2-carboxymethyl)hexyl] phthalate (mCMHP), 
mCPP, mBzP, mono-hexyl phthalate (mHxP), and mono-2-heptyl phthalate (mHpP) 
metabolite concentrations. For the DEHP group, we summed mECPP, mEHHP, mEOHP, 
and mCMHP metabolite concentrations and used MCPP metabolite concentrations 
as a proxy for DNOP exposure. Finally, PA is an end metabolite of all phthalates. PA 
metabolite concentrations were therefore analyzed separately as a proxy for total phthalate 
exposure. Regarding bisphenol concentrations, we calculated the sum for total bisphenol 
concentrations. Prior to the statistical analyses, all concentrations below the LOD were 
replaced with the LOD divided by the square root of 2.64
Nonverbal IQ at child age 6 years
Children’s nonverbal IQ was assessed by administering the Mosaics and Categories subtests 
from the Snijders-Oomen Nonverbal Intelligence Test–Revised (SON-R), a reliable and 
well-validated instrument.65-67 The correlation between the total score of the SON-R 
2.5-7 and the performance IQ score of the Wechsler Preschool and Primary Scale of 
Intelligence has been reported to be between 0.60 and 0.83, and the average reliability 
of the SON-R 2½–7 IQ score was 0.90.66-68 Further, the test is regarded as highly reliable 
and rated good (3 of 3) by the commission of Netherlands Institute for Psychologists. 
The two language-independent subtests that included items that probe visuospatial and 
abstract reasoning abilities were selected because of the multiethnic composition of the 
Generation R Study. Subtest raw test scores were converted into age-standardized nonverbal 
IQ scores. These standardized scores, based on the two subtests, correlated well (r=0.86) 
with those based on the complete instrument.69




Maternal reproductive, sociodemographic, and cognitive data were assessed by questionnaires 
and/or observations. During the first prenatal visit, height and weight were measured, but 
prepregnancy weight was self-reported by participants. These data were used to calculate 
body mass index (BMI). In addition, data was collected on maternal age (years), parity (0, 
1, or ≥2), smoking (no smoking during pregnancy, smoking until pregnancy recognized, 
and continued smoking during pregnancy), alcohol intake during pregnancy [no alcohol 
consumption during pregnancy, alcohol consumption until pregnancy recognized, 
continued occasionally (<1 glass/wk), and continued frequently (≥1 glass/wk)], marital 
status (married/partner or single), household total net income [<1,200 euros/month (i.e., 
below the Dutch social security level), 1,200–2,000 euros/month, >2,000 euros/month], 
highest completed education level [low (<3y at general secondary school) intermediate 
(≥3y of secondary education), and high (university degree or higher vocational training)], 
ethnicity (Dutch national origin, other-Western, and non-Western), and folic acid intake 
(none, started in first 10 wks of pregnancy, and started preconception). Maternal IQ 
was examined when mother–child pairs attended the 6-y examination and was assessed 
using a computerized Ravens Advanced Progressive Matrices Test, Set I.70 The test is a 
12-item reliable and validated short version of the Raven’s Progressive Matrices to assess 
nonverbal cognitive ability.71 The consumption of fruit and vegetables was assessed in 
the first trimester using a modified version of a validated food frequency questionnaire 
and was adjusted for energy intake.72 Except for BMI (12%), smoking (10%), income 
(15%), folic acid intake (21%), and fruit and vegetable intake (25%), the percentage of 
missing values was below 10%.
Statistical methods
Urinary phthalate metabolite and bisphenol concentrations were expressed on a creatinine 
basis and log10 transformed (in micrograms per gram creatinine). Missing phthalate 
metabolite and bisphenol concentration values (n=13 with missing data in one or two 
urinary collection periods during pregnancy) and all missing covariate data were imputed 
10 times with the multivariate imputation by chained equations method in R (version 
3.5.3; R Development Core Team).73,74 Urinary BPA and PA metabolite concentrations and 
the child nonverbal IQ score were included as predictors for the imputation of covariates. 
The outcome variable child nonverbal IQ was not imputed. We calculated intraclass 
correlation coefficients (ICCs) for individual measurements, for example, during early 
pregnancy (single-rater, relevant to the time-specific analyses), and for the mean of the three 
measurements across pregnancy (mean of k raters), using two-way mixed-effects models 
with absolute agreement.75 Further, we first performed regression analyses to estimate the 
associations of grouped phthalate and bisphenol urinary concentrations with nonverbal IQ 
for each collection phase (gestational age <18, 18–25, and >25 wks). Second, a mutually 
adjusted model was fitted in which the association of prenatal phthalate and bisphenol 
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urinary concentrations from each time period on nonverbal IQ were jointly estimated. 
To test whether the association between prenatal urinary concentrations of phthalate 
metabolites and bisphenols and nonverbal IQ differed across time windows of exposure 
(pinteraction<0.1), we used the multiple informant method, in which different exposure 
windows are treated as informants.76 We chose this strategy to identify possible windows 
of susceptibility and to be able to compare our results with other studies that used a single 
spot urine sample in pregnancy to determine phthalate and bisphenol concentrations. 
Third, we carried out regression analyses to estimate the association between the averaged 
prenatal urinary concentrations across pregnancy and nonverbal IQ. Urinary metabolite 
concentrations of phthalates and (especially) bisphenols vary over time. Therefore, the 
average is most likely a better approximation of each participant’s exposure during 
pregnancy than any exposure measurement on its own. Fourth, we presented restrictive 
cubic splines for untransformed grouped biomarker concentrations that were predictive 
of nonverbal IQ. Finally, several studies have suggested that sex may be a potential effect 
estimate modifier in the association of prenatal exposure to phthalates and bisphenols 
and neurodevelopmental outcomes.36,37,39-41,48-50 We therefore explored potential effect 
modification by sex via stratification, interaction terms, and augmented product terms 
(pinteraction<0.05).77
We present results from unadjusted and adjusted analyses. The adjustment variables 
were maternal age (continuous), ethnicity (categorical), education (categorical), income 
(categorical), marital status (categorical), alcohol consumption during pregnancy 
(categorical), maternal nonverbal IQ (continuous), prepregnancy BMI (continuous), 
parity (categorical), smoking during pregnancy (categorical), child sex (categorical), and 
child age at assessment (continuous). These potential confounders were selected a priori 
defined with a directed acyclic graph (DAG)78 based on previous studies of prenatal 
phthalate and bisphenol exposure and child neurodevelopment and on biologically 
plausible covariate–exposure and covariate–outcome associations observed in our data 
(see Figure S1).
Sensitivity analyses
Several sensitivity analyses were performed. First, we used another common method to 
adjust for creatinine by refitting visit-specific and averaged models, with concentrations 
expressed in nanograms per milliliter and creatinine concentration added as a separate 
covariate. We performed this sensitivity analyses to facilitate comparison with previous 
studies investigating prenatal exposure to nonpersistent chemicals and neurodevelopment 
that have used this adjustment method. Second, we performed post hoc analyses in 
which we explored the associations of individual phthalate metabolite and bisphenol 
concentrations with nonverbal IQ because individual phthalates and bisphenols within the 
summed groups may have different neurotoxic effects. Third, we used inverse probability 
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weighting (stabilized weights) to correct for potential selection bias79 and to provide results 
representative for the full Generation R Study cohort (n=9,901) given that children included 
in the analysis (n=1,282) were more likely to have parents who were of Dutch national 
origin, older, and from a higher socioeconomic.55 Baseline characteristics significantly 
different (p<0.20) between the initially recruited cohort and the current analysis sample 
are presented in Table S1. Fourth, because diet and the intake of healthy nutrients may 
confound the association between prenatal phthalate and bisphenol exposure (e.g., food 
packaging) and child cognition (e.g., healthy nutrients), we performed a sensitivity 
analyses in which we additionally adjusted for maternal fruit, vegetables, and folic acid 
intake. Fifth, to correct for multiple hypothesis testing, each p-value was compared with 
a threshold, defined as 0.05 divided by the effective independent number of tests.80 
The corrected P-value was calculated based on the correlation structure between the 
phthalate metabolite groups (LMWP, HMWP, DEHP, DNOP, and PA) for each time 
point separately (corrected p<18 wks of gestation=0.02, 18–25 wks of gestation=0.018, 
>25 wks of gestation=0.017), and for the average exposures (corrected p=0.017).
Results
Sample characteristics
At enrollment, most of the participating women were between 30 and 35 years of age 
(43%), nulliparous (61%), Dutch (54%), married (89%), and highly educated (50%) 
(Table 1). A large group had a prepregnancy BMI of between 18.5 and 25 (70%), a 
high income (68%), and did not consume alcoholic beverages (42%) or smoke (75%) 
during pregnancy.
Phthalate and bisphenol concentrations
The median LMWP metabolite concentrations for <18, 18–25, and >25 wks of gestation 
were 240, 103, and 232μg/g creatinine, respectively (Table 2). The median HMWP 
measured at <18, 18–25, and >25 wks of gestation were 69, 33, and 52μg/g creatinine. 
Total bisphenol concentrations comprised mostly BPA, and the median total bisphenol 
concentrations for <18, 18–25, and >25 wks of gestation were 2, 1, and 2μg/g creatinine, 
respectively. Descriptive statistics of the individual biomarkers from our study sample can be 
found in Tables S2 and S3. The ICC for the grouped phthalate metabolite concentrations 
varied between 0.2 and 0.4 for a single measurement and varied between 0.4 and 0.6 
for the mean of the three measurements (see Table S4). Regarding the bisphenol group, 




Table 1. Characteristics of  study participants (n=1282).
Phthalic acid a Bisphenols b Non-verbal IQ c
Maternal characteristics d Percentages Median P25, P75 Median P25, P75 Mean ± SD
Age in years
< 20 2.0 109.2 65.4, 162.5 1.5 1.2, 2.6 94 ± 15
20-< 25 11.5 85.5 61.9, 123.9 1.7 1.1, 2.8 94 ± 14
25-< 30 26.8 82.6 52.1, 129.7 1.7 1.1, 2.8 102 ± 15
30-< 35 42.9 84.7 52.5, 131.8 1.9 1.3, 2.9 104 ± 16
≥ 35 16.8 85.8 54.5, 135.5 1.9 1.1, 2.9 104 ±13
Pre-pregnancy body mass index (BMI) (kg/m2)
< 18.5 2.5 88.6 45.4, 123.5 1.9 1.3, 3.1 102 ± 16
18.5-< 25 69.8 79.9 51.1, 124.3 1.8 1.1, 2.8 103 ± 15
25-< 30 19.1 95.6 58.2, 146.0 2.1 1.3, 3.3 100 ± 15
≥ 30 8.6 95 67.7, 142.0 1.8 1.2, 3.0 98 ± 17
Parity
0 60.5 86 54.0, 133.9 1.8 1.2, 2.8 103 ± 15
1 28.2 79.9 52.5, 119.3 1.9 1.2, 3.0 102 ± 15
≥ 2 11.3 88.2 54.2, 139.8 1.7 1.1, 2.8 98 ± 15
Ethnicity
Dutch 53.9 81.1 50.4, 131.8 1.9 1.2, 2.9 106 ± 15
Other Western 12.4 78.2 52.9, 128.6 1.7 1.2, 2.5 102 ± 14
Non-Western 33.7 88.3 58.7, 132.9 1.8 1.1, 2.9 96 ± 15
Education e
Low 18.9 95.2 65.0, 151.7 1.8 1.2, 2.8 96 ± 15
Intermediate 30.7 85.9 55.3, 137.0 1.9 1.2, 3.1 100 ± 14
High 50.4 76.2 48.8, 122.1 1.8 1.1, 2.8 106 ± 14
Household income in Euros
<1200 per month 15.4 91.1 62.4, 135.9 1.6 1.1, 2.8 95 ± 15
1200–2000 per month 17.0 86.9 56.2, 137.3 1.9 1.3, 3.0 100 ± 15
> 2000 per month 67.6 81.2 50.7, 127.4 1.8 1.2, 2.9 105 ± 14
Marital status
Married/ living with partner 88.5 82.8 52.0, 128.9 1.8 1.2, 2.9 103 ± 15
No partner 11.5 96.2 67.7, 151.0 1.8 1.1, 3.1 99 ± 15
IQ-score
≤ 85 22.5 91.3 58.3, 145.5 1.9 1.1, 2.9 96 ± 15
>85-≤ 100 43.3 86.9 55.6, 134.8 1.8 1.2, 2.7 102 ± 14
>100 -< 115 17.9 79.3 50.8, 125.2 1.8 1.2, 2.8 105 ± 14
≥ 115 16.3 72.9 47.3, 118.6 1.9 1.3, 3.1 107 ± 16
Smoking
No smoking during pregnancy 75.3 78.7 51.5, 122.7 1.8 1.1, 2.8 103 ± 15
Until pregnancy recognized 10.2 97.6 62.8, 140.1 2.0 1.4, 3.2 101 ± 14
Continued during pregnancy 14.5 105.6 71.2, 154.8 1.9 1.2, 3.1 97 ± 15
Alcoholic beverage consumption
No alcohol consumption 42.1 86.5 56.6, 137.6 1.8 1.1, 2.8 99 ± 15
Until pregnancy recognized 17.0 78.5 52.4, 132.7 1.7 1.1, 2.7 103 ± 14
Continued occasionally f 35.2 85.5 51.3, 124.9 2.0 1.3, 3.0 105 ± 16
Continued frequently g 5.8 74.6 48.1, 129.7 2.0 1.4, 3.1 105 ± 14
Infant characteristics d Percentages Median P25, P75 Median P25, P75 Mean ± SD
Sex of infant at birth
Male 50.5 84.5 52.6, 130.7 1.9 1.2, 3.0 102 ± 16
Female 49.5 84.1 53.7, 132.3 1.7 1.2, 2.7 101 ± 15
Continue
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Associations with nonverbal IQ
Creatinine-adjusted LMWP, DNOP, and PA metabolite concentrations at <18 wks of 
gestation were significantly associated with child nonverbal IQ score (Table 3). For 
example, a 10-fold higher LMWP, DNOP, or PA metabolite concentration was associated 
with lower nonverbal IQ scores of 1.7 points [95% confidence interval (CI): −3.1, −0.3], 
2.0 points (95% CI: −3.7, −0.2), and 1.9 points (95% CI: −3.6, −0.3), respectively. The 
associations for HMWP [B=−1.8 (95% CI: −3.6, 0.0)], and DEHP [B=−1.7 (95% CI: 
−3.5, 0.1)] metabolite concentrations with nonverbal IQ were comparable in magnitude. 
When adjusted for mid and late pregnancy exposures, the associations of child nonverbal 
IQ with grouped phthalate metabolite concentrations were similar. Mid and late pregnancy 
concentrations of grouped phthalate metabolites were generally not significantly associated 
with nonverbal IQ. However, a 10-fold increase in DNOP metabolite concentration at 
>25 wks of gestation was associated with a 2.4-point lower nonverbal IQ score (95% CI: 
−4.8, 0.0). Further, the significant interaction terms between LMWP, HMWP, DNOP, 
and PA metabolite concentrations and timing of exposure (p=0.06, p=0.09, p=0.03, and 
p=0.05, respectively) suggested that the potential effects of prenatal LMWP, HMWP, 
DNOP, and PA metabolite concentrations on nonverbal IQ might differ depending 
on the timing of exposure. No significant interaction terms were observed for DEHP 
metabolite concentrations and timing of exposure. Further, compared with the associations 
observed at <18 wks of gestation, we observed similar estimates in terms of magnitude for 
averaged LMWP [B=−1.7 (95% CI: −3.7, 0.4)] and PA [B=−1.8 (95% CI: −4.6, 1.0)] 
metabolite concentrations, and a greater estimate in terms of magnitude for averaged 
DNOP metabolite concentrations [B=−3.0 (95% CI: −6.0, 0.0)]. Finally, representative 
restrictive cubic splines for untransformed grouped phthalate metabolite concentrations 
at <18 wks of gestation and DNOP metabolite concentrations at >25 wks of gestation (see 
Figure S2) indicated a slightly steeper inverse association between exposure and outcome 
at lower levels of exposure.
Note: BMI, body mass index; IQ, intelligence quotient; P, percentile; SD, standard deviation.
a. Average total phthalic acid in ug/g creatinine by category of characteristics.
b. Average total bisphenols in ug/g creatinine by category of characteristics.
c. Non-verbal IQ by category of characteristics.
d. There were missing observations for BMI (n=157), parity (n=8), ethnicity (n=13), education (n=60), household 
income (n=193), marital status (n=69), maternal IQ (n=34), smoking (n=132), alcohol consumption (n=91).
e. Low: No education finished, Primary education, lower vocational training, intermediate general school or <3 years 
at general secondary school. Intermediate: +3 years of secondary education, Intermediate vocational training or first 
year of higher vocational training. High: University degree or higher vocational training.
f. Less than 1 glass/week.




Table 2. Descriptive statistics of  creatinine adjusted phthalate and bisphenol concentrations a in 
urine samples measured in pregnancy. 
N min P25 P50 P75 max
Phthalate metabolite concentrations in ug/g 
creatinine b
LMWP <18 weeks 1274 0.4 109.5 239.5 603.3 102789.2
LMWP 18-25 weeks 1270 4.3 46.8 102.6 238.0 36050.2
LMWP >25 weeks 1269 21.1 103.0 232.3 530.5 8131.3
HMWP <18 weeks 1274 0.6 39.6 68.5 126.6 2837.4
HMWP 18-25 weeks c 1270 2.3 19.3 33.1 59.0 15577.1
HMWP >25 weeks c 1269 3.6 35.0 52.3 81.9 1683.6
DEHP <18 weeks 1274 0.3 31.4 55.2 103 2821.2
DEHP 18-25 weeks 1270 1.8 14.4 25.0 46.3 15574.4
DEHP >25 weeks 1269 3.2 29.6 45.0 71.0 1673.5
DNOP <18 weeks 1274 0 0.9 1.6 2.8 106.5
DNOP 18-25 weeks 1270 0 0.4 0.8 1.4 65.8
DNOP >25 weeks 1269 0 1.2 1.9 3.0 72.0
PA <18 weeks 1274 0.6 33.8 63.8 123.4 12433.4
PA 18-25 weeks 1270 4.3 56.5 111.6 250.1 2885.2
PA >25 weeks 1269 2.6 44.2 73.9 127.1 1562.4
Total bisphenol concentrations in ug/g 
creatinine
<18 weeks d 1274 0.1 1 2.1 5.2 982.8
18-25 weeks e 1270 0 0.6 1.2 2.5 277.6
>25 weeks f 1269 0.1 1.1 2.0 4.2 145.4
Abbreviations: n=number, min=minimum, P=percentile, max=maximum
a. Concentrations below the limit of detection(LOD) were imputed with LOD/√2.
b. Phthalate metabolites are grouped into: low molecular weight phthalate metabolites (LMWP) = sum of Mo-
nomethylphthalate, Monoethylphthalate, Mono-isobutylphthalate, and Mono-n-butylphthalate, high molecular 
weight phthalate metabolites (HMWP) = sum of mono-(2-ethyl-5-carboxypentyl) phthalate, mono-(2-ethyl-
5-hydroxyhexyl)phthalate, mono-(2-ethyl-5-ox-ohexyl) phthalate, mono-[(2-carboxymethyl)hexyl]phthalate, 
mono(3-carboxypropyl) phthalate, monobenzylphthalate, mono-hexylphthalate, and mono-2-hep-tylphthalate, 
Di-2-ethylhexylphthalate metabolites (DEHP) = sum of Mono-(2-ethyl-5-carboxypentyl)phthalate, Mono-(2-ethyl-
5-hydroxyhexyl)phthalate, Mono-(2-ethyl-5-oxohexyl)phthalate, and Mono-[(2-carboxymethyl)hexyl]phthalate, 
Di-n-octylphthalate metabolites (DNOP) = Mono(3-carboxypropyl)phthalate, Phthalic acid (PA) = a proxy for total 
phthalate exposure measured in ug/g creatinine.
c. with the exclusion of mono-hexylphthalate, and mono-2-hep-tylphthalate metabolite concentrations
d. Total bisphenol =-sum of Bisphenol A, bisphenol F, and Bisphenol S.
e. Total bisphenol =-sum of Bisphenol A, and Bisphenol S.
f. Total bisphenol =-sum of Bisphenol A and bisphenol F.
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Table 3. Difference in child non-verbal IQ score at age six years per log10 increase in creatinine 
adjusted maternal urine phthalate metabolite and bisphenol concentrations, by timing of  urine 
sampling.
Unadjusted Adjusted a Mutually adjusted b
Phthalate metabolites c B 95%CI B 95%CI B 95%CI
Σ LMWP metabolites
<18 weeks -3.21 -4.64, -1.78 -1.68 -3.05, -0.32 -1.75 -3.21, -0.29
18-25 weeks -1.70 -3.30, -0.11 0.27 -1.25, 1.79 1.04 -0.58, 2.67
>25 weeks -2.85 -4.52, -1.18 -1.07 -2.65, 0.51 -0.80 -2.50, 0.90
Averaged -4.85 -6.96, -2.75 -1.68 -3.72, 0.36 -
p d 0.06
Σ HMWP metabolites
<18 weeks -3.63 -5.55, -1.70 -1.80 -3.62, 0.03 -1.98 -3.82, -0.13
18-25 weeks e -0.87 -2.81, 1.07 1.04 -0.80, 2.87 1.19 -0.67, 3.05
>25 weeks e -0.14 -2.82, 2.54 0.73 -1.79, 3.26 0.79 -1.76, 3.33
Averaged -4.41 -7.69, -1.12 -0.37 -3.52, 2.78 -
 p d 0.09
Σ DEHP metabolites
<18 weeks -3.20 -5.09, -1.31 -1.73 -3.52, 0.05 -1.89 -3.69, -0.09
18-25 weeks -0.42 -2.33, 1.49 0.92 -0.88, 2.72 1.06 -0.76, 2.88
>25 weeks 0.20 -2.38, 2.77 0.65 -1.78, 3.09 0.71 -1.75, 3.16
Averaged -2.21 -4.64, 0.22 0.05 -2.26, 2.36 - -
 p d 0.11
Σ DNOP metabolites
<18 weeks -2.61 -4.46, -0.76 -1.98 -3.72, -0.23 -1.86 -3.65, -0.08
18-25 weeks -0.13 -2.20, 1.94 0.38 -1.57, 2.32 0.87 -1.1, 2.84
>25 weeks -1.10 -3.64, 1.43 -2.39 -4.76, -0.02 -2.10 -4.51, 0.30
Averaged -3.28 -6.47, -0.09 -2.97 -6.00, 0.06 -
 p d 0.03
PA metabolites
<18 weeks -2.59 -4.32, -0.87 -1.93 -3.55, -0.31 -1.90 -3.55, -0.25
18-25 weeks -0.90 -2.72, 0.91 0.85 -0.87, 2.57 1.07 -0.66, 2.80
>25 weeks -2.46 -4.75, -0.17 -1.09 -3.25, 1.07 -0.78 -2.98, 1.42
Averaged -4.64 -7.57, -1.71 -1.77 -4.57, 1.04 -
 p d 0.05
Unadjusted Adjusted a Mutually adjusted b
Bisphenol metabolites B 95%CI B 95%CI B 95%CI
<18 weeks f 0.38 -1.10, 1.86 0.49 -0.90, 1.87 0.48 -0.90, 1.87
18-25 weeks g 0.48 -1.19, 2.15 0.13 -1.44, 1.70 0.12 -1.44, 1.69
>25 weeks h 1.05 -0.74, 2.85 0.05 -1.62, 1.72 0.06 -1.61, 1.74
Averaged 1.81 -1.03, 4.65 0.76 -1.89, 3.42 -
 p d 0.92
a. Adjusted for maternal age, maternal non-verbal IQ, sex of child, age of the child at assessment, ethnicity, educati-
on, income, marital status, maternal alcohol consumption, BMI, parity categories, and smoking.
b. Adjusted model with the inclusion of the three exposures in one model.
c Phthalate metabolites are grouped into: low molecular weight phthalate metabolites (LMWP) = sum of Mo-
nomethylphthalate, Monoethylphthalate, Mono-isobutylphthalate, and Mono-n-butylphthalate, high molecular 
weight phthalate metabolites (HMWP) = sum of mono-(2-ethyl-5-carboxypentyl) phthalate, mono-(2-ethyl-
5-hydroxyhexyl)phthalate, mono-(2-ethyl-5-ox-ohexyl) phthalate, mono-[(2-carboxymethyl)hexyl]phthalate, 
mono(3-carboxypropyl) phthalate, monobenzylphthalate, mono-hexylphthalate, and mono-2-hep-tylphthalate, 
Di-2-ethylhexylphthalate metabolites (DEHP) = sum of Mono-(2-ethyl-5-carboxypentyl)phthalate, Mono-(2-ethyl-
5-hydroxyhexyl)phthalate, Mono-(2-ethyl-5-oxohexyl)phthalate, and Mono-[(2-carboxymethyl)hexyl]phthalate, 
Di-n-octylphthalate metabolites (DNOP) = Mono(3-carboxypropyl)phthalate, Phthalic acid (PA) = a proxy for total 
phthalate exposure measured in ug/g creatinine.
d. Tests whether exposure from different time points relates in the same manner to non-verbal IQ scores using the 
multiple informant method (Sanchez et al. 2011).
e. with the exclusion of mono-hexylphthalate, and mono-2-hep-tylphthalate metabolite concentrations
f. Total bisphenol =-sum of Bisphenol A, bisphenol F, and Bisphenol S.
g Total bisphenol =-sum of Bisphenol A, and Bisphenol S.
h. Total bisphenol =-sum of Bisphenol A and bisphenol F.
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Effect estimate modification by sex
No effect estimate modification by sex was observed for the association between maternal 
urinary concentrations of grouped phthalate metabolite concentrations and nonverbal 
IQ (see Table S5). Similarly, there was no effect estimate modification by sex for the 
association between maternal urinary bisphenol concentrations and nonverbal IQ.
Sensitivity analyses
First, the results with concentrations expressed as nanograms per milliliter and creatinine 
concentration added as a separate covariate were similar to the results of the main analyses 
using creatinine-corrected concentrations (see Table S6). Second, associations between 
individual urine phthalate metabolite concentrations at <18 wks of gestation and nonverbal 
IQ scores were inverse for all metabolites except for mHxP. Next, associations with mEP, 
mCMHP, and mCPP remained significant after confounder adjustment (Figure 1; see 
also Table S7). For example, the mean nonverbal IQ score was 1.3 points lower (95% CI: 
–2.4, –0.2) in association with a 10-fold increase in urine mEP concentration at <18 wks 
of gestation. Most mid and late pregnancy concentrations of phthalate metabolites were 
Figure 1. Difference in non-verbal IQ with a log10 increase in phthalate metabolite concentrations in ug/g 
creatinine at <18 weeks of gestation. Corresponding numeric data are reported in Table S7. A) Unadjusted 
model. B) Adjusted for maternal age, maternal non-verbal IQ, sex of child, age of the child at assessment, 
ethnicity, education, income, marital status, maternal alcohol consumption, BMI, parity categories, and 
smoking categories. mMP= mono-methyl phthalate, mEP= mono-ethyl phthalate, mIBP= mono-isobutyl 
phthalate, mBP= mono-n-butyl phthalate, mECPP= mono- (2-ethyl-5-carboxypentyl) phthalate, mEHHP= 
mono- (2-ethyl-5-hydroxyhexyl) phthalate, mEOHP= mono-(2-ethyl-5-oxohexyl) phthalate, mCMHP= 
mono-[(2-carboxymethyl)hexyl]phthalate, mCPP= mono(3-carboxypropyl) phthalate, mBzP= monobenzyl 
phthalate, mHxP= mono-hexylphthalate, mHpP= mono-2-heptylphthalate, PA= phthalic acid. Abbreviation
A) Di  erence in non-verbal IQ score (95% Cl)ff B) Di  erence in non-verbal IQ score (95% Cl)ff
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not significantly associated with nonverbal IQ. However, a 10-fold increase in mCPP 
metabolite concentrations at >25 wks of gestation was associated with a 2.4-point lower 
nonverbal IQ score (95% CI: −4.8, 0.0). As compared with the associations observed 
at <18 wks of gestation, when we observed similar estimates in terms of magnitude for 
averaged mEP and mCMHP metabolite concentrations as well as a greater estimate in 
terms of magnitude for averaged mCPP metabolite concentrations. No associations 
were observed for the BPA, BPS, and BPF. Third, the results using inverse probability 
weighting to correct for potential selection bias (see Table S8) and the results in which 
we additionally adjusted for diet (see Table S9) were similar to the main results. Fourth, 
when the main results were corrected for the effective independent number of tests, the 
adjusted and mutually adjusted associations of maternal LMWP metabolite concentrations 
at <18 wks of gestation with nonverbal IQ remained significant. Similarly, the adjusted 
association between PA metabolite concentrations at <18 wks of gestation with nonverbal 
IQ survived the multiple testing correction.
Discussion
In this large population-based study, we consistently observed that early pregnancy 
phthalate exposure was associated with lower child nonverbal IQ scores at 6 years of age. 
Urinary metabolite concentrations of early pregnancy LMWP, HMWP, DEHP, DNOP, 
and PA were associated with lower nonverbal IQ. We also found an inverse association 
between late pregnancy DNOP exposure and nonverbal IQ. Our findings did not support 
an association between other mid and late pregnancy grouped phthalate exposures, and 
we found little or no evidence of an association between prenatal bisphenol exposure 
and child nonverbal IQ. Finally, our results did not support effect modification by sex.
The results from our study may help clarify the so-far inconclusive results of epidemiological 
studies investigating the effect of prenatal exposure to phthalates on cognitive functioning. 
To our knowledge, most other previous studies have examined phthalate exposure during 
mid or late pregnancy. We did not find clear evidence for an association between mid and 
late pregnancy phthalate exposure and offspring IQ. Consistent with our results, previous 
studies have also found that prenatal phthalate metabolite concentrations measured at 
14–27 wks of gestation,42 at 22–29 wks of gestation,81 and at 26–36 wks of gestation82 
were not associated with IQ score measured in children. Similarly, Li et al. (2019) assessed 
the association between mid (range: 10–23 wks of gestation) and late pregnancy (19–35 
wks of gestation) biomarkers of phthalate exposure and child IQ and did not find an 
association for most phthalate metabolite concentrations. However, they did report an 
inverse association for mid mBzP metabolite concentrations. Moreover, contrary to our 
results, several studies found third-trimester LMWP, DEHP, and HMWP exposure to 
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be associated with cognition. A study demonstrated that a log-unit higher mBP and 
mIBP metabolite concentrations resulted in 2.7 lower IQ scores [mBP= (−2.7, 95% 
CI: −4.3, −1.1), mIBP= (−2.7, 95% CI: −4.2, −1.2)] in children 7 years of age.36 Other 
studies using the Bayles scales have estimated that higher DEHP and HMWP exposure 
was predictive of cognitive functioning in children 6 months to 3 years of age.37,38 Next, 
in contrast to previous studies examining DNOP exposure in late pregnancy,40,43,83 we 
found an inverse association with late pregnancy mCPP metabolite concentrations and 
cognition. Differences in results may be due to ethnic and socioeconomic differences and 
differences in cognitive measurement scales. For example, the study population of Factor-
Litvak et al. (2014) consisted of Hispanic and African American women of inner-city 
New York with low socioeconomic status. Our study population comprised mainly Dutch 
participants and fewer socioeconomically deprived persons, limiting comparability of the 
results. Further, the Bayley Scales of Infant Development measures cognition through 
evaluation of sensory perception, knowledge, memory, problem solving, and early language 
at a young age. We used the SON-R test to measure cognition at 6 years of age, which 
is an age when IQ is arguably more stable than in infants or toddlers.
Regarding bisphenols, our results are in line with those of previous studies that also 
were unable to detect an association between maternal urinary BPA concentrations 
and cognitive functioning in children.49-52,81 BPA concentrations measured at 12 wks 
of gestation,52 at 16–26 wks of gestation,50,51 and at 22–29 wks of gestation45 were not 
associated with IQ scores measured in children 1 and 8 years of age. Casas et al. (2015) 
used the Bayley Scales (at 1 year of age) and the McCarthy Scales of Children’s Abilities 
(at 4 years of age) to assess cognitive functioning but found no association for averaged 
first- and third-trimester BPA exposure. However, one study assessing BPA exposure 
using cord blood instead of maternal urine estimated an inverse association with IQ in 
children at 7 years of age.47
To our knowledge, only one previous study investigated prenatal BPS and BPF exposure 
in relation to cognitive functioning in children.53 The present study examined early 
pregnancy exposure to a mixture of endocrine-disrupting chemicals, including BPA, BPF, 
and BPS, and identified BPF as the primary chemical with a substantial contribution 
to the overall mixture effect on lower IQ among boys.53 Manufacturers seeking BPA 
alternatives have turned to other bisphenols to produce BPA-free products.84 However, 
experimental studies have shown that the BPA replacements have metabolism, potencies, 
and mechanisms of action that may be similar to that of BPA.85 BPF and BPS also display 
endocrine-disruptive properties.86,87 Further, an experimental study suggested that prenatal 
BPS exposure is able to induce hypothalamic neurogenesis.88 However, we did not find 
that prenatal exposure to BPF and BPS was associated with nonverbal IQ in children.
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Several studies have estimated sex differences in the association between prenatal phthalates 
or bisphenol exposure with neurobehavioral problems such as aggression, hyperactivity, 
inattention, emotional reactiveness, orientation, motor performance, anxiety, and depression 
and reduced masculine play in boys.48,89-96 In some studies of cognitive outcomes, effect 
modification by sex was estimated in the association of prenatal phthalate exposure and 
the Bayley Scales39,40,83,97 and IQ,41 but the findings are inconsistent regarding the exact 
phthalate metabolites, timing of exposure, and the sex-specific effect of the associations.
The phthalate and bisphenol concentrations in the present study were generally of the 
same magnitude as those reported by several other studies of pregnant women. For 
example median mEHHP (6–12 ng/mL), mEOHP (7–8 ng/mL), mBP (10–16 ng/mL), 
and BPA (1.1–1.5 ng/mL) concentrations in the present study were similar to those 
estimated in Canada (9, 6, 12, and 1 ng/mL, respectively)98 and Israel (6, 5, 10, and 2 ng/
mL, respectively).99 Concentrations measured in pregnant women from Korea, China, 
Taiwan, and the United States were, in general, somewhat higher.36-39,41,42,100 The difference 
in exposure levels between studies may be due to different dietary habits, methods and 
timing of urine sampling, product usage, and metabolic rate.
We found substantial confounding (~50%) of point estimates when adjusting for 
confounders and little change in the estimates when accounting for the exposure of other 
time windows. This suggests that the total effect of early pregnancy phthalate exposure on 
nonverbal IQ is mostly driven by the direct effect rather than by mid and late pregnancy 
phthalate exposure and that the effect of late pregnancy DNOP exposure is somewhat 
confounded by early and mid-pregnancy exposure.
The critical windows of fetal neurodevelopment toxicity for phthalate exposure is uncertain. 
To the best of our knowledge, this is one of the first studies among humans that investigated 
early pregnancy phthalate exposure in relation to offspring IQ. Our results suggest that 
early pregnancy might be a critical period for potential effects of phthalate exposure 
on cognitive development. Although biological mechanisms that might contribute to 
associations are uncertain, animal studies have shown that phthalates may interfere with 
processes essential for the development of the fetal brain.15,16 A potential mechanism is 
via the disruption of the thyroid function.15,16 Thyroid hormones are important for fetal 
neurodevelopment from early pregnancy onward. Animal studies have showed that thyroid 
hormones are involved in neocorticogenesis and the development of the hippocampus 
and cytoarchitecture of the somatosensory cortex.101,102 In addition, data from animal 
studies have shown that maternal hypothyroxinemia interferes with neuronal migration, 
differentiation, synaptogenesis, and cortical layer formation.103,104 During early gestation, 
the fetus depends fully on maternal thyroid hormones that cross the placenta because 
the fetal thyroid function does not start before 12–14 wks of pregnancy.103,105 Further, 
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after the onset of fetal thyroid hormone production, the fetus remains dependent on 
maternal thyroid hormones.103 Prenatal exposure to phthalates has been associated with 
changes in circulating thyroid hormone and low thyroid function in pregnant women, 
including during early pregnancy,13,106-108 which is an important determinant of offspring 
neurodevelopment.109,110 For example, earlier studies in the same cohort as the present 
study (the Generation R Study cohort) found maternal thyroid function during early 
pregnancy to be associated with nonverbal IQ.111
Another potential mechanism might be that prenatal phthalate exposure may affect 
neurodevelopment through interaction with peroxisome proliferator-activated 
receptors, a class of nuclear receptors involved in many physiologic processes central 
to neurodevelopment, including cellular reproduction and differentiation.15,16 Animal 
studies have shown that phthalates may induce peroxisome proliferator-activated receptor 
overexpression, resulting in apoptosis of undifferentiated neurons.112 Further, prenatal 
phthalate exposures may be associated with fetal growth113 which is a strong predictor 
of neurodevelopment.114 It is conceivable that fetal exposure to phthalates may affect 
neurodevelopment via growth restriction. However, recent reviews do not provide a clear 
conclusion about the effects of phthalates on pregnancy outcomes such as gestational 
age, birth weight, and preterm birth.113,115,116 Several phthalates are anti-androgenic, 
resulting in circulating testosterone and male reproductive tract abnormalities.117-122 
Gonadal hormones are important for sex-specific brain development, and they also play 
a crucial role in adolescent brain remodelling.123,124 Other potential mechanisms include 
the disruption of calcium signaling and lipid metabolism, which are essential for normal 
neurodevelopmental processes in fetal life.15,16
In the present study, we estimated that a 10-fold increase in early pregnancy phthalate 
metabolite concentrations and late pregnancy DNOP exposure was associated with 
1.7–2.4 lower IQ points in children. Higher child IQ is associated with healthier behavior 
and lifetime achievements (including educational achievement, well-paid employment, 
enhanced social status, and the accompanying benefits to health) later in life.125,126 Several 
studies have estimated the socioeconomic impact of IQ loss. The burden and disease 
costs of exposure to chemicals has been estimated to be high.127 For example, every IQ 
point lost from the U.S. average is estimated to have an annual cost of US$71 billion.128
A strength of the present study is the large sample size. The sample of our study was 
approximately two to three times larger than the abovementioned studies that investigated 
prenatal phthalates or bisphenol exposure and cognitive function in children. Another 
strength of the present study is the availability of more phthalate and bisphenol biomarkers 
as compared with previous studies investigating prenatal exposure to phthalates or 
bisphenols and neurodevelopment. Finally, the three repeated measures for exposure 
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estimation in three time windows across pregnancy is yet another strength. This allowed 
us to investigate potential windows of susceptibility.
Our study has a few limitations that need to be considered. Although we adjusted for 
many potential confounders, we cannot rule out residual confounding by unknown 
unobserved background risk factors related to the likelihood of exposure and cognitive 
functioning. Second, we used three spot urine samples during early, mid, and late 
pregnancy for measurements of chemicals. Although this is more frequent than most 
other studies investigating prenatal exposure to phthalates and bisphenols and cognitive 
functioning, misclassification of exposure due to the limited number of samples may 
have occurred and could have resulted in less precise exposure–response estimates.129,130 
This is particularly relevant for the time-specific analyses in which we relied on a single 
biomarker to estimate exposure. Phthalates and bisphenols have a short half-life and are 
quickly metabolized in the human body. Therefore, the use of multiple pooled urine 
specimens across trimesters is suggested to avoid exposure misclassification.129-131 Another 
limitation of the present study is the absence of information about the exact time of spot 
urine sampling. Because the urine spot samples were collected between 0800 and 1000 
hours, there may have been a combination of first morning and random spot samples. 
Concentrations of chemicals, urine volume, and the rate of excretion vary with fluid 
intake, time of day, and other factors.132-134 Although time of sample collection is unlikely 
to confound the association between phthalate and bisphenol exposure and nonverbal 
IQ, the difference in concentrations between morning and random spot urine could have 
increased the intra-individual variability. We used creatinine adjustment to account for 
urine dilution, which is advantageous because of its ease of measurement and the low 
cost and widespread availability of assays.135 However, creatinine excretion rates may 
vary across pregnancy136-138 and studies have suggested that specific gravity rather than 
creatinine adjustment may be more appropriate in populations undergoing physiological 
changes in renal function, such as pregnant women.139,140 For example, specific gravity 
has a slightly better within-person reproducibility and the least amount of systematic 
variation when compared with creatinine adjustment 140. However, high correlations 
(>0.8) between creatinine and specific gravity in spot urines have been reported.141-143 
Finally, the Generation R Study is representative of an urban population with varying 
ethnicities, socioeconomic statuses, and educational levels, and therefore less generalizable 
to populations where the phthalate and bisphenol exposure sources may differ.
In the present study, we did not observe that maternal biomarkers of bisphenols are 
associated with lower nonverbal IQ. We did observe that phthalate exposure in early 
pregnancy and DNOP exposure in late pregnancy is associated with lower nonverbal IQ 
scores in children. Our results might suggest that particularly early pregnancy is a sensitive 
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Table S1. Variables used in logistic regression model to calculate inverse probability of  attrition 
weights.
Variables Explored a Included b
Maternal educational level x x
Maternal ethnicity x x
Maternal age x x
Maternal parity x x
Maternal alcohol use during pregnancy x x
Maternal tobacco use during pregnancy x x
Maternal body mass index x x
Household income during pregnancy x x
Marital status during pregnancy x
Child’s sex x
Child’s birth weight x
Gestational age at birth x x
a. Characteristics explored in logistic regression models to test whether they differ between included and not-inclu-
ded participants of the Generation R Study cohort.
b. Characteristics that were predictive (P<0.20) of being included in our study.
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Table S2. Descriptive statistics of  urinary phthalate metabolite concentrations in ng/ml a across 
pregnancy measured in 1,282 women
N LOD <LOD min P25 P50 P75 max
LMWP concentrations
mMP <18 weeks 1274 0.06 0.2% 0 2.7 5.4 9.8 1231.8
mMP 18-25 weeks 1270 0.06 0.2% 0 1.9 3.5 6.4 2486.5
mMP >25 weeks 1269 0.06 0.5% 0 2.0 4.1 8.1 1660
mEP <18 weeks 1274 0.06 0.1% 0 40.5 139.2 484.5 27649.1
mEP 18-25 weeks 1270 0.06 0.0% 1.5 25.1 72.6 227.3 27602.6
mEP >25 weeks 1269 0.06 0.0% 1.4 44.7 127.8 410.9 17428.4
mBP <18 weeks 1274 0.14 0.7% 0.1 7.0 16.1 31.1 2715.6
mBP 18-25 weeks 1270 0.14 0.0% 0.2 5.5 9.7 19.1 23148.1
mBP >25 weeks 1269 0.14 0.2% 0.1 6.1 12.1 25.1 2573.4
mIBP <18 weeks 1274 0.09 0.2% 0.1 9.6 21.4 47.0 1826.6
mIBP 18-25 weeks 1270 0.09 0.0% 0.5 4.6 9.0 18.4 1773.7
mIBP >25 weeks 1269 0.09 0.2% 0.1 9.4 18.1 38.3 2057.1
HMWP concentrations
DEHP
mECPP <18 weeks 1274 0.29 0.2% 0.2 8.3 16.3 31.3 942.0
mECPP 18-25 weeks 1270 0.29 0.1% 0.2 5.9 10.7 20.7 93301.2
mECPP >25 weeks 1269 0.29 0.0% 0.7 9.4 18.2 34.3 578.5
mEHHP <18 weeks 1274 0.08 0.2% 0.1 5.8 11.8 22.7 548.8
mEHHP 18-25 weeks 1270 0.08 0.1% 0.1 3.0 5.6 11.0 273.1
mEHHP >25 weeks 1269 0.08 0.2% 0.1 5.2 10.3 19.7 336.9
mEOHP <18 weeks 1274 0.04 0.0% 0.1 3.5 7.7 15.1 416.5
mEOHP 18-25 weeks 1270 0.04 0.0% 0.2 3.7 7.5 16.6 11831
mEOHP >25 weeks 1269 0.04 0.0% 0.4 3.9 7.2 14.0 260.1
mCMHP <18 weeks 1274 0.04 0.1% 0 7.6 14.0 26.5 2729.6
mCMHP 18-25 weeks 1270 0.04 0.2% 0 2.3 4.2 7.5 5497.2
mCMHP >25 weeks 1269 0.04 1.1% 0 1.9 3.5 6.5 165.0
DINP
mINP <18 weeks 1274 0.18 85.5% 0.1 0.1 0.1 0.1 16.1
mINP 18-25 weeks 1270 0.18 98.6% 0.1 0.1 0.1 0.1 0.6
mINP >25 weeks 1269 0.18 99.9% 0.1 0.1 0.1 0.1 16.9
DIDP
mIDP <18 weeks 1274 0.89 92.6% 0.6 0.6 0.6 0.6 14.2
mIDP 18-25 weeks 1270 0.89 98.2% 0.6 0.6 0.6 0.6 4.7
mIDP >25 weeks 1269 0.89 96.7% 0.6 0.6 0.6 0.6 17.8
DNOP
mCPP <18 weeks 1274 0.008 0.0% 0 0.8 1.4 2.8 120.2
mCPP 18-25 weeks 1270 0.008 0.0% 0 0.5 0.9 1.8 75.4
mCPP >25 weeks 1269 0.008 0.1% 0 0.9 1.8 3.2 60.4
Continue
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N LOD <LOD min P25 P50 P75 max
mOP <18 weeks 1274 0.25 90.2% 0.2 0.2 0.2 0.2 9.3
mOP 18-25 weeks 1270 0.25 99.4% 0.2 0.2 0.2 0.2 0.8
mOP >25 weeks 1269 0.25 99.3% 0.2 0.2 0.2 0.2 1.7
mCHpP <18 weeks 1274 0.06 99.3% 0 0 0 0 0.2
mCHpP 18-25 weeks 1270 0.06 100.0% 0 0 0 0 0
mCHpP >25 weeks 1269 0.06 99.8% 0 0 0 0 3.7
Other HMWP
mBzP <18 weeks 1274 0.15 8.2% 0.1 2.3 5.8 12.1 613.8
mBzP 18-25 weeks 1270 0.15 1.7% 0.1 2.2 5.3 11.0 522.9
mBzP >25 weeks 1269 0.15 3.5% 0.1 1.2 3.1 6.5 211.0
mHxP <18 weeks 1274 0.06 23.9% 0 0.1 0.2 0.5 59.9
mHxP 18-25 weeks 1270 0.06 98.8% 0 0 0 0 0.4
mHxP >25 weeks 1269 0.06 98.1% 0 0 0 0 2.4
mHpP <18 weeks 1274 0.30 35.4% 0.2 0.2 0.6 1.5 78.7
mHpP 18-25 weeks 1270 0.30 96.6% 0.2 0.2 0.2 0.2 1.3
mHpP >25 weeks 1269 0.30 98.5% 0.2 0.2 0.2 0.2 24.5
mCHP <18 weeks 1274 0.04 80.3% 0 0 0 0 22.9
mCHP 18-25 weeks 1270 0.04 94.4% 0 0 0 0 1.4
mCHP >25 weeks 1269 0.04 99.3% 0 0 0 0 2.2
PA
PA <18 weeks 1274 1.11 0.2% 0.8 30.0 56.9 120.3 9450.0
PA 18-25 weeks 1270 1.11 0.1% 0.8 62.5 157.4 288.6 5367.5
PA >25 weeks 1269 1.11 0.4% 0.8 34.3 69.2 132.0 3580.0
Abbreviations: n=number, LOD=limit of detection, min=minimum, P=percentile, max=maximum. LMWP= 
Low molecular weight phthalates (Mono methyl phthalate (mMP), Mono ethyl phthalate (mEP), Mono-n-butyl 
phthalate (mBP), Mono-isobutyl phthalate (mIBP)), HMWP= High molecular weight phthalates (Di-2-ethyl-
hexyl phthalates (DEHP) [Mono-(2-ethyl-5-carboxypentyl) phthalate (mECPP), Mono-(2-ethyl-5-hydroxyhexyl) 
phthalate (mEHHP), Mono-(2-ethyl-5-oxohexyl) phthalate (mEOHP), Mono-[(2-carboxymethyl)hexyl] phthalate 
(mCMHP)], Di-isononyl phthalate (DINP) [Mono isononyl phthalate (mINP)], Di-isodecylphthalate (DIDP) 
[Mono-(8-methyl-1-nonyl) phthalate (MIDP)], Di-n-octylphthalate (DNOP) [ Mono(3-carboxypropyl) phthalate 
(mCPP), Monooctyl phthalate (mOP), Mono-(7-carboxy-n-heptyl) phthalate (mCHpP)], other HMWP [Monoben-
zyl phthalate (mBzP), Mono-hexyl phthalate (mHxP), Mono-2-heptylphthalate (mHpP), Monocyclohexyl phthalate 
(mCHP)]), PA= Phthalic acid.




Table S3. Descriptive statistics of  urinary bisphenol concentrations in ng/ml a across pregnancy 
measured in 1,282 women
N LOD %<LOD min P25 P50 P75 max
Bisphenol A <18 weeks 1274 0.15 20.6% 0.1 0.3 1.1 2.8 524.8
Bisphenol A 18-25 weeks 1270 0.15 6.9% 0.1 0.6 1.3 3.0 365
Bisphenol A >25 weeks 1269 0.15 10.1% 0.1 0.6 1.5 3.0 72.9
Bisphenol S <18 weeks 1274 0.05 32.2% 0 0 0.2 0.6 28.4
Bisphenol S 18-25 weeks 1270 0.05 70.2% 0 0 0 0.1 20.0
Bisphenol S >25 weeks 1269 0.05 81.0% 0 0 0 0 46.7
Bisphenol Z <18 weeks 1274 0.12 88.0% 0.1 0.1 0.1 0.1 2.3
Bisphenol Z 18-25 weeks 1270 0.12 96.2% 0.1 0.1 0.1 0.1 0.4
Bisphenol Z >25 weeks 1269 0.12 99.8% 0.1 0.1 0.1 0.1 1.3
Bisphenol B <18 weeks 1274 0.03 90.2% 0 0 0 0 1.6
Bisphenol B 18-25 weeks 1270 0.03 97.6% 0 0 0 0 0.5
Bisphenol B >25 weeks 1269 0.03 100% 0 0 0 0 0
Bisphenol F <18 weeks 1274 0.18 59.7% 0.1 0.1 0.1 0.4 82.7
Bisphenol F 18-25 weeks 1270 0.18 88.8% 0.1 0.1 0.1 0.1 14.3
Bisphenol F >25 weeks 1269 0.18 71.2% 0.1 0.1 0.1 0.5 42.7
Bisphenol AF <18 weeks 1274 0.79 100% 0.6 0.6 0.6 0.6 0.6
Bisphenol AF 18-25 weeks 1270 0.79 100% 0.6 0.6 0.6 0.6 0.6
Bisphenol AF >25 weeks 1269 0.79 100% 0.6 0.6 0.6 0.6 0.6
Bisphenol AP <18 weeks 1274 0.07 92.4% 0.1 0.1 0.1 0.1 6.3
Bisphenol AP 18-25 weeks 1270 0.07 100% 0.1 0.1 0.1 0.1 0.1
Bisphenol AP >25 weeks 1269 0.07 99.9% 0.1 0.1 0.1 0.1 0.2
Bisphenol P <18 weeks 1274 0.11 98.7% 0.1 0.1 0.1 0.1 0.5
Bisphenol P 18-25 weeks 1270 0.11 100% 0.1 0.1 0.1 0.1 0.1
Bisphenol P >25 weeks 1269 0.11 99.3% 0.1 0.1 0.1 0.1 0.2
Abbreviations: n=number, LOD=limit of detection, min=minimum, P=percentile, max=maximum.
a. Values below the LOD are imputed by LOD/√2.
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Table S4. Intra-class correlations between log10 transformed phthalate and bisphenol concentrati-
ons across gestational urinary collection phases
ICC a ICC b












Bisphenol metabolite concentrations in ng/ml
Total bisphenols d 0.05 0.14
Bisphenol concentrations in ug/g creatinine
Total bisphenols d 0.00 0.00
a. ICC = Intraclass Correlation Coefficients calculated using a single-measurement, absolute-agreement, and 2-way 
mixed-effects model.
b. ICC = Intraclass Correlation Coefficients calculated using a mean of three measurements, absolute-agreement, and 
2-way mixed-effects model.
c. Phthalate metabolites are grouped into: low molecular weight phthalate metabolites (LMWP) = sum of Mono 
methyl phthalate, Mono ethyl phthalate, Mono-isobutyl phthalate, and Mono-n-butyl phthalate, high molecular 
weight phthalate metabolites (HMWP) = sum of mono-(2-ethyl-5-carboxypentyl) phthalate, mono-(2-ethyl-
5-hydroxyhexyl) phthalate, mono-(2-ethyl-5-ox-ohexyl) phthalate, mono-[(2-carboxymethyl)hexyl] phthalate, 
mono(3-carboxypropyl) phthalate, monobenzyl phthalate, mono-hexyl phthalate, and mono-2-hep-tylphthalate, 
Di-2-ethylhexyl phthalate metabolites (DEHP) = sum of Mono-(2-ethyl-5-carboxypentyl) phthalate, Mono-(2-ethyl-
5-hydroxyhexyl) phthalate, Mono-(2-ethyl-5-oxohexyl) phthalate, and Mono-[(2-carboxymethyl)hexyl] phthalate, 
Di-n-octyl phthalate metabolites (DNOP) = Mono(3-carboxypropyl) phthalate, Phthalic acid (PA) = a proxy for 
total phthalate exposure measured in ug/g creatinine.
d. Total bisphenol =-sum of Bisphenol A, bisphenol F, and Bisphenol S.
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Table S5. Adjusted a associations between maternal urine phthalate metabolite and bisphenol 
concentrations in ug/g creatinine, by timing of  pregnancy and sex (n=1,282). 
Boys (N=647) Girls (N=635)
B 95%CI B 95%CI P-interaction P-interaction b
Phthalate metabolite concentrations c
LMWP <18 weeks -1.02 -3.05, 1.00 -2.38 -4.24, -0.52 0.34 0.40
LMWP 18-25 weeks 0.05 -2.20, 2.29 0.53 -1.53, 2.59 0.74 0.70
LMWP >25 weeks -2.28 -4.67, 0.11 -0.25 -2.38, 1.87 0.31 0.19
LMWP Averaged -2.07 -5.19, 1.06 -1.50 -4.21, 1.20 0.85 0.69
HMWP <18 weeks -1.94 -4.63, 0.75 -1.68 -4.19, 0.83 0.87 0.82
HMWP 18-25 weeks d 1.06 -1.74, 3.86 0.90 -1.53, 3.34 0.73 0.95
HMWP >25 weeks d 1.59 -2.28, 5.47 0.19 -3.13, 3.50 0.34 0.57
Averaged HMWP -0.19 -4.95, 4.58 -0.57 -4.80, 3.66 0.69 0.95
DEHP <18 weeks -1.95 -4.59, 0.69 -1.55 -4.00, 0.89 0.79 0.78
DEHP 18-25 weeks 0.93 -1.81, 3.66 0.78 -1.61, 3.18 0.79 0.95
DEHP >25 weeks 1.58 -2.14, 5.31 0.05 -3.14, 3.24 0.32 0.51
Averaged DEHP -0.13 -3.68, 3.41 0.03 -3.03, 3.09 0.95 0.91
DNOP <18 weeks -1.88 -4.47, 0.70 -2.31 -4.71, 0.08 0.77 0.90
DNOP 18-25 weeks 0.86 -1.99, 3.70 -0.41 -3.16, 2.33 0.44 0.55
DNOP >25 weeks -2.91 -6.49, 0.68 -1.47 -4.67, 1.74 0.82 0.54
Averaged DNOP -2.62 -7.06, 1.82 -3.63 -7.90, 0.63 0.55 0.81
PA <18 weeks -1.92 -4.35, 0.51 -1.91 -4.09, 0.27 0.81 0.86
PA 18-25 weeks 2.17 -0.35, 4.68 -0.26 -2.64, 2.12 0.15 0.16
PA >25 weeks -2.19 -5.34, 0.96 0.07 -2.90, 3.04 0.32 0.28
Averaged PA -1.15 -5.26, 2.95 -2.15 -6.01, 1.70 0.79 0.80
Bisphenol concentrations
TB <18 weeks e 0.95 -1.15, 3.05 -0.15 -1.99, 1.70 0.68 0.45
TB 18-25 weeks f 0.56 -1.68, 2.81 -0.25 -2.48, 1.99 0.54 0.56
TB >25 weeks g 1.36 -1.06, 3.78 -1.72 -4.06, 0.63 0.08 0.07
Averaged TB 2.83 -1.06, 6.72 -1.81 -5.48, 1.85 0.13 0.08
a. Adjusted for maternal age, maternal non-verbal IQ, age of the child at assessment, ethnicity categories (Dutch, 
other-western and non-western), education (low, intermediate and high), income (low, middle and high), marital 
status, maternal alcohol consumption (no alcohol consumption during pregnancy, alcohol consumption until preg-
nancy was known, occasionally alcohol consumption during pregnancy and frequently alcohol consumption during 
pregnancy), BMI, parity categories (0, 1, 2+), and smoking categories (no smoking during pregnancy, smoked until 
pregnancy was known, smoked during pregnancy).
b. Estimated with the use of the augmented product terms (Buckley et al. 2017).
c Phthalate metabolites are grouped into: low molecular weight phthalate metabolites (LMWP) = sum of Mono 
methyl phthalate, Mono ethyl phthalate, Mono-isobutyl phthalate, and Mono-n-butyl phthalate, high molecular 
weight phthalate metabolites (HMWP) = sum of mono-(2-ethyl-5-carboxypentyl) phthalate, mono-(2-ethyl-
5-hydroxyhexyl) phthalate, mono-(2-ethyl-5-ox-ohexyl) phthalate, mono-[(2-carboxymethyl)hexyl] phthalate, 
mono(3-carboxypropyl) phthalate, monobenzyl phthalate, mono-hexyl phthalate, and mono-2-hep-tylphthalate, 
Di-2-ethylhexyl phthalate metabolites (DEHP) = sum of Mono-(2-ethyl-5-carboxypentyl) phthalate, Mono-(2-ethyl-
5-hydroxyhexyl) phthalate, Mono-(2-ethyl-5-oxohexyl) phthalate, and Mono-[(2-carboxymethyl)hexyl] phthalate, 
Di-n-octyl phthalate metabolites (DNOP) = Mono(3-carboxypropyl) phthalate, Phthalic acid (PA) = a proxy for total 
phthalate exposure measured in ug/g creatinine.
d. with the exclusion of mono-hexyl phthalate, and mono-2-hep-tyl phthalate metabolite concentrations
e. Total bisphenol =-sum of Bisphenol A, bisphenol F, and Bisphenol S.
f. Total bisphenol =-sum of Bisphenol A, and Bisphenol S.
g. Total bisphenol =-sum of Bisphenol A and bisphenol F.
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Table S6. Difference in child non-verbal IQ score at age six years per log10 increase in maternal 
urinary phthalate and bisphenol concentrations in ng/ml with creatinine added as a separate 
covariate (n=1,282).
Adjusted a
Phthalate metabolites b B 95%CI
Σ LMWP metabolites
<18 weeks -1.65 -3.02, -0.27
18-25 weeks 0.16 -1.37, 1.69
>25 weeks -1.31 -2.86, 0.24
Averaged -1.82 -3.83, 0.19
Σ HMWP metabolites
<18 weeks -1.92 -3.88, 0.04
18-25 weeks c 0.95 -0.98, 2.88
>25 weeks c 0.01 -2.48, 2.50
Averaged -0.86 -4.08, 2.35
Σ DEHP metabolites
<18 weeks -1.80 -3.69, 0.09
18-25 weeks 0.82 -1.05, 2.70
>25 weeks -0.02 -2.40, 2.36
Averaged -0.91 -4.00, 2.19
Σ DNOP metabolites
<18 weeks -2.03 -3.86, -0.21
18-25 weeks 0.28 -1.66, 2.22
>25 weeks -2.82 -5.10, -0.54
Averaged -3.32 -6.31, -0.34
PA metabolites
<18 weeks -1.99 -3.68, -0.30
18-25 weeks 0.79 -1.05, 2.64
>25 weeks -1.48 -3.54, 0.57
Averaged -2.20 -5.03, 0.64
Adjusted a
Bisphenol metabolites B 95%CI
<18 weeks d 0.65 -0.85, 2.15
18-25 weeks e 0.02 -1.56, 1.59
>25 weeks f -0.28 -2.00, 1.44
Averaged 0.47 -2.27, 3.21
a. Adjusted for creatinine, maternal age, maternal non-verbal IQ, sex of child, age of the child at assessment, ethnici-
ty, education, income, marital status, maternal alcohol consumption, BMI, parity categories, and smoking.
b Phthalate metabolites are grouped into: low molecular weight phthalate metabolites (LMWP) = sum of Mono 
methyl phthalate, Mono ethyl phthalate, Mono-isobutyl phthalate, and Mono-n-butyl phthalate, high molecular 
weight phthalate metabolites (HMWP) = sum of mono-(2-ethyl-5-carboxypentyl) phthalate, mono-(2-ethyl-
5-hydroxyhexyl) phthalate, mono-(2-ethyl-5-ox-ohexyl) phthalate, mono-[(2-carboxymethyl)hexyl] phthalate, 
mono(3-carboxypropyl) phthalate, monobenzyl phthalate, mono-hexyl phthalate, and mono-2-hep-tylphthalate, 
Di-2-ethylhexyl phthalate metabolites (DEHP) = sum of Mono-(2-ethyl-5-carboxypentyl) phthalate, Mono-(2-ethyl-
5-hydroxyhexyl) phthalate, Mono-(2-ethyl-5-oxohexyl) phthalate, and Mono-[(2-carboxymethyl)hexyl] phthalate, 
Di-n-octyl phthalate metabolites (DNOP) = Mono(3-carboxypropyl) phthalate, Phthalic acid (PA) = a proxy for 
total phthalate exposure measured in ug/g creatinine.
c. with the exclusion of mono-hexyl phthalate, and mono-2-hep-tyl phthalate metabolite concentrations
d Total bisphenol =-sum of Bisphenol A, bisphenol F, and Bisphenol S.
e Total bisphenol =-sum of Bisphenol A, and Bisphenol S.
f. Total bisphenol =-sum of Bisphenol A and bisphenol F.
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Table S7. Difference in child non-verbal IQ score at age six years per log10 increase in individual 
urinary biomarkers (ug/g creatinine) of  phthalate and bisphenol exposure (n=1,282).
<18 weeks 18-25 weeks >25 weeks Averaged
Unadjusted B 95%CI B 95%CI B 95%CI B 95%CI
mMP -2.70 -4.42, -0.99 -0.90 -2.75, 0.94 -0.43 -2.26, 1.40 -2.80 -5.33, -0.27
mEP -2.26 -3.42, -1.09 -1.06 -2.34, 0.23 -1.90 -3.23, -0.56 -3.02 -4.66, -1.39
mIBP -3.85 -5.38, -2.31 -2.35 -4.06, -0.64 -2.85 -4.68, -1.01 -6.11 -8.46, -3.75
mBP -2.31 -3.89, -0.72 -1.35 -3.28, 0.58 -1.77 -3.73, 0.18 -4.26 -6.96, -1.56
mECPP -3.30 -5.14, -1.47 -1.61 -3.54, 0.32 -0.66 -3.19, 1.87 -4.53 -7.52, -1.54
mEHHP -2.22 -3.86, -0.58 0.10 -1.72, 1.93 0.71 -1.23, 2.66 -1.59 -4.41, 1.22
mEOHP -2.05 -3.65, -0.46 -0.63 -2.33, 1.08 0.41 -1.65, 2.47 -2.49 -5.33, 0.36
mCMHP -3.74 -5.71, -1.77 0.31 -1.63, 2.24 0.67 -1.54, 2.87 -2.51 -5.70, 0.68
mCPP -2.61 -4.46, -0.76 -0.13 -2.20, 1.94 -1.10 -3.64, 1.43 -3.28 -6.47, -0.09
mBzBP -2.52 -3.74, -1.30 -1.49 -2.96, -0.03 -1.27 -2.81, 0.26 -4.07 -6.10, -2.04
mHxP 0.69 -0.68, 2.07 - - - - - -
mHpP -2.29 -3.84, -0.73 - - - - - -
PA -2.59 -4.32, -0.87 -0.90 -2.72, 0.91 -2.46 -4.75, -0.17 -4.64 -7.57, -1.71
BPA -0.44 -1.69, 0.82 0.59 -0.99, 2.18 0.25 -1.38, 1.88 -0.44 -1.69, 0.82
BPS 0.99 -0.08, 2.06 0.10 -1.57, 1.76 - - 1.43 -0.35, 3.22
PBF 2.34 0.85, 3.82 - - 2.10 0.71, 3.50 4.36 2.35, 6.36
<18 weeks 18-25 weeks >25 weeks Averaged
Adjusted a B 95%CI B 95%CI B 95%CI B 95%CI
mMP -1.56 -3.17, 0.05 -0.08 -1.81, 1.65 -0.67 -2.39, 1.06 -1.62 -4.00, 0.76
mEP -1.30 -2.41, -0.19 0.17 -1.05, 1.39 -0.97 -2.24, 0.29 -1.28 -2.85, 0.29
mIBP -1.47 -2.97, 0.04 0.49 -1.17, 2.14 0.48 -1.31, 2.27 -0.61 -3.00, 1.78
mBP -1.03 -2.53, 0.47 1.05 -0.80, 2.90 -0.01 -1.87, 1.86 -0.34 -2.96, 2.28
mECPP -1.74 -3.48, 0.00 0.12 -1.70, 1.95 0.05 -2.33, 2.42 -1.43 -4.30, 1.43
mEHHP -1.32 -2.87, 0.22 0.87 -0.85, 2.58 0.64 -1.20, 2.48 -0.16 -2.83, 2.52
mEOHP -1.23 -2.73, 0.28 0.21 -1.39, 1.82 0.85 -1.09, 2.79 -0.57 -3.27, 2.14
mCMHP -1.98 -3.84, -0.12 1.44 -0.37, 3.25 0.72 -1.35, 2.79 0.11 -2.91, 3.12
mCPP -1.98 -3.72, -0.23 0.38 -1.57, 2.32 -2.39 -4.76, -0.02 -2.97 -6.00, 0.06
mBzBP -0.67 -1.84, 0.50 0.97 -0.46, 2.39 0.21 -1.24, 1.66 0.13 -1.88, 2.13
mHxP 0.55 -0.74, 1.83 - - - - - -
mHpP -0.20 -1.70, 1.29 - - - - - -
PA -1.93 -3.55, -0.31 0.85 -0.87, 2.57 -1.09 -3.25, 1.07 -1.77 -4.57, 1.04
BPA 0.22 -0.95, 1.40 0.26 -1.22, 1.75 -0.18 -1.70, 1.34 0.22 -0.95, 1.40
BPS 0.50 -0.50, 1.50 -0.54 -2.09, 1.01 - - 0.39 -1.29, 2.06
PBF 1.25 -0.15, 2.65 - - 0.64 -0.68, 1.96 1.85 -0.07, 3.78
Abbreviations: mMP= mono-methyl phthalate, mEP= mono-ethyl phthalate, mIBP= mono-isobutyl phthalate, 
mBP= mono-n-butyl phthalate, mECPP= mono- (2-ethyl-5-carboxypentyl) phthalate, mEHHP= mono- (2-et-
hyl-5-hydroxyhexyl) phthalate, mEOHP= mono-(2-ethyl-5-oxohexyl) phthalate, mCMHP= mono-[(2-carboxymet-
hyl)hexyl] phthalate, mCPP= mono(3-carboxypropyl) phthalate, mBzP= monobenzyl phthalate, mHxP= mono-hexyl 
phthalate, mHpP= mono-2-heptyl phthalate, PA= phthalic acid, BPA= bisphenol A, BPS= bisphenol S, BPF= 
bisphenol F.
a. Adjusted for maternal age, maternal non-verbal IQ, sex of child, age of the child at assessment, ethnicity, educati-
on, income, marital status, maternal alcohol consumption, BMI, parity categories, and smoking.
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Table S8. inverse probability weighted association between log10 transformed maternal urine 
phthalate and bisphenol metabolite concentrations in ug/g creatinine and child non-verbal IQ 
score at age six years (n=1,282).
Adjusted
Phthalate metabolites c B 95%CI
Σ LMWP metabolites
<18 weeks -1.70 -3.06, -0.34
18-25 weeks 0.25 -1.27, 1.76
>25 weeks -1.15 -2.73, 0.42
Averaged -1.74 -3.75, 0.28
Σ HMWP metabolites
<18 weeks -1.53 -3.36, 0.29
18-25 weeks e 1.23 -0.63, 3.08
>25 weeks e 0.53 -1.98, 3.05
Averaged -0.05 -3.23, 3.12
Σ DEHP metabolites
<18 weeks -1.49 -3.27, 0.30
18-25 weeks 1.14 -0.67, 2.95
>25 weeks 0.49 -1.93, 2.92
Averaged 0.41 -1.92, 2.75
Σ DNOP metabolites
<18 weeks -2.00 -3.73, -0.27
18-25 weeks 0.28 -1.66, 2.22
>25 weeks -2.81 -5.16, -0.46
Averaged -3.38 -6.41, -0.34
PA metabolites
<18 weeks -1.93 -3.53, -0.32
18-25 weeks 1.02 -0.70, 2.75
>25 weeks -1.33 -3.47, 0.81
Averaged -1.77 -4.56, 1.02
Adjusted
Bisphenol metabolites B 95%CI
<18 weeks f 0.72 -0.66, 2.11
18-25 weeks g 0.22 -1.35, 1.79
>25 weeks h -0.04 -1.72, 1.64
Averaged 1.07 -1.59, 3.73
a. Adjusted for maternal age, maternal non-verbal IQ, sex of child, age of the child at assessment, ethnicity, educati-
on, income, marital status, maternal alcohol consumption, BMI, parity categories, and smoking.
b. Adjusted model with the inclusion of the three exposures in one model.
c Phthalate metabolites are grouped into: low molecular weight phthalate metabolites (LMWP) = sum of Mono 
methyl phthalate, Mono ethyl phthalate, Mono-isobutyl phthalate, and Mono-n-butyl phthalate, high molecular 
weight phthalate metabolites (HMWP) = sum of mono-(2-ethyl-5-carboxypentyl) phthalate, mono-(2-ethyl-
5-hydroxyhexyl) phthalate, mono-(2-ethyl-5-ox-ohexyl) phthalate, mono-[(2-carboxymethyl)hexyl] phthalate, 
mono(3-carboxypropyl) phthalate, monobenzyl phthalate, mono-hexyl phthalate, and mono-2-hep-tylphthalate, 
Di-2-ethylhexyl phthalate metabolites (DEHP) = sum of Mono-(2-ethyl-5-carboxypentyl) phthalate, Mono-(2-ethyl-
5-hydroxyhexyl) phthalate, Mono-(2-ethyl-5-oxohexyl) phthalate, and Mono-[(2-carboxymethyl)hexyl] phthalate, 
Di-n-octyl phthalate metabolites (DNOP) = Mono(3-carboxypropyl) phthalate, Phthalic acid (PA) = a proxy for 
total phthalate exposure measured in ug/g creatinine.
d. Tests whether exposure from different time points relates in the same manner to non-verbal IQ scores using the 
multiple informant method (Sanchez et al. 2011).
e. with the exclusion of mono-hexyl phthalate, and mono-2-hep-tyl phthalate metabolite concentrations
f. Total bisphenol =-sum of Bisphenol A, bisphenol F, and Bisphenol S.
g Total bisphenol =-sum of Bisphenol A, and Bisphenol S.
h. Total bisphenol =-sum of Bisphenol A and bisphenol F.
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Table S9. Adjusted a association between log10 transformed maternal urinary phthalate metabo-
lite and bisphenol concentration in ug/g creatinine with additional adjustment for the maternal 




<18 weeks -1.64 -3.01, -0.28
18-25 weeks 0.29 -1.23, 1.81
>25 weeks -1.05 -2.64, 0.54
Averaged -1.63 -3.67, 0.41
Σ HMWP 
<18 weeks -1.72 -3.55, 0.11
18-25 weeks d 1.04 -0.80, 2.88
>25 weeks d 0.65 -1.88, 3.18
Averaged -0.33 -3.49, 2.82
Σ DEHP 
<18 weeks -1.66 -3.45, 0.13
18-25 weeks 0.91 -0.89, 2.71
>25 weeks 0.59 -1.85, 3.02
Averaged 0.08 -2.23, 2.39
Σ DNOP 
<18 weeks -1.93 -3.68, -0.18
18-25 weeks 0.40 -1.55, 2.34
>25 weeks -2.41 -4.79, -0.03
Averaged -2.92 -5.95, 0.12
PA 
<18 weeks -1.85 -3.47, -0.22
18-25 weeks 0.84 -0.88, 2.56
>25 weeks -1.01 -3.18, 1.16
Averaged -1.65 -4.45, 1.16
Bisphenol concentrations
<18 weeks e 0.51 -0.87, 1.90
18-25 weeks f 0.16 -1.40, 1.73
>25 weeks g 0.00 -1.68, 1.68
Averaged 0.79 -1.87, 3.46
a. Adjusted for maternal age, maternal non-verbal IQ, sex of child, age of the child at assessment, ethnicity, mater-
nal education, income, marital status, maternal alcohol consumption, maternal BMI, parity categories, maternal 
smoking, maternal fruit intake, maternal vegetable intake, and maternal folic acid intake.
b. maternal fruit and vegetable intake were adjusted for energy intake.
c Phthalate metabolites are grouped into: low molecular weight phthalate metabolites (LMWP) = sum of Mono 
methyl phthalate, Mono ethyl phthalate, Mono-isobutyl phthalate, and Mono-n-butyl phthalate, high molecular 
weight phthalate metabolites (HMWP) = sum of mono-(2-ethyl-5-carboxypentyl) phthalate, mono-(2-ethyl-
5-hydroxyhexyl) phthalate, mono-(2-ethyl-5-ox-ohexyl) phthalate, mono-[(2-carboxymethyl)hexyl] phthalate, 
mono(3-carboxypropyl) phthalate, monobenzyl phthalate, mono-hexyl phthalate, and mono-2-hep-tylphthalate, 
Di-2-ethylhexyl phthalate metabolites (DEHP) = sum of Mono-(2-ethyl-5-carboxypentyl) phthalate, Mono-(2-
ethyl-5-hydroxyhexyl) phthalate, Mono-(2-ethyl-5-oxohexyl) phthalate, and Mono-[(2-carboxymethyl)hexyl] 
phthalate, Di-n-octyl phthalate metabolites (DNOP) = Mono(3-carboxypropyl) phthalate, Phthalic acid (PA) = a 
proxy for total phthalate exposure measured in ug/g creatinine.
d. with the exclusion of mono-hexyl phthalate, and mono-2-hep-tyl phthalate metabolite concentrations
e. Total bisphenol =-sum of Bisphenol A, bisphenol F, and Bisphenol S.
f. Total bisphenol =-sum of Bisphenol A, and Bisphenol S.
g. Total bisphenol =-sum of Bisphenol A and bisphenol F.
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Figure S1. Directed Acyclic Graph of the prenatal phthalates and bisphenol exposure and child non-verbal 
IQ association.
Potential adjustment variables were selected a priori defined with a Directed Acyclic Graph (DAG) using the 
Dagitty software (Textor et al. 2017). The DAG was based on previous studies of phthalates and bisphenol 
exposure and child neurodevelopment and on biologically plausible covariate–exposure and covariate–
outcome associations observed in our data. Green circles represent ancestors of the exposure, blue circles 
ancestors of the outcome, pink circles ancestors of both exposure and outcome. Maternal BMI= Maternal 
body mass index, ses= socioeconomic status (maternal education, household income and marital status), age 

















Figure S2. Restricted cubic splines (and 95% confidence intervals) of adjusted child non-verbal IQ scores and 
(untransformed) grouped phthalate metabolite concentrations. A) LMWP= Low molecular weight phthalates 
(sum of mono methyl phthalate, mono ethyl phthalate, mono-n-butyl phthalate, mono-isobutyl phthalate) 
metabolites measured at <18 weeks of gestation. B) HMWP= High molecular weight phthalates (sum of 
mono-(2-ethyl-5-carboxypentyl) phthalate (mECPP), mono-(2-ethyl-5-hydroxyhexyl) phthalate (mEHHP), 
mono(2-ethyl-5-oxohexyl) phthalate (mEOHP), mono-[(2-carboxymethyl) hexyl] phthalate (mCMHP), 
Mono(3-carboxypropyl) phthalate (mCPP), monobenzyl phthalate, mono-hexyl phthalate, Mono-2-heptyl 
phthalate) metabolites measured at <18 weeks of gestation. C) DEHP= Di-2-ethylhexyl phthalates (sum of 
mECPP, mEHHP, mEOHP, and mCMHP) metabolites measured at <18 weeks of gestation. D) DNOP= 
Di-n-octyl phthalate (mCPP) metabolites measured at <18 weeks of gestation. E) PA=phthalic acid measured 
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Organophosphate pesticide metabolite 
concentrations in urine during 
pregnancy and offspring nonverbal IQ at 
age 6 years
Jusko, T. A., van den Dries, M. A., Pronk, A., Shaw, P. A., Guxens, M.,  
Spaan, S., Jaddoe, V.W.V., Tiemeier, H., & Longnecker, M. P. (2019). 




Background: Susceptibility to organophosphate (OP) pesticide neurotoxicity may be greatest 
during the prenatal period; however, previous studies have produced mixed findings concerning 
in utero OP pesticide exposure and child cognition.
Objectives: Our objective was to determine whether maternal urinary concentrations of OP 
pesticide metabolites are inversely associated with child nonverbal IQ at 6 y of age and to 
examine potential effect measure modification by the PON1 gene.
Methods: Data came from 708 mother–child pairs participating in the Generation R Study. 
Maternal urine concentrations of six dialkylphosphates (DAPs), collected at <18, 18–25, and 
>25 weeks of gestation, were determined. Child nonverbal IQ was measured at 6 y of age 
using the Mosaics and Categories subtests from the Snijders-Oomen Nonverbal Intelligence 
Test–Revised. PON1 was determined in cord blood for 474 infants. Multiple linear regression 
models were fit to estimate the DAP–IQ associations and PON1 interactions.
Results: Overall, associations between child nonverbal IQ and maternal DAP concentrations 
were small and imprecise, and these associations were inconsistent across urine sampling 
periods. However, for a 10-fold difference in total DAP concentration for the >25 weeks of 
gestation samples, adjusted child nonverbal IQ was 3.9 points lower (95% CI: −7.5, −0.3). 
Heterogeneity in the DAP–IQ association by PON1 gene allele status was not observed (n=474).
Conclusions: Consistent evidence of an association between higher maternal urinary DAP 
concentrations and lower child IQ scores at 6 y of age was not observed. There was some 
evidence for an inverse relation of child nonverbal IQ and late pregnancy urinary DAPs, but 
the estimated association was imprecise.




Organophosphate (OP) pesticides have been used for more than 50 y because they enhance 
crop yield and degrade rapidly. Some of the active pesticide, however, stays on food crops, 
and metabolites are often detected in human consumers.1 Most exposure in the general 
population is from diet,2-4 though other exposure routes can be important in selected 
populations.5 OP pesticide toxicity at high doses, via inhibition of acetylcholinesterase, 
has been well described;6 whether toxicity at lower doses occurs, via other mechanisms,7,8 
is unclear. Because susceptibility to adverse effects on cognition may be greatest during 
early development, many studies of low-dose exposure have focused on prenatal exposure, 
and the results have been suggestive in some cases9-12 but inconclusive overall.13 This 
heterogeneity may be explained by underlying genetic factors, specifically the PON1 
gene, which may modify the association between organophosphate pesticide exposure 
and cognition.13,14 Although the use of OP pesticides has been reduced, recent data show 
that the levels of metabolites in population biomonitoring studies have been stable for 
at least the first decade of this millennium.15
Among the dozens of OP pesticides in current use, some yield specific metabolites; 
most, however, degrade to one or more dialkylphosphates (DAPs), and the measurement 
of six DAPs in urine is the most-used method of estimating exposure to this class of 
compounds.16 The concentration of DAPs in urine reflects exposure in the past day or 
two, and individual exposure varies substantially from day to day, depending on diet.3 
This intraindividual variability means that estimates of exposure are improved if urine 
specimens are collected from an individual at more than one point in time. Often, however, 
epidemiologic studies have had at most two urine specimens per subject, which may have 
limited their statistical power to detect adverse associations.17
The present study examines maternal urinary concentrations of OP pesticide metabolites 
in relation to child nonverbal IQ at 6 y of age, with potential effect measure modification 
by the PON1 gene. Maternal urinary concentrations of OP pesticide metabolites were 
measured at three time points during pregnancy in the present study, with the intent to 
reduce possible exposure misclassification.
Methods
Study population and follow-up
Generation R is a prospective population-based birth cohort designed to identify early 
environmental and genetic determinants of development throughout life and has been 
described in detail previously.18 Briefly, all mothers who resided in the study area in 
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Rotterdam, Netherlands, and had a delivery date between April 2002 and January 2006 
were eligible. Mothers were enrolled during pregnancy or in the first months after the 
birth of their child when newborns visited the routine child health centers. Among the 
9,778 mothers who participated in the study, 8,879 (91%) were enrolled during pregnancy 
(Figure 1). Among the 4,918 women enrolled during pregnancy between February 2004 
and January 2006, spot urine specimens during early, middle, and late pregnancy (<18, 
18–25, >25 weeks of gestational age, respectively) were collected at the time of routine 
ultrasound examinations, which occurred throughout the day. In total, 2,083 women 
provided a complete set of three urine specimens. Mothers provided written informed 
consent for themselves and their children at the time of enrollment. The study protocol 
underwent human subjects review at Erasmus Medical Center, Rotterdam, Netherlands 
(institutional review board registration no. IRB00001482).
When the child was 6 y of age, families were invited to participate in an in-person follow-
up to collect cognitive data, additional biospecimens, and sociodemographic and health 
data. Of the 2,083 mother–child pairs with three pregnancy urine specimens, 1,998 
(96%) were followed to 6 y of age. From these 1,998 mother–child pairs with three 
prenatal urine specimens, women with missing data on maternal age and children with 
missing data on sex, birth weight, and without Child Behavior Checklist (CBCL) data at 
6 y of age were excluded (Figure 1). This resulted in a total of 1,449 mother–child pairs. 
From these 1,449 pairs, 800 mothers were selected using a random number generator 
for analyses of DAP metabolites in the maternal urine samples. Given our assumptions, 
800 mothers was sufficient to provide 80% power to detect a 2-point decrement in IQ 
per loge unit increase in average DAP concentration (calculations not shown). Next, 16 
participants were excluded from the lab analyses due to insufficient urine specimens. The 
final analytic sample included 708 mother–child pairs with exposure and outcome data 
and who had a sufficient volume of urine for analysis.
Urine collection and analysis of  DAP metabolites
Details of maternal and 6-y-old child urine specimen collection have been described 
elsewhere19 All urine samples were collected between 0800 and 2000 hours in 100-
mL polypropylene urine collection containers that were kept for a maximum of 20 
h in a cold room (4°C) before being frozen at −20°C in 20-mL portions in 25-mL 
polypropylene vials. Measurements of six nonspecific DAP metabolites of OP pesticides 
were conducted at the Institut National de Santé Publique (INSPQ) in Quebec, Canada, 
using gas chromatography coupled with tandem mass spectrometry (GC–MS/MS).20 
Three dimethyl (DM) metabolites [dimethylphosphate (DMP), dimethylthiophosphate 
(DMTP), and dimethyldithiophosphate (DMDTP)] were determined, as well as three 
diethyl (DE) metabolites [diethylphosphate (DEP), diethylthiophosphate (DETP), and 
diethyldithiophosphate (DEDTP)]. The limit of detection (LOD) was 0.26μg/L for 
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DMP, 0.40 for DMTP, 0.09 for DMDTP, 0.50 for DEP, 0.12 for DETP, and 0.06 for 
DEDTP. Measured values below the LOD were included in the data analysis. The inter-
day precision of the method during this project, expressed as the coefficient of variation 
percent, varied between 4.2 and 8.8 for DEDTP, 4.1 and 7.2 for DEP, 5.0 and 9.1 for 
DETP, 5.5 and 7.1 for DMDTP, 5.3 and 8.0 for DMP, and 5.5 and 7.7 for DMTP 
based on reference materials (clinical check-urine level II 637 E-495 and MRM E-459).
Molar concentrations were used to facilitate comparison of our results with those from 
other studies, based on the following molecular weights: DMP 126.0, DMTP 142.1, 
DMDTP 158.2, DEP 154.1, DETP 170.2, and DEDTP 186.2g/mol. To account for 
urinary dilution, creatinine concentrations were determined based on the Jaffe reaction.21,22 
The limit of detection for creatinine was 0.28 mmol/L, and the day-to-day coefficient of 
variation percent varied between 3.0 and 3.3.
Assessment of  child nonverbal IQ at 6 y of  age
The children’s nonverbal IQ was assessed by administering the Mosaics and Categories 
subtests from the Snijders-Oomen Nonverbal Intelligence Test–Revised, a well-validated 
instrument developed in Netherlands.23 These two language-independent subtests include 
items that probe visuospatial and abstract reasoning abilities and were selected because of 
the multiethnic composition of the Generation R Study. Raw scores were derived for each 
subtest and standardized to reflect a mean and standard deviation of the Dutch normative 
population for ages 2.5–7y. The sum of the standardized scores of the two subtests was 
converted into the SON-R IQ score using age-specific reference scores provided in the 
SON-R 2½-7 manual (mean=100, standard deviation=15). These standardized scores, 
based on the two subtests, correlated well (r=0.86) with those based on the complete 
instrument.24
Genetic analyses
In total, 474 children in the study sample had genetic data available from cord blood. 
Genotyping was performed using Illumina 610K and 660W arrays. Quality control 
included filters for sample (≥97.5%) and single nucleotide polymorphism (SNP) call 
rates (≥95%), minor allele frequencies (MAF; ≥1%), and deviations from the Hardy-
Weinberg equilibrium (p≤10−7). We additionally checked heterozygosity, sex accuracy, 
and relatedness. From this data set we extracted information on rs705379 (PON1-108), 
rs705381 (PON161), rs854560 (PON1-L55M), rs854572 (PON1-909), and rs662 
(PON1-Q192). Only the latter was directly genotyped, all others were imputed. We used 
Mach 1.025 to impute to the 1000 Genomes Iv3 reference panel.26 All four imputed SNPs 
had excellent imputation quality (all R2>0.95) and high MAF (all MAF>26%). SNPs 
were included as allele dosages ranging from zero to two copies of the effects allele.27 See 
Table S1 for effect allele and SNP descriptive statistics.




Maternal reproductive, sociodemographic, and cognitive data were assessed by multiple 
questionnaires and instruments throughout the study. During pregnancy, data on 
maternal height and weight were collected as was information on maternal age, parity 
(0, 1, or ≥2), smoking (no smoking during pregnancy, smoked until pregnancy was 
recognized, or continued smoking during pregnancy), alcohol intake during pregnancy 
[no alcohol consumption during pregnancy, alcohol consumption until pregnancy 
was recognized, continued occasionally (<1 glass/week), or continued frequently 
(≥1 glass/week)], marital status (married/partner or single), household total net income 
[<1,200 euros per month (i.e., below the Dutch social security level), 1,200–2,000 euros 
per month, >2,000 euros per month, highest completed education level (low: <3y at general 
secondary school; intermediate: ≥3y of secondary education; or high: university degree 
or higher vocational training), and ethnicity (Dutch national origin, other-Western, or 
non-Western)]. In addition, maternal dietary intake in the first trimester was assessed 
using a modified version of a validated semiquantitative food frequency questionnaire 
(FFQ), and the 293 food items were reduced to 24 predefined food groups (e.g., meat, 
grains, vegetables, fruits) according to the European Prospective Investigation into Cancer 
and Nutrition (EPIC)–soft classification, based on origin, culinary usage, and nutrient 
profiles.4,28
An adapted Infant/Toddler Home Observation for Measurement of the Environment 
(IT-HOME) inventory29 was administered during a home visit at approximately 3 months 
of age (SD=1.17 months). The validated 29-item version of the IT-HOME was used to 
measure the events, objects, and social interactions experienced by the child in the family 
context.30 Higher scores on the IT-HOME indicate a more enriched environment.
Maternal nonverbal IQ was measured when mother–child pairs attended the 6-y 
examination, and was assessed using a computerized Raven’s Advanced Progressive 
Matrices Test, set I31 The test is a 12-item reliable and validated short version of the 
Raven’s Progressive Matrices to assess nonverbal cognitive ability.32
Statistical methods
Exposure
The three DM metabolites (DMP, DMTP, and DMDTP) were summed as total DM 
(nmol/L) and the three DE metabolites (DEP, DETP, and DEDTP) were summed as 
total DE (nmol/L). Total DAP concentrations (nmol/L) were calculated by summing the 
six metabolites. Urinary concentrations were expressed on a volume and creatinine basis 
(nmol/g creatinine). Missing DAP metabolite values and missing covariate data were 
imputed (10 times) with the Multivariate Imputation by Chained Equation (MICE) method 
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in R (version 3.2.3; R Development Core Team).33,34 DAP metabolite concentrations 
were log10 transformed before running the multiple imputation (MI) procedure. Child 
nonverbal IQ was included as a predictor but was not imputed. Apart from household 
income (13%) and the IT-HOME score (29%), the percentage of missing values did not 
exceed 10% before imputation.
Statistical model
Initial exploratory data analyses suggested that the OP pesticide–nonverbal IQ associations 
were nonlinear in functional form and that multivariable models with log10-transformed 
exposure generally provided a better model fit than models with OP pesticide concentration 
untransformed (see Table S2). Thus, first, parametric models with DAP concentrations 
log10-transformed were fit to estimate the OP pesticide–nonverbal child IQ associations, 
and second, restricted cubic spline models were fit to describe the functional form of the 
exposure–outcome association utilizing the rms-package in R, which estimates a p-value 
for nonlinearity (i.e., statistically significant values indicate a departure from linearity) 
(Harrell 2018). These associations were graphically depicted by plots. In parametric models, 
nonverbal IQ associations for each urine collection phase (gestational age <18, 18–25, 
and >25 weeks) were modeled a) separately, b) as a single average of prenatal exposure, 
and c) for each urine collection phase modeled jointly (i.e., all three DAP concentrations 
included as three separate terms in each model). The first two regression models (model 
for each urine collection phase separately and the model for average prenatal exposure) 
consisted of an unadjusted model and an adjusted model. The third model consisted of a 
mutually adjusted model in which the three exposures from each time period were jointly 
estimated. The adjustment variables were maternal age, ethnicity, education, income, 
marital status, alcohol consumption during pregnancy, nonverbal IQ, body mass index 
(BMI), height, parity, and smoking during pregnancy; child sex; and the IT-HOME 
score. Potential adjustment variables were selected a priori based on previous studies 
of OP pesticides and child cognition and on biologically plausible covariate–exposure 
and covariate–outcome associations observed in our data.4,9-13,35,36 Finally, to investigate 
whether the association of DAP concentrations on child IQ differed according to PON1 
genotype, the interaction between DAP concentrations and PON1 genotype was formally 
tested using an a priori criteria for interaction of p<0.10. Genetic analyses were carried 
out in both the full sample and in the Dutch national origin sample.
Sensitivity analyses
First, values below the LOD were substituted with the LOD divided by the square root of 
2, instead of using measured values as in the primary analyses. The replacement of values 
below the LOD with the LOD divided by the square root of 2 is a common substitution 
method in environmental exposure studies.37 Second, models were refit with metabolite 
concentrations expressed as nanomoles per liter with creatinine concentration added as 
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a separate covariate.22,38 Third, models truncating the bottom and top 3% of exposure 
and child nonverbal IQ values were fit to test data robustness. Fourth, the primary 
models were adjusted for fruit and vegetable intake.4 Fifth, a multiple informants model 
was fit as an alternative strategy to model the OP pesticide concentrations collected at 
three points in time during pregnancy.39 Sixth, to examine potential selection effects by 
maternal education, interaction models to assess effect measure modification by maternal 
education were fit. Seventh, to examine potential sex-specific associations, OP pesticide 
× child sex interaction models were fit. Eighth, a “complete case” analysis of the data 
was conducted, utilizing only observations with complete data for all covariates. Ninth, 
summed models excluding DEDTP metabolites were fit because >80% of concentration 
values were <LOD. Last, each of the two subtests making up the child nonverbal IQ 
score (Mosaics and Categories) were modeled as the outcome of interest, in place of the 
nonverbal IQ score, to assess the specificity of results.
Results
Sample characteristics
Overall, the Generation R Study mothers were on average 30 y of age at enrollment (SD 
5 y), and diverse with respect to ethnicity, education, and income (Table 1). Compared 
with all women in the Generation R Study, the women in the present analysis were more 
likely to be older, nulliparous, Dutch, highly educated, married, and to occasionally 
consume alcoholic beverages during pregnancy. Women were also more likely to have a 
lower BMI and a higher income. Compared with all Generation R Study children who 
attended the 6-y examination, the IT-HOME scores of our sample were slightly higher. 
The average DAP concentration in maternal pregnancy urine was higher among those 
who were older, had a lower BMI, higher income and education, and had partners (Table 
1). Child DAP concentrations in urine were weakly associated with those in maternal 
pregnancy urine (r<|0.08|; see also Table S3). The child’s DAP concentrations were also 
slightly positively associated with the HOME scores (not shown). Child nonverbal IQ 
scores were most strongly related to maternal ethnicity, education, and income and to 
their IT-HOME score (Table 1).
DAP concentrations
Total DAPs comprised mostly dimethyl alkyl phosphates, and the distribution of 
concentrations was fairly stable across the three sampling periods (Figure 2). As reported 
previously, the intraclass correlation coefficient for total DAP concentration across the 
three phases of pregnancy urine collection in this study was 0.38 (Spaan et al. 2015).
Chapter 4
128
Table 1. Characteristics of  all Generation R cohort members and of  the participants included in 














Maternal and infant characteristics at time of 
enrollment
Sex of infant at birth
Male 50.6 % 51.3 % 378 (263, 511) 103 (16)
Female 49.4 % 48.7 % 341 (248, 480) 102 (14)
Missing, n 153 -
p-valuee 0.064 0.289
Age in years
< 20 4.2 % 1.7 % 292 (229, 477) 97 (15)
20-< 25 15.9 % 10.2 % 332 (250, 456) 91 (15)
25-< 30 26.4 % 26.4 % 324 (245, 476) 103 (15)
30-< 35 36.9 % 45.8 % 382 (257, 519) 104 (16)
≥ 35 16.6 % 16.0 % 384 (269, 489) 104 (13)
Missing, n - -
p-valuee 0.076 <0.001
BMI
< 18.5 2.1 % 2.4 % 365 (281, 563) 98 (21)
18.5-< 25 57.9 % 65.4 % 378 (269, 509) 103 (15)
25-< 30 26.3 % 23.4 % 344 (257, 460) 101 (15)
≥ 30 13.8 % 8.8 % 262 (196, 427) 99 (15)
Missing, n 899 3
p-valuee <0.001 0.047
Height in cm (quartiles)
< 161 23.6 % 16.4 % 343 (260, 505) 97 (15)
161 – < 168 27.4 % 31.0 % 349 (245, 490) 102 (15)
168 – < 173 24.6 % 25.3 % 343 (245, 489) 103 (15)
≥ 173 24.4 % 27.3 % 370 (279, 511) 105 (16)
Missing, n 934 1
p-valuee 0.709 <0.001
Parity (Previous births)
0 55.1 % 61.5 % 361 (258, 502) 103 (16)
1 30.2 % 27.3 % 379 (271, 502) 102 (15)
≥ 2 14.7 % 11.2 % 295 (216, 429) 100 (14)
Missing, n 378 4
p-valuee 0.017 0.468
Ethnicity
Dutch 50.0 % 57.9 % 370 (253, 487) 106 (15)
Other Western 11.6 % 12.4 % 365 (283, 514) 101 (15)
Non-Western 38.4 % 29.7 % 335 (248, 516) 96 (14)
Missing, n 694 -
p-valuee 0.587 <0.001
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Low (No education finished, Primary education, 
lower vocational training, intermediate general 
school or <3 years at general secondary school) 
26.5 % 14.8 % 315 (215, 459) 95 (16)
Intermediate (+3 years of secondary education, 
Intermediate vocational training or first year of 
higher vocational training)
30.7 % 30.0 % 331 (247, 478) 100 (15)
High (University degree or higher vocational 
training) 
42.8 % 55.2 % 384 (280, 509) 106 (15)
Missing, n 1221 24
p-valuee <0.001 <0.001
Household income in euro’s
<1200 per month 20.7 % 12.6 % 312 (219, 465) 96 (15)
1200–2000 per month 18.5 % 17.0 % 320 (247, 473) 101 (15)
> 2000 per month 60.8 % 70.4 % 381 (278, 501) 105 (15)
Missing, n 3066 90
p-valuee 0.007 <0.001
Marital status
Married/ living with partner 85.5 % 90.3 % 371 (267, 504) 103 (15)
No partner 14.5 % 9.7 % 268 (210, 415) 101 (16)
Missing, n 1213 29
p-valuee <0.001 0.211
IQ score
≤ 85 16.0 % 18.5 % 321 (219, 477) 96 (14)
>85-≤ 100 43.1 % 44.1 % 353 (263, 507) 102 (15)
>100 -< 115 16.7 % 19.1 % 373 (274, 468) 105 (15)
≥ 115 14.1 % 18.4 % 382 (252, 501) 107 (17)
Missing, n 3427 16
p-valuee 0.263 <0.001
Smoking
No smoking during pregnancy 73.4 % 78.1 % 375 (268, 505) 103 (15)
Until pregnancy recognized 8.6 % 8.5 % 342 (258, 500) 102 (13)
Continued during pregnancy 18.0 % 13.4 % 275 (186, 469) 98 (14)
Missing, n 1534 61 
p-valuee 0.001 0.008
Alcohol Beverage Consumption
No alcohol consumption during pregnancy 48.0 % 37.9 % 329 (246, 485) 99 (15)
Until pregnancy recognized 13.2 % 17.3 % 377 (268, 516) 104 (13)
Continued occasionally (less than 1 glass/week) 31.6 % 38.5 % 381 (257, 509) 105 (16)
Continued frequently (1 or more glass/week for 
at least two trimesters)
7.2 % 6.4 % 349 (295, 461) 106 (14)







Overall, the estimated differences in child nonverbal IQ for a log10-unit increase in OP 
pesticide concentration were inconsistent between adjacent sampling periods (Table 2). 
The heterogeneity in association across sampling periods was statistically significant for 
total DAPs and dimethyl alkyl phosphates. For each 10-fold difference in total DAP 
concentration for the >25 weeks of gestation samples, however, adjusted child nonverbal 
IQ was 3.9 points lower [95% confidence interval (CI): −7.5, −0.3]. The results for 
dimethyl alkyl phosphate at >25 weeks of gestation showed inverse associations that were 













Child at six years
Total DAP in nmol/g creatinine (quartiles)
<144 - 24.6 % 341 (248, 483) 100 (16)
144 – < 240 - 24.9 % 332 (244, 457) 103 (14)
240 – < 410 - 25.4 % 377 (266, 503) 102 (14)
≥410 - 25.1 % 380 (268, 519) 104 (17)
Missing, n - 28
p-valuee 0.152 0.140
Household income in euro’s
< 1600 per month 16.5% 15.0% 320 (223, 502) 96 (16)
1600–4000 per month 49.2% 47.0% 344 (252, 475) 101 (16)
> 4000 per month 34.3% 38.0% 390 (287, 529) 107 (14)
Missing, n 3953 40
p-valuee 0.001 <0.001
Child’s home environments
IT-HOME score f (quartiles)
<25 36,3% 22.6 % 321 (224, 469) 97 (16)
25–<27 24.9% 26.7 % 362 (258, 505) 101 (15)
27 – >28 18.2% 19.4 % 360 (264, 491) 103 (14)
≥ 28 20,6% 31.3 % 376 (269, 516) 104 (16)
Missing, n 5301 203
p-valuee 0.164 0.004
a. Values shown are percentages.
b. Average DAP exposure represents the average exposure during pregnancy (measured at three time points) in 
nmol/g creatinine. Values shown are medians (25th percentile, 75th percentile).
c. Values presented are based on the study sample (N=708).
d. Values shown are Means (SD).
e. P-value calculated with the use of Kruskal-Wallis test for differences in average DAP concentrations across preg-
nancy and non-verbal IQ scores by characteristic.
f. Infant-Toddler Home Observation for Measurement of the Environment (IT-HOME) inventory is a 29-item vali-
dated measure of the events, objects and social interactions experienced by a child in the family context. IT-HOME 
was assessed by observation during home visits at average child age of 3.38 months (SD=1.17).
Continued
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were essentially similar given the width of the 95% CIs for measures at >25 weeks. A 
representative spline (mean of 10 restricted spline smooths from the MICE models) for 
total DAP concentration at >25 weeks of gestation is shown in Figure 3 and indicates 
a slightly steeper and inverse association between exposure and outcome at lower levels 
of exposure, and the p value for nonlinearity was 0.11. Restricted cubic splines of all 12 
exposure–nonverbal IQ associations were largely consistent with results from parametric 
models (see Figures S1–S3).
p
Figure 2. Dialkylphosphate concentrations on a creatinine basis in maternal urine among Generation R 
participants included in analyses ( n=708 ). Statistics were computed using reported values below the limit 
of detection. The outer limits of the boxes (left to right) represent the 25th and 75th percentiles; the vertical 
bars within the boxes represent the 50th percentiles. The whiskers indicate 1.5 times the interquartile range 
(IQR), and the values more than 1.5 times the IQR are represented as points. Diethyl alkyl phosphates 
is the sum of DEDTP, DETP, and DEP. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP, 
and DMP. Total dialkylphosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP, and DMP. 
Note: DEDTP, diethyldithiophosphate; DEP, diethylphosphate; DETP, diethylthiophosphate; DMDTP, 
dimethyldithiophosphate; DMP, dimethylphosphate; DMTP, dimethylthiophosphate.
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Table 2. Difference in cognitive test score at age six (and 95% confidence interval) per log10 
nmol/g creatinine increase in maternal urine dialkyl phosphate metabolite concentration, by 
timing of  pregnancy urine sampling and degree of  adjustment (n=708).
Type of adjustment
None Adjusted b Mutually Adjusted c
Dialkyl Phosphate Type β (95% CI) β (95% CI) β (95% CI)
Dialkyl phosphates (total) a
< 18 weeks’ gestation -0.7 -4.1 to 2.8 -1.9 -5.3 to 1.5 -1.8 -5.3 to 1.6
18 – 25 weeks’ gestation 3.2 -0.6 to 7.0 0.9 -2.9 to 4.7 2.6 -1.4 to 6.6
> 25 weeks’ gestation -0.8 -4.4 to 2.8 -3.9 -7.5 to -0.3 -4.3 -8.1 to -0.6
Mean of three urines 0.6 -4.3 to 5.5 -2.5 -7.4 to 2.4 -
p homogeneity d 0.051
Diethyl alkyl phosphates e
< 18 weeks’ gestation 0.1 -2.4 to 2.6 -1.4 -3.8 to 1.1 -1.5 -4.0 to 1.0
18 – 25 weeks’ gestation 2.1 -0.4 to 4.7 0.6 -1.9 to 3.1 0.9 -1.7 to 3.5
> 25 weeks’ gestation 2.2 -0.3 to 4.7 -0.2 -2.8 to 2.3 -0.3 -2.9 to 2.3
Mean of three urines 4.4 0.6 to 8.2 1.0 -2.8 to 4.9 -
p homogeneity d 0.475
Dimethyl alkyl phosphates f
< 18 weeks’ gestation -1.6 -4.9 to 1.7 -2.5 -5.7 to 0.7 -2.3 -5.6 to 0.9
18 – 25 weeks’ gestation 2.6 -1.0 to 6.3 0.7 -3.0 to 4.3 2.3 -1.4 to 6.1
> 25 weeks’ gestation -1.6 -5.0 to 1.9 -4.1 -7.5 to -0.7 -4.3 -7.9 to -0.8
Mean of three urines -0.6 -5.4 to 4.1 -3.0 -7.7 to 1.7 -
p homogeneity d 0.030
a. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
b. Adjusted for age of the mother, sex of child, ethnicity categories (Dutch, other-western and non-western), educa-
tion (low, intermediate and high), income (low, middle and high), marital status, maternal alcohol consumption (no 
alcohol consumption during pregnancy, alcohol consumption until pregnancy was known, occasionally alcohol con-
sumption during pregnancy and frequently alcohol consumption during pregnancy), maternal non-verbal IQ, BMI 
categories (<18.5, 18.5-25, 25-30, 30+), height of the mother, parity categories (0, 1, 2+), IT-Home quartiles, and 
smoking categories (no smoking during pregnancy, smoked until pregnancy was known, smoked during pregnancy).
c. Adjusted model with the inclusion of the three exposures in one model.
d. Multiple-partial F test used to test whether exposure from different time points relates in the same manner to 
non-verbal IQ scores.
e. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
f. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
The results among the subset of mother–child pairs with child data on genotype showed 
that there was no strong statistical support for heterogeneity in the nonverbal child IQ–
DAP association by genotype, particularly considering the number of comparisons made 
(see Tables S4–S11). When the genetic analysis was restricted to Dutch national origin 
participants, the findings were again unremarkable (see Tables S12–S15).
Sensitivity analyses
As noted above, the sensitivity analyses examined the effects of a) the <LOD substitution 
method (see Table S16), b) adjustment of creatinine concentration as a separate covariate 
(see Table S17), c) the removal of extreme exposure and outcome values (see Table S18), 
Prenatal OP pesticide exposure and nonverbal IQ
133
4
d) adjustment for prenatal fruit and vegetable consumption (see Table S19), e) analyzing 
the data using a multiple informants model (see Table S20), f ) examining effect measure 
modification by maternal educational attainment (see Table S21), g) examining effect 
measure modification by child sex (see Table S22), h) fitting a “complete case” only model 
(see Table S23–S24), and i) excluding DEDTP (i.e., including only those metabolites 
with at least 80% of values >LOD) (see Table S25). Finally, Mosaics (see Table S26) and 
Categories (see Table S27) were modeled as the outcome of interest in place of nonverbal 
IQ. The sensitivity analyses supported the results shown in Table 2 and the absence of 
important differences when examining effect measure modification. However, with 















Total dialkyl phosphate metabolite concentrations in nmol/g creatinine at >25 weeks of gestation
Figure 3. Restricted cubic spline of adjusted child nonverbal IQ scores and (untransformed) total DAP 
concentration. The solid line represents the estimated mean value of nonverbal IQ scores at each total DAP 
metabolite concentration, and the shaded area indicates the corresponding 95% confidence band for these 
estimates. Adjusted for age of the mother, sex of child, ethnicity categories (Dutch, other-Western, and non-
Western), education (low, intermediate, and high), income (low, middle, and high), marital status, maternal 
alcohol consumption (no alcohol consumption during pregnancy, alcohol consumption until pregnancy 
was known, occasional alcohol consumption during pregnancy, and frequent alcohol consumption during 
pregnancy), maternal nonverbal IQ, BMI categories ( <18.5 , 18.5–25, 25–30, >30 kg/m2 ), height of 
the mother, parity categories (0, 1, ≥2 ), IT-Home quartiles, and smoking categories (no smoking during 
pregnancy, smoked until pregnancy was known, smoked during pregnancy). Note: BMI, body mass index; 





In this analysis of data on nonverbal IQ in children in relation to prenatal DAP 
concentrations in a diverse, urban population in Europe, evidence of an adverse association 
was weak overall, although there was some suggestion of an inverse relation between 
nonverbal IQ and late pregnancy urinary DAP concentration. Among the three groups 
of DAP metabolites analyzed, diethyl metabolites showed the weakest associations with 
child nonverbal IQ. Where inverse associations were suggested, the adjusted results were 
generally more strongly inverse than the crude results, consistent with negative confounding.
The results of our study share some consistencies with other published data. For example, 
in a pooled analysis of data on developmental indices at 2 y of age and DAPs measured in 
one or two prenatal urine specimens, there was a negative association at lower, as opposed 
to higher, concentrations of DAPs in three of the four pooled studies (with the fourth 
study showing linearity throughout the range of exposure), a finding similar to the pattern 
observed in our data (Figure 3).13 A larger negative association at lower concentrations 
was also present in Bouchard’s study with IQ measured at 7 y of age 7.9 In that analysis 
of 7-y-old children from the CHAMACOS cohort, each 10-fold difference in total DAP 
concentration—in the second half of pregnancy—was associated with a 3.5-point lower 
Weschler Intelligence Scale for Children (WISC)-IV Full-Scale IQ score and a 3.1-point 
lower Verbal Comprehension score.9 Results from the present study are similar: Each 
10-fold difference in total DAP concentration measured at >25 weeks was associated 
with a 3.9-point lower nonverbal IQ score. Results of our restricted cubic spline models 
illustrate that associations between DAPs and nonverbal IQ may be stronger at lower 
levels of exposure. There is evidence from animal and human studies that exposure–disease 
associations may not be linear.40 For instance, studies of lead exposure and child IQ have 
observed nonlinearity in the lead–IQ association across different persons, places, and 
times.41-44 For organophosphate pesticides, low-dose developmental toxicity may occur 
through noncholinergic mechanisms,8,45 which may have nonlinear dose–effect modes 
of action.
The timing of the DAP exposure assessment may explain differences across studies. 
Bouchard et al. (2011) examined child IQ at 7 y of age in relation to urinary DAPs from 
either the first or second half of pregnancy; the DAP-IQ coefficient was negative for both 
periods, but more so for the DAPs in the second half of pregnancy.9 Our results also 
showed a larger negative association later in pregnancy. Other factors may also explain 
variation in the results across studies.13 For example, variation across studies in the 
degree of confounding by fruit and vegetable intake, or the degree to which urine DAP 
metabolites concentrations reflect exposure to the active pesticide rather than degradation 
products, especially in regions where a larger proportion of measured DAP concentrations 
Prenatal OP pesticide exposure and nonverbal IQ
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is due to agricultural pesticide exposure46 may explain differences across studies. Other 
potential reasons for variation may be in the types of pesticides used on food consumed 
in different countries or in the socioeconomic status (SES) of the studied populations. 
The authors of two recent studies of organophosphate pesticide metabolites and IQ 
speculated that a reason for the lack of association in higher SES populations was due to 
the protective effects of higher SES.47,48 In the present data, adjusted results were more 
inverse than the crude results, consistent with the possibility of residual confounding by 
SES or other lifestyle factors. Additionally, the instruments used to measure IQ differed 
across studies. The present study utilized a global, nonverbal measure of intelligence. 
Other studies utilized more complete IQ batteries such as the WISC that may be more 
sensitive to cognitive deficits because the instrument measures both verbal and nonverbal 
domains of intellectual function. For instance, in the CHAMACOS cohort, total DAP 
concentrations were associated with lower scores on the Verbal Comprehension Index, 
but scores on the Perceptual Reasoning and Processing Speed indices of the WISC-IV 
were less strongly associated with DAP concentrations, if at all.35
In the present study, we did not observe any evidence of effect measure modification by 
the PON1 gene allele. When we restricted the total sample to only those of Dutch national 
origin, results also did not show evidence of interaction by PON1 genotype status. In 
other studies of effect measure modification by genotype, the results on cognitive measures 
and DAPs have been inconsistent.11,35 For example, Eskenazi et al. (2014) observed that 
the association between DAPs and Mental Development Index scores was the strongest 
in children with PON1-108T allele, but this and other interactions between DAPs and 
PON1 polymorphisms or enzymes were not statistically significant. On the other hand, 
Engel et al. (2011) observed a statistically significant interaction (p=0.09), showing a 
stronger inverse association between log10-DAP exposure and perceptual reasoning in 
children with the PON192QQ allele. Results based on mother and child genotypes 
tended to be similar within a given study.11,35
The concentration of DAPs in urine only captures short-term exposure, which varies 
substantially from day to day, depending on diet. Although DAPs were measured at three 
time points, the average exposure may not have been accurately captured.17 Furthermore, 
the proportion of the DAPs measured that reflected exposure to the active pesticide 
rather than to inactive degradation products was unknown. The rate of degradation of 
organophosphate pesticides under specific field conditions is hard to predict.49 of the 
Generation R population in the present study was higher than for the Generation R 
cohort as a whole, which may be a reflection of our exclusion criterion of having three 
urine specimens during pregnancy. Our results therefore may not be generalizable to the 
Generation R population; however, as noted above, we saw no evidence of effect measure 
modification by education, suggesting that potential selection bias is unlikely to have 
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materially affected our results. Among the strengths of our study were the relatively large 
size, the measurement of maternal DAPs at three time points during pregnancy, and a 
well-standardized and validated instrument for measuring outcome. Furthermore, as 
documented elsewhere, the median total DAPs among the Generation R Study mothers 
was more than 2-fold higher compared with background-exposed pregnant women in 
the United States living in nonagricultural communities, which suggests a greater range 
of exposure and statistical power with which to evaluate exposure–disease associations.50
Conclusions
Organophosphate pesticide exposure is ubiquitous, and experimental data and evidence 
from accidental poisoning in humans indicate that it is neurotoxic. The present study, 
utilizing a well-characterized pregnancy cohort in Rotterdam, Netherlands, examined 
maternal organophosphate exposure in 708 pregnant women in relation to child nonverbal 
IQ at 6 y of age. OP pesticide exposure was characterized by six measured dialkylphosphate 
metabolite concentrations in pregnancy urine specimens at three time points, and child 
nonverbal IQ was assessed at 6 y of age, after school entry, when IQ tests tend to have 
greater predictive validity for aspects of learning such as school achievement.51 Our results 
suggest that typical, background OP exposures during pregnancy are not consistently 
associated with lower child IQ at 6 y of age in this population; however, there was some 
evidence that late pregnancy may be a susceptible period for adverse effects on cognition.
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Table S1. Effect allele and single nucleotide polymorphism (SNP) descriptive statistics. 
PON1 SNP Al1 Al2 Freq1 MAF Quality R2
PON1-Q192 rs662 C T 0.35474 0.35474 0.99993 0.99989
PON1-108 rs705379 G A 0.56718 0.43282 0.98614 0.95791
PON1-161 rs705381 C T 0.74361 0.25639 0.99570 0.98359
PON1- L55M rs854560 A T 0.67882 0.32118 0.99974 0.99903
PON1-909 rs854572 C G 0.52449 0.47551 0.99881 0.99633
Note: rs662 was directly genotyped. rs705379, rs705381, rs854560 and rs854572 are based on imputed 
genotypes.
Table S2. Akaike information criterion (AIC) comparison between untransformed (UTF) and log10 
































1 5825.958 5825.072 5825.344 5826.025 5823.157 5821.785 5825.786 5825.331 5825.071 5823.574
2 5826.598 5825.442 5825.925 5826.666 5823.462 5821.939 5826.434 5826.020 5824.826 5822.834
3 5826.639 5826.015 5826.090 5826.748 5823.600 5822.573 5826.412 5826.123 5825.320 5824.369
4 5827.486 5827.284 5827.329 5828.101 5825.006 5823.170 5827.350 5827.205 5826.170 5824.875
5 5824.194 5823.400 5823.744 5824.393 5822.113 5820.892 5824.175 5823.845 5823.871 5822.498
6 5828.589 5827.536 5828.423 5829.002 5826.163 5824.449 5828.470 5828.001 5827.932 5825.837
7 5825.592 5824.710 5825.191 5825.782 5823.032 5821.161 5825.425 5824.928 5825.028 5822.869
8 5824.786 5823.832 5823.945 5824.831 5821.791 5820.049 5824.652 5824.162 5823.267 5821.500
9 5826.308 5825.438 5825.829 5826.475 5823.164 5821.843 5826.078 5825.800 5824.742 5823.239
10 5826.741 5825.873 5826.505 5826.959 5823.316 5821.546 5826.308 5825.769 5825.646 5823.532
Mean 
AIC
5826.289 5825.46 5825.833 5826.498 5823.48 5821.941 5826.109 5825.718 5825.187 5823.513
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Table S3. Correlation coefficients for maternal and 6-year-old child urine dialkyl phosphate meta-
bolite concentrations (n=708).
Spearman’s rho correlations coefficients < 18 weeks 
gestation
18 – 25 weeks 
gestation




Dialkyl phosphates (total) 
< 18 weeks’ gestation 1
18 – 25 weeks’ gestation 0.22** 1
> 25 weeks’ gestation 0.17** 0.31** 1
child at age 6 0.05 0.03 0.04 1
Diethyl alkyl phosphates
< 18 weeks’ gestation 1
18 – 25 weeks’ gestation 0.29** 1
> 25 weeks’ gestation 0.18** 0.28** 1
child at age 6 0.07 0.01 0.07 1
Dimethyl alkyl phosphates
< 18 weeks’ gestation 1
18 – 25 weeks’ gestation 0.19** 1
> 25 weeks’ gestation 0.15** 0.30** 1
child at age 6 0.02 0.03 0.02 1
Pearson correlation coefficients (log10) < 18 weeks 
gestation
18 – 25 weeks 
gestation




Dialkyl phosphates (total) 
< 18 weeks’ gestation 1
18 – 25 weeks’ gestation 0.24** 1
> 25 weeks’ gestation 0.18** 0.32** 1
child at age 6 -0.01 0.01 -0.01 1
Diethyl alkyl phosphates
< 18 weeks’ gestation 1
18 – 25 weeks’ gestation 0.22** 1
> 25 weeks’ gestation 0.12** 0.23** 1
child at age 6 0.01 -0.03 0.04 1
Dimethyl alkyl phosphates
< 18 weeks’ gestation 1
18 – 25 weeks’ gestation 0.20** 1
> 25 weeks’ gestation 0.16** 0.31** 1
child at age 6 -0.02 0.02 -0.01 1
*P<0.05 ** P<0.01. 
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Table S16. Concentrations <LOD substituted with LOD/√2: Difference in child non-verbal IQ test 
score at age six years (and 95% confidence interval) per log10 nmol/g creatinine increase in mater-
nal urine dialkyl phosphate metabolite concentration a, by timing of  pregnancy urine sampling 
and degree of  adjustment (N=708).
Type of adjustment
None Adjusted b Mutually adjusted c
Dialkyl Phosphate Type β (95% CI) β (95% CI) β (95% CI)
Dialkyl phosphates (total) d
< 18 weeks’ gestation -0.6 -4.1 to 2.9 -1.9 -5.3 to 1.5 -1.8 -5.3 to 1.7
18 – 25 weeks’ gestation 3.2 -0.6 to 7.0 0.9 -2.9 to 4.7 2.6 -1.4 to 6.7
> 25 weeks’ gestation -0.8 -4.5 to 2.8 -3.9 -7.5 to -0.3 -4.3 -8.1 to -0.6
Mean of three urines 0.6 -4.4 to 5.5 -2.5 -7.4 to 2.4
Diethyl alkyl phosphates e
< 18 weeks’ gestation 2.5 -0.4 to 5.5 0.5 -2.4 to 3.4 0.5 -2.5 to 3.5
18 – 25 weeks’ gestation 2.7 -0.2 to 5.7 0.4 -2.5 to 3.3 0.4 -2.7 to 3.5
> 25 weeks’ gestation 2.6 -0.4 to 5.5 -0.3 -3.3 to 2.6 -0.5 -3.5 to 2.5
Mean of three urines 4.3 0.5 to 8.2 1.0 -2.9 to 4.8
Dimethyl alkyl phosphates f
< 18 weeks’ gestation -1.6 -4.9 to 1.8 -2.4 -5.7 to 0.8 -2.3 -5.7 to 1.0
18 – 25 weeks’ gestation 2.7 -1.0 to 6.4 0.7 -2.9 to 4.3 2.4 -1.4 to 6.2
> 25 weeks’ gestation -1.5 -5.0 to 1.9 -4.1 -7.5 to -0.6 -4.3 -7.9 to -0.8
Mean of three urines -0.6 -5.4 to 4.1 -3.0 -7.7 to 1.7
a. Values below the limit of detection (LOD) substituted by the LOD/√2.
b. Adjusted for child sex, maternal age, ethnicity (Dutch, other-western, and non-western), education (low, in-
termediate, and high), income (low, middle, and high), marital status, maternal alcohol consumption (no alcohol 
consumption during pregnancy, alcohol consumption until pregnancy was known, occasional alcohol consumption 
during pregnancy, and frequent alcohol consumption during pregnancy), maternal non-verbal IQ, BMI categories 
(<18.5, 18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), IT-Home quartiles, and 
smoking categories (no smoking during pregnancy, smoked until pregnancy was known, and smoked during preg-
nancy).
c. Adjusted model with the inclusion of the three exposures in one model.
d. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
e. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
f. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
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Table S17. Creatinine adjustment as separate covariate: Difference in child non-verbal IQ test sco-
re at age six years (and 95% confidence interval) per log10 nmol/g creatinine increase in maternal 
urine dialkyl phosphate metabolite concentration, by timing of  pregnancy urine sampling and 
degree of  adjustment (N=708).
Type of adjustment
None a Adjusted b Mutually adjusted c
Dialkyl Phosphate Type β (95% CI) β (95% CI) β (95% CI)
Dialkyl phosphates (total) d
< 18 weeks’ gestation -1.8 -5.1 to 1.5 -2.4 -5.5 to 0.8 -2.5 -5.7 to 0.7
18 – 25 weeks’ gestation 3.2 -0.3 to 6.6 0.9 -2.5 to 4.3 2.7 -0.8 to 6.3
> 25 weeks’ gestation -1.8 -5.3 to 1.6 -3.9 -7.3 to -0.5 -4.5 -8.0 to -1.0
Mean of three urines -0.7 -5.5 to 4.1 -2.6 -7.3 to 2.1
Diethyl alkyl phosphates e
< 18 weeks’ gestation -0.4 -2.8 to 2.1 -1.6 -4.0 to 0.9 -1.6 -4.1 to 0.8
18 – 25 weeks’ gestation 2.3 -0.1 to 4.8 0.6 -1.9 to 3.0 1.0 -1.5 to 3.5
> 25 weeks’ gestation 1.6 -0.9 to 4.1 -0.5 -3.0 to 2.0 -0.6 -3.1 to 2.0
Mean of three urines 3.0 -0.6 to 6.7 0.5 -3.2 to 4.1
Dimethyl alkyl phosphates f
< 18 weeks’ gestation -2.5 -5.7 to 0.6 -2.8 -5.8 to 0.2 -2.9 -6.0 to 0.1
18 – 25 weeks’ gestation 2.7 -0.6 to 6.1 0.7 -2.6 to 4.0 2.6 -0.8 to 6.0
> 25 weeks’ gestation -2.4 -5.7 to 0.9 -4.0 -7.3 to -0.8 -4.6 -7.9 to -1.3
Mean of three urines -1.9 -6.6 to 2.7 -3.3 -7.8 to 1.3
a. “None” adjusted model is adjusted for creatinine concentrations.
b. Adjusted for creatinine concentrations, child sex, maternal age, ethnicity (Dutch, other-western, and non-western), 
education (low, intermediate, and high), income (low, middle, and high), marital status, maternal alcohol consumpti-
on (no alcohol consumption during pregnancy, alcohol consumption until pregnancy was known, occasional alcohol 
consumption during pregnancy, and frequent alcohol consumption during pregnancy), maternal non-verbal IQ, 
BMI categories (<18.5, 18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), IT-Home 
quartiles, and smoking categories (no smoking during pregnancy, smoked until pregnancy was known, and smoked 
during pregnancy).
c. Adjusted model with the inclusion of the three exposures in one model.
d. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
e. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
f. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
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Table S18. Removal of  extreme values: Difference in child non-verbal IQ test score at age six 
years (and 95% confidence interval) per log10 nmol/g creatinine increase in maternal urine 
dialkyl phosphate metabolite concentration, by timing of  pregnancy urine sampling and degree 
of  adjustment.
Type of adjustment
None Adjusted a Mutually adjusted b
Dialkyl Phosphate Type β (95% CI) β (95% CI) β (95% CI)
Dialkyl phosphates (total) c
< 18 weeks’ gestation (n=639) 1.2 -2.1 to 4.4 -0.5 -3.7 to 2.7 -0.5 -3.6 to 2.7
18 – 25 weeks’ gestation (n=638) 2.4 -1.2 to 5.9 0.6 -2.9 to 4.2 2.9 -0.7 to 6.4
> 25 weeks’ gestation (n=640) 0.3 -3.0 to 3.7 -2.8 -6.2 to 0.6 -2.8 -6.2 to 0.6
Mean of three urines (n=639) 3.5 -1.2 to 8.1 0.4 -4.4 to 5.1
Diethyl alkyl phosphates d
< 18 weeks’ gestation (n=638) 2.1 -0.7 to 4.9 -0.2 -3.0 to 2.6 0.7 -2.0 to 3.4
18 – 25 weeks’ gestation (n=639) 1.5 -0.7 to 3.8 0.2 -2.0 to 2.5 0.0 -2.3 to 2.3
> 25 weeks’ gestation (n=640) 1.8 -0.4 to 4.1 -0.3 -2.6 to 2.0 -1.2 -3.5 to 1.0
Mean of three urines (n=638) 2.1 -1.4 to 5.7 -1.0 -4.7 to 2.6
Dimethyl alkyl phosphates e
< 18 weeks’ gestation (n=640) 0.5 -2.6 to 3.6 -0.8 -3.8 to 2.3 -0.9 -3.9 to 2.1
18 – 25 weeks’ gestation (n=638) 1.8 -1.6 to 5.2 0.5 -2.9 to 3.9 2.5 -0.9 to 5.9
> 25 weeks’ gestation (n=640) -0.2 -3.4 to 3.0 -2.7 -6.0 to 0.5 -2.9 -6.2 to 0.4
Mean of three urines (n=638) 2.3 -2.2 to 6.8 0.0 -4.5 to 4.6
a. Adjusted for child sex, maternal age, ethnicity (Dutch, other-western, and non-western), education (low, inter-
mediate, and high), income (low, middle, and high), marital status, maternal alcohol consumption (no alcohol 
consumption during pregnancy, alcohol consumption until pregnancy was known, occasional alcohol consumption 
during pregnancy, and frequent alcohol consumption during pregnancy), maternal non-verbal IQ, BMI categories 
(<18.5, 18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), IT-Home quartiles, and 
smoking categories (no smoking during pregnancy, smoked until pregnancy was known, and smoked during preg-
nancy).
b. Adjusted model with the inclusion of the three exposures in one model.
c. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
d. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
e. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
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Table S19. Adjustment for prenatal fruit and vegetable consumption: Difference in child non-ver-
bal IQ test score at age six years (and 95% confidence interval) per log10 nmol/g creatinine incre-
ase in maternal urine dialkyl phosphate metabolite concentration, by timing of  pregnancy urine 
sampling and degree of  adjustment (N=708).
Type of adjustment
None Adjusted a Mutually adjusted b
Dialkyl Phosphate Type β (95% CI) β (95% CI) β (95% CI)
Dialkyl phosphates (total) c
< 18 weeks’ gestation -0.7 -4.1 to 2.8 -2.5 -5.9 to 1.0 -2.4 -5.9 to 1.2
18 – 25 weeks’ gestation 3.2 -0.6 to 7.0 0.8 -3.1 to 4.6 2.5 -1.5 to 6.6
> 25 weeks’ gestation -0.8 -4.4 to 2.8 -4.0 -7.6 to -0.3 -4.3 -8.1 to -0.5
Mean of three urines 0.6 -4.3 to 5.5 -2.9 -7.9 to 2.0
Diethyl alkyl phosphates d
< 18 weeks’ gestation 0.1 -2.4 to 2.6 -1.6 -4.1 to 0.9 -1.7 -4.3 to 0.8
18 – 25 weeks’ gestation 2.1 -0.4 to 4.7 0.5 -2.0 to 3.0 0.9 -1.7 to 3.5
> 25 weeks’ gestation 2.2 -0.3 to 4.7 -0.1 -2.7 to 2.4 -0.1 -2.8 to 2.5
Mean of three urines 4.4 0.6 to 8.2 0.9 -3.0 to 4.8
Dimethyl alkyl phosphates e
< 18 weeks’ gestation -1.6 -4.9 to 1.7 -3.1 -6.3 to 0.2 -2.9 -6.2 to 0.4
18 – 25 weeks’ gestation 2.6 -1.0 to 6.3 0.5 -3.2 to 4.1 2.2 -1.6 to 6.0
> 25 weeks’ gestation -1.6 -5.0 to 1.9 -4.2 -7.6 to -0.7 -4.3 -7.9 to -0.8
Mean of three urines -0.6 -5.4 to 4.1 -3.5 -8.3 to 1.3
a. Adjusted for child sex, maternal age, ethnicity (Dutch, other-western, and non-western), education (low, inter-
mediate, and high), income (low, middle, and high), marital status, maternal alcohol consumption (no alcohol 
consumption during pregnancy, alcohol consumption until pregnancy was known, occasional alcohol consumption 
during pregnancy, and frequent alcohol consumption during pregnancy), maternal non-verbal IQ, BMI categories 
(<18.5, 18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), IT-Home quartiles, smo-
king categories (no smoking during pregnancy, smoked until pregnancy was known, and smoked during pregnancy), 
fruit consumption in grams, vegetables consumption in grams, and energy intake in kcal.
b. Adjusted model with the inclusion of the three exposures in one model.
c. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
d. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
e. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
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Table S20. Multiple informants model: Difference in child non-verbal IQ test score at age six years 
(and 95% confidence interval) per log10 nmol/g creatinine increase in maternal urine dialkyl 
phosphate metabolite concentration, by timing of  pregnancy urine sampling (N=708).
Estimates based on the multiple informants approach a
Dialkyl Phosphate Type β (95% CI)
Dialkyl phosphates (total) b
< 18 weeks’ gestation -2.0 -5.3 to 1.4
18 – 25 weeks’ gestation 0.8 -2.9 to 4.5
> 25 weeks’ gestation -4.0 -7.5 to -0.4
p homogeneity c 0.049
Diethyl alkyl phosphates d
< 18 weeks’ gestation -1.4 -3.9 to 1.0
18 – 25 weeks’ gestation 0.6 -1.9 to 3.0
> 25 weeks’ gestation -0.2 -2.7 to 2.3
p homogeneity c 0.722
Dimethyl alkyl phosphates e
< 18 weeks’ gestation -2.5 -5.7 to 0.6
18 – 25 weeks’ gestation 0.6 -3.0 to 4.1
> 25 weeks’ gestation -4.2 -7.5 to -0.8
p homogeneity c 0.020
a. Adjusted for child sex, maternal age, ethnicity (Dutch, other-western, and non-western), education (low, inter-
mediate, and high), income (low, middle, and high), marital status, maternal alcohol consumption (no alcohol 
consumption during pregnancy, alcohol consumption until pregnancy was known, occasional alcohol consumption 
during pregnancy, and frequent alcohol consumption during pregnancy), maternal non-verbal IQ, BMI categories 
(<18.5, 18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), IT-Home quartiles, and 
smoking categories (no smoking during pregnancy, smoked until pregnancy was known, and smoked during preg-
nancy).
b. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
c. Tests whether the exposure from different time points relates in the same manner to non-verbal IQ scores.
d. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
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Table S22. Effect measure modification by child sex: Difference in child non-verbal IQ test score at 
age six years (and 95% confidence interval) per log10 nmol/g creatinine increase in maternal urine 
dialkyl phosphate metabolite concentration, by timing of  pregnancy urine sampling, degree of  
adjustment, and child sex (N=708).
Child sex
Boys Girls
Dialkyl phosphates (total) a B 95%CI B 95%CI P interaction
Type of adjustment
None
< 18 weeks’ gestation -0.4 -5.5 to 4.7 -1.1 -5.9 to 3.6 0.844
18 – 25 weeks’ gestation 1.9 -3.6 to 7.3 4.5 -0.8 to 9.8 0.499
> 25 weeks’ gestation 0.0 -5.4 to 5.4 -1.7 -6.5 to 3.1 0.651
Mean of three urines 0.5 -6.6 to 7.6 0.3 -6.4 to 7.1 0.976
Adjusted b
< 18 weeks’ gestation -2.0 -7.2 to 3.2 -1.8 -6.3 to 2.8 0.840
18 – 25 weeks’ gestation -0.3 -5.9 to 5.2 2.1 -3.3 to 7.4 0.619
> 25 weeks’ gestation -3.0 -8.5 to 2.4 -5.3 -10.2 to -0.3 0.626
Mean of three urines -2.6 -9.9 to 4.7 -2.7 -9.5 to 4.2 0.979
Mutually adjusted c
< 18 weeks’ gestation -1.8 -7.3 to 3.7 -1.6 -6.2 to 3.0 0.751
18 – 25 weeks’ gestation 0.9 -5.0 to 6.8 4.6 -1.0 to 10.2 0.550
> 25 weeks’ gestation -3.0 -8.6 to 2.7 -6.5 -11.7 to -1.3 0.566
a. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
b. Adjusted for maternal age, ethnicity categories (Dutch, other-western, and non-western), education (low, 
intermediate, and high), income (low, middle, and high), marital status, maternal alcohol consumption (no alcohol 
consumption during pregnancy, alcohol consumption until pregnancy was known, occasional alcohol consumption 
during pregnancy, and frequent alcohol consumption during pregnancy), maternal non-verbal IQ, BMI categories 
(<18.5, 18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), Home IT quartiles, and 
smoking categories (no smoking during pregnancy, smoked until pregnancy was known, and smoked during preg-
nancy).
c. Adjusted model with the inclusion of the three exposures in one model.
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Table S23. Complete-case only model (with the exclusion of  IT-Home score): Difference in 
child non-verbal IQ test score at age six years (and 95% confidence interval) per log10 nmol/g 
creatinine increase in maternal urine dialkyl phosphate metabolite concentration, by timing of  
pregnancy urine sampling, and degree of  adjustment, among mother-child pairs with complete 
covariate data.
Type of adjustment
None (n=708) Adjusted (n=541) a Mutually adjusted (n=541) b
Dialkyl Phosphate Type β (95% CI) β (95% CI) β (95% CI)
Dialkyl phosphates (total) c
< 18 weeks’ gestation -0.7 -4.2 to 2.8 -2.3 -6.1 to 1.5 -2.3 -6.2 to 1.6
18 – 25 weeks’ gestation 3.2 -0.6 to 7.0 1.1 -3.3 to 5.4 2.7 -1.8 to 7.2
> 25 weeks’ gestation -0.9 -4.5 to 2.7 -3.9 -8.1 to 0.4 -4.2 -8.6 to 0.2
Mean of three urines 0.6 -4.4 to 5.5 -2.5 -8.1 to 3.2
Diethyl alkyl phosphates d
< 18 weeks’ gestation 0.1 -2.4 to 2.6 -2.0 -4.6 to 0.6 -2.2 -4.9 to 0.5
18 – 25 weeks’ gestation 2.2 -0.4 to 4.7 1.1 -1.7 to 3.8 1.3 -1.5 to 4.2
> 25 weeks’ gestation 2.2 -0.3 to 4.7 0.4 -2.9 to 3.7 0.4 -2.9 to 3.8
Mean of three urines 0.6 -4.4 to 5.5 1.4 -2.9 to 5.8
Dimethyl alkyl phosphates e
< 18 weeks’ gestation -1.7 -5.0 to 1.6 -2.6 -6.3 to 1.0 -2.6 -6.2 to 1.1
18 – 25 weeks’ gestation 2.6 -1.0 to 6.3 0.5 -3.6 to 4.6 2.1 -2.2 to 6.4
> 25 weeks’ gestation -1.6 -5.1 to 1.8 -4.3 -8.3 to -0.3 -4.5 -8.6 to -0.4
Mean of three urines 0.6 -4.4 to 5.5 -3.1 -8.6 to 2.3
a. Adjusted for child sex, maternal age, ethnicity (Dutch, other-western, and non-western), education (low, in-
termediate, and high), income (low, middle, and high), marital status, maternal non-verbal IQ, maternal alcohol 
consumption (no alcohol consumption during pregnancy, alcohol consumption until pregnancy was known, occasi-
onal alcohol consumption during pregnancy, and frequent alcohol consumption during pregnancy), BMI categories 
(<18.5, 18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), and smoking categories (no 
smoking during pregnancy, smoked until pregnancy was known, and smoked during pregnancy).
b. Adjusted model with the inclusion of the three exposures in one model.
c. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
d. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
e. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
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Table S24. Complete-case only model (with the inclusion of  IT-Home score): Difference in child 
non-verbal IQ test score at age six years (and 95% confidence interval) per log10 nmol/g creatinine 
increase in maternal urine dialkyl phosphate metabolite concentration, by timing of  pregnancy 
urine sampling, and degree of  adjustment, among mother-child pairs with complete covariate 
data.
Type of adjustment
None (n=708) Adjusted (n=384) a Mutually adjusted (n=384) b
Dialkyl Phosphate Type β (95% CI) β (95% CI) β (95% CI)
Dialkyl phosphates (total) c
< 18 weeks’ gestation -0.7 -4.2 to 2.8 -0.5 -5.1 to 4.0 -1.0 -5.7 to 3.6
18 – 25 weeks’ gestation 3.2 -0.6 to 7.0 3.3 -1.7 to 8.4 4.4 -0.9 to 9.6
> 25 weeks’ gestation -0.9 -4.5 to 2.7 -2.5 -7.4 to 2.4 -3.4 -8.4 to 1.6
Mean of three urines 0.6 -4.4 to 5.5 0.9 -5.8 to 7.5
Diethyl alkyl phosphates d
< 18 weeks’ gestation 0.1 -2.4 to 2.6 -1.7 -4.6 to 1.3 -1.9 -4.8 to 1.1
18 – 25 weeks’ gestation 2.2 -0.4 to 4.7 1.7 -1.5 to 4.8 1.9 -1.3 to 5.1
> 25 weeks’ gestation 2.2 -0.3 to 4.7 0.1 -3.7 to 4.0 -0.1 -4.0 to 3.8
Mean of three urines 0.6 -4.4 to 5.5 0.9 -5.8 to 7.5
Dimethyl alkyl phosphates e
< 18 weeks’ gestation -1.7 -5.0 to 1.6 -1.1 -5.5 to 3.4 -1.3 -5.8 to 3.1
18 – 25 weeks’ gestation 2.6 -1.0 to 6.3 2.7 -2.2 to 7.5 3.6 -1.4 to 8.6
> 25 weeks’ gestation -1.6 -5.1 to 1.8 -2.7 -7.3 to 2.0 -3.3 -8.1 to 1.5
Mean of three urines 0.6 -4.4 to 5.5 0.9 -5.8 to 7.5
a. Adjusted for child sex, maternal age, ethnicity (Dutch, other-western, and non-western), education (low, interme-
diate, and high), income (low, middle, and high), marital status, maternal non-verbal IQ, maternal alcohol consump-
tion (no alcohol consumption during pregnancy, alcohol consumption until pregnancy was known, occasional alco-
hol consumption during pregnancy, and frequent alcohol consumption during pregnancy), BMI categories (<18.5, 
18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), IT-Home quartiles, and smoking 
categories (no smoking during pregnancy, smoked until pregnancy was known, and smoked during pregnancy).
b. Adjusted model with the inclusion of the three exposures in one model.
c. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
d. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
e. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
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Table S25. Excluding DEDTP (i.e., including only those metabolites with at least 80% of  values 
>LOD): Difference in child non-verbal IQ test score at age six years (and 95% confidence interval) 
per log10 nmol/g creatinine increase in maternal urine dialkyl phosphate metabolite concentrati-
on, by timing of  pregnancy urine sampling and degree of  adjustment (N=708).
Type of adjustment
None Adjusted a Mutually adjusted b
Dialkyl Phosphate Type β (95% CI) β (95% CI) β (95% CI)
Dialkyl phosphates (total) 
< 18 weeks’ gestation -0.7 -4.2 to 2.8 -1.9 -5.3 to 1.5 -1.9 -5.3 to 1.6
18 – 25 weeks’ gestation 3.2 -0.6 to 7.0 0.9 -2.9 to 4.7 2.6 -1.4 to 6.6
> 25 weeks’ gestation -0.8 -4.4 to 2.8 -3.9 -7.5 to -0.3 -4.3 -8.1 to -0.6
Mean of three urines 0.6 -4.3 to 5.5 -2.5 -7.4 to 2.4
Diethyl alkyl phosphates d
< 18 weeks’ gestation 0.1 -2.4 to 2.6 -1.4 -3.9 to 1.0 -1.6 -4.1 to 0.9
18 – 25 weeks’ gestation 2.1 -0.4 to 4.6 0.5 -2.0 to 3.0 0.9 -1.7 to 3.4
> 25 weeks’ gestation 2.2 -0.3 to 4.7 -0.2 -2.8 to 2.3 -0.3 -2.8 to 2.3
Mean of three urines 4.4 0.6 to 8.2 1.0 -2.8 to 4.9
Dimethyl alkyl phosphates e
< 18 weeks’ gestation -1.6 -4.9 to 1.7 -2.5 -5.7 to 0.7 -2.3 -5.6 to 0.9
18 – 25 weeks’ gestation 2.6 -1.0 to 6.3 0.7 -3.0 to 4.3 2.3 -1.4 to 6.1
> 25 weeks’ gestation -1.6 -5.0 to 1.9 -4.1 -7.5 to -0.7 -4.3 -7.9 to -0.8
Mean of three urines -0.6 -5.4 to 4.1 -3.0 -7.7 to 1.7
a. Adjusted for child sex, maternal age, ethnicity (Dutch, other-western, and non-western), education (low, inter-
mediate, and high), income (low, middle, and high), marital status, maternal alcohol consumption (no alcohol 
consumption during pregnancy, alcohol consumption until pregnancy was known, occasional alcohol consumption 
during pregnancy, and frequent alcohol consumption during pregnancy), maternal non-verbal IQ, BMI categories 
(<18.5, 18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), IT-Home quartiles, and 
smoking categories (no smoking during pregnancy, smoked until pregnancy was known, and smoked during preg-
nancy).
b. Adjusted model with the inclusion of the three exposures in one model.
c. Total dialkyl phosphates is the sum of DETP, DEP, DMDTP, DMTP and DMP.
d. Diethyl alkyl phosphates is the sum of DETP and DEP.
e. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
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Table S26. Difference in Mosaics test score at age six years (and 95% confidence interval) per 
log10 nmol/g creatinine increase in maternal urine dialkyl phosphate metabolite concentration, by 
timing of  pregnancy urine sampling and degree of  adjustment (N=708).
Type of adjustment
None Adjusted a Mutually adjusted b
Dialkyl Phosphate Type β (95% CI) β (95% CI) β (95% CI)
Dialkyl phosphates (total) c
< 18 weeks’ gestation -1.3 -4.9 to 2.3 -3.1 -6.5 to 0.4 -3.0 -6.6 to 0.6
18 – 25 weeks’ gestation 2.7 -1.2 to 6.7 0.1 -3.7 to 4.0 1.8 -2.3 to 5.9
> 25 weeks’ gestation 0.2 -3.6 to 3.9 -3.3 -7.0 to 0.4 -3.3 -7.2 to 0.5
Mean of three urines 0.5 -4.7 to 5.6 -3.4 -8.5 to 1.6
p homogeneity d 0.110
Diethyl alkyl phosphates e
< 18 weeks’ gestation 0.5 -2.1 to 3.2 -1.2 -3.7 to 1.3 -1.5 -4.1 to 1.1
18 – 25 weeks’ gestation 2.8 0.1 to 5.4 1.0 -1.5 to 3.6 1.2 -1.5 to 3.8
> 25 weeks’ gestation 3.7 1.0 to 6.3 0.9 -1.7 to 3.4 0.8 -1.9 to 3.4
Mean of three urines 5.7 1.7 to 9.6 1.6 -2.3 to 5.6
p homogeneity d 0.457
Dimethyl alkyl phosphates f
< 18 weeks’ gestation -2.2 -5.6 to 1.3 -3.6 -6.9 to -0.3 -3.4 -6.7 to 0.0
18 – 25 weeks’ gestation 2.2 -1.6 to 6.1 0.0 -3.7 to 3.7 1.8 -2.0 to 5.7
> 25 weeks’ gestation -1.1 -4.7 to 2.5 -3.9 -7.4 to -0.4 -3.9 -7.6 to -0.3
Mean of three urines -1.1 -6.0 to 3.9 -4.1 -9.0 to 0.7
p homogeneity d 0.039
a. Adjusted for child sex, maternal age, ethnicity (Dutch, other-western and non-western), education (low, intermedi-
ate, and high), income (low, middle, and high), marital status, maternal alcohol consumption (no alcohol consump-
tion during pregnancy, alcohol consumption until pregnancy was known, occasional alcohol consumption during 
pregnancy, and frequent alcohol consumption during pregnancy), maternal non-verbal IQ, BMI categories (<18.5, 
18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), IT-Home quartiles, and smoking 
categories (no smoking during pregnancy, smoked until pregnancy was known, and smoked during pregnancy).
b. Adjusted model with the inclusion of the three exposures in one model.
c. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
d. Multiple-partial F test used to test whether exposure from different time points relates in the same manner to 
Mosaics scores.
e. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
f. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
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Table S27. Difference in Categories test score at age six years (and 95% confidence interval) per 
log10 nmol/g creatinine increase in maternal urine dialkyl phosphate metabolite concentration, 
by timing of  pregnancy urine sampling and degree of  adjustment (N=708).
Type of adjustment
None Adjusted a Mutually adjusted b
Dialkyl Phosphate Type β (95% CI) β (95% CI) β (95% CI)
Dialkyl phosphates (total) c
< 18 weeks’ gestation 0.6 -2.9 to 4.1 0.6 -2.9 to 4.2 0.4 -3.3 to 4.1
18 – 25 weeks’ gestation 3.0 -0.8 to 6.8 2.4 -1.5 to 6.3 3.3 -0.9 to 7.4
> 25 weeks’ gestation -1.4 -4.9 to 2.2 -2.4 -6.1 to 1.4 -3.3 -7.2 to 0.6
Mean of three urines 1.2 -3.7 to 6.1 0.9 -4.2 to 6.0
p homogeneity d  0.128
Diethyl alkyl phosphates e
< 18 weeks’ gestation -0.5 -3.0 to 2.1 -1.0 -3.6 to 1.5 -1.1 -3.7 to 1.5
18 – 25 weeks’ gestation 1.1 -1.5 to 3.6 0.4 -2.2 to 3.0 0.8 -1.9 to 3.5
> 25 weeks’ gestation 0.0 -2.6 to 2.5 -0.9 -3.6 to 1.7 -1.0 -3.7 to 1.7
Mean of three urines 1.7 -2.2 to 5.5 0.6 -3.4 to 4.6
p homogeneity d 0.520
Dimethyl alkyl phosphates f
< 18 weeks’ gestation -0.1 -3.4 to 3.2 0.2 -3.2 to 3.5 0.1 -3.4 to 3.5
18 – 25 weeks’ gestation 2.6 -1.0 to 6.3 2.0 -1.8 to 5.8 2.8 -1.2 to 6.7
> 25 weeks’ gestation -1.3 -4.8 to 2.1 -2.1 -5.7 to 1.5 -2.8 -6.5 to 0.9
Mean of three urines 0.8 -3.9 to 5.5 0.8 -4.1 to 5.7
p homogeneity d 0.200
a. Adjusted for child sex, maternal age, ethnicity (Dutch, other-western and non-western), education (low, inter-
mediate, and high), income (low, middle, and high), marital status, maternal alcohol consumption (no alcohol 
consumption during pregnancy, alcohol consumption until pregnancy was known, occasional alcohol consumption 
during pregnancy, and frequent alcohol consumption during pregnancy), maternal non-verbal IQ, BMI catego-
ries (<18.5, 18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), IT-Home quartiles, 
and smoking categories (no smoking during pregnancy, smoked until pregnancy was known, and smoked during 
pregnancy).
b. Adjusted model with the inclusion of the three exposures in one model.
c. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
d. Multiple-partial F test used to test whether exposure from different time points relates in the same manner to 
Categories scores.
e. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
f. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
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 Figure S1. Restricted cubic spline (and 95% confidence interval) of adjusted child non-verbal IQ scores and 
(untransformed) total dialkyl phosphate concentrations, by timing of pregnancy urine sampling (n=708). 
Adjusted for child sex, maternal age, ethnicity (Dutch, other-western, and non-western), education (low, 
intermediate, and high), income (low, middle, and high), marital status, maternal alcohol consumption (no 
alcohol consumption during pregnancy, alcohol consumption until pregnancy was known, occasional alcohol 
consumption during pregnancy, and frequent alcohol consumption during pregnancy), maternal non-verbal 
IQ, BMI categories (<18.5, 18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), 
IT-Home quartiles, and smoking categories (no smoking during pregnancy, smoked until pregnancy was 
known, and smoked during pregnancy).
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Figure S2. Restricted cubic spline (and 95% confidence interval) of adjusted child non-verbal IQ scores and 
(untransformed) diethyl alkyl phosphate concentrations, by timing of pregnancy urine sampling (n=708). 
Adjusted for child sex, maternal age, ethnicity (Dutch, other-western and non-western), education (low, 
intermediate, and high), income (low, middle, and high), marital status, maternal alcohol consumption (no 
alcohol consumption during pregnancy, alcohol consumption until pregnancy was known, occasional alcohol 
consumption during pregnancy, and frequent alcohol consumption during pregnancy), maternal non-verbal 
IQ, BMI categories (<18.5, 18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), 
IT-Home quartiles, and smoking categories (no smoking during pregnancy, smoked until pregnancy was 
known, and smoked during pregnancy).
A) <18 weeks
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Figure S3. Restricted cubic spline (and 95% confidence interval) of adjusted child non-verbal IQ scores and 
(untransformed) dimethyl alkyl phosphate concentrations, by timing of pregnancy urine sampling (n=708). 
Adjusted for child sex, maternal age, ethnicity (Dutch, other-western and non-western), education (low, 
intermediate, and high), income (low, middle, and high), marital status, maternal alcohol consumption (no 
alcohol consumption during pregnancy, alcohol consumption until pregnancy was known, occasional alcohol 
consumption during pregnancy, and frequent alcohol consumption during pregnancy), maternal non-verbal 
IQ, BMI categories (<18.5, 18.5-25, 25-30, and 30+), height of the mother, parity categories (0, 1, and 2+), 
IT-Home quartiles, and smoking categories (no smoking during pregnancy, smoked until pregnancy was 
known, and smoked during pregnancy).
A) <18 weeks
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Organophosphate pesticide metabolite 
concentrations in urine during 
pregnancy and offspring attention-
deficit hyperactivity disorder and autistic 
traits
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Jusko, T. A., Longnecker, M. P., Ferguson, K. K., & Tiemeier, H. (2019). 




Background: Prenatal exposure to organophosphate (OP) pesticides has been associated 
with altered neuronal cell development and behavioral changes in animal offspring. However, 
the few studies investigating the association between prenatal OP pesticide exposure and 
neurodevelopmental outcomes such as Attention-Deficit Hyperactivity Disorder (ADHD) 
and autistic traits in children produced mixed findings.
Objectives: The objective of the present study was to examine whether maternal urinary 
concentrations of OP pesticide metabolites are associated with ADHD and autistic traits 
in children participating in the Generation R Study, a population-based birth cohort from 
Rotterdam, the Netherlands.
Method: Maternal concentrations of 6 dialkylphosphates (DAPs) were measured using 
gas chromatography coupled with tandem mass spectrometry in urine samples collected 
at <18 weeks, 18‐25 weeks, and > 25 weeks of gestation in 784 mother-child pairs. DAP 
metabolite concentrations were expressed as molar concentrations divided by creatinine levels 
and log10 transformed. ADHD traits were measured at ages 3, 6, and 10 years using the 
Child Behavior Checklist (CBCL) (n = 781) and autistic traits were measured at age 6 years 
using the Social Responsiveness Scale (SRS) (n = 622). First, regression models were fit for 
the averaged prenatal exposure across pregnancy. Second, we investigated associations for 
each collection phase separately, and applied a mutually adjusted model in which the effect 
of prenatal DAP concentrations from each time period on ADHD and autistic traits were 
jointly estimated. All associations were adjusted for relevant confounders.
Results: Median DAP metabolite concentration was 309 nmol/g creatinine at <18 weeks, 
316 nmol/g creatinine at 18–25 weeks, and 308 nmol/g creatinine at >25 weeks of gestation. 
Overall, DAP metabolite concentrations were not associated with ADHD traits. For instance, 
a log10 increase in averaged total DAP concentrations across gestation was not associated 
with a lower ADHD score (-0.03 per SD 95%CI: −0.28 to 0.23). Similarly, no associations 
between maternal DAP concentrations and autistic traits were detected.
Conclusions: In this study of maternal urinary DAP metabolite concentrations during 
pregnancy, we did not observe associations with ADHD and autistic traits in children. These 
are important null observations because of the relatively high background DAP concentrations 
across pregnancy, the relatively large sample size, and the 10-year follow-up of the offspring. 
Given the measurement error inherent in our OP pesticide exposure biomarkers, future 
studies using more urine samples are needed to accurately measure OP pesticide exposure 
over pregnancy in relation to ADHD and autistic traits.




Organophosphate (OP) pesticides are a class of insecticides commonly used in agriculture. 
Some of the active OP pesticides may remain on or in food after they are applied to food 
crops1 and the exposure of non-occupationally exposed individuals occurs most likely 
through their diet.2-5 After ingestion, most OP pesticides undergo bioactivation, during 
which the toxic oxon form is established, followed by detoxification, which produces up 
to 6 non-specific dialkyl phosphate (DAP) metabolites.6 Preformed DAP metabolites also 
exist in the food supply.7-9 It is therefore uncertain to what degree total DAP metabolite 
concentrations reflect actual OP pesticide exposure or the ingestion of possibly less toxic 
DAP metabolites.10 However, the estimation of urinary DAP metabolite concentrations 
is considered a non-invasive and useful biomarker for OP pesticide exposure,11 and thus, 
the most-used method of estimating exposure to this class of compounds in general 
populations.12
High OP pesticide exposure is neurotoxic for both animals and humans.13-15 However, 
both animal and human studies have suggested that even low-dose OP pesticide exposure 
may have negative health consequences.16 Animal studies investigating exposure to the OP 
pesticides chlorpyrifos, diazinon and malathion (of which the residues were frequently 
being detected on fruit and vegetables between 2004 and 2006 in the Netherlands)17 
have shown that exposure levels below the threshold for acetylcholinesterase inhibition 
can induce changes in neurochemistry and behavior,18 result in cognitive impairments19,20 
and change the expression of genes related to mental disorders.21 Low-dose OP pesticide 
exposure in animal studies also changed neuronal cell development,22 induced oxidative 
stress,23,24 and affected the thyroid and the reproductive systems.25-27 Moreover, animals 
prenatally exposed to these OP pesticides had higher activity rates, greater motor agitation 
and hyperactivity signs, lower level of social behavior, and animals were limited in their 
exploration of novel objects.28,29
Because the human brain is particularly susceptible to neurotoxicity during fetal life,30 and 
because OP pesticides can cross the placental barrier and the blood-brain barrier,31 most 
epidemiological studies of low-dose OP pesticide exposure focus on prenatal exposure in 
relation to neurodevelopment.32 Several of these studies have found prenatal OP pesticide 
exposure to be associated with or suggestive of poorer reflexes in neonates,33,34 mental and 
psychomotor developmental delays in the offspring aged 1 to 3 years,35-37 and decreased 
intellectual functioning in children aged 6 to 9 years35,38-40 Yet, other studies have not 
observed associations with neurodevelopmental outcomes.32 For example, Cartier et al. 
(2016) did not find evidence for an association between prenatal OP pesticide exposure 
and intellectual functioning in children aged 6 years.
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Few studies have explored the association between OP pesticide exposure and Attention-
Deficit Hyperactivity Disorder (ADHD) and autistic traits in children, and have reported 
inconsistent findings. A prospective birth cohort study among ethnic minorities from 
inner-city New York observed associations between prenatal OP pesticide exposure and 
ADHD traits in 228 children aged 3 years.37 Also, another birth cohort study among low-
income participants from farmworking communities in California observed associations 
with ADHD traits in 322 children aged 5 years.41 Yet, Eskenazi et al. (2007) did not 
observe these associations among children aged 2 years using data from the same cohort 
as Marks et al. (2010). These cohort studies were also used to assess the association 
between prenatal OP pesticide exposure and pervasive developmental disorder (PDD), 
which includes Autism Spectrum Disorders (ASDs) and found prenatal exposure to OP 
pesticides to be predictive of PDD at 2 to 3 years,36,37 but the number of PDD cases was 
small in one of the studies.37 Next, a study using data from the same cohort as Eskenazi et 
al. (2007) and Marks et al. (2010) found that children prenatally exposed to higher levels 
of OP pesticides had more autistic traits as measured with the Social Responsiveness Scale 
(SRS) in 246 children aged 14 years.42 Yet, another study using data from 224 mother-
child pairs from a metropolitan area in Ohio found that prenatal OP pesticide exposure 
did not increase autistic symptoms at age 8 years.43 Only in subgroups, Furlong et al. 
(2014) observed an association between OP pesticide exposure and autistic symptoms 
among Black (n = 42) and male children (n = 66) using 136 mother-child pairs from 
New York. Similarly, Philippat et al. (2018), using data from a cohort study of women at 
high risk for having a child with ASD, did not observe an overall association among 203 
children aged 3 years. However, after stratifying by sex prenatal OP pesticide exposure 
was associated with an increased risk of ASD among girls (n = 78).44
This heterogeneity may be explained by differences in study areas and study populations. 
For example, 3 studies took place in California in a farmworker community where the 
use of insecticides is abundant,36,41,42 whereas other studies took place in urban areas37,43,45 
where the source and route of OP pesticide exposure may be different. Next, several 
of these studies were small in sample size. This may have reduced the power to detect 
associations and perform interaction analyses. Also, most of these studies included 1 or 
2 urine specimens per subject to measure OP pesticide exposure. Analyzing multiple 
urine specimens per subject is of importance, because the urinary concentration of DAP 
metabolites reflects only recent exposure, and individual exposure differs substantially 
from day-to-day, depending on diet.4,46
Therefore, much uncertainty still exists about the relationship between fetal exposure to 
OP pesticides and the development of ADHD and ASD. The Generation R Study provides 
suitable data to address these research gaps because of the large sample size, 3 repeated 
measurements of maternal urinary concentrations of OP pesticide metabolites, repeated 
Prenatal OP pesticide exposure and ADHD and autistic traits
175
5
neurobehavioral measurements, and the availability of detailed demographic information. 
Furthermore, as documented elsewhere, the median total DAP concentrations among the 
Generation R Study mothers was more than 2-fold higher compared with background-
exposed pregnant women in the U.S living in non-agricultural communities, which 
suggests a greater range of exposure and thus statistical power with which to evaluate 
exposure—disease associations.47 The objective of the present study was to examine whether 
maternal urinary concentrations of OP pesticide metabolites is related to ADHD and 
autistic traits in young children.
Methods
Study population and follow-up
Generation R is a prospective population-based birth cohort designed to identify early 
environmental and genetic determinants of development.48 Briefly, all mothers who resided 
in the study area in Rotterdam, the Netherlands, and had a delivery date between April 
2002 and January 2006 were eligible. Mothers were enrolled during pregnancy or in the 
first months after the birth of their child when newborns attended child health centers 
for routine visits. The study protocol underwent human subjects review at Erasmus 
Medical Center, Rotterdam, the Netherlands (IRB Registration no.: IRB00001482, 
MEC 198.782.2001.31, MEC 217.595/2002/202, MEC-2007-413, MEC-2012-165). 
Mothers provided written informed consent for themselves and their children.
Among the 9778 mothers who participated in the study, 8879 (91%) were enrolled during, 
as opposed to after, pregnancy. Between February 2004 and January 2006, spot urine 
specimens during early, middle, and late pregnancy (<18, 18–25, >25 weeks of gestational 
age, respectively) were collected at the time of routine ultrasound examinations when in 
total, 4918 women were enrolled. Of these, 2083 women provided a complete set of 3 
urine specimens. From birth until the age of 4 years, data collection was performed by 
mailed questionnaires and by routine child health center visits. At child age 6 and 10 years, 
families were invited to participate in an in-person follow-up to collect neurobehavioral 
data, additional biospecimens, and sociodemographic and health data. We selected samples 
based on follow-up data with relevant outcomes, which was obtained for 1449 children 
of the 2083 women with a complete set of urine specimens. The availability of follow-
up data permitted studies of prenatal OP pesticide exposure and child health, including 
neurodevelopment. From these 1449, 800 mother-child pairs were selected at random 
for lab analyses of DAP metabolites in the maternal and child urine samples. Of those, 
784 had a sufficient volume of urine for analyses. The final analytic sample included 781 
mother-child pairs with exposure and data on ADHD traits (from age 3 to 10 years), 
and 622 mother-child pairs with exposure and data on autistic traits (at age 6 years).
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Urine collection and analysis of  DAP metabolites
Maternal spot urine specimens were collected during early, mid-, and late pregnancy 
(<18, 18–25, >25 weeks of gestational age, respectively). Child spot urine specimens 
were collected when mother-child pairs attended the 6-year examination. Details of urine 
specimen collection have been described elsewhere.49 All urine samples were collected 
between 8 am and 8 pm in 100 ml polypropylene urine collection containers that were 
kept for a maximum of 20 h in a cold room (4 °C) before being frozen at −20 °C in 
20 ml portions in 25 ml polypropylene vials. Measurements of 6 non-specific DAP 
metabolites of OP pesticides were conducted at Institut National de Santé Publique 
(INSPQ) in Quebec, Canada, using gas chromatography coupled with tandem mass 
spectrometry (GC–MS/MS).50 Three dimethyl (DM) metabolites (dimethylphosphate 
(DMP), dimethylthiophosphate (DMTP), and dimethyldithiophosphate (DMDTP)) 
were determined, as well as 3 diethyl (DE) metabolites (diethylphosphate (DEP), 
diethylthiophosphate (DETP), and diethyldithiophosphate (DEDTP)). The limit of 
detection (LOD) was 0.26 μg/l for DMP (0% < LOD), 0.40 for DMTP (2–4% < LOD), 
0.09 for DMDTP (18–20% < LOD), 0.50 for DEP (3–5% < LOD), 0.12 for DETP 
(12% < LOD) and 0.06 for DEDTP (81–85% < LOD). Measured concentrations below 
the LOD were included in the data analysis. The inter-day precision of the method during 
this project, expressed as the coefficient of variation (CV%), varied between 4.2 and 8.8 
for DEDTP, 4.1–7.2 for DEP, 5.0–9.1 for DETP, 5.5–7.1 for DMDTP, 5.3–8.0 for 
DMP and 5.5–7.7 for DMTP based on reference materials (clinical check-urine level II 
637 E-495 and MRM E-459).5 Molar concentrations were used to compare our results 
with those from other studies, based on the following molecular weights: DMP 126.0, 
DMTP 142.1, DMDTP 158.2, DEP 154.1, DETP 170.2, and DEDTP 186.2 g/mol. 
To account for urinary dilution, creatinine concentrations were determined based on the 
Jaffe reaction.51,52 The LOD for creatinine was 0.28 mmol/l, and the day-to-day CV% 
varied between 3.0 and 3.3.5
Assessment of  child ADHD traits
Child emotional and behavioral problems were assessed by maternal report with the 
Child Behavior Checklist (CBCL) 1.5–553 during the assessments at child age 3, and 
6 years, and with the CBCL 6–18 at child age 10 years.54 The CBCL is an internationally 
validated and reliable measure of emotional and behavioral problems.54 The CBCL 
measures emotional and behavioral problems on a continuous severity scale and research 
has shown that symptom scores predict psychiatric disorders as defined by the DSM 
in adulthood.55,56 Each item (CBCL 1.5–5: 99 items, CBCL 6–18: 112 items) within 
different scales (CBCL 1.5–5: 7 scales, CBCL 6–18: 8 scales) is scored on a 3 point rating 
scale 0 = ‘not true’, 1 = ‘somewhat or sometimes true’, and 2 = ‘very true or often true’, 
based on the preceding 2 months for the CBCL 1.5–5 and the preceding 6 months for 
the CBCL 6–18. The scales were found to be generalizable across 23 countries, including 
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the Netherlands.57 From the CBCL checklist, we used the standardized sum score of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM)-oriented ADHD traits 
across childhood for our analyses. The sum scores of ADHD traits were standardized 
to make the CBCL 1.5–5 (6 items) and the CBCL 6–18 (7 items) comparable, with a 
higher score indicating a higher level of ADHD traits.
Assessment of  child autistic traits
At age 6 years, the SRS was administered to obtain a measure of autistic traits.58 The SRS 
provides a valid quantitative measure of subclinical and clinical autistic traits and assesses 
various dimensions of interpersonal behavior, communication and repetitive/stereotypic 
behavior characteristic of ASD.59 The SRS represents the mothers’ observation of the child’s 
social behavior during the previous 6 months. The SRS is a useful screening tool to identify 
children who need further ASD-specific diagnostic assessment. The SRS has excellent 
correspondence to ASD classification according to the Developmental, Dimensional, and 
Diagnostic interview (3Di) and the Autism Diagnostic Observation Schedule (ADOS).60 
We used an abbreviated version of the SRS with a total of 18 items61 to reduce participant 
burden. These items cover 3 domains: social cognition, social communication, and autistic 
mannerism. Previous studies have shown high correlations (r > 0.90) between the total 
scores of the abbreviated version of the SRS and the complete version of the SRS.62 We 
used the SRS total score as a continuous measure in our analyses.
Additional data collection
Maternal reproductive, sociodemographic, and cognitive data were assessed by multiple 
questionnaires and instruments throughout the study. During pregnancy, data on 
maternal height and weight were collected, as was information on maternal age, maternal 
psychopathology (0= no problems, 1 = borderline: GSI score > 80%),63 parity (0, 1, or 
2+), smoking (no smoking during pregnancy, smoked until pregnancy recognized, and 
continued smoking during pregnancy), alcohol intake during pregnancy (no alcohol 
consumption during pregnancy, alcohol consumption until pregnancy recognized, continued 
occasionally (<1 glass/week), and continued frequently (1+ glass/week)), marital status 
(married/partner or single), household total net income (<1200 euro per month (i.e., below 
the Dutch social security level), 1200–2000 euro per month, >2000 euro per month), 
highest completed education level (low: <3 years of high school; intermediate: 3+ years 
of secondary education; and, high: university degree or higher vocational training), and 
ethnicity (Dutch national origin, other-Western and non-Western). Further, body mass 
index (BMI) was calculated and categorized into 4 groups (<18.5, 18.5–<25, 25–<30, 
and ≥30).
After birth, mothers reported on the duration of breastfeeding by postal questionnaire 
when the child was 2 months, 6 months and 12 months old. Mothers were asked whether 
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they ever breastfed their child, and if yes, duration of any breastfeeding was assessed 
by asking at what age of the infant they stopped breastfeeding (in months). Next, an 
adapted Infant/Toddler Home Observation for Measurement of the Environment (IT-
HOME) inventory64 was administered during a home visit at approximately 3 months 
of age (SD = 1.17 months). The validated 29-item version of the IT-HOME was used 
to measure the events, objects, and social interactions experienced by the child in the 
family context.65 Higher scores on the IT-HOME indicate a more enriched environment. 
Maternal IQ was measured when mother-child pairs attended the 6-year examination, 
and was assessed using a computerized Ravens Advanced Progressive Matrices Test, set 
I.66 The test is a 12-item reliable and validated short version of the Raven’s Progressive 
Matrices to assess non-verbal cognitive ability.67
Statistical methods
The 3 DM metabolites (DMP, DMTP, and DMDTP) were summed as total DM (nmol/l) 
and the 3 DE metabolites (DEP, DETP, and DEDTP) were summed as total DE (nmol/l). 
Total DAP concentrations (nmol/l) were calculated by summing the 6 metabolites. Urinary 
concentrations were expressed on a volume and creatinine basis (nmol/g creatinine) and 
log10 transformed. For DAP metabolites, a small number of concentrations were missing 
due to insufficient samples or machine errors (≤5 measurements for any visit for DMs; ≤23 
for DEs; ≤5 per visit for creatinine). Missing DAP metabolite values and missing covariate 
data were 10 times imputed with the Multivariate Imputation by Chained Equations 
(MICE) method in R.68,69 DAP metabolite concentrations were log10 transformed 
prior to the multiple imputation (MI) procedure to approach normality. Both ADHD 
traits scores and autistic traits scores were included as predictors for the imputation of 
covariates, but were not imputed.
To address our primary research objective, we created linear mixed effects models (LMM) 
using averaged DM, DE, and DAP concentrations over pregnancy in relation to repeated 
measures of ADHD and used linear regression models to assess the association between 
averaged DM, DE, and DAP concentrations and autistic traits. Because urinary DAP levels 
are highly variable over time, this average is likely a better estimate of each participant’s 
exposure than any single exposure measurement.70 As a secondary approach, we investigated 
the DAP – ADHD traits and the DAP–autistic traits association for each collection 
phase (gestational age <18 weeks, 18–25 weeks, and >25 weeks) separately, and applied 
a mutually adjusted model in which the effect of prenatal DAP concentration from each 
time period on ADHD and autistic traits was jointly estimated. This additional approach 
was chosen to identify possible windows of vulnerability and to be able to compare our 
results with other studies that used a single spot urine sample in pregnancy to determine 
OP pesticide exposure.
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Each LMM included a random intercept, a random slope of time (the age of the child at 
the outcome ascertainment in years), and an Autoregressive (order 1) covariance structure 
which improved the model fit based on a lower Akaike information criteria (AIC). The 
inclusion of an interaction term between time and exposure did not improve the model 
AIC significantly. For the DAP–autistic traits analyses the autistic traits score was square 
root transformed to approach normality of the residuals.
All analyses consisted of an unadjusted model and an adjusted model. The adjustment 
variables were maternal age, psychopathology score, ethnicity, education, income, marital 
status, alcohol consumption during pregnancy, non-verbal IQ, BMI, height, parity, 
smoking during pregnancy, and child sex. Potential adjustment variables were selected a 
priori defined with a Directed Acyclic Graph (DAG) using the Dagitty software.71 The 
DAG was based on previous studies of OP pesticide exposure and child neurodevelopment 
and on biologically plausible covariate–exposure and covariate–outcome associations 
observed in our data (See Supplementary Fig. S1). Additionally, adjusting for the possible 
confounders breastfeeding in months and IT-HOME score did not change the effect 
estimates meaningfully and were not included in the models.
Sensitivity analyses
Several sensitivity analyses were performed. First, potential effect modification by sex 
was explored via interaction terms, stratification, and augmented product terms,72 
because other studies have reported sex specific effects of the association between prenatal 
DAP metabolite concentrations with ADHD and autistic traits.41,44,45 Second, we refit 
models with using dichotomous ADHD and autistic traits scores because several studies 
investigated the association between DAP metabolite concentrations with the use of 
clinical cases.36,73 The dichotomization was based on the borderline clinical cut-off score 
for ADHD (>93rd percentile)53,54 and SRS cut-off value for screening in the population 
(consistent with weighted scores of ≥1.078 for boys and ≥1.000 for girls),59 and based on 
the >80th percentile of the ADHD and autistic traits scores (to increase power). Third, 
we used inverse probability weighting to correct for loss to follow-up and to account 
for potential selection bias because participants in our study sample were more likely 
be Dutch, older, have a higher level of education, and a higher income compared with 
the full cohort (Table S1). Fourth, we substituted values below the LOD with LOD/√2 
rather than the use of the measured concentrations below the LOD, which were included 
in the primary analysis. The replacement of values below the LOD with LOD/√2 is 
a common substitution method in environmental exposure studies.74 Fifth, we refit 
models with metabolite concentrations expressed as nmol/l with creatinine concentration 
added as a separate covariate which is another common method to adjust for creatinine 
concentrations. Sixth, because DAP metabolite concentrations demonstrated only weak 
to moderate reliability over pregnancy (e.g., intraclass correlation coefficient (ICC) for 
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DAP metabolites = 0.30),70 we examined the effect of adjusting for measurement error 
by applying regression calibration.75 Seventh, because preformed DAP metabolites may 
exist on fruits, and fruit intake is associated with DAP metabolite concentrations5 in 
our study population, we additionally stratified the main analyses for maternal fruit 
intake (assessed using a modified version of a validated semiquantitative food frequency 
questionnaire.76 The stratification was based on dichotomizing intake at the first quantile 
(75 g per day). Eight, we also adjusted for season of urine collection because there may 
be seasonal variation in food consumption and OP pesticides use which could affect 
DAP concentrations.77 Ninth, since previous studies have suggested that families with 
low social economic status (SES) are more vulnerable to OP pesticide exposure,78-80 we 
explored potential effect modification by education as a proxy of SES. Finally, we explored 
potential associations of child DAP metabolite concentrations with ADHD and autistic 
traits and investigated potential effect modification by sex, since few studies have reported 
these associations.81,82 The child-DAP analyses were adjusted for maternal education, 
maternal age, maternal smoking, averaged prenatal DAP metabolite concentrations across 
pregnancy, child sex, child BMI at age 6 years, child ethnicity, household income at child 
age 6 years, and marital status of the mother at child age 6 years.
Results
Sample characteristics
Table 1 presents the maternal and infant characteristics at time of enrollment. The age 
at enrollment of the mothers participating in this study averaged 31 years (sd=5 years). 
Women included in the present analysis were older, had lower BMIs, nulliparous, Dutch, 
highly educated, married, occasional consumers of alcoholic beverages during pregnancy, 
less likely to smoke, and had higher incomes and lower maternal psychopathology scores 
compared with those not included.
DAP concentrations
Total DAP metabolites comprised mostly DM metabolites, and the median concentrations 
were fairly similar across the 3 sampling periods (Table 2). The total DAP metabolite 
concentrations measured between 18-25 weeks of gestation (median = 316 nmol/g 
creatinine) was slightly higher compared with the DAP metabolite concentrations 
measured at <18 weeks of gestation (median = 309 nmol/g creatinine) and > 25 weeks 
of gestation (median = 308 nmol/g creatinine). The ICC (estimated by using a 2-way 
mixed-effects model with absolute-agreement) for DAP metabolite concentrations varied 
between 0.22 and 0.26 for a single-measurement and 0.51 and 0.54 for the mean of 
the 3 measurements (Table S2). Moreover, the DAP metabolite concentrations across 
pregnancy showed weak correlations (r = 0.18–0.35) (Table S3).
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Table 1. Characteristics of  all participants of  the Generation R Study and of  the participants 





Included in the 
ADHD analyses a
(n=781) c




Sex of infant at birth
Male 50.6 % 50.8 % 51.4 %
Female 49.4 % 49.2 % 48.6 %
Missing, n 153 -
Mother characteristics
Age in years
< 20 4.2 % 1.8 % 1.1 %
20-< 25 15.9 % 10.0 % 7.4 %
25-< 30 26.4 % 26.6 % 25.6 %
30-< 35 36.9 % 46.0 % 49.0 %
≥ 35 16.6 15.7 % 16.9
Missing, n - - -
BMI
< 18.5 2.1 % 2.3 % 2.4 %
18.5-< 25 57.9 % 65.9 % 67.3 %
25-< 30 26.3 % 23.5 % 22.3 %
≥ 30 13.8 % 8.3 % 8.1 %
Missing, n 899 4 2
Height in cm (quartiles)
< 161 23.6 % 15.7 % 13.0 %
161 – < 168 27.4 % 30.6 % 29.1 %
168 – < 173 24.6 % 26.2 % 27.9 %
≥ 173 24.4 % 27.5 % 30.0 %
Missing, n 934 1 1
Parity (Previous births)  
0 55.1 % 62.4 % 63.5 %
1 30.2 % 26.6 % 26.0 %
≥ 2 14.7 % 11.0 % 10.5 %
Missing, n 378 4 2
Ethnicity
Dutch 50.0 % 57.6 % 63.3 %
Other Western 11.6 % 8.9 % 9.0 %
Non-Western 38.4 % 33.5 % 27.7 %
Missing, n 694 - -
Education d
Low 26.5 % 14.8 % 11.9 %
Intermediate 30.7 % 30.2 % 27.8 %
High 42.8 % 55.0 % 60.2 %
Missing, n 1221 25 11
Household income in euro’s
<1200 per month 20.7 % 12.6 % 9.1 %
1200–2000 per month 18.5 % 16.6 % 15.5 %
> 2000 per month 60.8 % 70.8 % 75.4 %
Missing, n 3066 101 62
Marital status
Married/ living with partner 85.5 % 89.8 % 91.4 %
No partner 14.5 % 10.2 % 8.6 %
Missing, n 1213 29 18 
Non-verbal IQ score
≤ 85 29.7 % 17.9 % 15.7 %
>85-≤ 100 25.7 % 22.8 % 23.3 %
>100 -< 115 34.7 % 31.2 % 31.3 %
≥ 115 19.8 % 28.0 % 29.7 %








Included in the 
ADHD analyses a
(n=781) c




< 0.08 24.1 % 24.9 % 26.4 %
0.08–< 0.17 25.2 % 29.7 % 29.6 %
0.17–> 0.38 25.7 % 24.4 % 24.9 %
≥ 0.38 25.0 % 21.1 % 19.1 %
Missing, n 3128 95 72
Smoking
No smoking during pregnancy 73.4 % 77.1 % 79.7 %
Until pregnancy recognized 8.6 % 8.9 % 9.1 %
Continued during pregnancy 18.0 % 14.0 % 11.2 %
Missing, n 1534 63 51
Alcohol Beverage Consumption
No alcohol consumption during 
pregnancy
48.0 % 36.7 % 33.7 %
Until pregnancy recognized 13.2 % 17.5 % 17.2 %
Continued occasionally (less than 1 
glass/week)
31.6 % 39.3 % 42.0 %
Continued frequently (1 or more glass/
week for at least two trimesters)
7.2 % 6.5 % 7.1 %
Missing, n 1870 40 29
a. ADHD traits was measured at child mean age three, six and ten years.
b. Autistic traits was measured at child mean age six years.
c. Values shown are percentages.
d. Low: no education finished, Primary education, lower vocational training, intermediate general school or <3 
years at general. Intermediate: ≥3 years of secondary education, Intermediate vocational training or first year of 
higher vocational training. High: university degree or higher vocational training.
Continued
Table 2. Descriptive statistics of  maternal urinary dialkyl phosphate metabolite concentrations of  
781 mothers participating in this study. 
nmol/g creatinine nmol/l
min p25 p50 p75 max min p25 p50 p75 max
Dialkyl phosphates in nmol/g 
creatinine (total) a
< 18 weeks’ gestation 15.4 188.1 309.4 499.3 6444.5 6.3 124.8 219.0 421.2 7798.7
18 – 25 weeks’ gestation 41.0 206.8 316.1 485.9 3069.5 10.0 120.0 227.2 407.2 4607.7
> 25 weeks’ gestation 21.0 194.1 308.0 489.3 3013.3 10.5 121.6 223.8 408.2 3332.6
Diethyl alkyl phosphates in 
nmol/g creatinine b
< 18 weeks’ gestation 0.0 25.0 43.1 79.4 3030.5 0.0 15.5 31.3 65.1 6818.6
18 – 25 weeks’ gestation 0.0 23.3 41.6 74.5 660.5 0.0 12.6 27.9 57.0 1093.4
> 25 weeks’ gestation 0.0 21.6 41.7 77.3 745.1 0.0 14.4 30.7 62.2 593.2
Dimethyl alkyl phosphates in 
nmol/g creatinine c
< 18 weeks’ gestation 6.7 148.6 242.4 416.1 6106.5 0.9 100.1 182.4 344.7 4221.0
18 – 25 weeks’ gestation 24.8 169.4 268.6 415.4 2612.0 7.6 98.9 185.6 335.9 3902.2
> 25 weeks’ gestation 12.2 157.1 248.3 398.9 2908.1 8.5 99.5 184.2 333.0 3300.5
a. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
b. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
c. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
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ADHD and autistic traits descriptive statistics
Table 3 presents the descriptive statistics of the ADHD and autistic traits score. The 
mean ADHD score measured at age 3 years (m = 3.1, sd = 2.3) and at 6 years (m = 3.2, 
sd = 2.6) was slightly higher than the mean ADHD score measured at 10 years (m = 2.6, 
sd = 2.7). The percentage of participants within the ADHD borderline clinical range was 
6.8% at 3 years, 5.3% at 6 years, and 6.6% at 10 years. The mean autistic traits score 
was 4.1 (sd = 4.2) and 1.9% of the participants were within the clinical range of autism.
Table 3. Descriptive statistics of  ADHD and autistic traits scores. 
Mean ± SD Min Max
clinical cases
(N (%)) a, b N
ADHD score at age three years 3.1 ± 2.3 0.0 11.0 42 (6.8%) 618
ADHD score at age six years 3.2 ± 2.6 0.0 12.0 41 (5.3%) 777
ADHD score at age ten years 2.6 ± 2.7 0.0 12.0 39 (6.6%) 588
Autistic traits at age six years 4.1 ± 4.2 0.0 32 12 (1.9%) 622
a. Any ADHD score that falls below the 93rd percentile is considered normal, scores above the 93 percentile are 
borderline clinical, or clinical cases.53,54
b. We utilized the cut-off values recommended by the authors of the SRS for screening in population-based studies 
(consistent with weighted scores of 1.078 for boys and 1.000 for girls) (Constantino, 2003).
Secondary analyses of  DAP–ADHD and autistic traits associations
No association between DAP, DE, and DM metabolite concentrations and ADHD 
traits was observed in any of the 3 urine collection periods during pregnancy (Table 4). 
Next, similar to the separate regressions, the mutually adjusted DAP and DM metabolite 
concentrations were not statistically significantly associated with ADHD traits. However, 
we observed an inverse association between DE metabolite concentrations measured at 
>25 weeks of gestation in the mutually adjusted model. A 10-fold higher level of DE 
metabolite concentrations at >25 weeks of gestation was associated with a 0.15 standard 
deviation lower level of in ADHD traits (95% confidence interval (CI) = −0.28, −0.01).
No association between DAP, DE, and DM metabolite concentrations and autistic 
traits was observed in any of the 3 urine collection periods during pregnancy (Table 5). 
Moreover, similar to the separate regressions, the mutually adjusted DAP, DE, and DM 
metabolite concentrations were not statistically significantly associated with autistic traits.
Sensitivity analyses
No effect modification by sex was observed (P-value for interaction <0.1) with regard 
to the associations between log10 transformed DAP metabolite concentrations and 
ADHD traits (Table S4) or autistic traits (Table S5). Further, the results with the use 
of the clinical cut-off score (Tables S6 and S7), the inverse probability weighted results 
(Table S8), the results with concentrations below the LOD substituted by LOD/√2 
(Table S9), the results with metabolite concentrations expressed as nmol/l with creatinine 
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concentration added as a separate covariate (Table S10), were all similar to the main 
analyses. When we adjusted for the measurement error in our exposure biomarkers by 
assessing averaged urinary DAP concentrations on ADHD and autistic traits with the 
application of regression calibration, we observed that the effect estimates were stronger 
(i.e., further away from the null) compared to the results from the primary model, but 
that the standard errors were increased (Table S11). We observed no difference in the 
associations when stratified by fruit intake (Tables S12 and S13), and the results with 
additional adjustment for season of urine collection were similar to the main results (Table 
S14). Next, no effect modification by SES was observed (Tables S15 and S16). Finally, 
no associations of child DAP metabolite concentrations with ADHD and autistic traits 
were detected (Table S17), and these associations did not differ by sex (Table S18).
Table 4. Difference in standardized ADHD score a (and 95% confidence interval) across childhood 
(and 95% confidence interval) per 10-fold increase in maternal urine dialkyl phosphate metabo-
lite concentrations in nmol/g creatinine, by timing of  pregnancy urine sampling and degree of  
adjustment.
Childhood ADHD scores  (N=781) b
Unadjusted Adjusted c Mutually adjusted d
Dialkyl Phosphate Type B (95% CI) B (95% CI) B (95% CI)
Dialkyl phosphates (total) e
< 18 weeks’ gestation -0.15 -0.33 to 0.04 -0.06 -0.23 to 0.11 -0.07 -0.25 to 0.11
18 – 25 weeks’ gestation -0.03 -0.22 to 0.17 0.05 -0.14 to 0.23 0.08 -0.13 to 0.28
> 25 weeks’ gestation -0.12 -0.31 to 0.07 -0.02 -0.20 to 0.16 -0.03 -0.22 to 0.16
Mean of three urines -0.20 -0.46 to 0.07 -0.03 -0.28 to 0.23
Diethyl alkyl phosphates f
< 18 weeks’ gestation -0.09 -0.22 to 0.05 -0.03 -0.15 to 0.10 -0.03 -0.15 to 0.10
18 – 25 weeks’ gestation -0.03 -0.16 to 0.11 0.05 -0.08 to 0.18 0.08 -0.05 to 0.22
> 25 weeks’ gestation -0.23 -0.37 to -0.10 -0.13 -0.26 to 0.00 -0.15 -0.28 to -0.01
Mean of three urines -0.25 -0.45 to -0.05 -0.08 -0.27 to 0.11
Dimethyl alkyl phosphates g
< 18 weeks’ gestation -0.11 -0.29 to 0.06 -0.04 -0.20 to 0.12 -0.05 -0.22 to 0.12
18 – 25 weeks’ gestation -0.03 -0.22 to 0.15 0.03 -0.15 to 0.20 0.03 -0.16 to 0.22
> 25 weeks’ gestation -0.05 -0.23 to 0.13 0.03 -0.14 to 0.20 0.02 -0.16 to 0.20
Mean of three urines -0.14 -0.39 to 0.12 0.00 -0.24 to 0.25
a. Positive scores indicating more symptomatic behavior.
b. 781 mother-child pairs and 1983 observations.
c. Adjusted for maternal age, maternal psychopathology (0 = no problems, 1= borderline GSI score > 80%), sex of 
the child, ethnicity (Dutch, other-western and non-western), education (low, intermediate and high), income (low, 
middle and high), marital status, maternal alcohol consumption (no alcohol consumption during pregnancy, alcohol 
consumption until pregnancy was known, occasionally alcohol consumption during pregnancy and frequently 
alcohol consumption during pregnancy), non-verbal IQ of the mother, BMI categories (<18.5, 18.5-25, 25-30, 
30+), height of the mother, parity categories (0, 1, 2+), and smoking (no smoking during pregnancy, smoked until 
pregnancy was known, smoked during pregnancy).
d. Adjusted model with the inclusion of the three exposures in one model.
e. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
f. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
g. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.




In this large population-based study, higher maternal urinary concentrations of DAP 
metabolites during pregnancy were not associated with more ADHD traits in 3 to 
10- year old children or with autistic traits in 6- year old children. Moreover, no effect 
modification by sex was observed. Finally, those exposed to higher urinary concentrations 
of DAP metabolites in childhood also did not have more ADHD traits and autistic traits.
Our results were consistent with a previous study from the Center for Health Assessment 
of Mothers and Children of Salinas (CHAMACOS) cohort36 investigating the association 
between prenatal OP pesticide exposure and ADHD in children aged 2 years, but not 
Table 5. Difference in autistic traits score a,b (and 95% confidence interval) per 10-fold increase 
in maternal urine dialkyl phosphate metabolite concentration in nmol/g creatinine, by when in 
pregnancy the urine sample was collected.
Autistics traits score at 6 years
(N=622)
Unadjusted Adjusted c Mutually adjusted d
Dialkyl Phosphate Type B (95% CI) B (95% CI) B (95% CI)
Dialkyl phosphates (total) e
< 18 weeks’ gestation 0.05 -0.20 to 0.30 0.15 -0.10 to 0.39 0.15 -0.11 to 0.40
18 – 25 weeks’ gestation -0.07 -0.35 to 0.20 0.02 -0.25 to 0.29 -0.03 -0.32 to 0.26
> 25 weeks’ gestation -0.09 -0.35 to 0.16 0.06 -0.20 to 0.32 0.05 -0.22 to 0.32
Mean of three urines -0.07 -0.43 to 0.30 0.17 -0.20 to 0.54
Diethyl alkyl phosphates f
< 18 weeks’ gestation -0.05 -0.22 to 0.12 0.02 -0.15 to 0.18 0.04 -0.13 to 0.21
18 – 25 weeks’ gestation -0.12 -0.30 to 0.06 -0.05 -0.22 to 0.13 -0.02 -0.21 to 0.16
> 25 weeks’ gestation -0.28 -0.48 to -0.07 -0.16 -0.37 to 0.04 -0.16 -0.37 to 0.05
Mean of three urines -0.29 -0.56 to -0.02 -0.12 -0.39 to 0.15
Dimethyl alkyl phosphates g
< 18 weeks’ gestation 0.10 -0.14 to 0.34 0.17 -0.07 to 0.40 0.16 -0.08 to 0.40
18 – 25 weeks’ gestation -0.04 -0.30 to 0.22 0.05 -0.21 to 0.31 -0.03 -0.30 to 0.25
> 25 weeks’ gestation -0.02 -0.26 to 0.23 0.13 -0.12 to 0.38 0.12 -0.15 to 0.38
Mean of three urines 0.03 -0.32 to 0.39 0.25 -0.11 to 0.61
a. Square root transformed.
b. Positive scores indicating more symptomatic behavior.
c. Adjusted for maternal age, maternal psychopathology (0 = no problems, 1= borderline GSI score > 80%), sex of 
the child, ethnicity (Dutch, other-western and non-western), education (low, intermediate and high), income (low, 
middle and high), marital status, maternal alcohol consumption (no alcohol consumption during pregnancy, alcohol 
consumption until pregnancy was known, occasionally alcohol consumption during pregnancy and frequently 
alcohol consumption during pregnancy), non-verbal IQ of the mother, BMI categories (<18.5, 18.5-25, 25-30, 
30+), height of the mother, parity categories (0, 1, 2+), and smoking (no smoking during pregnancy, smoked until 
pregnancy was known, smoked during pregnancy).
d. Adjusted model with the inclusion of the three exposures in one model.
e. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
f. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
g. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
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consistent with to 2 other studies, which suggested that prenatal OP pesticide exposure 
was associated with ADHD.37,41 Marks et al. (2010), using data from the same birth cohort 
study as Eskenazi et al. (2007), found prenatal OP pesticide exposure to be associated 
with more ADHD traits at child age 5 years. Rauh et al. (2006), using data from a study 
population from inner-city New York, found that prenatal exposure to chlorpyrifos 
measured in blood was associated with offspring’s ADHD traits at the age of 3 years. Our 
null results for autistic traits are not in line with the results in children aged 14 years from 
a previous study of the CHAMACOS cohort,42 but consistent with findings of the Mount 
Sinai Children’s Environmental Health Study45 and Health Outcomes and Measures of 
the Environment (HOME) Study43 in children aged 8 years that also measured autistic 
traits with the use of the SRS in children.
Several other researchers found some evidence for an association between prenatal OP 
pesticide exposure and autism in studies of clinical cases73,83 or PDD cases aged 2 to 
3 years.36,37 However, often the associations were limited to subgroups.41,44,45 Marks et al. 
(2010) reported an association between OP and ADHD traits, only in boys, Furlong et 
al. (2014) between prenatal DE metabolite concentrations and autistic traits (SRS-score), 
only in boys and in black children (aged 5 years), and Philippat et al. (2018), between 
DMTP metabolites and ASD in girls (aged 3 years) using data from the Markers of 
Autism Risk in Babies–Learning Early Signs (MARBLES) mother-child cohort. We did 
not replicate these findings.
Next, we explored whether children with higher DAP metabolite concentrations at age 
6 years had higher levels of ADHD or autistic traits since few studies using data from 
NHANES and Children Pesticide Survey (CPS) reported these associations81,82 in children 
aged 7 to 15 years. We found no evidence for any association.
The inconsistency of results may be related to differences in OP pesticide exposure sources 
across study areas, the exposure mixture, or the exposure assessment methodology. Most 
previous studies were carried out in the US and the exposure mixture of OP pesticides 
in Europe is different than in the US due to differences in regulations regarding the 
use of OP pesticides. Within the US, the majority of the studies were conducted in 
California36,41,42,44,73,83 where agricultural insecticides are extensively used. In contrast, 
the Generation R population lives in urban settings, where the main route of exposure 
is through the ingestion of food, and most likely fruits.5 Furthermore, DAP metabolites 
are non-specific biomarkers of OP pesticide exposure, thus it is possible that the mixture 
of parent compounds differed across cohorts and thus toxicity varies even if DAP levels 
were similar. Also, because preformed DAP metabolites are present on food crops and 
in the natural environment,7-9 it is uncertain which amount of the total DAP metabolite 
concentrations is due to the ingestion of the less toxic DAP metabolites from the natural 
Prenatal OP pesticide exposure and ADHD and autistic traits
187
5
environment.10 Finally, the majority of these studies, including our study, measured 
DAP metabolites in urine as a biomarker of OP pesticide exposure. However, some 
studies took a different approach. For example, 3 studies used maternal residence near 
agricultural pesticide applications to estimate exposure,42,73,83 and another study used 
parent compounds measured in umbilical cord blood collected at delivery to measure 
the level of OP pesticide exposure.37 Differences in exposure sources, mixtures, routes, 
and assessments across studies complicate the comparison.
Discrepancies in the results of studies may be related to differences in study populations. 
For example, the majority of our study sample consisted of Dutch participants with 
a relatively high SES. Apart from the study of Millenson et al. (2017), that reported 
similar results, most previous studies mainly included participants from ethnic minorities 
or with low SES.36,37,41,42,45 It is conceivable that these populations with low SES were 
exposed to unobserved background risk factors that are related to the likelihood of OP 
pesticide exposure and the risk for ADHD or autistic traits. Although these studies 
adjusted for SES related confounders, there may still be residual confounding. In our 
study, the unadjusted models predicting ADHD and autistic traits were almost all in a 
negative direction, suggesting a protective effect. After adjustment (including SES related 
confounders), the observed inverse associations were closer to the null or in the positive 
direction (albeit clearly non-statistically significant), suggesting the presence of some 
observed negative confounding.84 However, the inverse association for DE metabolite 
concentrations measured at >25 weeks of gestation and ADHD traits in the mutually 
adjusted model remained. We must be cautious in interpreting this association which may 
be a result of multiple testing. Also, this finding is contrary to the findings of Eskenazi et 
al. (2007) and Marks et al. (2010) who observed that higher DE metabolite concentrations 
were associated with more PDD and ADHD problems. Although we included many 
potential confounders in the model, we cannot rule out that other underlying factors 
such as a healthier lifestyle among those exposed to OP pesticides, might have resulted 
in unobserved negative confounding. Millenson et al. (2017) and Cartier et al. (2016) 
observed a similar pattern of negative confounding in the association between maternal 
DE metabolite concentrations and child neurodevelopment among persons with relatively 
high SES. These studies showed a significant unadjusted association of maternal DE 
metabolite concentrations with autistic traits and verbal comprehensive score in an 
unexpected direction (i.e. higher DE metabolite concentrations–less problems). However, 
after adjustment the observed inverse associations were closer to the null.
Another notable difference between our study and other studies investigating the association 
between OP pesticide exposure and ADHD and autistic traits is that in this study the 
DAP metabolite concentrations (308–316 nmol/g creatinine) were 2–3 times higher 
than in previous studies.2,4,36,44,85-87 This could be due to higher consumption of fruits and 
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vegetables, higher SES (which is associated with more healthy food consumption), or due 
to the extensive farming practices in the Netherlands.5,88 Nevertheless, we did not find any 
evidence for an association between OP pesticide exposure and ADHD and autistic traits.
A few limitations of the present study need to be considered. As mentioned above, DAP 
metabolites also exist in the food supply.7-9 It is therefore uncertain to what extent the 
total DAP metabolite concentrations are due to the OP pesticide exposure or due to the 
ingestion of the less toxic DAP metabolites.10 Further, DAP metabolite concentrations 
provide non-specific information about the cumulative exposure to a class of OP pesticides 
rather than a single OP pesticide.89 It is therefore unknown to which specific OP parent 
pesticide(s) our study population was exposed. However, the estimation of urinary DAP 
metabolite concentrations is considered an appropriate and useful tool to identify and 
compare levels of OP pesticide exposure among various population.11
Urinary DAP metabolites have a short half-life. These metabolites are excreted in urine 
within approximately 24 h, which implies that the measured DAP concentrations may 
vary from day-today within each subject46 giving rise to chance findings. It would be ideal 
to collect a broad range of urine specimens more often during pregnancy,90 especially 
since the ICCs of DAP metabolite concentrations are modest.70 To achieve excellent 
reliability of OP pesticide exposure over pregnancy, 4 weekly pools of 15 to 20 urine 
samples would be needed.91 The present study includes 3 spot-urine measures of maternal 
DAP metabolite concentrations per subject from a large sample. Although our sampling 
frequency is higher than that of most other studies of maternal urinary DAP metabolite 
concentrations and neurodevelopment,32 the urinary measurement variability may have 
still resulted in attenuated estimates due to measurement error in our biomarkers.90 Indeed, 
adjusting for measurement error with regression calibration resulted in effect estimates 
that were further from the null albeit more imprecise.92
Another limitation of this study is the absence of information about the exact time of 
spot urine sampling. Because the urine spot samples were collected between 8 am and 
8 pm, there may have been a combination of first morning and random spot samples. 
Concentrations of chemicals, urine volume and the rate of excretion vary with fluid intake, 
time of day, and other factors.93-95 Although time of sample collection is unlikely to confound 
the association between DAP metabolite concentrations and child neurodevelopmental 
outcomes, the use of DAP metabolite concentrations without the adjustment of timing 
of urine sampling may have resulted in high intra-individual variability and less precise 
associations. To increase precision, we adjusted the main analyses for season of urine 
collection. The results were essentially the same.
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Although the percentage of participants above the SRS cut-off value for screening in the 
population (1.9%)59 was similar to the overall prevalence of ASD (0.6–2.2%) in children 
aged 8 years,96 the percentages of participants considered borderline clinical or clinical 
ADHD cases53,54 in our study (5.3–6.8%) was lower than the prevalence of ADHD 
(7–14%).97 Because the children in our study have parents with a higher education, 
more income, and who were less likely to smoke during pregnancy, it is possible that the 
children were generally healthier than the source population. This could have resulted in 
lower variability in ADHD and autistic traits which may explain our null findings. Also, 
the differences in characteristics between our study sample and the source population, 
i.e., the total Generation R cohort, may have introduced selection bias. Yet, we used 
inverse probability weighting to account for potential selection bias and the results were 
essentially the same.
A strength of this study is the evaluation of ADHD and ASD phenotype on a continuous 
spectrum rather than the use of a clinical cut-off (presence versus absence of disease). 
For example, several other studies used a clinical diagnosis of ASD44,73,83 or clinical 
cut-off.36,37 Other studies, including ours, relied on the CBCL and SRS measured on a 
continuous scale. Although the use of the SRS and CBCL does not provide a clinical 
diagnosis, it has many advantages. For instance, the use of a continuous scale increases 
power and allow us to account for children with fewer symptoms who may not have met 
the diagnostic criteria when a clinical cut-off is used, and reduces the impact of outcome 
misclassification.98 Further, the use of repeated measures of ADHD traits is another 
strength. Repeated measures of ADHD traits increase statistical power by allowing for 
missing observation at various time points, and gave us the ability to include a random 
slope for time to account for varying effects of time on ADHD across subjects.99-103 Finally, 
the availability of a broad range of contextual information for confounder adjustment is 
another strength of this study.
In conclusion, in this study of maternal urinary DAP metabolite concentrations during 
pregnancy, we did not observe associations with ADHD and autistic traits in children. 
These are important null observations because of the relatively high background DAP 
concentrations across pregnancy, the relatively large sample size, and the 10-year follow-
up of the offspring. Given the measurement error inherent in our OP pesticide exposure 
biomarkers, future studies using more urine samples are needed to accurately measure 
OP pesticide exposure over pregnancy in relation to ADHD and autistic traits. Further, 
the Generation R Study is representative of an urban population with varying ethnicities, 
SES, and educational level, and therefore less generalizable to populations where the OP 
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Table S1. Variables used in logistic regression model to calculate inverse probability.
Variables Explored Included
Maternal educational level x x
Maternal ethnicity x x
Maternal age x
Maternal parity x x
Maternal alcohol use during pregnancy x x
Maternal tobacco use during pregnancy x
Maternal body mass index x x
Household income during pregnancy x





Child’s birth weight x
Gestational age at birth x x
Child IT-HOME score x x
Table S2. Intraclass correlation coefficients for log10 transformed maternal urine dialkyl phospha-
te metabolite concentrations in nmol/g creatinine (n=781).
ICC a ICC b
Dialkyl phosphates (total) c 0.259 0.511
Diethyl alkyl phosphates d 0.217 0.454
Dimethyl alkyl phosphates e 0.230 0.473
a. ICC = Intraclass Correlation Coefficients calculated using a single-measurement, absolute-agreement, and 2-way 
mixed-effects model.
b. ICC = Intraclass Correlation Coefficients calculated using a mean of three measurements, absolute-agreement, and 
2-way mixed-effects model.
c. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
d. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
e. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
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Table S3. Correlation coefficients a for log10 transformed maternal and 6-year-old child urine 
dialkyl phosphate metabolite concentrations in nmol/g creatinine.
Pearson correlation coefficients < 18 weeks 18 – 25 weeks > 25 weeks Child at age 6
Dialkyl phosphates (total) b 
< 18 weeks of gestation 1
18 – 25 weeks of gestation 0.26** 1
> 25 weeks of gestation 0.18** 0.35** 1
child at age 6 0.01 0.02 0.01 1
Diethyl alkyl phosphates c
< 18 weeks of gestation 1
18 – 25 weeks of gestation 0.22** 1
> 25 weeks of gestation 0.14** 0.25** 1
child at age 6 0.02 -0.01 0.05 1
Dimethyl alkyl phosphates d
< 18 weeks of gestation 1
18 – 25 weeks of gestation 0.23** 1
> 25 weeks of gestation 0.15** 0.33** 1
child at age 6 -0.01 0.02 0.01 1
a. N=781 between correlations of maternal DAP urinary concentrations across pregnancy, N=747 between correlati-
ons of maternal and child DAP urinary concentrations.
b. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
c. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
d. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
** P<0.01.
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Table S4. Sex stratified difference in standardized ADHD score (and 95% confidence interval) 
across childhood per 10-fold increase in maternal urine dialkyl phosphate metabolite concentrati-
on in nmol/g creatinine.
Childhood ADHD scores (N=781) a
Boys Girls
Total dialkyl phosphates b B 95%CI B 95%CI P-value c P-value d 
None
< 18 weeks of gestation -0.19 -0.45 to 0.07 -0.14 -0.38 to 0.10 0.774 0.774
18 – 25 weeks of gestation 0.07 -0.21 to 0.34 -0.20 -0.47 to 0.06 0.173 0.173
> 25 weeks of gestation -0.19 -0.47 to 0.09 -0.07 -0.31 to 0.17 0.523 0.523
Mean of three urines -0.21 -0.59 to 0.18 -0.27 -0.62 to 0.08 0.827 0.827
Adjusted e
< 18 weeks of gestation -0.10 -0.35 to 0.15 -0.01 -0.25 to 0.23 0.652 0.608
18 – 25 weeks of gestation 0.06 -0.21 to 0.32 -0.06 -0.33 to 0.20 0.565 0.560
> 25 weeks of gestation -0.09 -0.36 to 0.18 0.08 -0.16 to 0.33 0.337 0.351
Mean of three urines -0.10 -0.47 to 0.28 0.01 -0.35 to 0.37 0.692 0.670
Mutually adjusted f
< 18 weeks of gestation -0.12 -0.39 to 0.15 -0.01 -0.26 to 0.23 0.614 0.599
18 – 25 weeks of gestation 0.12 -0.17 to 0.40 -0.10 -0.39 to 0.18 0.547 0.538
> 25 weeks of gestation -0.10 -0.38 to 0.18 0.12 -0.15 to 0.38 0.358 0.354
a. Positive scores indicating more symptomatic behavior.
b. Total Dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
c. P-value for interaction.
d. P-value for interaction based on the augmented product term approach (Buckley et al. 2017).
e. Adjusted for maternal age, maternal psychopathology (0 = no problems, 1= borderline:: GSI score > 80%), 
ethnicity (Dutch, other-Western and non-Western), education (low, intermediate and high), income (low, middle 
and high), marital status, maternal alcohol consumption (no alcohol consumption during pregnancy, alcohol con-
sumption until pregnancy was known, occasionally alcohol consumption during pregnancy and frequently alcohol 
consumption during pregnancy), non-verbal IQ of the mother, BMI categories (<18.5, 18.5-25, 25-30, 30+), height 
(≤168,>168) of the mother, parity categories (0, 1, 2+), and smoking (no smoking during pregnancy, smoked until 
pregnancy was known, smoked during pregnancy).
f. adjusted model with the inclusion of the three exposures in one model.
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Table S5. Sex stratified difference in autistic traits score (and 95% confidence interval) per 10-fold 
increase in maternal urine dialkyl phosphate metabolite concentration in nmol/g creatinine.
Autistics traits score at 6 years (N=622) a,b
Boys Girls
Total dialkyl phosphates c B 95%CI B 95%CI P-value d P-value e 
None
< 18 weeks of gestation 0.04 -0.30 to 0.38 0.02 -0.34 to 0.38 0.923 0.923
18 – 25 weeks of gestation -0.08 -0.44 to 0.28 -0.09 -0.50 to 0.31 0.963 0.963
> 25 weeks of gestation -0.16 -0.52 to 0.20 -0.03 -0.39 to 0.34 0.601 0.601
Mean of three urines -0.12 -0.61 to 0.37 -0.06 -0.61 to 0.48 0.872 0.872
Adjusted f
< 18 weeks of gestation 0.14 -0.21 to 0.48 0.13 -0.23 to 0.50 0.887 0.989
18 – 25 weeks of gestation -0.07 -0.43 to 0.30 0.05 -0.37 to 0.47 0.654 0.677
> 25 weeks of gestation -0.02 -0.39 to 0.35 0.08 -0.30 to 0.46 0.631 0.714
Mean of three urines 0.00 -0.39 to 0.38 0.12 -0.25 to 0.49 0.585 0.699
Mutually adjusted g
< 18 weeks of gestation 0.17 -0.19 to 0.53 0.12 -0.25 to 0.49 0.908 0.954
18 – 25 weeks of gestation -0.12 -0.52 to 0.28 0.01 -0.44 to 0.46 0.579 0.615
> 25 weeks of gestation 0.00 -0.39 to 0.38 0.06 -0.35 to 0.46 0.620 0.722
a. Square root transformed.
b. Positive scores indicating more symptomatic behavior.
c. Total Dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
d. P-value for interaction.
e. P-value for interaction based on the augmented product term approach (Buckley et al. 2017).
f. Adjusted for maternal age, maternal psychopathology (0 = no problems, 1= borderline: GSI score > 80%), ethnici-
ty (Dutch, other-Western and non-Western), education (low, intermediate and high), income (low, middle and high), 
marital status, maternal alcohol consumption (no alcohol consumption during pregnancy, alcohol consumption until 
pregnancy was known, occasionally alcohol consumption during pregnancy and frequently alcohol consumption 
during pregnancy), non-verbal IQ of the mother, BMI categories (<18.5, 18.5-25, 25-30, 30+), height (≤168,>168) 
of the mother, parity categories (0, 1, 2+), and smoking (no smoking during pregnancy, smoked until pregnancy was 
known, smoked during pregnancy).
g. adjusted model with the inclusion of the three exposures in one model.
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Table S8. Inverse probability weighted a associations (and 95% confidence intervals) between 
log10 transformed maternal urine dialkyl phosphate metabolite concentrations in nmol/g creatini-
ne and standardized ADHD scores across childhood and autistic traits scores at age 6 years. 
ADHD scores across childhood
(N=781)
Autistic traits scores at age 6 years b
(N=622)
Dialkyl phosphates (total) c B           95% CI B           95% CI
Unadjusted
< 18 weeks of gestation -0.15 -0.33 to 0.03 0.05 -0.20 to 0.30
18 – 25 weeks of gestation -0.04 -0.23 to 0.15 -0.06 -0.33 to 0.21
> 25 weeks of gestation -0.12 -0.31 to 0.07 -0.09 -0.35 to 0.17
Mean of three urines -0.21 -0.47 to 0.06 -0.06 -0.42 to 0.31
Adjusted d
< 18 weeks of gestation -0.06 -0.23 to 0.11 0.14 -0.11 to 0.38
18 – 25 weeks of gestation 0.04 -0.14 to 0.23 0.03 -0.24 to 0.30
> 25 weeks of gestation -0.02 -0.20 to 0.16 0.05 -0.21 to 0.30
Mean of three urines -0.03 -0.29 to 0.22 0.16 -0.21 to 0.52
Mutually adjusted e
< 18 weeks of gestation -0.07 -0.25 to 0.11 0.14 -0.11 to 0.39
18 – 25 weeks of gestation 0.07 -0.13 to 0.27 -0.02 -0.31 to 0.28
> 25 weeks of gestation -0.03 -0.22 to 0.16 0.03 -0.24 to 0.30
a. Weighted for the inverse probability to be included in the study sample.
b. square root transformed.
c. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
d. Adjusted for maternal age, maternal psychopathology (0 = no problems, 1= borderline: GSI score > 80%), sex of 
the child, ethnicity (Dutch, other-Western and non-Western), education (low, intermediate and high), income (low, 
middle and high), marital status, maternal alcohol consumption (no alcohol consumption during pregnancy, alcohol 
consumption until pregnancy was known, occasionally alcohol consumption during pregnancy and frequently 
alcohol consumption during pregnancy), non-verbal IQ of the mother, BMI categories (<18.5, 18.5-25, 25-30, 30+), 
height (≤168,>168) of the mother, parity categories (0, 1, 2+), and smoking (no smoking during pregnancy, smoked 
until pregnancy was known, smoked during pregnancy).
e. Adjusted model with the inclusion of the three exposures in one model.
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Table S9. Associations (and 95% confidence intervals) between log10 transformed maternal urine 
dialkyl phosphate metabolite concentrations in nmol/g creatinine and standardized ADHD scores 
across childhood and autistic traits scores at age 6 years, in which the values below the LOD are 
replaced with LOD/√2. 
ADHD scores across childhood
(N=781)
Autistic traits scores at age 6 years a
N=623)
Dialkyl phosphates (total) b B           95% CI B           95% CI
Unadjusted
< 18 weeks of gestation -0.16 -0.34 to 0.03 0.05 -0.20 to 0.30
18 – 25 weeks of gestation -0.04 -0.23 to 0.15 -0.08 -0.35 to 0.19
> 25 weeks of gestation -0.12 -0.31 to 0.06 -0.09 -0.35 to 0.17
Mean of three urines -0.22 -0.48 to 0.05 -0.07 -0.44 to 0.30
Adjusted c
< 18 weeks of gestation -0.06 -0.23 to 0.11 0.15 -0.10 to 0.39
18 – 25 weeks of gestation 0.04 -0.14 to 0.23 0.02 -0.26 to 0.29
> 25 weeks of gestation -0.02 -0.20 to 0.16 0.07 -0.19 to 0.33
Mean of three urines -0.03 -0.29 to 0.22 0.17 -0.20 to 0.54
Mutually adjusted d
< 18 weeks of gestation -0.07 -0.25 to 0.10 0.15 -0.10 to 0.39
18 – 25 weeks of gestation 0.07 -0.13 to 0.27 0.02 -0.26 to 0.29
> 25 weeks of gestation -0.03 -0.22 to 0.16 0.07 -0.19 to 0.33
a. square root transformed.
b. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
c. Adjusted for maternal age, maternal psychopathology (0 = no problems, 1= borderline: GSI score > 80%), sex of 
the child, ethnicity (Dutch, other-Western and non-Western), education (low, intermediate and high), income (low, 
middle and high), marital status, maternal alcohol consumption (no alcohol consumption during pregnancy, alcohol 
consumption until pregnancy was known, occasionally alcohol consumption during pregnancy and frequently 
alcohol consumption during pregnancy), non-verbal IQ of the mother, BMI categories (<18.5, 18.5-25, 25-30, 30+), 
height (≤168,>168) of the mother, parity categories (0, 1, 2+), and smoking (no smoking during pregnancy, smoked 
until pregnancy was known, smoked during pregnancy).
d. Adjusted model with the inclusion of the three exposures in one model.
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Table S10. Associations (and 95% confidence intervals) between log10 transformed maternal urine 
dialkyl phosphate metabolite concentrations in nmol/l and standardized ADHD scores across 
childhood and autistic traits scores at age 6 years.
ADHD scores across childhood
(N=781)
Autistic traits scores at age 6 years
(N=622)
Dialkyl phosphates (total) b B           95% CI B           95% CI
Unadjusted
< 18 weeks of gestation -0.11 -0.28 to 0.06 0.06 -0.18 to 0.29
18 – 25 weeks of gestation 0.00 -0.17 to 0.18 0.05 -0.20 to 0.29
> 25 weeks of gestation -0.11 -0.29 to 0.07 -0.12 -0.37 to 0.12
Mean of three urines -0.13 -0.39 to 0.12 0.07 -0.26 to 0.41
Adjusted c
< 18 weeks of gestation -0.05 -0.21 to 0.11 0.09 -0.14 to 0.32
18 – 25 weeks of gestation 0.08 -0.09 to 0.24 0.12 -0.12 to 0.36
> 25 weeks of gestation -0.03 -0.20 to 0.14 -0.01 -0.25 to 0.23
Mean of three urines -0.01 -0.25 to 0.23 0.15 -0.18 to 0.48
Mutually adjusted d
< 18 weeks of gestation -0.06 -0.22 to 0.11 0.09 -0.14 to 0.33
18 – 25 weeks of gestation 0.10 -0.08 to 0.27 0.11 -0.15 to 0.37
> 25 weeks of gestation -0.05 -0.22 to 0.13 -0.05 -0.30 to 0.20
a. square root transformed.
b. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
c. Adjusted for creatinine, maternal age, maternal psychopathology (0 = no problems, 1= borderline: GSI score > 
80%), sex of the child, ethnicity (Dutch, other-Western and non-Western), education (low, intermediate and high), 
income (low, middle and high), marital status, maternal alcohol consumption (no alcohol consumption during 
pregnancy, alcohol consumption until pregnancy was known, occasionally alcohol consumption during pregnancy 
and frequently alcohol consumption during pregnancy), non-verbal IQ of the mother, BMI categories (<18.5, 18.5-
25, 25-30, 30+), height (≤168,>168) of the mother, parity categories (0, 1, 2+), and smoking (no smoking during 
pregnancy, smoked until pregnancy was known, smoked during pregnancy).
d. Adjusted model with the inclusion of the three exposures in one model.
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Table S11. Regression calibration estimated associations a (and 95% confidence intervals) between 
log10 transformed maternal urine dialkyl phosphate metabolite concentrations in nmol/g creatini-
ne and standardized ADHD scores across childhood and autistic traits scores at age 6 years.
Naive model Regression calibration model
ADHD scores across childhood (N=781) B 95%CI B 95%CI
Averaged dialkyl phosphates (total) b -0.03 -0.28 to 0.23 -0.09 -1.00 to 0.82
Averaged diethyl alkyl phosphates c -0.08 -0.27 to 0.11 -0.42 -1.26 to 0.43
Averaged dimethyl alkyl phosphates d 0.00 -0.24 to 0.25 0.03 -1.08 to 1.15
Naive model Regression calibration model
Autistic traits scores (N=622) e B 95%CI B 95%CI
Averaged dialkyl phosphates (total) b 0.17 -0.20 to 0.54 0.54 -0.87 to 1.95
Averaged diethyl alkyl phosphates c -0.12 -0.39 to 0.15 -0.52 -1.77 to 0.73
Averaged dimethyl alkyl phosphates d 0.25 -0.11 to 0.61 1.06 -0.71 to 2.83
a. Adjusted for maternal age, maternal psychopathology (0 = no problems, 1= borderline: GSI score > 80%), sex of 
the child, ethnicity (Dutch, other-Western and non-Western), education (low, intermediate and high), income (low, 
middle and high), marital status, maternal alcohol consumption (no alcohol consumption during pregnancy, alcohol 
consumption until pregnancy was known, occasionally alcohol consumption during pregnancy and frequently 
alcohol consumption during pregnancy), non-verbal IQ of the mother, BMI categories (<18.5, 18.5-25, 25-30, 30+), 
height (≤168,>168) of the mother, parity categories (0, 1, 2+), and smoking (no smoking during pregnancy, smoked 
until pregnancy was known, smoked during pregnancy).
b. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
c. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
d. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
e. square root transformed.
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Table S12. Fruit intake a stratified difference in standardized ADHD score (and 95% confidence 
interval) across childhood per 10-fold increase in maternal urine dialkyl phosphate metabolite 
concentrations in nmol/g creatinine.
ADHD score (N=781)
<75 grams fruit a day 
(N=156)
≥75 grams fruit a day 
(N=625)
Total dialkyl phosphates b B 95%CI B 95%CI P interaction
None
< 18 weeks of gestation -0.10 -0.54 to 0.34 -0.12 -0.33 to 0.09 0.912
18 – 25 weeks of gestation 0.02 -0.51 to 0.54 0.01 -0.23 to 0.24 0.969
> 25 weeks of gestation -0.25 -0.72 to 0.21 -0.04 -0.25 to 0.17 0.388
Mean of three urines -0.22 -0.89 to 0.46 -0.11 -0.42 to 0.21 0.787
Adjusted c
< 18 weeks of gestation -0.16 -0.61 to 0.30 -0.05 -0.26 to 0.16 0.928
18 – 25 weeks of gestation -0.03 -0.52 to 0.46 0.08 -0.14 to 0.31 0.790
> 25 weeks of gestation -0.22 -0.71 to 0.28 0.09 -0.12 to 0.30 0.498
Mean of three urines -0.27 -0.93 to 0.39 0.08 -0.23 to 0.40 0.812
Mutually adjusted d
< 18 weeks of gestation -0.14 -0.62 to 0.35 -0.07 -0.28 to 0.14 0.923
18 – 25 weeks of gestation 0.08 -0.47 to 0.63 0.08 -0.15 to 0.31 0.775
> 25 weeks of gestation -0.22 -0.77 to 0.34 0.08 -0.14 to 0.30 0.515
a. Fruit intake stratified for <75 grams (<1st quantile) versus ≥75 (≥1st quantile)
b. Total Dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
c. Adjusted for maternal age, maternal psychopathology (0 = no problems, 1= borderline: GSI score > 80%), sex of 
the child, ethnicity (Dutch, other-Western and non-Western), education (low, intermediate and high), income (low, 
middle and high), marital status, maternal alcohol consumption (no alcohol consumption during pregnancy, alcohol 
consumption until pregnancy was known, occasionally alcohol consumption during pregnancy and frequently alco-
hol consumption during pregnancy), non-verbal IQ of the mother, BMI categories (<18.5, 18.5-25, 25-30, 30+), 
height (≤168,>168) of the mother, parity categories (0, 1, 2+), and smoking (no smoking during pregnancy, smoked 
until pregnancy was known, smoked during pregnancy).
d. adjusted model with the inclusion of the three exposures in one model.
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Table S13. Fruit intake a stratified difference in autistic traits score (and 95% confidence interval) 
at age 6 years per 10-fold increase in maternal urine dialkyl phosphate metabolite concentrations 
in nmol/g creatinine.
Child autistic traits score (N=622) b
<75 grams fruit a day 
(N=109)
≥75 grams fruit a day 
(N=513)
Total dialkyl phosphates c B 95%CI B 95%CI P interaction
None
< 18 weeks of gestation 0.11 -0.49 to 0.70 0.10 -0.19 to 0.38 0.981
18 – 25 weeks of gestation 0.12 -0.58 to 0.81 -0.08 -0.40 to 0.23 0.605
> 25 weeks of gestation 0.11 -0.53 to 0.76 -0.11 -0.41 to 0.20 0.546
Mean of three urines 0.21 -0.68 to 1.10 -0.06 -0.50 to 0.38 0.602
Adjusted d
< 18 weeks of gestation 0.00 -0.63 to 0.64 0.15 -0.13 to 0.44 0.689
18 – 25 weeks of gestation 0.01 -0.78 to 0.80 -0.01 -0.32 to 0.30 0.422
> 25 weeks of gestation 0.25 -0.45 to 0.95 0.04 -0.27 to 0.35 0.447
Mean of three urines 0.17 -0.82 to 1.15 0.15 -0.30 to 0.59 0.632
Mutually adjusted e
< 18 weeks of gestation -0.03 -0.72 to 0.66 0.16 -0.13 to 0.44 0.680
18 – 25 weeks of gestation -0.08 -0.94 to 0.79 -0.05 -0.38 to 0.28 0.460
> 25 weeks of gestation 0.28 -0.46 to 1.02 0.04 -0.28 to 0.36 0.460
a. Fruit intake stratified for <75 grams (<1st quantile) versus ≥75 (≥1st quantile).
b. Square root transformed.
c. Total Dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
d. Adjusted for maternal age, maternal psychopathology (0 = no problems, 1= borderline: GSI score > 80%), sex of 
the child, ethnicity (Dutch, other-Western and non-Western), education (low, intermediate and high), income (low, 
middle and high), marital status, maternal alcohol consumption (no alcohol consumption during pregnancy, alcohol 
consumption until pregnancy was known, occasionally alcohol consumption during pregnancy and frequently 
alcohol consumption during pregnancy), non-verbal IQ of the mother, BMI categories (<18.5, 18.5-25, 25-30, 30+), 
height (≤168,>168) of the mother, parity categories (0, 1, 2+), and smoking (no smoking during pregnancy, smoked 
until pregnancy was known, smoked during pregnancy).
e. adjusted model with the inclusion of the three exposures in one model.
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Table S14. Associations (and 95% confidence intervals) between log10 transformed maternal 
urine dialkyl phosphate metabolite concentrations in nmol/g creatinine and standardized ADHD 
scores across childhood and autistic traits scores at age 6 years, with additional adjustment for the 
season of  urine collection.
ADHD scores across childhood
(N=781)
Autistic traits scores at age 6 years
(N=622)
Dialkyl phosphates (total) b B 95% CI B  95% CI
Unadjusted c
< 18 weeks of gestation -0.15 -0.33 to 0.03 0.05 -0.20 to 0.30
18 – 25 weeks of gestation -0.04 -0.23 to 0.16 -0.09 -0.36 to 0.18
> 25 weeks of gestation -0.12 -0.31 to 0.07 -0.09 -0.35 to 0.17
Mean of three urines -0.21 -0.47 to 0.06 -0.10 -0.47 to 0.27
Adjusted d
< 18 weeks of gestation -0.06 -0.23 to 0.11 0.14 -0.10 to 0.38
18 – 25 weeks of gestation 0.04 -0.15 to 0.23 0.01 -0.26 to 0.28
> 25 weeks of gestation -0.02 -0.20 to 0.16 0.06 -0.20 to 0.32
Mean of three urines -0.04 -0.30 to 0.22 0.13 -0.24 to 0.50
Mutually adjusted e
< 18 weeks of gestation -0.07 -0.25 to 0.11 0.15 -0.10 to 0.40
18 – 25 weeks of gestation 0.08 -0.13 to 0.28 -0.03 -0.32 to 0.26
> 25 weeks of gestation -0.05 -0.24 to 0.15 0.05 -0.22 to 0.32
a. square root transformed.
b. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
c. Unadjusted model adjusted for season of urine collection.
d. Adjusted for season of urine collection, maternal age, maternal psychopathology (0 = no problems, 1= borderline: 
GSI score > 80%), sex of the child, ethnicity (Dutch, other-Western and non-Western), education (low, intermediate 
and high), income (low, middle and high), marital status, maternal alcohol consumption (no alcohol consumption 
during pregnancy, alcohol consumption until pregnancy was known, occasionally alcohol consumption during preg-
nancy and frequently alcohol consumption during pregnancy), non-verbal IQ of the mother, BMI categories (<18.5, 
18.5-25, 25-30, 30+), height (≤168,>168) of the mother, parity categories (0, 1, 2+), and smoking (no smoking 
during pregnancy, smoked until pregnancy was known, smoked during pregnancy).
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Table S18. Sex stratified difference (and 95% confidence interval) in ADHD score at child age 6 
and 10 years and autistic traits score at child age 6 years per 10-fold increase in child urine total 
dialkyl phosphate metabolite concentrations a in nmol/g creatinine measured at age 6 years
Boys Girls
B 95%CI B 95%CI P-value b P-value c
ADHD scores at 6 years (N=743) d
Unadjusted dialkyl phosphates (total) -0.18 -0.36 to -0.01 -0.08 -0.26 to 0.11 0.404 0.404
Adjusted e dialkyl phosphates (total) -0.09 -0.26 to 0.09 -0.03 -0.22 to 0.15 0.649 0.676
ADHD scores at 10 years (N=562) d
Unadjusted dialkyl phosphates (total) -0.15 -0.36 to 0.06 0.03 -0.18 to 0.24 0.221 0.221
Adjusted e dialkyl phosphates (total) -0.08 -0.29 to 0.13 0.00 -0.20 to 0.21 0.303 0.597
Autistic traits at 6 years (N=597) d
Unadjusted dialkyl phosphates (total) -0.12 -0.33 to 0.09 0.10 -0.12 to 0.33 0.146 0.146
Adjusted e dialkyl phosphates (total) -0.03 -0.24 to 0.18 0.17 -0.06 to 0.39 0.176 0.205
a. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
b. P-value for interaction.
c. P-value for interaction based on the augmented product term approach (Buckley et al. 2017).
d. Square root transformed.
e. Adjusted for maternal age, sex of the child, child ethnicity (Dutch, other-Western and non-Western), maternal 
education (low, intermediate and high), household income at child age 6 years (low, middle, and high), marital status 
at child age 6 years, age standardized BMI of the child at the age of 6 years, and maternal smoking (no smoking 
during pregnancy, smoked until pregnancy was known, smoked during pregnancy).
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Figure 1. Directed Acyclic Graph of the prenatal organophosphate pesticides and = Attention-Deficit/
Hyperactivity Disorder and autistic traits association. Potential adjustment variables were selected a priori 
defined with a Directed Acyclic Graph (DAG) using the Dagitty software (Textor et al. 2017). The DAG 
was based on previous studies of OP pesticides and child neurodevelopment and on biologically plausible 
covariate–exposure and covariate–outcome associations observed in our data. Green circles represent ancestors 
of the exposure, blue circles ancestors of the outcome, pink circles ancestors of both exposure and outcome, 
and gray circles represent unobserved variables. ADHD/ASD= Attention-Deficit/Hyperactivity Disorder and 
autistic traits in children. OPs= Prenatal exposure to organophosphate pesticides. Maternal BMI: Maternal 
body mass index. Maternal nutrition: Fruit intake. Maternal SES= maternal socio-economic status: maternal 
education, household income and marital status. Child age: Child age at assessment. Home environment: 
Infant/Toddler Home Observation for Measurement of the Environment.
I
Maternal BMI
Maternal height Urine dilution
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Organophosphate pesticides exposure in 
pregnant women and maternal and cord 
blood thyroid hormone concentrations
Mulder, T. A., van den Dries, M. A., Korevaar, T., Ferguson, K. K.,  
Peeters, R. P., & Tiemeier, H. (2019). 




Background: Animal studies suggest that organophosphate (OP) pesticides exposure affects 
thyroid function, but evidence in humans remains sparse and inconclusive. Gestational exposure 
is of particular interest, since thyroid hormone is essential for fetal brain development. OP 
pesticides are able to cross the placental and blood-brain barrier and may interfere with fetal 
development processes regulated by thyroid hormone.
Objective: To investigate the association of gestational OP pesticides exposure during pregnancy 
with maternal and cord blood thyroid hormone concentrations.
Methods: This study was embedded within Generation R (Rotterdam, the Netherlands), a 
prospective population-based birth cohort. Mother-child pairs with OP pesticides assessment 
and maternal (N = 715) or cord blood (N = 482) thyroid hormone measurements were included. 
OP pesticides exposure was assessed at <18, 18–25, and >25 weeks gestation by measuring 
six urinary dialkylphosphate (DAP) metabolites. Thyroid stimulating hormone (TSH) and 
free thyroxine (FT4) were measured in maternal and cord blood. Maternal measures also 
included total thyroxine (TT4) and TPO antibodies (TPOAbs). To study the association of 
creatinine-adjusted DAP metabolite concentrations with thyroid function and TPO antibodies, 
multivariable linear regression models including relevant confounders were used.
Results: There was no association of DAP metabolites with maternal TSH, FT4, TT4 
or TPOAb concentrations during pregnancy. Similarly, there was no association of DAP 
metabolites with cord blood TSH or FT4. Results did not change when DAP concentrations 
were analyzed at individual time points or as mean gestational exposure.
Conclusion: Gestational OP pesticides exposure, as assessed by repeatedly measured urinary 
DAP metabolite concentrations in an urban population, was not associated with maternal or 
cord blood thyroid hormone concentrations. These findings do not support a mediating role 
for serum thyroid hormone availability in the relation of early life exposure to low levels of 
OP pesticides with child neurodevelopment. However, disruption of the thyroid system at 
tissue level cannot be excluded. In addition, this is one of the first studies on this subject and 
measurement error in DAP metabolites might have resulted in imprecise estimates. Future 
studies should use more urine samples to increase precision and should investigate specific 
OP pesticide metabolites.




Organophosphate (OP) pesticides are widely applied for pest control in agriculture 
worldwide, which leads to widespread exposure of the general population to low levels of 
OP pesticides.1 Some populations are occupationally exposed, but the exposure of pregnant 
women most likely occurs through their diet.2-5 Importantly, OP pesticides can cross the 
placental and blood-brain barriers and may interfere with optimal fetal development at 
different levels.6 Fetal growth and differentiation of almost all tissues, including the brain, 
adipose tissue and bone is regulated by thyroid hormones.7 During pregnancy, major changes 
occur in thyroid physiology in order to provide sufficient hormones to both the mother 
and fetus. Since the fetal thyroid gland is not fully mature before 20 weeks of gestation, 
the fetus largely depends on the supply of maternal thyroxine during early pregnancy.8 
The increase in thyroid hormone binding globulin and thyroid hormone degradation due 
to placental expression of deiodinase type 3 requires an increased production of maternal 
thyroid hormones.9 This increased demand suggests that pregnancy may be a vulnerable 
period for potential thyroid disruption by different stressors, including environmental 
chemical exposures.
The association of OP pesticides with thyroid hormone on fetal neurodevelopment is 
of specific interest. Thyroid hormones play a major role in neuronal cell proliferation, 
migration, and differentiation.10,11 High exposure levels of OP pesticides can have neurotoxic 
effects by inhibiting acetylcholinesterase. Animal studies have shown that exposure at levels 
below the threshold for acetylcholinesterase inhibition can also adversely affect thyroid 
hormone-dependent neurodevelopment.12,13 Both prenatal thyroid hormone shortage 
and exposure to OP pesticides have been associated with adverse neurobehavioral and 
birth outcomes in children.14-18 Therefore, it has been hypothesized that disruption of 
thyroid function is a potential mechanism relating prenatal OP pesticides exposure to 
brain development.19
Results from animal studies suggest that organophosphates might interfere with thyroid 
function, although findings are inconclusive. Some studies in adult animals report an 
increased20 or decreased21 serum total thyroxine (TT4) concentration after exposure 
to dimethoate or malathion, respectively, whereas chlorpyrifos-methyl, malathion, or 
monocrotophos did not affect TT4 concentrations.22-25 Findings for thyroid stimulating 
hormone (TSH) and thyroid peroxidase (TPO) are also mixed. Serum TSH concentrations 
were found to be lower after exposure to monocrotophos, 25 but did not differ after 
exposure to dimethoate or chlorpyrifos-methyl.20,22
Studies in humans are equally inconclusive, scarce, and do not specifically test windows 
of vulnerability such as pregnancy. Another gap is that studies in humans did not utilize 
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repeated measurements of OP pesticide exposure.26 Analyzing multiple urine specimens 
per subject is of importance, because OP pesticides are known to have a short half-life, 
which can result in substantial day-to-day variability within subjects.27 In addition, 
repeated measurements of OP pesticides during pregnancy enable the investigation of 
potential developmental windows of vulnerability. While one study in pregnant women 
in China found that higher gestational OP pesticide exposure, as measured by urinary 
dialkylphosphate (DAP) metabolite concentrations, is associated with higher FT4 and 
lower TSH at hospital admission for delivery,28 all other studies but one have been 
performed in adult males and reported contradictive results.26 Higher urinary DAP 
metabolite concentrations were associated with higher TT4 and TSH in occupationally 
exposed males.29 In contrast, higher urinary levels of 5,6-trichloro-2-pyridinol (TCPy), a 
metabolite of chlorpyrifos, were associated with lower FT4 and higher TSH concentrations 
in males visiting an infertility clinic.30 Furthermore, higher urinary TCPy levels were 
associated with lower FT4 and TSH in males from the general population, whereas TCPy 
levels were associated with higher TSH among women > 60 years of age only.31 No study 
investigated the association of maternal OP pesticides exposure during pregnancy with 
thyroid function of their offspring.
To address these inconsistencies and research gaps, we investigated the association of 
repeatedly measured gestational OP pesticides exposure with maternal and cord blood 
thyroid hormone concentrations in an urban population with relatively high exposure 
levels compared to those observed in most other birth cohorts.32-35 We hypothesized 




This study was embedded in Generation R, a prospective population-based cohort from 
fetal life onwards.36 Eligible participants were pregnant women living in Rotterdam, 
the Netherlands, with an expected delivery date between April 2002 and January 2006. 
Mothers were enrolled during pregnancy or in the first months after the birth of their child 
when newborns attended child health centers for routine visits. The baseline participation 
rate was estimated at 61%. Of the 9,778 mothers who participated in the study, 8,879 
(91%) were enrolled during pregnancy. Between February 2004 and January 2006, spot 
urine specimens were collected during early, middle, and late pregnancy (<18, 18–25, 
>25 weeks of gestational age, respectively) at the time of routine ultrasound examinations 
when in total 4,918 women were enrolled. Of these, 2,083 women provided a complete 
set of three urine specimens. Of the women with a singleton pregnancy and follow-up 
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data including neurobehavioral, sociodemographic and health data on the offspring 
(n=1,449), 800 were randomly selected for measurements of urinary dialkylphosphate 
(DAP) metabolites.5 Of these, 784 had sufficient urine volume for analyses. Of those, 
730 women had TSH or FT4 measurements available. Of the offspring, 490 had cord 
blood TSH or FT4 measurements available. We excluded women with a known thyroid 
disorder (n = 10 and n = 5, respectively). Most of the women with a known thyroid disorder 
received thyroid (interfering) medication including levothyroxine during pregnancy 
(n = 9 and n = 4, respectively). In addition, we excluded women who had undergone in 
vitro fertilization (n = 5 and n = 3, respectively) (Fig. 1). The Medical Ethics Committee 
of the Erasmus Medical Centre, Rotterdam, approved the study and written informed 
consent was obtained from all parents.
Figure. 1. Flowchart of the study population.
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Urine collection and analysis of  DAP metabolites
Measurements of six non-specific DAP metabolites of OP pesticides were conducted 
at Institut National de Santé Publique (INSPQ) in Quebec, Canada, using gas 
chromatography coupled with tandem mass spectrometry (GC–MS/MS).37 Three 
dimethyl (DM) metabolites (dimethylphosphate (DMP), dimethylthiophosphate 
(DMTP), and dimethyldithiophosphate (DMDTP)) were determined, as well as three 
diethyl (DE) metabolites (diethylphosphate (DEP), diethylthiophosphate (DETP), and 
diethyldithiophosphate (DEDTP))). The limit of detection (LOD) was 0.26 μg/L for DMP, 
(0% < LOD), 0.40 for DMTP, (2–4% < LOD), 0.09 for DMDTP, (18–20% < LOD), 
0.50 for DEP, (3–5% < LOD), 0.12 for DETP (12% < LOD) and 0.06 for DEDTP 
(81–85% < LOD). Measured concentrations below the LOD were included in the data 
analysis as the original values determined by the GC–MS/MS. The inter-day precision 
of the method, expressed as the coefficient of variation (CV%), varied between 4.2 and 
8.8 for DEDTP, 4.1–7.2 for DEP, 5.0–9.1 for DETP, 5.5–7.1 for DMDTP, 5.3–8.0 
for DMP and 5.5–7.7 for DMTP based on reference materials (clinical check-urine 
level II 637 E-495 and MRM E-459) 5. To account for urinary dilution, OP pesticide 
metabolite concentrations were divided by urinary creatinine concentrations, which were 
determined based on the Jaffe reaction.38 The ranges (min-max) for measured creatinine 
concentrations in early, middle and late pregnancy were 0.03–3.97, 0.04–4.29, and 
0.07–4.96, respectively. A more detailed description of the urine collection and analysis 
of DAP metabolites can be found elsewhere.5,39
Thyroid function measurements
Maternal serum samples were obtained in the first half of pregnancy (<18 weeks, mean 
12.9 weeks, SD 1.81, 95% range 9.8–17.1). These samples were collected concurrently 
with the spot urine specimens obtained during the first urine collection phase. Cord 
blood samples were obtained directly after birth (mean 40.3 weeks, SD 1.32, 95% range 
37.1–42.3). Maternal reference ranges were 0.03–4.04 mU/L for TSH, 10.4–22.0 pmol/L 
for FT4, and 96.0–219.0 nmol/L for TT4. Cord reference ranges were 3.41–33.80 mU/L 
for TSH and 15.3–28.1 pmol/L for FT4. Plain tubes were centrifuged and serum was 
stored at −80 °C. TSH, FT4, and TT4 concentrations in maternal and cord blood serum 
samples were determined using chemiluminiscence assays (Vitros ECI; Ortho Clinical 
Diagnostics). The intra- and interassay coefficients of variation were <4.1% for TSH, 
<5.4% for FT4 and <6.4% for TT4. TPOAbs were measured only in maternal blood 
using the Phadia 250 immunoassay (Phadia AB, Uppsala, Sweden) and considered 
positive when >60 IU/ml.40
Covariates
Potential confounders were selected a priori based on previous studies of OP pesticides 
and thyroid function.26,28 Gestational age at blood sampling and child sex were included as 
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independent predictors of thyroid function. Information on maternal age at enrollment, 
ethnicity, parity (0, 1, or >1), and smoking behavior (no smoking during pregnancy, smoked 
until pregnancy recognized, and continued smoking during pregnancy), and fruit intake 
was obtained through postal questionnaires filled in during pregnancy. Maternal ethnicity 
was based on parent’s country of birth and considered Dutch when both parents were 
born in the Netherlands, and non-Dutch if one parent was born outside the Netherlands. 
This categorization was defined according to the classification of Statistics Netherlands.41 
Fruit intake was assessed in the first trimester using a modified version of a validated food 
frequency questionnaire and was adjusted for energy intake. Body mass index (BMI) 
was calculated using length and weight as measured at study enrollment. Urinary iodine 
concentration and creatinine concentration were measured in spot urine samples in early 
and middle pregnancy at the time of OP pesticide metabolites measurements. The urinary 
iodine-to-creatinine ratio (UICr) was used as a measure of iodine status.42,43
Midwives and hospital registries provided information on child sex and gestational age at 
birth. Maternal gestational age at blood and urine sampling was defined using ultrasound 
measurements of crown-rump length or biparietal diameter, using dating curves derived 
from this cohort.44 Except for smoking (8%) and fruit intake (22%), missing data on 
covariates were all <1%.
Statistical analyses
For each urine collection phase, the three DM metabolites (nmol/L) were summed as 
total DM and the three DE metabolites (nmol/L) were summed as total DE. Total DAP 
concentrations (nmol/L) per urine collection phase were calculated by summing the six 
metabolites. Urinary DAP concentrations were expressed on a volume and creatinine 
basis to control for urine dilution (nmol/g creatinine). The geometric means of the total 
DAP, DM, and DE concentrations at three different time points were calculated to get 
an estimate of OP pesticides exposure across pregnancy. Subsequently, the geometric 
means were log10 transformed in order to reduce the influence of outliers and to have 
a better model fit. In addition, log transformation of the DAP concentrations improves 
comparability since previous studies have used log transformed DAP concentrations.28,29 
To approach normality, TSH values were also log10 transformed.
We used multivariable linear regression models to study the association of OP pesticide 
metabolites with maternal (TSH, FT4, and TT4) and cord blood (TSH and FT4) 
thyroid hormone concentrations. In the analyses of maternal thyroid function, we only 
studied DAP metabolite concentrations measured concurrently (<18 weeks gestation) 
with thyroid function. DAP concentrations at individual time points or as the mean of 
the three measurements were studied as determinants of cord blood thyroid hormones. 
Assumptions of linear regression models, including linearity, homoscedasticity, and normal 
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distributions of the model residuals, were assessed with residual plots, Q-Q plots and 
histograms and were met for all models.
All models were adjusted for gestational age at blood sampling, and additionally adjusted 
for maternal age, parity, smoking and ethnicity, and child sex. When the association 
between metabolite concentrations at individual time points and thyroid function was 
tested, models were additionally adjusted for creatinine, gestational age at urine sampling, 
and season of urine collection.
Effect modification by child sex was explored by introducing a product interaction term of 
DAP concentration and child sex to the model with cord blood TSH or FT4 as outcome. 
A P-value below 0.05 was used for interaction terms to screen for effect modification.
Several additional analyses were performed. First, the association of DM, DE, and DAP 
concentrations with TPOAb positivity was analyzed with the use of logistic regression 
models by using two cut-offs for TPOAb positivity: 60 and 20 IU/ml. We did not only 
use the assay-specific cut-off of 60 IU/ml but ran analyses using the latter, since the 
manufacturer cut-off for TPOAb positivity may fail to identify women with TPOAb 
concentrations sufficient to affect thyroid function. In Generation R, higher mean TSH 
and lower FT4 concentrations were already observed for TPOAbs >26 IU/ml.45 Second, 
the analyses on maternal thyroid function were repeated in TPOAb negative women only 
to rule out confounding and effect modification by TPOAb positivity. Third, models were 
additionally adjusted for maternal BMI, UICr, TPOAbs, or fruit intake. We adjusted for 
maternal UICr at the time of thyroid function measurement in models with maternal 
thyroid function, or for the average maternal UICr from two time points during pregnancy 
in models with cord blood thyroid hormone concentrations. Maternal BMI might be a 
determinant as well as a consequence of thyroid function.46,47 TPOAbs might be on the 
OP pesticides – thyroid function pathway. In addition, UICr and TPOAbs affect thyroid 
function but are less likely to affect DAP metabolite concentrations. Therefore, maternal 
BMI, UICr, and TPOAbs were not included in the main analyses. Fruit intake was used 
as a proxy for a healthy diet including micronutrients important for a normal thyroid 
function. Fourth, effect modification by UICr or TPOAbs was tested by introducing a 
product interaction term of DAP concentration and UICr or TPOAbs to the models. 
Fifth, we refitted models with metabolite concentrations expressed as nmol/L without 
correction for creatinine, as very high or low creatinine values might influence the results. 
Sixth, we used inverse probability weighting to correct for loss to follow-up and to account 
for potential selection bias because participants in our study sample were more likely 
be older, have a lower BMI, a higher level of education, and a higher income compared 
to the full cohort (Table S5).Missing covariate and DAP metabolite data were imputed 
10 times with the Multivariate Imputation by Chained Equations (MICE) method in 
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R.48,49 DAP metabolite concentrations were log10 transformed prior to the multiple 
imputation procedure to approach normality. Thyroid function variables were included 
as predictors for the imputation, but were not imputed. DAP metabolite concentrations, 
thyroid function parameters and all covariates indicated above were used to impute 
missing data. In addition, variables likely to be associated with these covariates or shown 
to be associated with DAP metabolite concentrations were used to impute missing data.5 
These included birthweight, marital status, household income, and maternal education. 
All statistical analyses were performed with R statistical software version 3.3.2. using a 
2-sided significance level of P < 0.05.
Results
The final study population consisted of 715 pregnant women and 482 newborns (Fig. 1). 
Descriptive statistics are shown in Table 1. Mean differences between DAP concentrations 
across time points were modest. The intra class correlations (estimated by using a 2-way 
mixed-effects model with absolute-agreement) for DAP metabolite concentrations varied 
between 0.22 and 0.26 for a single-measurement and between 0.48 and 0.52 for the mean 
of the three measurements (Table S1).
Median gestational age at first DAP measurement and serum thyroid measurements was 
12.9 weeks (95% range 9.8–17.1) in pregnant women. Cord blood samples were obtained 
directly after birth at median gestational age 40.3 weeks (95% range 37.1–42.3). The 
women had a median TSH concentration of 1.31 mU/L and a median FT4 concentration 
of 14.6 pmol/L. We observed TPOAb positivity in 42 (5.9%) women. The neonatal 
median TSH and FT4 concentrations were 9.43 mU/L and 20.9 pmol/L, respectively. 
In non-response analyses, maternal and cord blood TSH and FT4 concentrations did 
not meaningfully differ between women grouped on the basis of organophosphates data 
availability. However, women included in the analyses were more often Dutch, had a 
higher mean age, a lower mean BMI, and a higher mean fruit consumption (Table S10).
There was no association of DM, DE, or DAP concentrations measured concurrently 
with thyroid function with maternal TSH, FT4 or TT4 in adjusted models (Table 2). 
For example, a 10-fold higher total DAP concentration at the time of thyroid function 
measurement was not associated with TSH (β [95% CI]: 0.00 [−0.04 to 0.04]). The results 
were similar after the exclusion of TPOAb positive women (Table S2). In addition, there 
was no association of DM, DE or DAP measured concurrently with thyroid function and 
TPOAb positivity, irrespective of the cut-off chosen (Table S3). Finally, DM, DE, or DAP 
concentrations measured during early, mid, and late pregnancy (Table S4) or as mean 
of the three measurements (Table 3) were not associated with cord blood TSH or. There 
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Table 1. Descriptive characteristics of  Mother and Child Pairs
  Maternal thyroid hormones 
available (n=715)
Cord blood thyroid hormones 
available (n=482)
Characteristic Median (95% range)c Median (95% range)c
Gestational age at urine sampling, weeks
Urine collection phase 1 12.9 (9.8-17.1) 12.9 (9.6-17.1)
Urine collection phase 2 20.4 (18.9-22.8) 20.4 (18.9-22.4)
Urine collection phase 3 30.2 (28.9-32.5) 30.2 (28.9-32.5)
Gestational age at blood sampling, weeks 12.9 (9.8-17.1) 40.3 (37.1-42.3)
Maternal age, years 31.0 (20.4-38.9) 30.9 (20.2-38.7)
Maternal BMI, Kg/m2 23.1 (18.7-35.6) 23.0 (18.3-34.6)
Paritya 
0 442 61.8 296 61.4
1 190 26.6 53 11.0
≥2 83 11.6 67 13.9
Smokinga 
No smoking during pregnancy 543 75.9 370 76.8
Until pregnancy recognized 71 9.9 48 10.0
Continued during pregnancy 101 14.1 64 13.3
Ethnicitya
Dutch 410 57.3 283 58.7
Morrocan 38 5.3 25 5.2
Turkish 40 5.6 26 5.4
Surinamese 63 8.8 43 8.9
Other western 92 12.9 61 12.7
Other non-western 72 10.1 44 9.1
Child sexa (girls %) 353 49.4 234 48.5
Dimethyl metabolites, nmol/g creatinine
Urine collection phase 1 239.8 (56.2-1178.8) 256.0 (54.2-1368.6)
Urine collection phase 2 269.1 (59.6-1225.1) 268.1 (61.3-1260.8)
Urine collection phase 3 249.6 (59.0-1037.8) 249.3 (55.6-1083.5)
Diethyl metabolites, nmol/g creatinine
Urine collection phase 1 42.8 (7.3-258.8) 42.5 (7.9-267.4)
Urine collection phase 2 41.5 (6.6-260.2) 41.5 (7.5-282.0)
Urine collection phase 3 41.1 (6.4-219.1) 41.1 (7.9-246.7)
Total dialkylphosphate metabolites, nmol/g 
creatinine
Urine collection phase 1 306.0 (66.5-1363.5) 317.5 (66.0-1531.8)
Urine collection phase 2 317.7 (79.0-143.5) 316.1 (84.9-1346.3)
Urine collection phase 3 305.5 (71.7-1124.6) 307.5 (71.7-1223.0)
Average dialkylphosphate metabolites across 
pregnancy, nmol/g creatinine
Dimethyl metabolites 259.5 (81.8-686.8) 259.1 (83.7-698.5)
Diethyl metabolites 42.6 (9.8-144.6) 43.2 (11.4-148.3)
Total dialkylphosphate metabolites 311.6 (97.0-800.5) 312.0 (102.2-813.7)
TSH, mU/L 1.31 (0.0-4.24) 9.43 (2.78-36.67)
FT4, pmol/L 14.6 (10.3-21.9) 20.9 (15.6-32.1)
TPOAb positivitya, b 42 5.9 . .
Urinary iodine to creatinine ratio, μg/g
Urine collection phase 1 207.0 (70.3-561.7) 203.3 (73.7-538.4)
Urine collection phase 2 231.5 (67.4-568.6) 229.3 (75.5-563.0)
Data are shown after multiple imputation (see methods section) and are extracted from the 10th imputed dataset.
a Data shown as n (%).
b Considered positive when >60 IU/ml.
c 5th and 95th percentile.
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Table 2. Associations between dialkyl phosphate metabolite concentrations and maternal thyroid 
function during pregnancy
  Mean TSH Mean FT4 Mean TT4
<18 weeks gestation β (95% CI) p β (95% CI) p β (95% CI) p
Total dialkyl phosphates
Model 1 0.00 (-0.04 to 0.04) 0.95 0.33 (-0.32 to 0.97) 0.32 -2.33 (-9.03 to 4.38) 0.50
Model 2 0.00 (-0.04 to 0.04) 0.92 0.36 (-0.27 to 0.99) 0.27 -1.24 (-7.83 to 5.35) 0.71
Dimethyl alkyl phosphates
Model 1 0.01 (-0.03 to 0.04) 0.79 0.20 (-0.41 to 0.81) 0.51 -2.66 (-9.03 to 3.71) 0.41
Model 2 0.00 (-0.04 to 0.04) 0.90 0.25 (-0.35 to 0.85) 0.41 -1.97 (-8.23 to 4.29) 0.54
Diethyl alkyl phosphates
Model 1 -0.01 (-0.04 to 0.02) 0.42 0.28 (-0.19 to 0.75) 0.24 -0.27 (-5.16 to 4.62) 0.91
Model 2 -0.02 (-0.05 to 0.01) 0.30 0.27 (-0.19 to 0.72) 0.25 0.73 (-4.02 to 5.81) 0.76
All dialkyl phosphate metabolite concentrations (nmol/g creatinine) and TSH values were log transformed.
N= 710 for TSH, n=709 for FT4, and n=712 for TT4.
Model 1 was adjusted for gestational age at blood sampling and creatinine.  
Model 2 was additionally adjusted for maternal age, parity, smoking and ethnicity, child sex, and season.
Table 3. Associations between dialkyl phosphate metabolite concentrations during pregnancy and 
cord blood thyroid hormone concentrations
  Mean TSH Mean FT4
Averaged across pregnancy β (95% CI) p β (95% CI) p
Total dialkyl phosphates
Model 1 -0.07 (-0.17 to 0.03) 0.16 0.13 (-1.43 to 1.69) 0.87
Model 2 -0.07 (-0.18 to 0.03) 0.15 0.28 (-1.35 to 1.90) 0.74
Dimethyl alkyl phosphates
Model 1 -0.07 (-0.17 to 0.02) 0.13 0.06 (-1.44 to 1.56) 0.94
Model 2 -0.07 (-0.17 to 0.02) 0.14 0.16 (-1.38 to 1.71) 0.84
Diethyl alkyl phosphates
Model 1 -0.02 (-0.10 to 0.06) 0.64 0.29 (-0.95 to 1.53) 0.64
Model 2 -0.03 (-0.11 to 0.05) 0.43 0.40 (-0.89 to 1.68) 0.55
Average dialkyl phosphate metabolite concentrations (nmol/g creatinine) were computed by the geometric mean of 
the three urine collection phases.
All dialkyl phosphate metabolite concentrations and TSH values were log transformed.
N= 472 for TSH and n=477 for FT4.
Model 1 was adjusted for gestational age at blood sampling.  
Model 2 was additionally adjusted for maternal age, parity, smoking and ethnicity, and child sex.
Chapter 6
230
was no effect modification of the association between DAP metabolite concentrations 
and cord blood TSH or FT4 by child sex (data not shown).
Additional adjustment for maternal BMI, UICr, TPOAbs, fruit intake, or inverse probability 
attrition weights did not change the results for maternal or cord blood thyroid hormones 
(Table S6 and S7). UICr and TPOAbs did not modify the association between DAP 
metabolite concentrations and maternal or cord blood thyroid hormone concentrations). 
Finally, DM, DE, and DAP concentrations were not associated with maternal or cord 
blood thyroid hormones when metabolite concentrations were expressed as nmol/L 
without correction for creatinine (Table S8 and S9).
Discussion
In the current study, gestational OP pesticide exposure, as assessed by urinary DAP 
metabolite concentrations, was not associated with maternal or cord blood thyroid 
hormone concentrations. DAP concentrations measured concurrently with thyroid 
function were not associated with maternal TSH, FT4, TT4 or TPOAb concentrations. 
Similarly, DAP concentrations at individual time points or average DAP concentrations 
across pregnancy were not associated with cord blood TSH or FT4.
We were able to study the association of gestational OP pesticides exposure with maternal 
and cord blood thyroid hormone concentrations using a large dataset with repeated 
measurements of exposure biomarkers and detailed data on potential confounders. 
Analyzing multiple urine specimens per subject is of importance, because the urinary 
concentration of DAP metabolites reflects only recent exposure, and individual exposure 
differs substantially from day-to-day, depending on diet.3,27 The estimation of gestational 
OP exposure improves if multiple urine specimens across pregnancy are collected from 
a subject during multiple periods across pregnancy.
Our findings are generalizable to urban populations but cannot be generalized to 
occupationally exposed individuals for different reasons. First, occupational exposure 
might involve different OP pesticides resulting in different toxic oxon derivatives after 
bioactivation. Second, occupational exposure routes might be different compared to 
our study population. The Generation R population lives in urban settings, where the 
main route of exposure is through the ingestion of food, and most likely fruits.5 Third, 
occupational exposure may result in higher exposure levels. However, DAP metabolite 
concentrations were 2–3 times higher in our study (311 nmol/g creatinine, 224 nmol/L) 
than those reported in other birth cohorts from Canada, the United States, and European 
Prenatal OP pesticide exposure and thyroid hormone concentrations
231
6
countries.32-35 The relatively high DAP concentrations in our study may be related to the 
high consumption of fruits and the intense farming practices in the Netherlands.5
DAP concentrations in our study are comparable to those observed in a Chinese birth 
cohort study (270 nmol/g creatinine), which found that higher DAP concentrations 
were associated with higher FT4 and lower TSH.28 Importantly, total DM metabolite 
concentrations in our study were higher (259 vs 186 nmol/g creatinine), whereas total DE 
metabolite concentrations were lower (43 vs 84 nmol/g creatinine) than in the Chinese 
birth cohort. Although still being detected, several OP pesticides were banned in or 
before 2006 in the Netherlands, but are still in use in China.50,51 These include diazinon 
and phosalone (both OP pesticides that generate DE metabolites) and dichlorvos, naled, 
fenitrothion, oxydemeton-methyl, and temephos (all OP pesticides that generate DM 
metabolites). In addition, methamidophos, parathion-methyl, and parathion are banned 
since 2007 for agricultural use in China, but could still be detected in vegetables.52 
Other OP pesticides types and mixtures as well as the assessment of DAP metabolite 
concentrations and maternal thyroid hormones on the day of hospital admission for 
delivery only, while maternal thyroid function samples were obtained before 18 weeks 
of gestation in our study, best explain why the results in the Chinese birth cohort study 
are not in line with our findings.
Previous studies in humans were mainly conducted in adult men and reported positive 
associations of OP pesticides exposure with TT429 and TSH,29,30 and negative associations 
with FT430,31 and TSH.31 These results are not comparable to those obtained in women 
during pregnancy because of sex-selective effects of OP pesticides. Rodent studies show 
higher vulnerability to chlorpyrifos exposure in males compared to females with respect 
to thyroid function.22,53 A large cross-sectional study found no association between ever 
use of OP pesticides by males with the risk of hypo- and hyperthyroidism among their 
female spouses, whereas organochlorine insecticides and fungicides were associated with 
thyroid disease in these women.54 Prior studies assessed OP pesticides exposure only once 
and only one study focused on OP pesticide exposure during pregnancy.28-31 To the best 
of our knowledge, this is the first study investigating maternal OP pesticide exposure 
during pregnancy and cord blood thyroid hormones using repeated measurements of 
DAP concentrations.
Importantly, cord blood concentrations of TSH and FT4 reflect fetal thyroid function 
to a different extent. Since trans placental transfer of TSH is poor,55 cord blood TSH 
concentrations reflect fetal thyroid function. In contrast, serum T4 could be detected in 
cord blood of neonates without a functional thyroid, indicating trans placental transfer 
of T4 during late gestation.56 Although transfer of FT4 from mother to fetus decreases 
throughout pregnancy alongside an increased production of fetal thyroid hormones,8 
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FT4 concentrations in cord blood do not only reflect fetal thyroid function, but maternal 
thyroid function as well. Therefore, although not very likely, an association between OP 
pesticides and fetal FT4 concentrations could have been missed.
Our findings are not in line with results from animal studies, which show that gestational 
OP pesticides exposure can interfere with maternal and newborn thyroid function.53,57 
This discrepancy may suggest that OP pesticides exert different effects on human or animal 
thyroid function. However, these animal studies are inconsistent, showing opposing effects 
on thyroid hormone physiology. Some studies in adult animals report an increased20 or 
decreased21 serum total thyroxine (TT4) concentration after exposure to dimethoate 
or malathion, respectively, whereas chlorpyrifos-methyl, malathion, or monocrotophos 
did not affect TT4.22-25 Findings for thyroid stimulating hormone (TSH) and thyroid 
peroxidase (TPO) are also mixed. Serum TSH concentrations were found to be lower 
after exposure to monocrotophos,25 but no differences in serum TSH concentrations were 
observed after exposure to dimethoate or chlorpyrifos-methyl.20,22 Our results cannot be 
directly compared to animal studies for different reasons. First, our study population 
may have been exposed to a mixture of multiple OP pesticides, whereas animal studies 
investigate the effects of specific OP pesticides. DAP metabolites are non-specific and 
cannot be traced back to individual pesticides.58 The dimethyl OP pesticide dimethoate 
was the organophosphate most frequently used in 2004 in the Netherlands, whereas other 
OP pesticides investigated in animal studies were not or less frequently applied on food 
crops (e.g. chlorpyrifos and malathion).5 Thus, the DAP metabolites in our population 
likely do not reflect the same organophosphates used in animal studies. However, we 
must be cautious because residues of OP pesticides that were banned during the urine 
collection of our study (2004-2006) were being detected on fruit and vegetables.50 Second, 
animals were exposed to different concentrations of OP pesticides compared to our study 
population. For example, the minimal doses used to study the effects of chlorpyrifos and 
dimethoate on thyroid function in rodents were 1mg/kg and 2 mg/kg, respectively.20,53,57 
The acceptable daily intake (ADI) concentration for those organophosphates are 0.01 and 
0.002 mg/kg in humans.59 Although the exact exposure levels of our study population 
are unknown, it is likely that these are similar to or below the ADI and thus much lower 
than those used in animal studies.
Our findings do not preclude disruption of the thyroid system at tissue level. Thyroid 
hormones were measured in serum and this does not provide information about thyroid 
hormone availability or effects in specific tissues. Interestingly, an in vitro study showed 
that the diethyl OP pesticide malathion can competitively bind to the thyroxine transporter 
transthyretin.60 Because TTR is highly expressed in the placenta and brain, OP pesticides 
might affect thyroid hormone action in these tissues specifically. Moreover, results from 
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a study in goldfish indicate that OP pesticides might have tissue-specific effects by 
differentially affecting the three types of deiodinases.24
In our study population, OP pesticides exposure during pregnancy most likely occurs 
through diet, with fruit intake being the main source of exposure.5 A healthy diet 
including many fruits, vegetables, nuts, and fish is therefore not only a source of 
beneficial micronutrients such as selenium, iodine and iron, but can also be a source 
of OP pesticides. These micronutrients are important for an adequate thyroid function 
and might counteract the adverse effects of OP pesticide exposure.61 Therefore, negative 
confounding by these micronutrients could have attenuated the association between 
OP pesticide exposure and thyroid function in the current study. However, results did 
not change when we adjusted our analyses for fruit intake as a proxy for a healthy diet. 
Moreover, iodine might act as an effect modifier in the association of OP pesticides and 
thyroid function, since iodine deficient populations may be more vulnerable to thyroid 
disrupting chemicals.62 Our study was performed in an iodine-sufficient area, which may 
mitigate the effects of OP pesticides on thyroid function.63 However, our study provides 
no evidence for effect modification by iodine concentration.
This study was limited by the fact that DAP metabolites were used as a proxy for OP 
pesticide exposure instead of measuring OP pesticides exposure directly. Since preformed 
DAP metabolites are present in foods and the environment,64,65 the extent to which DAP 
metabolite concentrations reflect exposure to the active parent pesticide rather than to 
less toxic metabolites remains unclear.66 Yet, the estimation of urinary DAP metabolite 
concentrations is considered a non-invasive and useful biomarker for OP pesticides 
exposure67 and is therefore the most-used method of estimating exposure to this class of 
compounds in general populations.68 Moreover, no information was available about the 
exact time of day of spot urine sampling. The samples include both first morning and 
random spot samples, since the urine spot samples were collected between 8 am and 
8 pm. Concentrations of chemicals, urine volume, and the rate of excretion vary with 
fluid intake, time of day, and other factors.69-71 However, time of sample collection is 
unlikely to confound the association between OP pesticide exposure and thyroid function, 
since FT4 does not display a circadian rhythm and TSH only varies clearly from day to 
night.72 Another limitation of this study is that creatinine concentrations vary during 
pregnancy. Sensitivity analyses without creatinine correction yielded slightly different 
results with regards to the direction of some associations. However, all associations 
remained non-significant.
Although this study used three measurements of DAP metabolite concentrations, it would 
be ideal to collect urine samples more often during pregnancy. Intraclass correlation 
coefficients of DAP metabolites were modest in this study. Future studies should use 
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more urine samples to increase precision of OP pesticide exposure during pregnancy. 
Chemiluminiscence assays were used to measure FT4 concentrations. These assays may 
not adequately measure FT4 concentrations due to a rise in thyroid hormone binding 
proteins during pregnancy.73 However, this increase in proteins mainly occurs in the third 
trimester of pregnancy, whereas FT4 concentrations were measured in the first half of 
pregnancy in the current study. TT4 concentrations were also measured, which are not 
affected by binding protein interference and results for TT4 were also not significant.
The current study provides no evidence for an association of gestational OP pesticides 
exposure with maternal or cord blood thyroid hormone concentrations. Since OP 
pesticides exposure is widespread among pregnant women, our findings are important on 
a population level. These findings suggest that, contrary to some hypotheses, associations 
of gestational OP pesticides exposure with neurodevelopment are not mediated by thyroid 
function. However, we cannot preclude thyroid disruption at the tissue level and our 
results strictly apply to urban populations and not to occupationally exposed individuals.
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Table S1. Intraclass correlation coefficients for log10 transformed dialkyl phosphate metabolite 
concentrations in nmol/g creatinine (n=784).
ICCa ICCb
Total dialkyl phosphatesc 0.26 0.52
Dimethyl alkyl phosphatese 0.24 0.48
Diethyl alkyl phosphatesd 0.22 0.45
a. ICC = Intraclass Correlation Coefficients calculated using a single-measurement, absolute-agreement, and 2-way 
mixed-effects model.
b. ICC = Intraclass Correlation Coefficients calculated using a mean of three measurements, absolute-agreement, 
and 2-way mixed-effects model.
c. Total dialkyl phosphates is the sum of DEDTP, DETP, DEP, DMDTP, DMTP and DMP.
d. Diethyl alkyl phosphates is the sum of DEDTP, DETP and DEP.
e. Dimethyl alkyl phosphates is the sum of DMDTP, DMTP and DMP.
Table S2. Associations between dialkyl phosphate metabolite concentrations and maternal thyroid 
function during pregnancy in TPOAb negative women.
  Mean TSH Mean FT4 Mean TT4
<18 weeks gestation β (95% CI) p β (95% CI) p β (95% CI) p
Total dialkyl phosphates
Model 1 0.00 (-0.04 to 0.04) 0.99 0.30 (-0.36 to 0.96) 0.37 -2.40 (-9.25 to 4.45) 0.49
Model 2 0.00 (-0.04 to 0.04) 0.95 0.36 (-0.29 to 1.02) 0.27 -1.56 (-8.29 to 5.17) 0.65
Dimethyl alkyl phosphates
Model 1 0.00 (-0.03 to 0.04) 0.86 0.17 (-0.46 to 0.79) 0.60 -2.47 (-8.97 to 4.02) 0.45
Model 2 0.00 (-0.04 to 0.04) 0.90 0.25 (-0.37 to 0.87) 0.43 -2.01 (-8.39 to 4.37) 0.54
Diethyl alkyl phosphates
Model 1 -0.02 (-0.05 to 0.01) 0.29 0.32 (-0.16 to 0.8) 0.19 -0.18 (-5.15 to 4.8) 0.94
Model 2 -0.02 (-0.05 to 0.01) 0.22 0.33 (-0.14 to 0.79) 0.17 0.73 (-4.12 to 5.57) 0.77
All dialkyl phosphate metabolite concentrations (nmol/g creatinine) and TSH values were log transformed.
N= 668 for TSH, n=667 for FT4, and n=670 for TT4.
Model 1 was adjusted for gestational age at blood sampling and creatinine.
Model 2 was additionally adjusted for maternal age, parity, smoking and ethnicity, child sex, and season.
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Table S3. Associations between dialkyl phosphate metabolite concentrations and TPO antibody 
concentrations
  TPOAbs > 60 TPOAbs > 20
<18 weeks gestation OR (95%CI) p OR (95%CI) p
Total dialkyl phosphates
Model 1 0.94 (0.35 to 2.51) 0.90 0.95 (0.42 to 2.16) 0.90
Model 2 0.81 (0.29 to 2.27) 0.69 0.78 (0.33 to 1.86) 0.58
Dimethyl alkyl phosphates
Model 1 0.99 (0.39 to 2.51) 0.98 1.07 (0.49 to 2.34) 0.87
Model 2 0.87 (0.33 to 2.29) 0.77 0.90 (0.40 to 2.04) 0.81
Diethyl alkyl phosphates
Model 1 0.96 (0.47 to 1.96) 0.91 0.82 (0.47 to 1.43) 0.48
Model 2 0.91 (0.44 to 1.89) 0.80 0.78 (0.45 to 1.36) 0.38
Abbrevations: OR: odds ratio; TPOAbs: thyroperoxidase antibodies (n= 720).
Dialkyl phosphate metabolite concentrations (nmol/g creatinine) were log transformed.
Model 1 was adjusted for gestational age at blood sampling.
Model 2 was additionally adjusted for maternal age, parity, smoking and ethnicity, child sex, and season.
Table S4. Associations between dialkyl phosphate metabolite concentrations during pregnancy per 
urine collection phase and cord blood thyroid hormone concentrations
  Mean TSH Mean FT4
Per urine collection phase β (95% CI) p β (95% CI) p
Total DAP < 18 weeks gestation
Model 1 -0.05 (-0.12 to 0.02) 0.20 -0.39 (-1.47 to 0.70) 0.48
Model 2 -0.03 (-0.10 to 0.04) 0.36 -0.33 (-1.43 to 0.77) 0.56
Total DAP 18-25 weeks gestation
Model 1 -0.05 (-0.12 to 0.03) 0.20 0.27 (-0.90 to 1.44) 0.65
Model 2 -0.05 (-0.13 to 0.02) 0.16 0.40 (-0.79 to 1.59) 0.51
Total DAP >25 weeks gestation
Model 1 -0.02 (-0.10 to 0.05) 0.54 0.27 (-0.86 to 1.40) 0.64
Model 2 -0.01 (-0.09 to 0.06) 0.71 0.32 (-0.84 to 1.47) 0.59
All dialkyl phosphate metabolite concentrations (nmol/g creatinine) and TSH values were log transformed.
N= 472 for TSH and n=477 for FT4.
Model 1 was adjusted for gestational age at blood sampling and creatinine. 
Model 2 was additionally adjusted for maternal age, parity, smoking and ethnicity, child sex, and season.
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Table S5. Variables used to calculate inverse probability of  attrition weights.
Variables Explored Included
Maternal educational level x x
Maternal ethnicity x
Maternal age x x
Maternal parity x x
Maternal alcohol use during pregnancy x
Maternal tobacco use during pregnancy x
Maternal body mass index x x
Household income during pregnancy x x
Marital status during pregnancy x
Child’s birth weight x
Gestational age at birth x x
Table S6. Associations between dialkyl phosphate metabolite concentrations and maternal thyroid 
function during pregnancy additionally adjusted for BMI, UICr, TPOAbs, fruit intake, or stan-
dardized weights.
  Mean TSH Mean FT4 Mean TT4
<18 weeks gestation β (95% CI) p β (95% CI) p β (95% CI) p
Total dialkyl phosphates
Model 1 0.00 (-0.04 to 0.04) 0.98 0.28 (-0.35 to 0.91) 0.38 -0.78 (-7.37 to 5.80) 0.82
Model 2 0.00 (-0.04 to 0.04) 0.98 0.33 (-0.32 to 0.97) 0.32 -1.89 (-8.58 to 4.80) 0.58
Model 3 0.00 (-0.04 to 0.04) 0.94 0.36 (-0.28 to 0.99) 0.27 -1.16 (-7.75 to 5.43) 0.73
Model 4 -0.01 (-0.05 to 0.03) 0.73 0.34 (-0.30 to 0.99) 0.29 -1.67 (-8.35 to 5.01) 0.62
Model 5 0.00 (-0.04 to 0.04) 0.94 0.31 (-0.32 to 0.94) 0.34 -1.69 (-8.30 to 4.93) 0.62
Dimethyl alkyl phosphates
Model 1 0.00 (-0.03 to 0.04) 0.82 0.19 (-0.4 to 0.79) 0.53 -1.61 (-7.86 to 4.65) 0.61
Model 2 0.00 (-0.04 to 0.04) 0.83 0.22 (-0.39 to 0.83) 0.48 -2.66 (-9.03 to 3.71) 0.41
Model 3 0.00 (-0.04 to 0.04) 0.89 0.25 (-0.35 to 0.85) 0.41 -1.88 (-8.14 to 4.38) 0.56
Model 4 0.00 (-0.04 to 0.04) 0.91 0.24 (-0.37 to 0.85) 0.44 -2.37 (-8.71 to 3.97) 0.46
Model 5 0.00 (-0.04 to 0.04) 0.87 0.21 (-0.39 to 0.81) 0.50 -2.41 (-8.69 to 3.87) 0.45
Diethyl alkyl phosphates
Model 1 -0.01 (-0.04 to 0.02) 0.39 0.19 (-0.27 to 0.64) 0.41 1.22 (-3.56 to 5.99) 0.62
Model 2 -0.02 (-0.05 to 0.01) 0.31 0.26 (-0.20 to 0.71) 0.27 0.58 (-4.20 to 5.37) 0.81
Model 3 -0.02 (-0.05 to 0.01) 0.29 0.27 (-0.19 to 0.72) 0.25 0.69 (-4.09 to 5.46) 0.78
Model 4 -0.02 (-0.05 to 0.01) 0.22 0.26 (-0.20 to 0.72) 0.27 0.51 (-4.30 to 5.32) 0.84
Model 5 -0.02 (-0.04 to 0.01) 0.31 0.24 (-0.21 to 0.69) 0.30 0.53 (-4.23 to 5.29) 0.83
All dialkyl phosphate metabolite concentrations (nmol/g creatinine) and TSH values were log transformed.
N= 710 for TSH, n=709 for FT4, and n=712 for TT4.
Model 1 was adjusted for all covariates indicated in model 2 (Table 2), and additionally adjusted for BMI.  
Model 2 was adjusted for all covariates in model 2 (Table 2), and additionally adjusted for UICr.
Model 3 was adjusted for all covariates in model 2 (Table 2), and additionally adjusted for TPOAbs.
Model 4 was adjusted for all covariates in model 2 (Table 2), and additionally adjusted for fruit intake.
Model 5 was adjusted for all covariates in model 2 (Table 2), and additionally adjusted for standardized weights.
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Table S7. Associations between dialkyl phosphate metabolite concentrations during pregnancy 
and cord blood thyroid hormone concentrations additionally adjusted for BMI, UICr, TPOAbs, 
fruit intake, or standardized weights.
  Mean TSH Mean FT4
Averaged across pregnancy β (95% CI) p β (95% CI) p
Total dialkyl phosphates
Model 1 -0.08 (-0.19 to 0.02) 0.11 0.21 (-1.44 to 1.85) 0.80
Model 2 -0.08 (-0.18 to 0.02) 0.13 0.16 (-1.49 to 1.80) 0.85
Model 3 -0.07 (-0.18 to 0.03) 0.15 0.27 (-1.35 to 1.90) 0.74
Model 4 -0.06 (-0.17 to 0.04) 0.23 0.22 (-1.44 to 1.88) 0.80
Model 5 -0.08 (-0.18 to 0.02) 0.14 0.28 (-1.34 to 1.90) 0.73
Dimethyl alkyl phosphates
Model 1 -0.08 (-0.18 to 0.02) 0.10 0.10 (-1.46 to 1.67) 0.90
Model 2 -0.08 (-0.18 to 0.02) 0.11 0.04 (-1.53 to 1.61) 0.96
Model 3 -0.07 (-0.17 to 0.02) 0.14 0.16 (-1.39 to 1.71) 0.84
Model 4 -0.06 (-0.16 to 0.04) 0.21 0.10 (-1.48 to 1.68) 0.90
Model 5 -0.08 (-0.17 to 0.02) 0.12 0.17 (-1.37 to 1.72) 0.82
Diethyl alkyl phosphates
Model 1 -0.04 (-0.12 to 0.04) 0.31 0.34 (-0.97 to 1.65) 0.61
Model 2 -0.04 (-0.12 to 0.05) 0.39 0.35 (-0.94 to 1.64) 0.60
Model 3 -0.03 (-0.11 to 0.05) 0.43 0.40 (-0.89 to 1.69) 0.54
Model 4 -0.03 (-0.11 to 0.06) 0.53 0.37 (-0.94 to 1.67) 0.58
Model 5 -0.03 (-0.11 to 0.05) 0.42 0.36 (-0.93 to 1.64) 0.58
Average dialkyl phosphate metabolite concentrations (nmol/g creatinine) were computed by the geometric mean of 
the three urine collection phases.
All dialkyl phosphate metabolite concentrations and TSH values were log transformed.
N= 472 for TSH and n=477 for FT4.
Model 1 was adjusted for all covariates indicated in model 2 (Table 3), and additionally adjusted for BMI.
Model 2 was adjusted for all covariates in model 2 (Table 3), and additionally adjusted for UICr.
Model 3 was adjusted for all covariates in model 2 (Table 3), and additionally adjusted for TPOAbs.
Model 4 was adjusted for all covariates in model 2 (Table 3), and additionally adjusted for fruit intake.
Model 5 was adjusted for all covariates in model 2 (Table 3), and additionally adjusted for standardized weights.
Table S8. Associations between dialkyl phosphate metabolite concentrations (nmol/L) and mater-
nal thyroid function during pregnancy.
  Mean TSH Mean FT4 Mean TT4
<18 weeks gestation β (95% CI) p β (95% CI) p β (95% CI) p
Total dialkyl phosphates
Model 1 -0.02 (-0.05 to 0.01) 0.16 0.23 (-0.26 to 0.72) 0.35 1.93 (-3.20 to 7.06) 0.46
Model 2 -0.02 (-0.05 to 0.01) 0.20 0.27 (-0.21 to 0.75) 0.27 1.49 (-3.53 to 6.50) 0.56
Dimethyl alkyl phosphates
Model 1 -0.02 (-0.05 to 0.01) 0.24 0.16 (-0.31 to 0.63) 0.51 1.44 (-3.50 to 6.39) 0.57
Model 2 -0.02 (-0.05 to 0.01) 0.29 0.21 (-0.25 to 0.67) 0.37 0.85 (-4.00 to 5.70) 0.73
Diethyl alkyl phosphates
Model 1 -0.02 (-0.05 to 0.00) 0.06 0.23 (-0.17 to 0.63) 0.26 2.13 (-2.06 to 6.32) 0.32
Model 2 -0.02 (-0.05 to 0.00) 0.06 0.23 (-0.16 to 0.62) 0.24 2.07 (-2.00 to 6.14) 0.32
All dialkyl phosphate metabolite concentrations (nmol/L) and TSH values were log transformed.
N= 710 for TSH, n=709 for FT4, and n=712 for TT4.
Model 1 was adjusted for gestational age at blood sampling.
Model 2 was additionally adjusted for maternal age, parity, smoking and ethnicity, child sex, and season.
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Table S9. Associations between dialkyl phosphate metabolite concentrations (nmol/L) during 
pregnancy and cord blood thyroid hormone concentrations 
  Mean TSH Mean FT4
Averaged during pregnancy β (95% CI) p β (95% CI) p
Average total dialkyl phosphates
Model 1 -0.04 (-0.11 to 0.04) 0.38 -0.47 (-1.69 to 0.76) 0.45
Model 2 -0.01 (-0.09 to 0.07) 0.77 -0.57 (-1.83 to 0.68) 0.37
Average dimethyl alkyl phosphates
Model 1 -0.04 (-0.11 to 0.04) 0.34 -0.47 (-1.65 to 0.71) 0.43
Model 2 -0.01 (-0.09 to 0.06) 0.71 -0.59 (-1.80 to 0.63) 0.34
Average diethyl alkyl phosphates
Model 1 -0.01 (-0.08 to 0.06) 0.86 -0.19 (-1.26 to 0.87) 0.72
Model 2 0.00 (-0.07 to 0.07) 0.97 -0.26 (-1.34 to 0.82) 0.63
Average dialkyl phosphate metabolite concentrations (nmol/L) were computed by the geometric mean of the three
urine collection phases.
All dialkyl phosphate metabolite concentrations and TSH values were log transformed.
N= 472 for TSH and n=477 for FT4.
Model 1 was adjusted for gestational age at blood sampling.  
Model 2 was additionally adjusted for maternal age, parity, smoking and ethnicity, and child sex.









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Prenatal exposure to organophosphate 
pesticides and brain morphology 
and white matter microstructure in 
preadolescents
van den Dries, M. A., Lamballais, S., El Marroun, H., Pronk, A., Spaan, S., 
Ferguson, K. K., Longnecker, M. P., Tiemeier, H., & Guxens, M. (2020). 




Background: Prenatal exposure to organophosphate (OP) pesticides associate with impaired 
neurodevelopment in humans and animal models. However, much uncertainty exists 
about the brain structural alterations underlying these associations. The objective of this 
study was to determine whether maternal OP pesticide metabolite concentrations in urine 
repeatedly measured during gestation are associated with brain morphology and white matter 
microstructure in 518 preadolescents aged 9–12 years.
Method: Data came from 518 mother–child pairs participating in the Generation R Study, a 
population-based birth cohort from Rotterdam, the Netherlands. Maternal urine concentrations 
were determined for 6 dialkylphosphates (DAPs) including 3 dimethyl (DM) and 3 diethyl 
(DE) alkyl phosphate metabolites, collected at early, mid, and late pregnancy. At child’s age 
9–12 years, magnetic resonance imaging was performed to obtain T1-weighted images for 
brain volumes and surface-based cortical thickness and cortical surface area, and diffusion 
tensor imaging was used to measure white matter microstructure through fractional anisotropy 
(FA) and mean diffusivity (MD). Linear regression models were fit for the averaged prenatal 
exposure across pregnancy.
Results: DM and DE metabolite concentrations were not associated with brain volumes, 
cortical thickness, and cortical surface area. However, a 10-fold increase in averaged DM 
metabolite concentrations across pregnancy was associated with lower FA (B = −1.00, 95%CI 
= −1.80, −0.20) and higher MD (B = 0.13, 95%CI = 0.04, 0.21). Similar associations were 
observed for DE concentrations.
Conclusions: This study provides the first evidence that OP pesticides may alter normal 
white matter microstructure in children, which could have consequences for normal 
neurodevelopment. No associations were observed with structural brain morphology, including 
brain volumes, cortical thickness, and cortical surface area.




Organophosphate (OP) pesticides are chemical agents often used in agriculture to protect 
crops against insects. At present, five billion pounds of pesticides are being applied 
worldwide and approximately 33% are OP pesticides.1 Similarly, between 1998 and 
2008 one third of the insecticides used in the Netherlands were OP pesticides.2 In the 
past decade, the use of OP pesticides has been declining in both the Netherlands and the 
European Union (EU) due to stricter legislations. However, several OP pesticides such 
as malathion are currently approved by the EU and OP pesticide residues are frequently 
detected on tested vegetables and fruits coming from importation.3,4
Since OP pesticide residues may persist on or in food after crop harvesting,5 there is 
an increasing concern about their potential harmful health effects. The exposure to OP 
pesticides generally occurs through the consumption of food.6 However, residential 
exposure can also occur through the use of insecticides in and around the house or by 
living in close proximity to agricultural lands were OP pesticides are being applied.7-12
It is well established that the exposure to high concentrations of OP pesticides is neurotoxic 
to both humans and animals.5,13 However, evidence exist that OP pesticide exposure at 
fairly low-dose levels may also have a negative health effect.14,15 OP pesticides are able to 
pass the placental and the blood-brain barrier16 and, during gestation, the development 
of the human brain is especially susceptible to neurotoxic effects.17 Therefore, pregnancy 
exposure to low-dose levels of OP pesticides might affect fetal normal brain development.
Although several epidemiological studies have reported associations between pregnancy OP 
pesticide exposure and offspring’s neuropsychological development,18 much uncertainty 
exists about the brain structural alterations underlying these associations. Magnetic 
resonance imaging (MRI) is a useful instrument for addressing these knowledge gaps and 
can help identify the associations between neurotoxic exposures and brain development.19 
In humans, altered brain morphology and white matter microstructure is associated with 
impaired cognition, behavior problems, and neurodevelopmental disorders.20-23 So far, 
only few animal studies and one small epidemiological study have investigated the effect 
of OP pesticide exposure on morphological brain measures. Experimental animal studies 
showed that OP pesticide exposure was associated with smaller brain volumes, both 
thinning and thickening of the cortex, and alterations of white matter microstructure.24-26 
In humans, prenatal exposure to the OP pesticide chlorpyrifos measured in cord blood 
was associated with thinner cortices and alterations in cortical surface area in 40 children 
at 6-11 years of age.27 However, this previous human study only analyzed a specific OP 
pesticide, was restricted to a small sample size, and was unable to investigate the exposure 
across the entire pregnancy. Moreover, no previous epidemiological study investigated 
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the association between prenatal OP pesticide exposure and white matter microstructure, 
which has been observed in a previous animal study.24
Therefore, the objective of this study was to determine whether maternal OP pesticide 
metabolite concentrations in urine repeatedly measured during gestation are associated 
with brain morphology and white matter microstructure in 518 preadolescents at 9–12 
years of age. Understanding the association between prenatal OP pesticide exposure and 
brain morphology and white matter microstructure may help explain the association 
between pregnancy OP pesticide exposure and offspring’s neuropsychological development 
observed in previous studies. Further, findings of the present study may assist in future 
policies regarding the regulation of OP pesticide application.
Materials and methods
Study population and follow-up
This research was embedded in the Generation R Study, a population-based cohort 
from early fetal life onwards in Rotterdam, the Netherlands, which has been described 
in detail previously.28 Figure  S1 presents a flowchart of this study. Briefly, all pregnant 
women who lived in the study area in Rotterdam, the Netherlands and were expected 
to have a delivery between 2002 and 2006 were eligible. A total of 8879 women were 
enrolled during pregnancy. A random sample of 800 mother-child pairs were selected for 
assessment of OP pesticide metabolites among the 1449 that provided three spot urine 
samples during pregnancy and had child’s neurodevelopmental data at postnatal visits. 
Of those, 518 children were included in the present study as they had good quality data 
on MRI measurements at 9–12 years of age. Human subjects review for the procedure 
of this study was carried out and approved by the Medical Ethics Committee of the 
Erasmus Medical Center, Rotterdam (IRB Registration no.: IRB00001482, MEC-2012-
165, MEC-2007-413, MEC, 217.595/2002/202, and MEC 198.782.2001.31). Written 
informed consent for the children and mothers was provided by the mothers.
Urine collection and analysis of  OP pesticide metabolites
A more detailed description of urine specimen collection and measurement of OP pesticide 
metabolites have been published previously29 and can be found in the supplement (Methods 
S1). Briefly, 6 non-specific urinary dialkylphosphate (DAP) metabolites of OP pesticides 
were measured from urine samples collected at <18, 18–25, and >25 weeks of gestation 
by gas chromatography coupled with tandem mass spectrometry (GC–MS/MS). These 
include 3 dimethyl alkyl phosphate (DM) and 3 diethyl alkyl phosphate (DE) metabolites. 
Creatinine concentrations were also measured in order to correct for urinary dilution. All 
urine samples had detectable concentrations of most metabolites. The intraclass correlation 
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of DAP metabolite concentrations was weak for a single concentration (0.22–0.26) and 
moderate for the average of the 3 concentrations (0.51–0.54).30
Magnetic resonance imaging
Details of the neuroimaging acquisition and processing can be found in the supplemental 
material (Methods S2). The global brain metrics derived from T1-weighted images included 
total brain volume, cerebral and cerebellar white and grey matter volume, and subcortical 
grey matter volume. Additionally, we focused on the corpus callosum and the subcortical 
regions: amygdala, caudate nucleus, hippocampus, pallidum, putamen, nucleus accumbens 
and the thalamus.31 Surface-based thickness and surface area maps were made of the 
cerebral cortex.31 Diffusion tensor imaging (DTI) was used to fit diffusion tensors at each 
voxel and fractional anisotropy (FA) and mean diffusivity (MD) were computed.32 Twelve 
major white matter tracts were identified via probalistic tractography with the FSL plugin 
AutoPtx.33,34 These included the forceps minor and major, and the bilateral tracts of the 
cingulum bundle, corticospinal tract, the inferior and superior longitudinal fasciculi, and 
the uncinate fasciculus. The mean FA and MD per tract, weighted by the connectivity 
distribution, were then computed. A confirmatory factor analysis was performed to model 
a single latent FA and MD measure across the 12 tracts, which represented global FA and 
MD across the brain.35 Global FA indicates the tendency for preferential water diffusion 
in white matter tracts. A lower FA score indicates in general that the comprising axons are 
less densely packed and the directionality of the water diffusion is not uniformly directed 
as compared with well-organized tracts. Global MD describes the magnitude of average 
water diffusion in all directions within brain tissue, with higher values generally occurring 
in white matter tracts that show a less well-organized structure.36,37
Potential confounders
Potential adjustment variables were selected a priori defined as the minimal sufficient 
adjustment set with a Directed Acyclic Graph (DAG) using the Dagitty software.38 The DAG 
was based on previous studies of prenatal OP pesticide exposure and neurodevelopment and 
on biologically plausible covariate–exposure and covariate–outcome associations observed 
in our data (see Fig. S2). We further included adjustment variables that are ancestors of 
the exposure and ancestors of the outcome to increase precision. The adjustment variables 
were household income [less than 1200 euro/month (i.e., less than the social security level 
of the Netherlands), 1200–2000 euro/month, more than 2000 euro/month], maternal 
highest achieved level of education [low (less than 3 years of high school), intermediate (3 
or more years of secondary education), and high (university degree or higher vocational 
training)], maternal ethnical background (Dutch, other Western, and non-Western), 
maternal age at enrolment, marital status (married/living with partner versus single), 
maternal parity (0, 1, or 2 or more children), maternal smoking habits during pregnancy 
(none, only until pregnancy known, or continued after pregnancy known), maternal 
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gestational alcohol use [none, only until pregnancy known, continued infrequently (<1 
glass/week) or continued regularly (≥1 glass/week)], maternal pre-pregnancy body mass 
index (BMI) (kg/m2), maternal IQ (assessed when the mother-child pairs visited the 
research center for the 6-year examination and measured by using the computerized Ravens 
Advanced Progressive Matrices Test, set I,39 child sex, and the child age at the MRI scan.
Statistical methods
Total DM (nmol/l) was created by summing dimethylphosphate, dimethylthiophosphate, 
and dimethyldithiophosphate metabolite concentrations. Total DE (nmol/l) was defined as 
the sum of diethylphosphate, diethylthiophosphate, and diethyldithiophosphate metabolite 
concentrations. Total DAP (nmol/l) was created by summing the 6 metabolites. These 
concentrations were creatinine adjusted (nmol/g creatinine) and transformed using a log 
transformation (base 10) to improve linearity of the dose-response relation and model fit. 
Few concentrations were missing because of an inadequate sample or machine error. We 
therefore imputed missing concentrations (<1%) and missing confounder information 
10 times by using the Multivariate Imputation by Chained Equations (MICE) package 
in R.40,41 We included total brain volume and global FA in the imputation procedure as 
predictors, but we did not impute them.
As a first step, we applied linear regression to examine the association of averaged DM, 
DE, and DAP concentrations over pregnancy with brain volumes. To account for multiple 
testing (14 tests for each exposure), we applied the false discovery rate (FDR) correction. 
As a second step, we investigated metabolite concentrations – brain volume associations 
for each exposure time point (early, mid, and late pregnancy) separately. We performed 
this second step for the identification of possible periods of susceptibility and to have 
the ability to compare our findings with studies that only used one urine sample during 
gestation to measure the exposure to OP pesticides. These analyses were also corrected 
for multiple testing using the FDR correction. The same multiple linear regressions were 
applied for the DAP – global white matter tract (FA and MD) associations. Post-hoc 
analyses were run on the 12 major individual white matter tracts when the analysis yielded 
a significant association between prenatal DAP metabolite concentrations and global 
white matter tracts. We explored whole-brain vertex-wise statistics using the QDECR 
R package (https://qdecr.com) for total DM, DE, and DAP metabolite concentrations 
in association with local cortical thickness and cortical surface area. Vertex-wise analyses 
were corrected for multiple testing by the application of Gaussian Monte Carlo null-Z 
simulations (The cluster-forming threshold defined as p < 0.001). Next, these analyses were 
also corrected by applying a Bonferroni adjustment for the analyses of both hemispheres.
All models were adjusted for potential confounders described above. Additionally, we 
adjusted models of subcortical and cerebellar volumes for intracranial volume to ascertain 
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relativity to head size. Models of the other volumes were not adjusted for intracranial 
volume as they were highly correlated (between r = 0.81 and r = 0.93).
As sensitivity analyses, first, we investigated potential effect modification by sex via 
interaction terms (P-value for interaction<0.05) to compare our results with previous 
studies who observed sex specific effects.27,42 Second, we applied inverse probability 
weighting to adjust all models for loss to follow-up and to deal with potential selection 
bias because participants included in this study were older, had higher educational level, 
and more frequently Dutch as compared to the complete Generation R Study cohort.29 
Third, because diet and the intake of healthy nutrients may confound the association 
between prenatal OP pesticide exposure (e.g., residues on fruits)29 and brain development 
(e.g., healthy nutrients) (Figure S2), we performed a sensitivity analyses in which we 
additionally adjusted for maternal fruit and vegetables intake. The consumption of fruit 
and vegetables was assessed in the first trimester using a modified version of a validated 
food frequency questionnaire and was adjusted for energy intake.43
Results
Descriptive analysis
The median age of the mothers at enrolment was 31.2 years (IQR = 5.4) and the median 
age of the child at MRI assessment was 9.8 years (IQR = 0.3) (Table 1). The majority 
of mothers participating in this study were ethnically Dutch (61.4%), were nulliparous 
(66.3%), were none smokers (79.1%), had a high educational level (60.2%), and had 
a high income (73.6%). Total DAP metabolite concentrations comprised mostly DM 
metabolite concentrations (Table 2). The median nmol/g creatinine concentrations were 
comparable across the three sampling periods. The median total brain volume was 1215 
cm3 (IQR = 138 cm3) and median FA was 0.0 (IQR = 2.3) (Table S1).
OP pesticide metabolite concentrations and brain volume
No associations were observed between averaged maternal DM and DE metabolite 
concentrations and all brain volumes (Table 3). When specific pregnancy periods were 
analyzed separately, higher DM and DE metabolite concentrations at >25 weeks of gestation 
were associated with lower thalamus volume, higher DM metabolite concentration at 
18–25 weeks of gestation was associated with higher putamen volume, and higher DE 
metabolite concentrations at >25 weeks of gestation were associated with lower cerebellum 
cortex volume (Table S2). However, these associations did not remain after correction for 
multiple testing. The results for the total DAP metabolite concentrations were similar to 
the results observed for the DM and DE metabolite concentrations (Table S3).
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Table 1. Demographic and lifestyle characteristics of  518 mother-child pairs from the Generation 
R Study population.
Median (25th, 75th percentile) or %
Maternal characteristics

















Non-verbal IQ 100.0 (90.0, 107.0)
Missing, n 7








No smoking during pregnancy 79.1%
Until pregnancy recognized 8.8%
Continued during pregnancy 12.1%
Missing, n 40
Alcohol consumption during pregnancy
No consumption during pregnancy 33.2%
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Table 2. Descriptive statistics of  pregnancy DAP metabolite concentrations (n=518).
nmol/g creatinine nmol/l
min p25 p50 p75 max min p25 p50 p75 max
 DM metabolites in 
nmol/g creatinine a
< 18 weeks 6.6 153.6 255.3 420.4 6106.5 0.9 96.1 183.4 346.7 2627.3
18 – 25 weeks 24.8 184.2 272.1 433.6 2444.1 7.6 99.6 190.8 336.4 2396.8
> 25 weeks 29.2 165.8 248.9 397.6 2857.8 10.5 103.9 194.2 326.6 3300.5
Averaged 26.3 191.3 269.3 361.8 1381.0 14.7 118.5 179.6 289.4 1105.1
 DE metabolites in 
nmol/g creatinine b
< 18 weeks 0.0 25.3 46.4 86.3 3030.5 0.0 16.0 31.3 66.2 6818.6
18 – 25 weeks 3.3 25.2 43.4 79.6 624.3 0.6 13.9 30.1 58.4 1093.4
> 25 weeks 4.1 22.0 43.9 81.5 671.4 1.1 14.7 31.5 64.4 538.2
Averaged 2.6 29.4 44.3 68.9 601.4 3.2 19.3 30.7 49.8 407.3
DAP metabolites in 
nmol/g creatinine c
< 18 weeks 15.4 197.3 321.4 521.7 6444.5 6.3 119.6 224.7 422.2 7798.7
18 – 25 weeks 41.0 222.2 323.0 519.8 2817.0 10.0 123.2 235.9 406.1 3056.7
> 25 weeks 42.1 204.1 308.0 495.7 3003.1 15.2 127.2 228.8 403.4 3332.6
Averaged 36.7 234.6 329.9 441.2 1818.8 30.2 144.4 220.7 348.9 1259.3
Abbreviations: Min=minimum, p25=25th percentile, P50=median (50th percentile), p75=75th per-
centile, max=maximum, DM= Dimethyl alkyl phosphates, DE= Diethyl alkyl phosphates, DAP= Total 
dialkyl phosphates.
a. DM is the sum of dimethylphosphate (DMP), dimethylthiophosphate (DMTP), and dimethyldithio-
phosphate (DMDTP).
b. DE is the sum of diethylphosphate (DEP), diethylthiophosphate (DETP), and diethyldithiophospha-
te (DEDTP).
c. DAP is the sum of DMDTP, DMTP, DMP, DEDTP, DETP, and DEP.
OP pesticide metabolite concentrations and white matter microstructure
Table 3 presents the association between averaged DM and DE metabolite concentrations 
and white matter microstructure. We observed an association between a 10-fold increase 
in averaged DM and DE metabolite concentrations and lower FA [B = −1.00 (95%CI: 
−1.80, −0.20) and B = −0.63 (95%CI: −1.24, −0.02), respectively]. Next, a 10-fold 
increase in averaged DM and DE metabolite concentrations were associated with higher 
MD [B = 0.13 (95%CI: 0.04, 0.21) and B = 0.06 (95%CI: 0.00, 0.13), respectively]. 
Regarding the specific pregnancy periods, we observed similar associations for DM and DE 
concentrations at <18 weeks and at 18–25 weeks of gestation (Table S3). The associations 
between maternal DAP metabolite concentrations and white matter microstructure were 
comparable to the results of DM and DE metabolite concentrations (Table S3).
Regarding the individual 12 major white matter tracts, we observed that DM metabolite 
concentrations averaged across pregnancy were associated with lower FA and higher 
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MD in most of the tracts except for the uncinate fasciculus tract of left hemisphere, the 
forceps major, and the corticospinal tract of the right hemisphere (Fig. 1 and Table S4). 
We observed that higher averaged DE metabolite concentrations were associated with 
lower FA in the superior longitudinal fasciculus tract of the left hemisphere and the 
corticospinal tracts, and with higher MD in the cingulate gyrus of the cingulum tract 
of the left hemisphere, the forceps minor tract, and the inferior longitudinal fasciculus 
tract of the left hemisphere (Fig. 1 and Table S5). The results of the total DAP metabolite 
Table 3. Adjusted a association between averaged log10 transformed maternal concentrations of  
DM b and DE c metabolite concentrations in nmol/g creatinine and brain volumes (n=441) and 
white matter microstructure (n=474) assessed at child age 10 years. 
Averaged DM metabolite 
concentrations in nmol/g 
creatinine
Averaged DE metabolite 
concentrations in nmol/g 
creatinine
B 95%CI B 95%CI
Brain volumes
Total brain 12.81 -26.31 to 51.92 0.22 -28.98 to 29.42
Total gray 4.69 -18.75 to 28.13 -3.38 -20.88 to 14.12
Subcortical gray matter 0.26 -1.53 to 2.04 -0.69 -2.03 to 0.65
Cerebral white matter 8.16 -9.57 to 25.90 4.27 -8.98 to 17.53
Thalamus d -0.36 -0.74 to 0.02 -0.18 -0.47 to 0.11
Caudate d 0.18 -0.18 to 0.55 -0.11 -0.38 to 0.16
Putamen d 0.42 0.00 to 0.85 -0.01 -0.33 to 0.31
Pallidum d 0.05 -0.10 to 0.20 -0.05 -0.16 to 0.06
Hippocampus d -0.10 -0.35 to 0.16 0.02 -0.17 to 0.21
Amygdala d 0.05 -0.08 to 0.18 0.05 -0.05 to 0.15
Nucleus accumbens d 0.00 -0.07 to 0.07 0.00 -0.05 to 0.06
Cerebellum cortex d -2.68 -6.51 to 1.15 -2.30 -5.16 to 0.57
Cerebellar white matter d -0.08 -1.08 to 0.91 -0.46 -1.20 to 0.28
Corpus callosum d -0.06 -0.27 to 0.16 -0.01 -0.17 to 0.15
White matter microstructure 
Global FA -1.00 -1.80 to -0.20 -0.63 -1.24 to -0.02
Global MD 0.13 0.04 to 0.21 0.06 0.00 to 0.13
Abbreviations: DM= Dimethyl alkyl phosphates, DE= Diethyl alkyl phosphates, FA= fractional anisot-
ropy, MD= mean diffusivity
a. Adjusted for age of child during the magnetic resonance imaging assessment and sex of child, and 
maternal age, ethnicity (Dutch, other-western, and non-western), education (low, intermediate, and 
high), income (low, middle, and high), marital status (married/living with partner and single), alcohol 
consumption during pregnancy (no alcohol consumption during pregnancy, alcohol consumption until 
pregnancy was known, occasionally alcohol consumption during pregnancy, and frequently alcohol con-
sumption during pregnancy), body mass index, parity (0, 1, and 2+), and smoking during pregnancy 
(no smoking during pregnancy, smoked until pregnancy was known, and smoked during pregnancy).
b. DM is the sum of dimethylphosphate, dimethylthiophosphate, and dimethyldithiophosphate.
c. DE is the sum of diethylphosphate, diethylthiophosphate, and diethyldithiophosphate.
d. Additionally adjusted for intracranial volume.
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concentrations were also almost identical to the results observed for the DM and DE 
metabolite concentrations (Table S6).
OP pesticide metabolite concentrations and cortical thickness and cortical 
surface area
We did not find any evidence of an association between prenatal DM, DE, or DAP 
metabolite concentrations and cortical thickness and cortical surface area using whole-
brain vertex-wise analyses (data not shown).
Sensitivity analyses
Effect modification by sex was not observed in the association between averaged DAP 
metabolite concentrations with cortical and subcortical volumes or with white matter 
microstructure (Table S7). When models were re-run correcting for the potential selection 
bias using inverse probability weighting, results were similar to the main analyses (Table S8). 
Of note, a 10-fold increase in averaged DAP metabolite concentrations was significantly 
associated with a 0.50 (95%CI = −0.89, −0.11) decrease in thalamus volume, but the 
result did not survive the multiple testing correction. Finally, the results in which we 
additionally adjusted for maternal diet were similar to the main results (Table S9).
Figure 1. The white matter tracts of global fractional anisotropy (FA) and global mean diffusivity (MD) that 
are associated (blue= negative, green = positive) with <18 weeks, 18-25 weeks and averaged maternal dimethyl 
(DM) and diethyl (DE) alkyl phosphate metabolite concentrations in nmol/g creatinine. CGC= Cingulum 
bundle, CST= corticospinal tract, ILF= inferior longitudinal fasciculus, SLF= superior longitudinal fasciculus, 




In this population-based study, we observed that OP pesticide metabolite concentrations 
measured during pregnancy were not associated with brain morphological measures 
including brain volumes, cortical thickness, and cortical surface area in pre-adolescents 
at 9–12 years of age. However, we showed that higher prenatal exposure to OP pesticides, 
in particular during early- and mid-pregnancy, was associated with lower FA and higher 
MD, generally considered as indicators for atypical white matter microstructure. When 
we explored the specific white matter tracts, we observed that OP pesticide exposure was 
associated with projection, association, limbic system, and callosal fibers.
Although prior studies have noted the importance of the use of neuroimaging tools to 
address existing research gaps by identifying structural neurotoxic effects of prenatal OP 
pesticide exposure on the brain,19 only one small epidemiological study has investigated 
this research question.27 This study observed that prenatal exposure to chlorpyrifos, which 
devolves into the DE metabolites diethylphosphate and diethylthiophosphate,44 was 
predictive of enlargement of the cortical surface in several areas including superior and 
middle temporal gyrus, post-central gyrus, superior frontal gyrus, cuneus and precuneus, 
and gyrus rectus.27 Furthermore, increased exposure was associated with lower cortical 
thickness of frontal, temporal, and parietal regions. In contrast to these findings, no 
evidence of an association with cortical surface area and cortical thickness was observed 
in our study. The inconsistency in the results may be explained by the differences in OP 
pesticide exposure, in exposure assessment methodology, or in study populations. Rauh 
et al. (2012) measured a single OP pesticide chlorpyrifos in cord blood, while in our 
study we measured DAP metabolites at early-, mid-, and late-pregnancy in urine as a 
biomarker of OP pesticide exposure. DAP metabolites provide non-specific data about the 
total exposure to several OP pesticides instead of the exposure to a single OP pesticide. 
Mothers in the current study were most likely exposed to a combination of different OP 
pesticides that also produce DE metabolites. Of all the insecticides that were applied in 
2004 in the Netherlands, 32% were OP pesticides that produce DM metabolites and 
only 1% were pesticides that generate DE metabolites.2 Of the latter, the OP pesticide 
chlorpyrifos accounted for 1/3 of the total generated DE metabolites. This may suggest 
that exposure to chlorpyrifos may have been lower in our population. However, between 
2004 and 2006 OP pesticide residues of chlorpyrifos coming from importation have 
been detected on tested vegetables and fruits.3 Of note, DAP metabolite concentrations 
in this study are higher compared to most other birth-cohort studies.29 Other differences 
between the studies relate to socio-economic status, as the population in the previous 
study was socially disadvantaged. It is conceivable that in these populations unmeasured 
background risk factors related to both chlorpyrifos exposure and brain morphology 
might lead to potential residual confounding.
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To our knowledge, this is the first epidemiological study that investigated prenatal exposure 
to OP pesticides and white matter microstructure. In preadolescents aged 9–12 years, the 
development of many white matter tracts, such as projection of the prefrontal cortex, is 
still ongoing.45 Altered maturation of white matter microstructure might therefore result 
in neurodevelopmental problems with long-term clinical implications. Studies have found 
that altered white matter microstructure is associated with impaired cognition, behavior 
problems, and neurodevelopmental disorders.20 We observed that increased OP pesticide 
exposure during pregnancy was associated with lower FA and higher MD of white matter 
and that the direction of the associations was consistent across most specific tracts. To 
help interpret these results we calculated the association of child age with white matter 
microstructure, as age is a robust determinant of the latter. A one-year increase in age was 
associated with 0.88 (95%CI = 0.35, 1.42) increase in global FA and a 0.10 (95%CI = 
−0.16, −0.05) decrease in global MD. This implies that, for example, a 10-fold increase 
in averaged DM concentrations during pregnancy has a similar effect as being 1.1 years 
younger in terms of white matter microstructure.
Global FA and MD are indicators of white matter microstructure.36 FA describes 
the propensity for enhanced water diffusion in the white matter tracts whereas MD 
expresses the scale of average water diffusion in every direction within brain tissue.36 
A lower FA and higher MD can be a result of several reasons including lower packing 
of axons, higher membrane permeability, disturbance of internal axonal structure, and 
decreased myelination.45 Animal studies also observed similar associations in white matter 
microstructure in relationship with exposure to OP pesticides. Prenatally chlorpyrifos 
exposed guinea pigs had lower FA and higher MD within the corpus callosum and the 
amygdala and rats postnatal (day 1 until day 6) exposed to chlorpyrifos had a decreased 
expression of the myelin-associated glycoprotein in the brain which is crucial for the 
preservation of the mature myelinated unit.24,46 Moreover, chlorpyrifos exposure reduces 
the polymerization of tubulin.47 Tubulin is an protein which plays an important role in 
the creation of microtubules which are needed for the preservation of the structural and 
functional integrity of axons.47,48 In our study we further found an association between OP 
pesticide exposure and white matter microstructure specific tracts present in projection, 
association, limbic system, and callosal fibers. Further work is required to confirm our 
observed association between prenatal OP pesticide exposure and altered white matter 
microstructure in children.
We observed that the first and second trimester (<18 weeks, and 18–25 weeks) OP 
pesticide exposure were driving the association with lower FA and higher MD. White 
matter growth starts in early gestation and myelination begins in the second trimester.17,49,50 
OP pesticide exposure has been shown to disrupt the expression of genes and proteins 
important for the myelination.51 During the second trimester, the development of white 
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matter is especially dependable on signaling pathways such as extracellular ligands, secreted 
molecules, and transcriptional regulations.52 Thus, OP pesticide exposure may alter the 
courses of later brain development by influencing axonal growth adhering and group 
formation and white matter myelination via gene expression alteration.
This study has several limitations. First, urinary DAP metabolite concentrations provide 
information regarding the joint exposure to multiple OP pesticides instead of providing 
specific information regarding the exact OP pesticide exposure.53-55 It is therefore unknown 
to which specific OP parent pesticide(s) our study population was exposed. However, the 
use of DAP metabolites as biomarkers of OP pesticides is also a strength because it allows 
for the identification and comparison of OP pesticide exposure levels within and between 
study populations.56 Second, DAP metabolites are characterized by a short half-life and are 
excreted in urine within one or two days. This implies that the biomarker concentrations 
may differ from day-to-day within each subject as a consequence of variable contact with 
exposure sources (e.g., variable diet patterns) and result in (within-subject) temporal 
variability.6,57-59 Although we included 3 urine spot samples which is more frequent than 
most other studies exploring the association between prenatal OP pesticide exposure 
and neurodevelopment, it would be preferable to collect more urine specimens during 
pregnancy to reduce the measurement error and attenuation bias caused by the within-
subject variability.60 Third, this study was restricted by the nonappearance of information 
on possible residential pesticide use by the participant, another household member, or 
a professional exterminator. Participants in this study might have been exposed through 
the use of residential products which may contain OP pesticides such as insecticides 
for the lawn and garden (e.g., emulsifiable concentrate), insecticides for house plants, 
residential pest products (e.g., fly control insecticides and moth killer cassettes), and flea 
products for pets. Although the use of products that contain OP pesticides is unlikely to 
confound the association between prenatal OP pesticide exposure and brain morphology, 
such information would be helpful in determining the exact sources of the exposure. The 
Generation R Study is representative of an urban population of which the exposure to 
OP pesticides most likely occurs through diet.29 The results of this study may therefore 
not be fully generalizable to semi-urban and rural areas in the Netherlands where the 
source of OP pesticide exposure could be different. Finally, this study was limited by 
the absence of information on exposure to other types of pesticides. While we included 
many possible confounders in our analyses, we cannot eliminate the existence of potential 
residual confounding in this study as a consequence of unidentified background risk 
factors that are predictive of OP pesticide exposure and brain development.
The present study has a number of strengths. This study has a large sample size and the 
availability of many potential confounders such as the IQ of the mother and socio-economic 
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factors. Further, the scanning procedure in which all brains were scanned using the same 
MRI scanner and software to reduce potential measurement error is another strength.
In conclusion, prenatal OP pesticide exposure was not associated with brain volumes, 
cortical thickness, and cortical surface area in preadolescents aged 9–12 years. However, 
we found that prenatal OP pesticide exposure was associated with lower FA and higher 
MD of white matter, and that early and mid-pregnancy exposure were driving these 
associations. These findings suggest that prenatal exposure to worldwide commonly 
applied OP pesticides may alter normal white matter microstructure development 
in children, which could have consequences for normal neurodevelopment. Besides 
structural brain changes, functional brain alteration may also provide opportunities to 
deepen the understanding of the effects of prenatal exposure to OP pesticides on the 
brain, as a recent study has done.42 Future studies on brain imaging are warranted to 
reproduce our findings, as well as to investigate the mediating role of the structural and 
functional brain alterations in the association between prenatal exposure to OP pesticides 
and neuropsychological development. If the findings of this study are confirmed, public 
health policies that aim towards stricter regulation and control of OP pesticides application 
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Maternal spot urine specimens were collected during early, middle, and late pregnancy 
(<18, 18-25, >25 weeks of gestational age, respectively). Details of urine specimen 
collection have been described elsewhere.1 Briefly, all urine samples were collected between 
8 am and 8 pm in 100 mL polypropylene urine collection containers that were kept for a 
maximum of 20 h in a cold room (4°C) before being frozen at −20°C in 20 mL portions 
in 25 mL polypropylene vials.
Measurements of 6 non-specific urinary dialkylphosphate (DAP) metabolites of OP 
pesticides were conducted at the Institut National de Santé Publique (INSPQ) in 
Quebec, Canada, using gas chromatography coupled with tandem mass spectrometry 
(GC–MS/MS).2 More details of DAP metabolite measurements can be found elsewhere.3 
Briefly, 3 dimethyl alkyl phosphates (DM) metabolites (dimethylphosphate (DMP), 
dimethylthiophosphate (DMTP), and dimethyldithiophosphate (DMDTP)) and 3 
diethyl alkyl phosphates (DE) metabolites (diethylphosphate (DEP), diethylthiophosphate 
(DETP), and diethyldithiophosphate (DEDTP)) were measured. The limit of detection 
(LOD) was 0.26 μg/l for DMP, 0.40 for DMTP, 0.09 for DMDTP, 0.50 for DEP, 0.12 for 
DETP, and 0.06 for DEDTP. The inter-day precision of the method during this project, 
expressed as the coefficient of variation (CV) and measured with the inclusion of the 
values <LOD, varied between 4.2–8.8% for DEDTP, 4.1–7.2% for DEP, 5.0–9.1% for 
DETP, 5.5–7.1% for DMDTP, 5.3–8.0% for DMP, and 5.5–7.7% for DMTP based on 
reference materials (clinical check-urine level II 637 E-495 and MRM E-459).4
Apart for DEDTP, only a small proportion of the concentrations were below the limit of 
detection (LOD).4 The lab reported concentrations below the LOD (DMP = 0.26 μg/L, 
DMTP = 0.40 μg/L, DMDTP = 0.09 μg/L, DEP = 0.50 μg/L, DETP = 0.12 μg/L, and 
DEDTP = 0.06 μg/L) were included in the data analysis. Molar concentrations were 
used to facilitate comparison of our results with those from other studies. To account for 
urinary dilution, creatinine concentrations were determined based on the Jaffe reaction 
and molar concentrations were converted to nmol/g creatinine.5
The intraclass correlation (ICC) – estimated by using a 2-way mixed-effects model with 
absolute-agreement – for DAP metabolite concentrations varied between 0.22 and 0.26 for 
a single measurement and between 0.51 and 0.54 for the mean of the three measurements.6




Neuroimaging was performed using a 3T General Electric scanner (Discovery MR750W; 
GE Worldwide, Milwaukee, WI) with an 8-channel head coil. The protocol has been 
described elsewhere.7 T1-weighted data were collected using an inversion recovery fast 
spoiled gradient recalled sequence (TR = 8.77 ms, TE = 3.4 ms, TI = 600 ms, flip angle = 
10° , field of view = 220 mm x 220 mm, acquisition matrix = 220 x 220, ARC acceleration 
factor = 2, number of slices = 230, slice thickness = 1.0 mm). Diffusion-weighted images 
were collected with 3 b = 0 volumes and 35 noncollineair diffusion directions using an 
echo planar imaging sequence (TR = 12,500 ms, TE = 72 ms, field of view = 240 mm x 
240 mm, acquisition matrix = 120 x 120, Asset acceleration factor = 2, number of slices 
= 65, slice thickness = 2 mm, b = 900 s/mm2).
Cortical reconstruction and volumetric segmentation were carried out with FreeSurfer 
Image Analysis Suite 6.0.8,9 Non-brain tissue was removed and images were normalized 
for B1 field inhomogeneities, followed by tissue segmentation, as well as parcellation in 
accordance with the Desikan-Killiany atlas.10 Global metrics included total brain volume, 
cerebral and cerebellar white and gray matter volume, and subcortical gray matter volume. 
Furthermore, we included volumes of the corpus callosum, the thalamus, caudate nucleus, 
putamen, pallidum, hippocampus, amygdala, and nucleus accumbens. Finally, surface-
based thickness and surface area maps were made of the cerebral cortex. The maps were 
coregistered to a standard stereotaxic space for all participants and consequently smoothed 
with a 10 mm full-width half-maximum Gaussian kernel. All images were inspected for 
surface reconstruction accuracy using automated and manual methods.9
Diffusion tensor imaging (DTI) images were further processed with the FMRIB Software 
Library (FSL), version 5.0.9.11 Non-brain tissue was removed, and images were corrected 
for eddy-current artifacts and translations/rotations due to motion. The RESTORE 
method from the Camino toolkit was then used to fit diffusion tensors at each voxel,12 
and fractional anisotropy (FA) and mean diffusivity (MD) were computed. Twelve major 
white matter tracts (cingulum bundle, corticospinal tract, forceps major, forceps minor, 
inferior longitudinal fasciculus, superior longitudinal fasciculus and the uncinate fasciculus) 
were identified via probalistic tractography with the FSL plugin AutoPtx.13,14 The mean 
FA and MD per tract, weighted by the connectivity distribution, were then computed. A 
confirmatory factor analysis was performed to model a single latent FA and MD measures 
across the 12 tracts, which represented global FA and MD across the brain.15
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Table S1. Descriptive statistics of  brain volume (n=441) and white matter microstructure (n=474) 







Total brain 857.4 1140.7 1214.5 1278.4 1592.2
Total gray volume 546.5 721.8 768.2 801.5 970.6
Subcortical gray matter 46.0 57.3 59.9 63.2 76.4
Cerebral white matter 290.6 391.9 420.3 450.1 592.4
Thalamus 10.9 14.0 14.7 15.7 20.2
Caudate 5.6 7.5 8.2 8.8 11.3
Putamen 6.5 10.0 10.8 11.5 13.6
Pallidum 2.8 3.6 3.9 4.1 5.1
Hippocampus 5.9 7.5 7.9 8.5 10.1
Amygdala 2.3 3.3 3.5 3.7 4.6
Nucleus accumbens 0.7 1.2 1.4 1.5 1.9
Cerebellum cortex 89.5 111.2 117.7 124.9 156.3
Cerebellar white matter 18.1 24.0 25.8 27.5 35.3
Corpus callosum 2.2 3.0 3.3 3.6 5.2
White matter microstructure
Global FA -6.0 -1.3 0.0 1.0 4.7
Global MD -0.6 -0.1 0.0 0.1 0.8
Abbreviations: min= minimum, max=maximum, FA= fractional anisotropy, MD=mean diffusivity.
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Table S2. Adjusteda association between log10 transformed maternal concentrations of  DMb and 
DEc metabolite concentrations in nmol/g creatinine and brain volumes (n=441) and white matter 
microstructure (n=474) assessed at child age 10 years.
<18 weeks 18-25 weeks >25 weeks
Brain volumes B 95%CI B 95%CI B 95%CI
Total brain DMs -1.98 -26.29 to 22.34 10.76 -17.38 to 38.90 10.67 -15.99 to 37.33
DEs 5.67 -14.50 to 25.85 -0.85 -22.94 to 21.25 -3.93 -25.94 to 18.09
Total gray volume DMs -1.24 -15.75 to 13.26 5.11 -11.75 to 21.97 3.49 -12.48 to 19.45
DEs 2.53 -9.55 to 14.61 -5.32 -18.52 to 7.88 -3.20 -16.38 to 9.97
Subcortical gray 
matter
DMs -0.42 -1.52 to 0.69 0.74 -0.55 to 2.03 0.20 -1.02 to 1.42
DEs -0.17 -1.09 to 0.76 -0.11 -1.13 to 0.91 -0.69 -1.69 to 0.31
Cerebral white 
matter
DMs -0.70 -11.79 to 10.39 5.76 -6.99 to 18.51 7.11 -4.99 to 19.20
DEs 3.31 -5.86 to 12.48 4.87 -5.18 to 14.92 -0.07 -10.07 to 9.94
Thalamusd DMs -0.11 -0.35 to 0.13 -0.10 -0.38 to 0.18 -0.28 -0.54 to -0.02
DEs 0.00 -0.20 to 0.20 -0.10 -0.32 to 0.12 -0.23 -0.45 to -0.02
Caudated DMs 0.05 -0.18 to 0.28 0.19 -0.07 to 0.45 0.02 -0.23 to 0.27
DEs -0.07 -0.26 to 0.12 -0.14 -0.35 to 0.07 0.02 -0.19 to 0.23
Putamend DMs 0.07 -0.19 to 0.34 0.35 0.04 to 0.66 0.19 -0.10 to 0.48
DEs 0.03 -0.19 to 0.25 0.05 -0.19 to 0.29 -0.07 -0.31 to 0.16
Pallidumd DMs 0.00 -0.09 to 0.09 0.09 -0.02 to 0.20 -0.01 -0.11 to 0.09
DEs -0.03 -0.11 to 0.05 0.02 -0.06 to 0.11 -0.05 -0.14 to 0.03
Hippocampusd DMs -0.12 -0.28 to 0.04 0.07 -0.12 to 0.25 -0.04 -0.22 to 0.13
DEs 0.05 -0.09 to 0.18 0.01 -0.13 to 0.16 -0.03 -0.17 to 0.12
Amygdalad DMs -0.03 -0.12 to 0.05 0.08 -0.01 to 0.18 0.03 -0.06 to 0.13
DEs 0.05 -0.02 to 0.12 0.03 -0.04 to 0.11 0.01 -0.07 to 0.08
Nucleus accumbensd DMs -0.01 -0.06 to 0.03 0.04 -0.01 to 0.09 -0.02 -0.07 to 0.03
DEs -0.01 -0.05 to 0.03 0.01 -0.03 to 0.05 0.02 -0.03 to 0.06
Cerebellum cortexd DMs -0.54 -2.93 to 1.84 -2.42 -5.17 to 0.32 -0.92 -3.53 to 1.70
DEs -0.72 -2.69 to 1.25 -0.99 -3.17 to 1.19 -2.31 -4.45 to -0.16
Cerebellar white 
matterd
DMs 0.05 -0.56 to 0.67 -0.08 -0.79 to 0.64 -0.11 -0.79 to 0.57
DEs -0.09 -0.60 to 0.42 -0.35 -0.91 to 0.22 -0.46 -1.02 to 0.10
Corpus callosumd DMs 0.01 -0.12 to 0.14 -0.03 -0.18 to 0.12 -0.06 -0.21 to 0.08
DEs 0.01 -0.10 to 0.12 0.04 -0.08 to 0.16 -0.07 -0.19 to 0.04
White matter 
microstructure B 95%CI B 95%CI B 95%CI
Global FA DMs -0.60 -1.10 to -0.11 -0.62 -1.17 to -0.06 -0.05 -0.60 to 0.49
DEs -0.46 -0.89 to -0.03 -0.25 -0.68 to 0.19 -0.22 -0.68 to 0.23
Global MD DMs 0.04 -0.01 to 0.09 0.10 0.04 to 0.16 0.03 -0.03 to 0.08
DEs 0.04 0.00 to 0.09 0.03 -0.02 to 0.07 0.02 -0.02 to 0.07
Abbreviations: DM= Dimethyl alkyl phosphates, DE= Diethyl alkyl phosphates
a. Adjusted for age of child during the magnetic resonance imaging assessment, sex of child, and maternal age, 
ethnicity (Dutch, other-western, and non-western), education (low, intermediate, and high), income (low, middle, 
and high), marital status (married/living with partner and single), alcohol consumption during pregnancy (no alcohol 
consumption during pregnancy, alcohol consumption until pregnancy was known, occasionally alcohol consumption 
during pregnancy, and frequently alcohol consumption during pregnancy), body mass index, parity (0, 1, and 2+), 
and smoking during pregnancy (no smoking during pregnancy, smoked until pregnancy was known, and smoked 
during pregnancy).
b. DM is the sum of dimethylphosphate, dimethylthiophosphate, and dimethyldithiophosphate.
c. DE is the sum of diethylphosphate, diethylthiophosphate, and diethyldithiophosphate.





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table S7. P-value of  the interaction between averaged log10 transformed DAPa metabolite 
concentrations in nmol/g creatinine and sex in the adjustedb association between averaged log10 
transformed maternal concentrations of  DAP metabolite and brain volumes (n=441) and white 
matter microstructure (n=474).
Brain volumes P-value for interaction
Total brain 0.052
Total gray 0.065
Subcortical gray matter 0.264









Cerebellar white matterc 0.703
Corpus callosumc 0.298
White matter microstructure P-value for interaction
Global FA 0.241
Global MD 0.610
Abbreviations: DAP= Dialkyl phosphates, FA= fractional anisotropy, MD= mean diffusivity
a. DAP is the sum of dimethylphosphate, dimethylthiophosphate, dimethyldithiophosphate, diethylphosphate, 
diethylthiophosphate, and diethyldithiophosphate.
b. Adjusted for age of child during the magnetic resonance imaging assessment, sex of child, and maternal age, eth-
nicity (Dutch, other-western, and non-western), education (low, intermediate, and high), income (low, middle, and 
high), marital status (married/living with partner and single), alcohol consumption during pregnancy (no alcohol 
consumption during pregnancy, alcohol consumption until pregnancy was known, occasionally alcohol consumption 
during pregnancy, and frequently alcohol consumption during pregnancy), body mass index, parity (0, 1, and 2+), 
and smoking during pregnancy (no smoking during pregnancy, smoked until pregnancy was known, and smoked 
during pregnancy).
c. Additionally adjusted for intracranial volume.
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Table S8. Adjusteda inverse probability weighted association between averaged log10 transformed 
maternal concentrations of  DAPb metabolite concentrations in nmol/g creatinine and brain volu-
mes (n=441) and white matter microstructure (n=474) assessed at child age 10 years. 
Averaged DAP metabolite concentrations in nmol/g creatinine
Brain volumes B 95%CI
Total brain 14.73 -25.37 to 54.84
Total gray 3.39 -20.77 to 27.54
Subcortical gray matter 0.00 -1.84 to 1.84
Cerebral white matter 11.51 -6.53 to 29.55
Thalamusc -0.50 -0.89 to -0.11
Caudatec 0.08 -0.29 to 0.44
Putamenc 0.40 -0.03 to 0.83
Pallidumc 0.00 -0.15 to 0.15
Hippocampusc -0.08 -0.33 to 0.18
Amygdalac 0.08 -0.05 to 0.22
Nucleus accumbensc 0.02 -0.06 to 0.09
Cerebellum cortexc -2.54 -6.45 to 1.36
Cerebellar white matterc -0.15 -1.16 to 0.87
Corpus callosumc -0.02 -0.23 to 0.20
White matter microstructure B 95%CI
Global FA -1.03 -1.86 to -0.20
Global MD 0.13 0.04 to 0.22
Abbreviations: DAP= Dialkyl phosphates, FA= fractional anisotropy, MD= mean diffusivity
a. Adjusted for age of child during the magnetic resonance imaging assessment, sex of child, and maternal age, eth-
nicity (Dutch, other-western, and non-western), education (low, intermediate, and high), income (low, middle, and 
high), marital status (married/living with partner and single), alcohol consumption during pregnancy (no alcohol 
consumption during pregnancy, alcohol consumption until pregnancy was known, occasionally alcohol consumption 
during pregnancy, and frequently alcohol consumption during pregnancy), body mass index, parity (0, 1, and 2+), 
and smoking during pregnancy (no smoking during pregnancy, smoked until pregnancy was known, and smoked 
during pregnancy).
b. DAP is the sum of dimethylphosphate, dimethylthiophosphate, dimethyldithiophosphate, diethylphosphate, 
diethylthiophosphate, and diethyldithiophosphate.
c. Additionally adjusted for intracranial volume.
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Table S9. Adjusteda association between averaged log10 transformed maternal concentrations of  
DAPb metabolite concentrations in nmol/g creatinine and brain volumes (n=441) and white mat-
ter microstructure (n=474) assessed at child age 10 years with additional adjustment for maternal 
fruit and vegetable intake.
Averaged DAP metabolite concentrations in nmol/g creatinine
Brain volumes B 95%CI
Total brain 11.09 -29.35 to 51.53
Total gray 2.17 -22.00 to 26.35
Subcortical gray matter 0.02 -1.83 to 1.86
Cerebral white matter 9.05 -9.37 to 27.46
Thalamusc -0.35 -0.74 to 0.04
Caudatec 0.04 -0.34 to 0.41
Putamenc 0.43 -0.01 to 0.86
Pallidumc 0.05 -0.10 to 0.21
Hippocampusc -0.08 -0.34 to 0.19
Amygdalac 0.05 -0.09 to 0.19
Nucleus accumbensc 0.00 -0.07 to 0.08
Cerebellum cortexc -2.58 -6.51 to 1.34
Cerebellar white matterc -0.09 -1.11 to 0.93
Corpus callosumc -0.03 -0.25 to 0.18
White matter microstructure B 95%CI
Global FA -0.96 -1.81 to -0.11
Global MD 0.14 0.05 to 0.23
Abbreviations: DAP= Dialkyl phosphates, FA= fractional anisotropy, MD= mean diffusivity
a. Adjusted for age of child during the magnetic resonance imaging assessment, sex of child, and maternal age, eth-
nicity (Dutch, other-western, and non-western), education (low, intermediate, and high), income (low, middle, and 
high), marital status (married/living with partner and single), alcohol consumption during pregnancy (no alcohol 
consumption during pregnancy, alcohol consumption until pregnancy was known, occasionally alcohol consumption 
during pregnancy, and frequently alcohol consumption during pregnancy), body mass index, parity (0, 1, and 2+), 
smoking during pregnancy (no smoking during pregnancy, smoked until pregnancy was known, and smoked during 
pregnancy), energy adjusted maternal fruit intake, and energy adjusted vegetable intake.
b. DAP is the sum of dimethylphosphate, dimethylthiophosphate, dimethyldithiophosphate, diethylphosphate, 
diethylthiophosphate, and diethyldithiophosphate.
c. Additionally adjusted for intracranial volume.
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Mothers participating in The Generation R Study 
N=9778 
Mothers enrolled during pregnancy 
N=8879 
Mothers who provided 3 urine samples during 
pregnancy 
N=2083 
Mother-child pairs who provided 
neurodevelopmental data at postnatal visits 
N=1449 





Mothers enrolled after pregnancy 
N=899 
Excluded: 
Mothers who provided Q 
urine sample during gestation 
N=6796 
Excluded: 




Mother-child pairs who 
were not selected 
N=649 
Excluded: 




good quality MRI data 
N=266 
Figure S1. Flowchart of study population.
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Figure S2. Directed Acyclic Graph of the OP pesticide exposure and brain development. Potential adjustment 
variables were selected a priori defined with a Directed Acyclic Graph (DAG) using the Dagitty software (Textor 
et al. 2017). The DAG was based on previous studies of OP pesticide exposure and child neurodevelopment 
and on biologically plausible covariate–exposure and covariate–outcome associations observed in our data. 
Green circles represent ancestors of the exposure, blue circles ancestors of the outcome, pink circles ancestors 
of both exposure and outcome. BMI= Maternal body mass index, SES= socioeconomic status (maternal 
education, household income and marital status), age C= child age at assessment, age M= age mother, IQ= 
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Organophosphate pesticide exposure 
in pregnancy in association with 
ultrasound and delivery measures of  
fetal growth
Ferguson, K. K., van den Dries, M. A., Gaillard, R., Pronk, A., Spaan, S., 
Tiemeier, H., & Jaddoe, V.W.V. (2019). 




Background: Perturbations in fetal growth may have adverse consequences for childhood and 
later life health. Organophosphate pesticide (OP) exposure has been associated with reduced 
birth weight at delivery but results are not consistent.
Objectives: We investigated this question by utilizing ultrasound measures of size in utero 
in combination with measures from delivery.
Methods: Within Generation R, a population-based prospective cohort conducted between 
2002 and 2006 in Rotterdam, Netherlands, we measured dialkyl phosphates (DAPs), OP 
metabolites, in urine samples from early, middle, and late pregnancy and created a subject-
specific average to estimate OP exposure (n=784). Ultrasound measures of head circumference, 
femur length, and estimated fetal weight from middle and late pregnancy and delivery measures 
were converted to standard deviation scores (SDS). Associations with DAP average were 
examined in linear mixed effects models that included an interaction term between gestational 
age at measurement and DAP average to investigate whether the relationship differed over 
time. Windows of vulnerability to exposure were assessed by modeling urinary DAPs from 
each visit in relation to growth measurements.
Results: A 10-fold increase in average DAPs was associated with a −0.53 SDS decrease in 
fetal length (95% CI =−0.83, −0.23) and a −0.32 SDS decrease in estimated fetal weight 
(95% CI =−0.59, −0.04) at 20 weeks of gestation. These differences corresponded to 5% 
and 6% decreases relative to the mean. Effect estimates were greatest in magnitude for DAP 
concentrations measured early in pregnancy. Associations between average DAPs and growth 
measures at delivery were positive but not significant for head circumference and length and 
were null for weight.
Conclusions: Maternal urinary DAPs were associated with decreased fetal weight and length 
measured during mid-pregnancy, but not at delivery.




Perturbations in normal fetal growth are linked to numerous adverse health outcomes 
both in childhood1 and later life.2 Suboptimal fetal growth is classically approximated by 
birth weight at delivery with or without adjustment for gestational duration. However, 
for diagnostic purposes, assessment of fetal growth longitudinally during pregnancy 
is preferred.3 In research, repeated ultrasound measures of growth allow for the a) 
improved ability to detect deviations from normality that occur during gestation, not 
just at delivery; b) investigation of rates of change in growth, rather than a snapshot of 
size; and c) assessment of specific fetal growth measures, such as length as an indicator 
of skeletal size, which are not fully captured by birth weight alone. Utilizing these data, 
researchers have demonstrated specific time periods in pregnancy where changes in rate 
of growth may have the greatest impact on childhood health outcomes (e.g., adiposity, 
neurodevelopment).4,5 Similarly, studies of environmental factors and fetal growth have 
used these data to augment understanding of windows when exposures have the strongest 
influence on growth and which specific anthropometric parameters are most affected 
(e.g., head circumference vs. weight).6-9
To our knowledge, longitudinal ultrasounds in pregnancy have not been used to investigate 
the association between organophosphate pesticide (OP) exposure and fetal growth. 
OPs such as dimethoate and parathion are a class of high-production insecticides with 
neurotoxic capacity. Exposure can occur through occupational use or proximity to areas 
with agricultural application, but most populations are exposed through diet.10-13 There 
is strong biologic plausibility for an effect of OPs on in utero growth and development 
through interference with adenyl cyclase activity, which is crucial for cell differentiation,14 
disruption of normal thyroid hormone function in the mother or fetus,15 or dysregulation 
of nutrient transport across the placenta 16. Evidence for an association with birth weight 
has been demonstrated in some but not all rodent studies of OPs.17-20 Results from human 
studies on the association between biomarkers of OPs and birth weight, including a recent 
pooled analysis, have also been ambiguous, and associations may differ by individuals’ 
ability to detoxify OPs by the paraoxonase.21
In the present study, we investigated the association between maternal OP exposure in 
pregnancy and fetal growth as assessed by repeated ultrasound measurements during 
pregnancy in combination with neonatal assessments. We utilized urinary dialkyl 
phosphates (DAPs), metabolites of OPs, measured in urine samples collected at three time 
points in pregnancy as proxies of exposure. Our primary aim was to assess associations 
of average DAPs over pregnancy with repeated measures of head circumference, length, 
and weight measured at two time points during pregnancy by ultrasound and at delivery. 
Our secondary aim was to identify potential windows of vulnerability to exposure by 
Chapter 9
314
examining outcomes in association with DAP concentrations at each individual time 




Generation R is a prospective population-based birth cohort designed to identify early 
environmental and genetic determinants of development throughout life and which has 
been described in detail previously.22 Briefly, all mothers who resided in the study area 
in Rotterdam, Netherlands, and had a delivery date between April 2002 and January 
2006 were eligible. Mothers were enrolled during pregnancy or in the first months after 
the birth of their child when newborns visited the routine child health centers. Among 
the 9,778 mothers who participated in the study 8,879 (91%) were enrolled during 
pregnancy. Among the 4,918 women enrolled during pregnancy between February 
2004 and January 2006, spot urine specimens during early, middle, and late pregnancy 
(<18, 18–25, and >25 weeks of gestational age, respectively) were collected at the time 
of routine ultrasound examinations. In total, 2,083 women provided a complete set of 
three urine specimens. The study protocol underwent human subjects review at Erasmus 
Medical Center, Rotterdam, Netherlands (institutional review board registration no. 
IRB00001482, MEC 198.782.2001.31). Mothers provided written informed consent 
for themselves and their children.
Among the women with urine specimens collected at each of the three visits in pregnancy, 
1,449 had complete information on childhood health assessments.22 From these women, 
800 were randomly selected for a study designed to assess the relationship between prenatal 
exposure to OPs and childhood neurodevelopmental outcomes.13 Due to limitations in 
urine sample volume, 784 individuals were included in the final study population (n=778 
with three samples; n=5 with two samples; n=1 with one sample). A flow chart describing 
the selection process is shown in Figure S1. Women in this subset had higher education 
levels and were slightly older and a greater proportion were Dutch compared with the 
broader Generation R cohort.22
Ultrasound and delivery measures of  size
During pregnancy, ultrasound scans were performed to calculate gestational age and to 
measure fetal growth on the entire study population, as described in detail elsewhere.23 
Head circumference and length were measured in middle and late pregnancy and 
estimated fetal weight for each time point was calculated using the formula of Hadlock 
et al. (1985).24 At birth, head circumference, length, and weight were measured. Standard 
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deviation scores (SDS) for each measurement were calculated using longitudinal growth 
curves that accounted for gestational age at measurement but not fetal sex.23
Urinary dialkyl phosphate measurement
At each of the three study visits, urine samples were collected from participants in 
polypropylene cups and stored until analysis at 20°C.25,26 Six nonspecific DAPs were 
measured using gas chromatography coupled with tandem mass spectrometry (GC-MS/
MS) at the Institute National de Santé Publique (INSPQ) in Quebec, Canada, with 
methods described in detail elsewhere.26,27 These measurements included three dimethyl 
metabolites (dimethylphosphate, dimethythiophosphate, and dimethyldithiophosphate; 
DMPs) and three diethyl metabolites (diethylphosphate, diethylthiophosphate, and 
diethyldithiophosphate; DEPs). Limits of detection were between 0.06 and 0.5μg/L 
and coefficients of variation for inter-day reliability were <10%.13 Values below the limit 
of detection were imputed with machine-reported values when available. We calculated 
nanomolar sums of DMPs, DEPs, and total DAPs using molecular weights.13,26 To adjust 
for urine dilution, we measured creatinine concentrations using the Jaffe reaction and 
corrected each sum so that final concentrations are presented in nanomoles per gram 
creatinine. Finally, we calculated subject-specific geometric averages of DMP, DEP, and 
DAP concentrations from levels measured at each of the three visits in pregnancy in order 
to create more stable estimates of exposure for our primary aim.13
PON1 genotyping
Cord blood from 523 children included in the present analysis was genotyped using 
Illumina 610K and 660W arrays, as described previously.28 We examined single nucleotide 
polymorphisms (SNPs) for PON1−Q192, which was directly genotyped, and four other 
SNPs that were imputed in the genotype data set, including rs705379 (PON1−108), 
rs705381 (PON1−161), rs854560 (PON1−L55M), and rs854572 (PON1−909). MaCH 
1.029 was used to impute the 1000 Genomes Iv3 reference panel,30 and all four imputed 
SNPs had excellent imputation quality (R2>0.95) and high minor allele frequencies 
(>26%). For individuals with no genotyping data available, all SNPs were imputed as 
described below.
Statistical methods
All analyses were performed using R (version 3.4.3; R Development Core Team).31 To 
address missing data, we imputed the data 10 times using multiple imputation by chained 
equation (MICE) in R (package mice).32 For DAPs, a small number of concentrations 
were missing due to insufficient sample or machine error (≤5 measurements for any 
visit for DMPs; ≤23 for DEPs; ≤5 for creatinine). Imputations were performed prior to 
calculating nanomolar sums, creatinine correction, and calculation of subject-specific 
averages. Missing covariates listed in Table 1 (<20% for all) were imputed, and the 
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following covariates were additionally included as predictors for imputation: maternal 
education level; caloric intake; caloric intake from vegetables and caloric intake from 
fruits; paternal education level; maternal ethnicity; and body mass index (BMI). We 
also imputed missing ultrasound and delivery SDS of fetal or newborn size. Due to 
the correlation between size measurements, only birth-weight SDS was included as a 
predictor in the MICE procedure. Finally, for individuals missing all PON1 genotyping 
data, we imputed SNPs in the same MICE procedure as has been done in our previous 
analyses; however, PON1 was not used as a predictor in the imputation step due to a 
high proportion of missing measures. Thus, unless stated otherwise, all models presented 
contain the full sample (n=784) and complete observations at all time points.
We calculated distributions of demographic characteristics and DAP averages and examined 
Pearson correlations between DAPs at individual time points and for averages. We calculated 
raw (i.e., unstandardized) ultrasound and delivery measures of size in the unimputed data 
set for interpretation purposes. To address our primary research question, we created linear 
mixed effects models using the nlme package,33 modeling average DMP, DEP, or DAP 
exposure over pregnancy in relation to repeated SDS of head circumference, length, or 
weight (ultrasound measures from middle and late pregnancy in combination with birth 
measurements at delivery). In this and other pregnant populations, within-individual 
variation in urinary DAP concentrations is greater than variation between individuals.34,35 
This reflects daily variation in exposure through, for example, variable dietary patterns, 
as well as rapid metabolic clearance of these compounds.13 Consequently, if exposures 
are relatively consistent over longer periods of time, average DAP concentrations based 
on multiple urine samples should provide a more accurate measure of usual exposure at 
any point during pregnancy than DAP concentrations measured in an individual sample. 
Therefore, in our primary analyses, we used pregnancy average DAP concentrations to 
estimate usual exposure across pregnancy despite the fact that this included urinary 
biomarkers from late pregnancy that were collected after the mid-pregnancy ultrasound. 
DAP averages were log10-transformed for analysis to improve model fit. All models included 
a random intercept for each subject as well as a random slope for gestational age at growth 
measurement. We additionally included an interaction term between DAP average and 
gestational age at growth measurement to allow the exposure–outcome association to 
differ by timing of outcome measurement. Because results differed based on the timing 
of outcome measurement and because presentation of main effect and interaction terms 
can be difficult to interpret, we presented results from models where the intercept was 
varied so that the results would represent associations where the outcome was measured 
at 20, 30, and 40 weeks of gestation.
For adjusted models, we included an a priori set of covariates based on previously 
observed associations with the exposure and outcome or covariates known to improve 
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the precision of the outcome estimate. These included fetal sex (categorical), maternal 
age (continuous), prepregnancy weight (continuous), height (continuous), maternal 
education level (categorical), maternal ethnicity (categorical), parity (categorical), smoking 
in pregnancy (categorical), alcohol use in pregnancy (categorical), folic acid use, and 
gestational age at growth measurement (continuous). Folic acid was included in this study 
population because it has been associated with fetal growth and because it is a strong 
indicator of socioeconomic status (SES), a predictor of urinary DAP concentrations.13,36,37 
Maternal height and weight were included instead of the aggregate BMI because each is 
an independent predictor of fetal growth.38
Our second aim was to examine windows of vulnerability to exposure. To do so, we created 
cross-sectional models of total urinary DAP concentrations measured at each study visit 
in relation to outcome measurements at middle and late pregnancy and at delivery (i.e., 
one exposure time point and one outcome time point per model). For these analyses, 
we examined only outcomes at the same or subsequent visits (i.e., we did not model 
late pregnancy exposure biomarkers in association with middle pregnancy fetal growth 
measurements). All models retained the same covariates as those used in the repeated 
measures analyses. Results for all cross-sectional models are reported for associations 
with outcomes at early, middle, or late pregnancy and are referred to as such. To assess 
effect modification of the relationship between DAPs and fetal growth by fetal sex, we 
examined associations in models stratified by this variable, and we additionally included 
a two-way interaction term between sex and exposure in repeated measures models to 
test the significance of any observed differences. A similar approach was used to estimate 
effect modification by PON1 genotype. Interaction terms with p<0.05 were considered 
statistically significant.
To test the robustness of our results, we first examined the influence of imputing 
outcome measurements. To do so, we created a new set of 10 imputed data sets in 
which the low proportion missing for exposures and covariates were imputed, but the 
outcome was not. We then recreated linear mixed effects models for comparison. Second, 
we examined results with DMPs and DEPs included in the same model in order to 
distinguish the effects of the two classes. Third, because these metabolites demonstrate 
only weak-to-moderate reliability over pregnancy (e.g., intraclass correlation coefficient for 
DAP metabolites=0.30),35 we examined the effect of adjusting for measurement error by 
applying regression calibration.39 We applied the calibration to repeated measures models 
of average DAP concentrations in associations with each fetal growth outcome. Fourth, to 
test the robustness of our results to adjustment for additional SES factors, we examined 
models additionally adjusted for marital status and income level. Fifth, because season 
has been associated both with urinary DAP13 and with birth weight in some studies,40 
we examined the effect of additionally adjusting for this potential confounder. Finally, 
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we examined associations after removing babies who were born preterm (i.e., prior to 37 
weeks of completed gestation) in order to determine whether or not our results could be 
attributed to gestational age at delivery rather than size.
Results
Of the 784 women included in the present analysis, the median maternal age was 31 y, 
most of the women were Dutch (58%), and the prepregnancy median weight was 64kg 
(Table 1). For 62% of women this was their first pregnancy, and smoking and alcohol 
use was low to moderate in the study population. A small percentage of women never 
took folic acid supplements either prior to or at any point during pregnancy.
The median gestational ages for middle and late pregnancy ultrasounds were 20.4 weeks 
[95% confidence interval (CI): 20.3, 20.5] and 30.4 weeks (95% CI: 30.3, 30.5), 
respectively, and the median gestational age at delivery was 40 weeks (95% CI: 40.0, 
40.2) (Table 2).
Almost all participants included in the present analysis had ultrasound measurements 
available at these two time points prior to imputation. All participants had data available on 
birth weight at delivery, but a smaller proportion had head circumference (61%) or birth 
length (72%) assessed. Thus, a larger proportion of head circumference and birth length 
measurements were imputed. Distributions of urinary DMPs, DEPs, and DAPs by study 
visit and on average are presented in Table 3. As previously reported, concentrations by 
visit showed weak-to-moderate reliability (intraclass correlation coefficients 0.14–0.38).35 
DMPs and DAPs were highly correlated both for averages and at individual study visits 
(Pearson r=0.97–0.98), but DEPs were less correlated with DAPs (Pearson r=0.53–0.63) 
and DMPs (Pearson r=0.43–0.47) (see Table S1).
Primary analysis: repeated measures models
Effect estimates from fully adjusted repeated measures models, accounting for interaction 
between exposure and gestational age at growth measurement, demonstrated that 
associations between pregnancy averages of exposure and outcomes differed based on 
the timing of outcome measurement (i.e., interactions between exposure and time were 
statistically significant; see Table S2). For the presentation of results, we calculated effect 
estimates for outcomes at 20, 30, and 40 weeks (Table 4).
At 20 weeks, a 10-fold increase in pregnancy-averaged total DAPs was associated with a 
0.53-SDS shorter length (95% CI: −0.83, −0.23) and a 0.32-SDS lower weight (95% CI: 
−0.59, −0.04). For length, this difference corresponds to −2mm, or −5%, relative to the 
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Table 1. Demographic and lifestyle characteristics of  784 mothers with singleton live births from 
the Generation R study population.
Median (25th, 75th) or N (%)
Maternal age in years 31 (28, 34)
<20 14 (1.79)
20- <25 79 (10.1)
25- <30 208 (26.5)











Household income in Euros
<1200 per month 86 (11.0)
1200-2000 per month 113 (14.4)




No partner 78 (10.3)
missing 29 (3.70)
Weight pre-pregnancy in kg 64.0 (58.0, 72.0)
missing 96 (12.2)








No smoking during pregnancy 555 (70.8)
Until pregnancy recognized 64 (8.16)
Continued during pregnancy 102 (13.0)
missing 63 (8.04)
Alcohol consumption
No consumption during pregnancy 273 (34.8)
Until pregnancy recognized 130 (16.6)
Continued occasionally 293 (37.4)




Started in first 10 weeks of pregnancy 212 (27.0)





Preterm (<37 weeks of gestation)
No 762 (97.1)
Yes 22 (2.90)





Table 2. Distribution of  fetal and neonatal anthropometric parameters (unimputed).
N (%) Mean (SD)
Middle pregnancy (ultrasound)
Gestational age (weeks) 784 (100) 20.4 (0.92)
Head circumference (mm) 774 (98.7) 178 (12.3)
Femur length (mm) 779 (99.4) 33.1 (2.98)
Estimated fetal weight (grams) 777 (99.1) 369 (73.8)
Late pregnancy (ultrasound)
Gestational age (weeks) 784 (100) 30.4 (0.83)
Head circumference (mm) 777 (99.1) 286 (11.4)
Femur length (mm) 784 (100) 57.6 (2.80)
Estimated fetal weight (grams) 782 (99.7) 1626 (238)
Delivery (physical exam)
Gestational age (weeks) 784 (100) 40.1 (1.48)
Birth head circumference (cm) 478 (61) 33.7 (1.72)
Birth length (cm) 562 (71.7) 50.4 (2.24)
Birth weight (g) 784 (100) 3452 (505)
Table 3. Distribution of  organophosphate pesticide metabolite concentrations by study visit and 
on average (nmol/g creatinine).
Percentiles
Geometric Mean 25th 50th 75th 95th
Dimethyl phosphates (DMPs)a
Early pregnancy 249.8 148.6 244.1 413.6 860.0
Middle pregnancy 263.6 168.8 268.6 415.4 854.3
Late pregnancy 247.4 157.1 247.8 398.9 863.1
Average 253.5 183.1 259.1 355.3 582.9
Diethyl phosphates (DEPs)b
Early pregnancy 42.9 25.1 43.1 79.3 175.6
Middle pregnancy 40.5 23.2 41.6 74.3 179.8
Late pregnancy 40.1 21.6 41.5 77.3 176.3
Average 40.0 28.2 42.6 64.6 116.6
Dialkyl phosphates (DAPs)c
Early pregnancy 308.4 188.1 306.9 499.3 989.0
Middle pregnancy 317.9 206.7 316.5 485.9 1001.9
Late pregnancy 301.5 194.0 307.9 489.0 984.8
Average 309.2 226.4 311.0 438.8 687.3
aDMPs represent a molar sum of dimethylphosphate (DMP), dimethylthiophosphate (DMTP), and dimethyldithi-
ophosphate (DMDTP). bDEPs represent a molar sum of diethylphosphate (DEP), diethylthiophosphate (DETP), 
and diethyldithiophosphate (DEDTP). cDAPs represent a molar sum of all of the above. Percent below the limit of 
detection by individual metabolite in early, middle, and late pregnancy: DMDTP: 19.9, 18.1, 18.0; DMP: 0.1, 0, 
0; DMTP: 3.5, 3.6, 2.4; DEDTP: 81.1, 84.5, 85.0; DEP: 2.7, 5.4, 4.1; DETP: 12.1, 11.8, 11.7. Number of meta-
bolites missing due to machine error in early, middle, and late pregnancy: DMDTP: 0, 0, 3; DMP: 0, 0, 0; DMTP: 
0, 0, 1; DEDTP: 0, 1, 1; DEP: 1, 0, 0; DETP: 13, 22, 16. Number of metabolites missing due to insufficient urine 
volume for analyses: early pregnancy=5; middle pregnancy=1; late pregnancy=1 (6 participants total).
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mean for length at 20 weeks of gestation. For weight, this corresponds to −24g, or −6%, 
relative to the mean for estimated fetal weight at 20 weeks of gestation. DMPs and DEPs 
individually were also inversely associated with length and weight at this time point, but 
none of the DAPs were significantly associated with differences in head circumference. 
Interaction terms between exposure and gestational age indicated that associations became 
weaker as pregnancy progressed, so that at 30 or 40 weeks no significant associations 
between DAPs and fetal measurements were observed (Table 4).
To illustrate these effects, we plotted estimated coefficients and confidence intervals by 
time for associations between DAPs and head circumference (Figure 1A), length (Figure 
1B), and weight (Figure 1C). This shows that at delivery associations were null for weight 
and positive but nonsignificant for head circumference and length. These results are also 
consistent with those from cross-sectional models of pregnancy averages in association 
with growth measurements from each study visit (middle pregnancy, late pregnancy, and 
delivery). Cross-sectional associations with pregnancy averages are displayed in Figure 
2D, with effect estimates in Table S3.
Table 4. Adjusteda difference in fetal head circumference, length, or weight standard deviation 
(SDS) score at selected weeks gestation in association with pregnancy average urinary organop-
hosphate pesticide metabolite concentrations.
Total DMPs Total DEPs Total DAPs
Difference in SDS score 
(95% CI)
Difference in SDS score  
(95% CI)
Difference in SDS score  
(95% CI)
Head circumference
20 weeks -0.11 (-0.42, 0.19) 0.00 (-0.13, 0.14) -0.09 (-0.40, 0.23)
30 weeks 0.12 (-0.14, 0.38) 0.07 (-0.04, 0.18) 0.13 (-0.14, 0.39)
40 weeks 0.35 (-0.07, 0.78) 0.13 (-0.06, 0.33) 0.34 (-0.11, 0.79)
Length
20 weeks -0.46 (-0.75, -0.17) -0.17 (-0.30, -0.04) -0.53 (-0.83, -0.23)
30 weeks -0.09 (-0.32, 0.14) -0.06 (-0.17, 0.04) -0.13 (-0.37, 0.10)
40 weeks 0.29 (-0.05, 0.63) 0.05 (-0.11, 0.21) 0.27 (-0.08, 0.61)
Weight
20 weeks -0.27 (-0.54, 0.00) -0.16 (-0.28, -0.04) -0.32 (-0.59, -0.04)
30 weeks -0.10 (-0.32, 0.12) -0.08 (-0.18. 0.02) -0.13 (-0.36, 0.09)
40 weeks 0.06 (-0.22, 0.35) 0.00 (-0.13, 0.13) 0.05 (-0.25, 0.34)
aResults from linear mixed effects models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight 
(continuous), height (continuous), education level (categorical), maternal ethnicity (categorical), parity (categorical), 
smoking (categorical), alcohol use (categorical), folic acid use (categorical), and gestational age at ultrasound or 
delivery (continuous). Models contain an interaction term between exposure concentration and gestational age at 
ultrasound/delivery, a random intercept for each participant, and a random slope for gestational age at ultrasound/




Figure 1. Adjusted repeated measures associations between pregnancy average total dialkyl phosphate (DAP) 
concentrations and standard deviation scores (SDS) of (A) head circumference, (B) length, and (C) weight 
by gestational age at growth measurement in the Generation R Study population ( n=784 ). Models adjusted 
for fetal sex, maternal age (continuous), prepregnancy weight (continuous), height (continuous), education 
level (categorical), maternal ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use 
(categorical), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Model 
contains an interaction term between exposure concentration and gestational age at ultrasound/delivery, a 
random intercept for each participant, and a random slope for gestational age at ultrasound/delivery. Main 
effect and interaction terms (95% CIs) for each plot are as follows: (A) −0.51 ( −1.32, 0.29); 0.02 ( −0.01, 
0.05); (B) −1.33 ( −2.00, −0.66); 0.04 (0.02, 0.06); (C) −0.68 ( −1.24, −0.12); 0.02 (0.00, 0.04). This figure 
includes imputed data. Note: CI, confidence interval; DAPs, dialkyl phosphates; SDS, standard deviation scores.
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Figure 2. Adjusted cross-sectional associations between visit-specific total dialkyl phosphate (DAP) 
concentrations measured in total urinary DAPs in A) early pregnancy, B) middle pregnancy, C) late pregnancy, 
and D) averaged over pregnancy and standard deviation scores (SDS) of fetal growth parameters (head 
circumference, length, and weight) measured during pregnancy by ultrasound and by clinical examination 
at delivery in the Generation R Study population ( n=784 ). Model adjusted for fetal sex, maternal age 
(continuous), prepregnancy weight (continuous), height (continuous), education level (categorical), maternal 
ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (categorical), folic acid use 
(categorical), and gestational age at ultrasound or delivery (continuous). This figure includes imputed data. 
Note: CI, confidence interval; DAPs, dialkyl phosphates; SDS, standard deviation scores.
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Secondary analysis: windows of  vulnerability to exposure
Cross-sectional models of visit-specific urinary DAP concentrations in association with 
each outcome demonstrated some differences by timing of exposure (Figure 2A–C; see 
also Tables S4–S6). In general, total urinary DAPs measured in early pregnancy showed 
the strongest associations with length and weight (Figure 2A; Table S4). A 10-fold increase 
in concentrations measured in samples collected in early pregnancy was associated with 
lower fetal length (β=−0.30, 95% CI: −0.50, −0.10) and weight (β=−0.22, 95% CI: −0.4, 
−0.04) at mid-pregnancy, and also with lower fetal length (β=−0.16, 95% CI: −0.36, 
0.04) and weight (β=−0.19, 95% CI: −0.39, 0.01) in late pregnancy, although the latter 
association was not statistically significant. Levels measured in mid-pregnancy samples were 
associated with lower fetal length (β=−0.2, 95% CI: −0.42, 0.02) and weight (β=−0.14, 
95% CI: −0.34, 0.06) in mid-pregnancy but not in late pregnancy or at delivery (Figure 
2B; Table S5). Finally, levels measured in late pregnancy samples were not associated with 
differences in length or weight but were positively associated with head circumference 
measured at delivery (Figure 2C; Table S6). Patterns for DMPs and DEPs were similar 
to the overall DAPs (see Figures S2–S3 and Tables S4–S6).
Effect modification by sex and genotype
Interaction terms between total DAPs and sex demonstrated associations with length and 
weight that were stronger (i.e., more negative) for males compared with females (Table 
5), although associations were still observed for females in models of length. Adjusted 
associations by gestational age and sex are displayed in Figures 3A–C for length, weight, and 
head circumference respectively. These figures show how the exposure–response associations 
differ in males and females based on timing of outcome measurement. Interaction terms 
between total DAPs and PON1 genotype were not statistically significant (p=0.18–0.93) 
and there were no clear differences in exposure–outcome associations according to SNP 
genotypes (see Tables S7A–E).
Sensitivity analyses
For repeated measures models, associations without adjustment for covariates were slightly 
greater in magnitude (i.e., more negative) but otherwise similar to those observed in our 
primary analysis (see Table S8). Associations in models without imputed outcome were 
also similar, although effect estimates for head circumference were closer to the null (see 
Table S9). Summed DEPs and DMPs were moderately correlated (Pearson r=0.45). When 
exposures were both included in a mutually adjusted model, associations were similar 
to the primary single-pollutant findings (see Table S10). In both, effect estimates were 
greater in magnitude (i.e., more negative) for DMPs compared with DEPs for all growth 
parameters. We additionally examined the effect of adjusting for the measurement error 
inherent in our exposure biomarkers by creating our repeated measures models of average 
urinary DAPs with application of regression calibration. As expected, we observed that 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3. Adjusted and sex-stratified repeated measures associations between pregnancy average total dialkyl 
phosphate (DAP) concentrations and standard deviation scores of (A) head circumferences, (B) length, and 
(C) weight by gestational age at growth measurement in the Generation R Study population (n=784, 398 
males 386 females). Model adjusted for maternal age (continuous), prepregnancy weight (continuous), height 
(continuous), education level (categorical), maternal ethnicity (categorical), parity (categorical), smoking 
(categorical), alcohol use (categorical), folic acid use (categorical), and gestational age at ultrasound or delivery 
(continuous). Models contained an interaction term between exposure concentration and gestational age 
at ultrasound/delivery, a random intercept for each participant, and a random slope for gestational age at 
ultrasound/delivery. Main effect and interaction terms (95% CIs) for each plot are as follows: (A) male: −0.35 
( −1.35 , 0.66); 0.01 ( −0.02 , 0.05); female: −0.92 ( −2.06 , 0.22); 0.04 (0.00, 0.08); (B) male: −1.67 ( −2.62 
, −0.72 ); 0.04 (0.01, 0.08); female: −0.93 ( −1.90 , 0.04); 0.03 (0.00, 0.07); (C) male: −1.13 ( −1.93 , −0.33 
); 0.03 (0.00, 0.05); female: −0.15 ( −0.93 , 0.64); 0.01 ( −0.02 , 0.03). This figure includes imputed data. 
Note: CI, confidence interval; DAPs, dialkyl phosphates; SDS, standard deviation scores.
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the effect estimates were less attenuated (i.e., farther from the null) compared with the 
results from the primary model but that variances were increased (see Table S11). Finally, 
we observed minimal differences when we added marital status and family income as 
additional measures of SES to the model, when we included season of sample collection, 
or when our population was restricted to babies born at term (see Table S12–S14, 
respectively, for DAPs only).
Discussion
In a study of pregnant women in the Netherlands, we observed that elevated urinary 
biomarkers of OP exposure were associated with reduced fetal size as indicated by 
measurements of length and weight in mid-pregnancy, but not at delivery. Furthermore, 
elevated biomarkers of exposure from early as well as mid-pregnancy demonstrated 
associations with growth measurements that were greatest in magnitude and the most 
precise. The latter suggests that early pregnancy exposure may be an important vulnerable 
window for the relationship between OP exposure and fetal growth.
The results from our analysis may shed light on previous epidemiologic studies with 
ambiguous findings on this relationship. All previous studies have examined exposure 
in association with measurements at delivery, and few have found evidence of effects. 
This is consistent with what we would expect based on our study given that we observed 
no associations between exposure biomarkers and outcomes measured at delivery. A 
recent pooled study combined data from four U.S. studies for a powerful assessment of 
this research question (total sample size~1,100); however, no association was observed 
overall between prenatal urinary exposure biomarkers and birth weight, length, or head 
circumference.21 Other individual studies using urinary biomarkers have noted some 
associations between these exposures and outcomes, with differences by timing of exposure 
assessment, PON1 genotype or expression, and, in some instances, fetal sex; however, no 
clear patterns emerge upon review of the data.41-49
Some notable differences exist between this previous work and our present study. First, 
all but two of the previous studies had significantly smaller sample sizes (n~50–450). 
However, those with similar sample sizes had null findings. The largest study to date was 
the pooled analysis, although the authors of that study noted the difficulties in combining 
these data across populations with differing demographics and exposure levels (n~1,000).21 
The second largest study from the Odense Child Cohort in Denmark (n=858) measured 
urinary DAP concentrations at ~28 weeks of gestation and was unable to detect associations 
with birth weight, length, or abdominal or head circumference at delivery.47 Second, all 
but three studies assessed urine concentrations in a single spot urine sample collected 
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during gestation or at delivery. Those with repeated measures had largely null findings, 
although they were also more limited in sample size. Woods et al. (n=272) averaged 
measures from 16 and 26 weeks of gestation and did not detect associations with birth 
weight.49 Naksen et al. (n=52) and Huang et al. (n=105) modeled urinary concentrations 
from two visits during pregnancy and at delivery separately, with primarily null results.43,48 
OPs are metabolized quickly in the human body, and urinary DAP concentrations show 
only moderate stability over pregnancy;13,48 thus, the availability of repeated measures for 
estimating more stable subject-specific averages is an advantage in our study. Even though 
these averages included a urinary measurement (late pregnancy) that was taken after the 
time of some outcome measurements (ultrasound measures from mid-pregnancy), the 
average is the best choice for exposure assessment because individual measurements are 
highly variable over time due to variations in exposure sources (e.g., diet) in combination 
with rapid metabolic excretion.34,35 Consequently, if we assume that exposures are generally 
consistent over pregnancy, the average measure will be the best estimate.
In addition, availability of repeated measurements enabled us to investigate windows of 
vulnerability to exposure during gestation. We observed that urinary DAP concentrations 
from early pregnancy were associated with reduced length and estimated fetal weight 
in mid- and late pregnancy. DAP levels from mid- and late pregnancy, however, were 
not associated with growth measurements. This could suggest that early pregnancy is 
a particularly sensitive window to exposure. Early to mid-pregnancy is a time of rapid 
placental development that could be mediating these effects.
A third major difference between our study and those previously published is in exposure 
biomarker levels, which differ greatly across these populations. The average urinary DAP 
concentration in this study population was 312 nmol/g creatinine, whereas levels in most 
studies range from 10–100 nmol/g creatinine. Levels may be higher in the Generation 
R cohort participants due to a higher consumption of fruits in this study population or 
to the application of larger quantities of pesticides in farms in the Netherlands.13 The 
only study to note higher levels was the abovementioned study by Huang et al. (2017), 
which reported geometric mean concentrations of summed DMP and DEP metabolites 
as high as 569 and 282 nmol/g creatinine, respectively, in samples analyzed at 11 and 26 
weeks of gestation and at delivery. It is not apparent that studies with higher exposure 
levels are more likely to demonstrate an association with differences in birth outcomes at 
delivery; however, this might be difficult to detect if all members of the given population 
are more highly exposed.
Associations observed between urinary DAPs and fetal length and weight in mid-pregnancy 
were more pronounced in males compared with females. Similar sex differences have been 
observed in associations between this exposure and neurobehavioral deficits, with males 
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demonstrating stronger associations.50,51 Placental differences by sex, including epigenetic 
patterns,52 could influence the amount of the toxic compound that is transferred to the 
fetus and partially explain these differences. Alternatively, the differences observed may 
be due to the fact that the male fetus is more vulnerable to adverse pregnancy outcomes, 
particularly to perturbations during their rapid growth in early pregnancy.53,54
The findings from the present study may be difficult to interpret clinically because 
no associations were detected with size at delivery. However, differences in growth in 
early pregnancy may be crucial for health outcomes later in life. First-trimester growth 
restriction is associated with faster weight gain and adverse cardiovascular profiles in 
school-age children.55,56 This may be a particularly sensitive time in development, and 
the consequences of the associations we observed should be investigated in future work.
Our ability to detect differences in growth in association with exposure early in pregnancy 
could be due to methodological issues as well. Estimated fetal weight as calculated by a 
combination of ultrasound measures is subject to much more measurement error compared 
with birth weight.57 However, we would predict that this would lead to improved ability 
to detect associations between exposure and weight at delivery rather than early in 
pregnancy. Alternatively, because fetal weight gain occurs primarily in the third trimester, 
the influence of any error in the estimate of gestational age might be more pronounced 
toward the end of pregnancy. This could partially explain this difference in our findings 
based on timing of outcome measurement.
The primary limitation of this study is the nonspecificity of DAPs. Because OPs are 
metabolized rapidly, these biomarkers remain the best and most commonly used indices 
of total individual-level exposure.58 However, DAPs reflect human exposure to both the 
toxic compounds as well as their nontoxic metabolites, which are formed outside the 
body and can enter the human body through the same exposure routes as the parent 
compounds. Urinary concentrations of DAPs, therefore, may overestimate exposure to the 
toxic compounds of interest. This may mean, however, that the associations observed with 
DAPs in this and other studies may be lower than those that would have been observed 
with a better estimator of exposure.59
In general, our estimates of exposure are superior to those from other human studies 
because we measured spot urine concentrations of DAPs at three time points in pregnancy, 
creating subject-specific averages that may be a more stable reflection of exposure over 
time.35 Despite this improvement, the measurement error may have biased our effect 
estimates toward the null. Indeed, adjusting for measurement error with regression 
calibration resulted in effect estimates that were farther from the null but more imprecise, 
illustrating the known trade-off between bias and variance.60
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Our study was also limited by smaller sample sizes with available information on head 
circumference and body length on neonates. However, we handled missingness by imputing 
using the MICE procedure, which we previously showed was a suitable approach for 
fetal growth data.61 In addition, associations in an unimputed data set were very similar 
to those shown in our primary results, with the exception of the associations between 
DAPs and head circumference, which were closer to the null. Last, combining measures 
of fetal size with measures at delivery in repeated measures models may be problematic 
because they are measured differently and hence reflect different outcomes. This could be 
another explanation for the differences we observed between associations with ultrasound 
measurements in mid-pregnancy vs. anthropometric measurements at delivery. However, 
we also observed associations closer to the null at late pregnancy with measurements also 
taken by ultrasound, so we believe this is unlikely to be the case.
The major strengths of our study were the large sample size, the availability of three 
urinary measurements of DAP metabolites to assess exposure, and the use of repeated 
ultrasound scans that captured fetal size at multiple time points in pregnancy and in 
different parameters (e.g., length in addition to weight). This allowed us to investigate 
associations with OP exposure during gestation that have not been previously examined 
and enabled detection of decreased fetal growth in early pregnancy in association with 
exposure.
In summary, urinary biomarkers of OPs were inversely associated with length and weight 
in mid-pregnancy, with stronger associations observed for exposure biomarkers measured 
in urine samples collected during early and mid-pregnancy as well as with stronger 
associations observed in males compared with females. Future research should be directed 
toward improving the understanding of the consequence of these differences observed 
on health outcomes later in life.
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Table S1. Pearson correlations between log10 transformed DAP metabolite concentrations from 
early, middle, and late pregnancy as well as on average (N=784).
DAPs DEPs DMPs




Late 0.18 0.34 -
Mean 0.68 0.74 0.71 -
DEPs
Early 0.63 0.20 0.14 0.46 -
Mid 0.24 0.61 0.23 0.50 0.24 -
Late 0.16 0.30 0.61 0.50 0.15 0.27 -
Mean 0.40 0.41 0.33 0.53 0.61 0.64 0.59 -
DMPs
Early 0.97 0.23 0.16 0.65 0.47 0.20 0.14 0.31 -
Mid 0.24 0.98 0.34 0.72 0.17 0.47 0.28 0.34 0.22 -
Late 0.16 0.33 0.97 0.68 0.12 0.21 0.46 0.26 0.15 0.32 -
Mean 0.67 d0.72 0.70 0.98 0.37 0.41 0.42 0.43 0.67 0.73 0.70
Table S2. Main effects and interaction terms from adjusteda repeated measures models of  associ-
ations between pregnancy average urinary organophosphate pesticide metabolite concentrations 
and standard deviation scores of  fetal growth parameters measured during pregnancy by ultra-
sound and by clinical examination at delivery.
Main effect Interaction with gestational age
ß (95% CI) ß (95% CI)
Head circumference
Total DMPs -0.58 (-1.34, 0.19) 0.02 (0.00, 0.05)
Total DEPs -0.13 (-0.48, 0.22) 0.01 (-0.01, 0.02)
Total DAPs -0.51 (-1.32, 0.29) 0.02 (-0.01, 0.05)
Length
Total DMPs -1.20 (-1.86, -0.54)  0.04 (0.02, 0.06)
Total DEPs -0.39 (-0.70, -0.08) 0.01 (0.00, 0.02)
Total DAPs -1.33 (-2.00, -0.66) 0.04 (0.02, 0.06)
Weight
Total DMPs -0.60 (-1.15, -0.05) 0.02 (0.00, 0.03)
Total DEPs -0.32 (-0.57, -0.08) 0.01 (0.00, 0.02)
Total DAPs -0.68 (-1.24, -0.12) 0.02 (0.00, 0.04)
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (categori-
cal), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Models contain an inter-
action term between exposure concentration and gestational age at ultrasound/delivery, a random intercept for each 
participant, and a random slope for gestational age at ultrasound/delivery. Abbreviations: DMPs, dimethyl phosphates; 
DEPs, diethyl phosphates; DAPs, dialkyl phosphates; CI, confidence interval.
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Table S3. Adjusteda cross-sectional associations between pregnancy average urinary organophosp-
hate pesticide metabolite concentrations and standard deviation scores of  fetal growth parame-
ters measured during pregnancy by ultrasound and at delivery.
Total DMPs Total DEPs Total DAPs
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Head circumference
Middle pregnancy -0.06 (-0.36, 0.23) 0.03 (-0.10, 0.16) -0.06 (-0.36, 0.25)
Late pregnancy 0.01 (-0.28, 0.30) 0.02 (-0.11, 0.15) 0.04 (-0.26, 0.34)
Delivery 0.44 (-0.09, 0.98) 0.15 (-0.06, 0.37) 0.43 (-0.14, 1.00)
Length
Middle pregnancy -0.35 (-0.64, -0.06) -0.11 (-0.23, 0.02) -0.40 (-0.70, -0.10)
Late pregnancy -0.13 (-0.42, 0.15) -0.10 (-0.23, 0.02) -0.19 (-0.48, 0.11)
Delivery 0.20 (-0.20, 0.60) 0.01 (-0.18, 0.20) 0.17 (-0.24, 0.57)
Weight
Middle pregnancy -0.22 (-0.49, 0.05) -0.13 (-0.25, -0.01) -0.26 (-0.54, 0.01)
Late pregnancy -0.14 (-0.42, 0.14) -0.12 (-0.24, 0.01) -0.18 (-0.47, 0.11)
Delivery 0.02 (-0.28, 0.31) 0.00 (-0.14, 0.13) 0.00 (-0.31, 0.31)
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (categori-
cal), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Results represent associa-
tions from linear models of associations between pregnancy average organophosphate pesticide metabolite concentra-
tions and outcomes from middle pregnancy, late pregnancy, and delivery in separate models. Abbreviations: DMPs, 
dimethyl phosphates; DEPs, diethyl phosphates; DAPs, dialkyl phosphates; CI, confidence interval.
Table S4. Adjusteda cross-sectional associations between urinary organophosphate pesticide me-
tabolite concentrations measured in early pregnancy (<18 weeks of  gestation) and standard devi-
ation scores of  fetal growth parameters measured during pregnancy by ultrasound and at delivery.
Total DMPs Total DEPs Total DAPs
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Head circumference
Middle pregnancy -0.09 (-0.28, 0.10) -0.06 (-0.20, 0.08) -0.10 (-0.30, 0.10)
Late pregnancy -0.04 (-0.23, 0.15) 0.04 (-0.10, 0.18) -0.03 (-0.23, 0.17)
Delivery 0.14 (-0.19, 0.47) 0.16 (-0.08, 0.40) 0.18 (-0.17, 0.52)
Length
Middle pregnancy -0.23 (-0.42, -0.04) -0.21 (-0.34, -0.07) -0.29 (-0.49, -0.10)
Late pregnancy -0.10 (-0.29, 0.08) -0.13 (-0.26, 0.01) -0.16 (-0.36, 0.03)
Delivery 0.09 (-0.18, 0.36) -0.02 (-0.21, 0.16) 0.10 (-0.17, 0.37)
Weight
Middle pregnancy -0.18 (-0.36, -0.01) -0.14 (-0.26, -0.01) -0.22 (-0.40, -0.03)
Late pregnancy -0.12 (-0.31, 0.06) -0.19 (-0.32, -0.05) -0.19 (-0.38, 0.00)
Delivery -0.03 (-0.22, 0.17) -0.10 (-0.25, 0.04) -0.05 (-0.25, 0.15)
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (categori-
cal), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Results represent associa-
tions from linear models of associations between pregnancy average organophosphate pesticide metabolite concentra-
tions and outcomes from middle pregnancy, late pregnancy, and delivery in separate models. Abbreviations: DMPs, 
dimethyl phosphates; DEPs, diethyl phosphates; DAPs, dialkyl phosphates; CI, confidence interval.
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Table S5. Adjusteda cross-sectional associations between urinary organophosphate pesticide 
metabolite concentrations measured in middle pregnancy (18-25 weeks of  gestation) and standard 
deviation scores of  fetal growth parameters measured during pregnancy by ultrasound and at 
delivery.
Total DMPs Total DEPs Total DAPs
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Head circumference
Middle pregnancy 0.01 (-0.20, 0.22) 0.00 (-0.15, 0.14) 0.01 (-0.21, 0.23)
Late pregnancy 0.07 (-0.14, 0.27) 0.01 (-0.13, 0.15) 0.09 (-0.13, 0.30)
Delivery 0.34 (-0.09, 0.77) 0.07 (-0.15, 0.30) 0.31 (-0.13, 0.76)
Length
Middle pregnancy -0.15 (-0.35, 0.06) -0.17 (-0.31, -0.04) -0.20 (-0.41, 0.02)
Late pregnancy 0.01 (-0.19, 0.22) -0.09 (-0.23, 0.05) 0.00 (-0.22, 0.21)
Delivery 0.09 (-0.18, 0.37) 0.05 (-0.14, 0.23) 0.08 (-0.20, 0.37)
Weight
Middle pregnancy -0.09 (-0.28, 0.10) -0.18 (-0.31, -0.05) -0.14 (-0.33, 0.06)
Late pregnancy -0.02 (-0.22, 0.18) -0.09 (-0.22, 0.05) -0.01 (-0.22, 0.20)
Delivery 0.07 (-0.14, 0.28) 0.02 (-0.12, 0.16) 0.06 (-0.16, 0.28)
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (categori-
cal), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Results represent associa-
tions from linear models of associations between pregnancy average organophosphate pesticide metabolite concentra-
tions and outcomes from middle pregnancy, late pregnancy, and delivery in separate models. Abbreviations: DMPs, 
dimethyl phosphates; DEPs, diethyl phosphates; DAPs, dialkyl phosphates; CI, confidence interval.
Table S6. Adjusteda cross-sectional associations urinary organophosphate pesticide metabolite 
concentrations measured in late pregnancy (>25 weeks of  gestation) and standard deviation sco-
res of  fetal growth parameters measured during pregnancy by ultrasound and at delivery.
Total DMPs Total DEPs Total DAPs
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Head circumference
Late pregnancy 0.00 (-0.20, 0.19) 0.05 (-0.09, 0.19) 0.01 (-0.20, 0.21)
Delivery 0.16 (-0.16, 0.48) 0.04 (-0.23, 0.32) 0.15 (-0.19, 0.48)
Length
Late pregnancy -0.09 (-0.29, 0.10) -0.04 (-0.18, 0.11) -0.09 (-0.30, 0.11)
Delivery 0.09 (-0.19, 0.37) -0.09 (-0.30, 0.13) 0.05 (-0.24, 0.34)
Weight
Late pregnancy -0.05 (-0.24, 0.14) 0.03 (-0.11, 0.16) -0.04 (-0.24, 0.16)
Delivery -0.01 (-0.21, 0.19) 0.04 (-0.10, 0.19) 0.00 (-0.22, 0.21)
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (categori-
cal), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Results represent associa-
tions from linear models of associations between pregnancy average organophosphate pesticide metabolite concentra-
tions and outcomes from middle pregnancy, late pregnancy, and delivery in separate models. Abbreviations: DMPs, 
dimethyl phosphates; DEPs, diethyl phosphates; DAPs, dialkyl phosphates; CI, confidence interval.
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Table S7a. Adjusteda repeated measures associations between pregnancy average urinary dialkyl 
phosphate pesticide metabolite concentrations and standard deviation scores of  fetal growth 
parameters measured during pregnancy by ultrasound and at delivery in models stratified by 
PON1108 genotype.
TT CT CC
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Difference in SDS score  
(95% CI)
Head circumference
Middle pregnancy 0.10 (-0.76, 0.96) 0.03 (-0.52, 0.58) 0.03 (-0.52, 0.58)
Late pregnancy 0.31 (-0.55, 1.16) 0.13 (-0.26, 0.52) -0.03 (-0.50, 0.43)
Delivery 0.51 (-0.69, 1.71) 0.23 (-0.42, 0.88) 0.34 (-0.28, 0.97)
p (interaction)b 0.76
Length
Middle pregnancy -0.35 (-1.22, 0.53) -0.54 (-1.04, -0.04) -0.73 (-1.35, -0.11)
Late pregnancy 0.07 (-0.63, 0.78) -0.26 (-0.63, 0.12) -0.19 (-0.66, 0.29)
Delivery 0.50 (-0.59, 1.59) 0.03 (-0.47, 0.53) 0.36 (-0.28, 1.00)
p (interaction)b 0.62
Weight
Middle pregnancy -0.17 (-1.00, 0.67) -0.25 (-0.72, 0.23) -0.51 (-1.11, 0.09)
Late pregnancy -0.01 (-0.66, 0.64) -0.13 (-0.51, 0.24) -0.24 (-0.70, 0.22)
Delivery 0.15 (-0.73, 1.03) -0.02 (-0.50, 0.46) 0.03 (-0.50, 0.56)
p (interaction)b 0.86
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (cate-
gorical), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Models contain an 
interaction term between exposure concentration and gestational age at ultrasound/delivery, a random intercept for 
each participant, and a random slope for gestational age at ultrasound/delivery. Models of head circumference, femur 
length, and weight include measurements taken at delivery (head circumference, birth length, and birth weight, 
respectively). bp values for the interaction term between exposure concentration and genotype. Abbreviations: CI, 
confidence interval; SDS, standard deviation score.
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Table S7b. Adjusteda repeated measures associations between pregnancy average urinary dialkyl 
phosphate pesticide metabolite concentrations and standard deviation scores of  fetal growth 
parameters measured during pregnancy by ultrasound and at delivery in models stratified by 
PON1-161 genotype
GG CG CC
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Head circumference
Middle pregnancy -0.12 (-1.59, 1.35) -0.37 (-0.93, 0.20) 0.06 (-0.42, 0.55)
Late pregnancy 0.02 (-1.14, 1.18) -0.04 (-0.52, 0.43) 0.22 (-0.13, 0.57)
Delivery 0.16 (-1.39, 1.71) 0.28 (-0.46, 1.03) 0.37 (-0.16, 0.90)
p (interaction)b 0.47
Length
Middle pregnancy -0.92 (-2.36, 0.53) -1.01 (-1.61, -0.40) -0.23 (-0.67, 0.22)
Late pregnancy -0.56 (-1.66, 0.54) -0.28 (-0.71, 0.15) -0.03 (-0.38, 0.32)
Delivery -0.20 (-1.58, 1.17) 0.44 (-0.15, 1.03) 0.17 (-0.32, 0.66)
p (interaction)b 0.18
Weight
Middle pregnancy -0.36 (-1.62, 0.89) -0.67 (-1.19, -0.15) -0.05 (-0.47, 0.37)
Late pregnancy -0.24 (-1.31, 0.84) -0.30 (-0.75, 0.15) 0.01 (-0.32, 0.35)
Delivery -0.11 (-1.39, 1.17) 0.08 (-0.51, 0.67) 0.08 (-0.35, 0.51)
p (interaction)b 0.19
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (cate-
gorical), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Models contain an 
interaction term between exposure concentration and gestational age at ultrasound/delivery, a random intercept for 
each participant, and a random slope for gestational age at ultrasound/delivery. Models of head circumference, femur 
length, and weight include measurements taken at delivery (head circumference, birth length, and birth weight, 
respectively). bp values for the interaction term between exposure concentration and genotype. Abbreviations: CI, 
confidence interval; SDS, standard deviation score..
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Table S7c. Adjusteda repeated measures associations between pregnancy average urinary dialkyl 
phosphate pesticide metabolite concentrations and standard deviation scores of  fetal growth 
parameters measured during pregnancy by ultrasound and at delivery in models stratified by 
PON1-L55m genotype.
TT AT AA
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Head circumference
Middle pregnancy -0.03 (-1.05, 1.00) -0.43 (-1.02, 0.16) 0.14 (-0.39, 0.67)
Late pregnancy 0.46 (-0.36, 1.29) -0.03 (-0.50, 0.43) 0.14 (-0.27, 0.55)
Delivery 0.95 (-0.24, 2.13) 0.36 (-0.33, 1.06) 0.14 (-0.52, 0.80)
p (interaction)b 0.80
Length
Middle pregnancy -0.81 (-1.97, 0.35) -0.54 (-1.10, 0.03) -0.52 (-1.05, 0.00)
Late pregnancy -0.32 (-1.15, 0.51) -0.09 (-0.53, 0.35) -0.19 (-0.57, 0.20)
Delivery 0.24 (-0.93, 1.42) 0.36 (-0.21, 0.93) 0.15 (-0.38, 0.68)
p (interaction)b 0.93
Weight
Middle pregnancy -0.54 (-1.40, 0.32) -0.46 (-0.98, 0.06) -0.13 (-0.62, 0.35)
Late pregnancy -0.22 (-0.91, 0.46) -0.25 (-0.71, 0.20) -0.01 (-0.40, 0.38)
Delivery 0.09 (-0.83, 1.01) -0.04 (-0.66, 0.57) 0.11 (-0.40, 0.62)
p (interaction)b 0.39
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (categori-
cal), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Models contain an interac-
tion term between exposure concentration and gestational age at ultrasound/delivery, a random intercept for each par-
ticipant, and a random slope for gestational age at ultrasound/delivery. Models of head circumference, femur length, 
and weight include measurements taken at delivery (head circumference, birth length, and birth weight, respectively). 
bp values for the interaction term between exposure concentration and genotype. Abbreviations: CI, confidence in-
terval; SDS, standard deviation score. Note: Model for femur length under PON1-L55 would not converge and thus 
results presented are for model without inclusion of a random slope for gestational age at ultrasound/delivery.
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Table S7d. Adjusteda repeated measures associations between pregnancy average urinary dialkyl 
phosphate pesticide metabolite concentrations and standard deviation scores of  fetal growth 
parameters measured during pregnancy by ultrasound and at delivery in models stratified by 
PON1-909 genotype.
GG CG CC
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Head circumference
Middle pregnancy 0.22 (-0.72, 1.16) -0.02 (-0.56, 0.52) -0.36 (-0.99, 0.27)
Late pregnancy 0.41 (-0.25, 1.08) 0.08 (-0.39, 0.54) 0.04 (-0.49, 0.58)
Delivery 0.61 (-0.38, 1.59) 0.17 (-0.50, 0.84) 0.45 (-0.35, 1.24)
p (interaction)b 0.58
Length
Middle pregnancy -0.28 (-1.07, 0.51) -0.67 (-1.15, -0.19) -0.55 (-1.16, 0.06)
Late pregnancy 0.22 (-0.46, 0.91) -0.33 (-0.73, 0.06) -0.12 (-0.57, 0.33)
Delivery 0.73 (-0.27, 1.72) 0.00 (-0.54, 0.54) 0.32 (-0.35, 0.98)
p (interaction)b 0.39
Weight
Middle pregnancy -0.14 (-0.86, 0.59) -0.35 (-0.78, 0.07) -0.33 (-0.89, 0.22)
Late pregnancy 0.08 (-0.50, 0.67) -0.23 (-0.61, 0.16) -0.10 (-0.58, 0.39)
Delivery 0.30 (-0.53, 1.13) -0.10 (-0.65, 0.45) 0.13 (-0.50, 0.77)
p (interaction)b 0.74
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (cate-
gorical), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Models contain an 
interaction term between exposure concentration and gestational age at ultrasound/delivery, a random intercept for 
each participant, and a random slope for gestational age at ultrasound/delivery. Models of head circumference, femur 
length, and weight include measurements taken at delivery (head circumference, birth length, and birth weight, 
respectively). bp values for the interaction term between exposure concentration and genotype. Abbreviations: CI, 
confidence interval; SDS, standard deviation score.
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Table S7e. Adjusted repeated measures associations between pregnancy average urinary dialkyl 
phosphate pesticide metabolite concentrations and standard deviation scores of  fetal growth pa-
rameters measured during pregnancy by ultrasound and at delivery in models stratified by PON1 
Q192R genotype.
TT (QQ) CT (QR) CC (RR)
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Head circumference
Middle pregnancy -0.35 (-0.89, 0.18) -0.05 (-0.59, 0.49) 0.66 (-0.62, 1.95)
Late pregnancy 0.09 (-0.37, 0.55) -0.03 (-0.44, 0.39) 0.86 (-0.19, 1.91)
Delivery 0.53 (-0.21, 1.27) -0.01 (-0.56, 0.55) 1.05 (-0.26, 2.37)
p (interaction)b 0.20
Length
Middle pregnancy -0.69 (-1.24, -0.13) -0.42 (-0.92, 0.09) -0.63 (-2.12, 0.86)
Late pregnancy -0.13 (-0.54, 0.28) -0.18 (-0.55, 0.19) -0.07 (-1.16, 1.02)
Delivery 0.43 (-0.18, 1.03) 0.06 (-0.45, 0.57) 0.49 (-1.15, 2.13)
p (interaction)b 0.90
Weight
Middle pregnancy -0.47 (-0.95, 0.01) -0.20 (-0.68, 0.28) -0.30 (-1.57, 0.97)
Late pregnancy -0.18 (-0.59, 0.24) -0.20 (-0.57, 0.16) 0.27 (-0.80, 1.34)
Delivery 0.11 (-0.43, 0.65) -0.21 (-0.66, 0.24) 0.84 (-0.75, 2.43)
p (interaction)b 0.35
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (cate-
gorical), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Models contain an 
interaction term between exposure concentration and gestational age at ultrasound/delivery, a random intercept for 
each participant, and a random slope for gestational age at ultrasound/delivery. Models of head circumference, femur 
length, and weight include measurements taken at delivery (head circumference, birth length, and birth weight, 
respectively). bp values for the interaction term between exposure concentration and genotype. Abbreviations: CI, 
confidence interval; SDS, standard deviation score.
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Table S8. Unadjusteda repeated measures associations between pregnancy average urinary organ-
ophosphate pesticide metabolite concentrations and standard deviation scores of  fetal growth 
parameters measured during pregnancy by ultrasound and at delivery.
Total DMPs Total DEPs Total DAPs
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Head circumference
Middle pregnancy -0.13 (-0.45, 0.20) 0.00 (-0.15, 0.15) -0.10 (-0.44, 0.23)
Late pregnancy 0.11 (-0.14, 0.35) 0.06 (-0.05, 0.18) 0.11 (-0.14, 0.37)
Delivery 0.34 (-0.06, 0.75) 0.13 (-0.06, 0.32) 0.33 (-0.10, 0.76)
Length
Middle pregnancy  -0.57  (-0.87, -0.28)  -0.20 (-0.34, -0.06)  -0.65  (-0.96, -0.35)
Late pregnancy -0.20 (-0.42, 0.02) -0.09 (-0.20, 0.01) -0.25 (-0.48, -0.03)
Delivery 0.17 (-0.15, 0.50) 0.02 (-0.14, 0.17) 0.15 (-0.18, 0.48)
Weight
Middle pregnancy -0.36 (-0.63, -0.09) -0.18 (-0.30, -0.06) -0.41 (-0.68, -0.13)
Late pregnancy -0.19 (-0.40, 0.02) -0.10 (-0.20, 0.00) -0.22 (-0.44, 0.00)
Delivery -0.02 (-0.30, 0.26) -0.02 (-0.15, 0.11) -0.04 (-0.33, 0.25)
a Models contain an interaction term between exposure concentration and gestational age at ultrasound/delivery, a 
random intercept for each participant, and a random slope for gestational age at ultrasound/delivery. Abbreviations: 
DMPs, dimethyl phosphates; DEPs, diethyl phosphates; DAPs, dialkyl phosphates; CI, confidence interval.
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Table S9. Adjusteda repeated measures associations between pregnancy average urinary organ-
ophosphate pesticide metabolite concentrations and standard deviation scores of  fetal growth 
parameters measured during pregnancy by ultrasound and at delivery in dataset without outcome 
imputed.
Total DMPs Total DEPs Total DAPs
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Difference in SDS score 
(95% CI)
Head circumference
Middle pregnancy -0.03 (-0.35, 0.30) 0.02 (-0.13, 0.16) -0.01 (-0.34, 0.33)
Late pregnancy 0.01 (-0.23, 0.25) 0.05 (-0.06, 0.16) 0.02 (-0.23, 0.27)
Delivery 0.04 (-0.35, 0.44) 0.09 (-0.10, 0.28) 0.05 (-0.35, 0.44)
Length
Middle pregnancy -0.46 (-0.78, -0.15) -0.18 (-0.32, -0.04) -0.54 (-0.86, -0.22)
Late pregnancy -0.17 (-0.40, 0.06) -0.08 (-0.18, 0.02) -0.21 (-0.44, 0.02)
Delivery 0.12 (-0.23, 0.47) 0.02 (-0.13, 0.17) 0.12 (-0.24, 0.48)
Weight
Middle pregnancy -0.29 (-0.57, -0.02) -0.17 (-0.29, -0.05) -0.34 (-0.62, -0.06)
Late pregnancy -0.12 (-0.34, 0.09) -0.09 (-0.19, 0.01) -0.16 (-0.38, 0.07)
Delivery 0.05 (-0.23, 0.32) -0.01 (-0.14, 0.11) 0.03 (-0.26, 0.31)
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (categori-
cal), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Models contain an inter-
action term between exposure concentration and gestational age at ultrasound/delivery, a random intercept for each 
participant, and a random slope for gestational age at ultrasound/delivery. Abbreviations: DMPs, dimethyl phosp-
hates; DEPs, diethyl phosphates; DAPs, dialkyl phosphates; CI, confidence interval. N=784 for all models since each 
participant had at least one outcome measurement; however, the number of observations at each time point differed 
as follows: head circumference (n=774 for middle pregnancy; n=777 for late pregnancy; n=478 for delivery); length 
(n=779 for middle pregnancy; n=784 for late pregnancy; n=562 for delivery); weight (n=777 for middle pregnancy; 
n=782 for late pregnancy; n=784 for delivery).
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Table S10. Adjusteda repeated measures associations between mutually adjusted pregnancy aver-
age urinary dimethyl phosphate and diethyl phosphate pesticide metabolite concentrations and 
standard deviation scores of  fetal growth parameters measured during pregnancy by ultrasound 
and at delivery.
Total DMPs Total DEPs
Difference in SDS score (95% CI) Difference in SDS score (95% CI)
Head circumference
Middle pregnancy -0.17 (-0.51, 0.17) -0.01 (-0.16, 0.14)
Late pregnancy 0.06 (-0.20, 0.32) 0.06 (-0.06, 0.17)
Delivery 0.29 (-0.12, 0.71) 0.12 (-0.07, 0.31)
Length
Middle pregnancy -0.45 (-0.77, -0.14) -0.17 (-0.31, -0.03)
Late pregnancy -0.08 (-0.32, 0.16) -0.06 (-0.17, 0.05)
Delivery 0.29 (-0.04, 0.63) 0.05 (-0.11, 0.21)
Weight
Middle pregnancy -0.23 (-0.51, 0.06) -0.16 (-0.29, -0.03)
Late pregnancy -0.06 (-0.29, 0.17) -0.08 (-0.18, 0.02)
Delivery -0.15 (-0.93, 0.64) 0.00 (-0.13, 0.13)
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (categori-
cal), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Models contain an inter-
action term between exposure concentration and gestational age at ultrasound/delivery, a random intercept for each 
participant, and a random slope for gestational age at ultrasound/delivery. Abbreviations: DMPs, dimethyl phosphates; 
DEPs, diethyl phosphates; CI, confidence interval.
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Table S11. Adjusteda repeated measures associations between pregnancy average urinary dialkyl 
phosphate concentrations and standard deviation scores of  fetal growth parameters measured 
during pregnancy by ultrasound and at delivery with the application of  regression calibration.
Primary modelb Regression calibrationb
Difference in SDS score (95% CI) Difference in SDS score (95% CI)
Head circumference
Middle pregnancy -0.15 (-0.47, 0.17) -0.54 (-1.72, 0.64)
Late pregnancy 0.07 (-0.17, 0.30) 0.26 (-0.61, 1.24)
Delivery 0.28 (-0.04, 0.61) 1.05 (-0.14, 2.45)
Length
Middle pregnancy -0.57 (-0.88, -0.26) -2.11 (-3.24, -0.97)
Late pregnancy -0.17 (-0.40, 0.06) -0.64 (-1.48, 0.21)
Delivery 0.22 (-0.09, 0.54) 0.83 (-0.32, 1.99)
Weight
Middle pregnancy -0.33 (-0.61, -0.05) -1.22 (-2.26, -0.19)
Late pregnancy -0.15 (-0.37, 0.07) -0.56 (-1.37, 0.25)
Delivery 0.03 (-0.25, 0.31) -0.11 (-0.93, 1.15)
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (cate-
gorical), folic acid use (categorical), and gestational age at ultrasound or delivery (continuous). Models contain an 
interaction term between exposure concentration and gestational age at ultrasound/delivery, a random intercept for 
each participant, and a random slope for gestational age at ultrasound/delivery.
b Results from 1 imputed dataset and thus differ slightly from results in Table 4.
Abbreviation: CI, confidence interval.
Table S12. Adjusteda repeated measures associations between pregnancy average urinary dialkyl 
phosphate concentrations and standard deviation scores of  fetal growth parameters measured 
during pregnancy by ultrasound and at delivery with marital status and family income included 
as covariates.
Total DAPs
Difference in SDS score (95% CI)
Head circumference
Middle pregnancy -0.15 (-0.48, 0.19)
Late pregnancy 0.07 (-0.19, 0.33)
Delivery 0.28 (-0.15, 0.72)
Length
Middle pregnancy  -0.58  (-0.89, -0.26)
Late pregnancy -0.18 (-0.41, 0.06)
Delivery 0.22 (-0.11, 0.56)
Weight
Middle pregnancy -0.35 (-0.64, -0.07)
Late pregnancy -0.17 (-0.40, 0.05)
Delivery 0.01 (-0.28, 0.29)
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (categori-
cal), folic acid use (categorical), gestational age at ultrasound or delivery (continuous), marital status (categorical), and 
household income (categorical). Models contain an interaction term between exposure concentration and gestational 
age at ultrasound/delivery, a random intercept for each participant, and a random slope for gestational age at ultra-
sound/delivery. Abbreviations: DMPs, dimethyl phosphates; DEPs, diethyl phosphates; DAPs, dialkyl phosphates; CI, 
confidence interval.
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Table S13. Adjusteda cross-sectional associations between early pregnancy urinary dialkyl phosp-
hate concentrations and standard deviation scores of  fetal growth parameters measured during 
pregnancy by ultrasound and at delivery with season of  sample collection included as a covariate.
Total DAPs
Difference in SDS score (95% CI)
Head circumference
Middle pregnancy -0.10 (-0.30, 0.10)
Late pregnancy -0.03 (-0.23, 0.17)
Delivery 0.14 (-0.29, 0.57)
Length
Middle pregnancy -0.30 (-0.49, -0.10)
Late pregnancy -0.15 (-0.35, 0.05)
Delivery 0.05 (-0.21, 0.32)
Weight
Middle pregnancy -0.22 (-0.41, -0.03)
Late pregnancy -0.18 (-0.37, 0.01)
Delivery -0.05 (-0.25, 0.15)
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (categori-
cal), folic acid use (categorical), gestational age at ultrasound or delivery (continuous), and season of early pregnancy 
urine sample collection. Abbreviations: DMPs, dimethyl phosphates; DEPs, diethyl phosphates; DAPs, dialkyl phosp-
hates; CI, confidence interval.
Table S14. Adjusteda repeated measures associations between pregnancy average urinary dialkyl 
phosphate concentrations and standard deviation scores of  fetal growth parameters measured 
during pregnancy by ultrasound and at delivery among term births (>=37 weeks) only.
Total DAPs
Difference in SDS score (95% CI)
Head circumference
Middle pregnancy -0.15 (-0.49, 0.19)
Late pregnancy 0.05 (-0.23, 0.32)
Delivery 0.24 (-0.26, 0.75)
Length
Middle pregnancy -0.62 (-0.94, -0.30)
Late pregnancy -0.23 (-0.47, 0.00)
Delivery 0.16 (-0.17, 0.49)
Weight
Middle pregnancy -0.37 (-0.66, -0.09)
Late pregnancy -0.21 (-0.43, 0.02)
Delivery -0.04 (-0.32, 0.25)
a Models adjusted for fetal sex, maternal age (continuous), pre-pregnancy weight (continuous), height (continuous), 
education level (categorical), ethnicity (categorical), parity (categorical), smoking (categorical), alcohol use (categori-
cal), folic acid use (categorical), gestational age at ultrasound or delivery (continuous), marital status (categorical), and 
household income (categorical). Models contain an interaction term between exposure concentration and gestational 
age at ultrasound/delivery, a random intercept for each participant, and a random slope for gestational age at ultra-




Figure S1. Flow chart from the overall Generation R study population to the participants included in the 
present study.
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Figure S2. Adjusted cross-sectional associations between visit-specific total dimethyl phosphate (DMP) 
concentrations and standard deviation scores of fetal growth parameters measured during pregnancy by 
ultrasound and by clinical examination at delivery. Model adjusted for fetal sex, maternal age (continuous), 
pre-pregnancy weight (continuous), height (continuous), education level (categorical), maternal ethnicity 
(categorical), parity (categorical), smoking (categorical), alcohol use (categorical), folic acid use (categorical), 
and gestational age at ultrasound or delivery (continuous). Abbreviations: DAPs, dialkyl phosphates; CI, 
confidence interval.
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
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Figure S3. Adjusted cross-sectional associations between visit-specific total diethyl phosphate (DEP) 
concentrations and standard deviation scores of fetal growth parameters measured during pregnancy by 
ultrasound and by clinical examination at delivery. Model adjusted for fetal sex, maternal age (continuous), 
pre-pregnancy weight (continuous), height (continuous), education level (categorical), maternal ethnicity 
(categorical), parity (categorical), smoking (categorical), alcohol use (categorical), folic acid use (categorical), 
and gestational age at ultrasound or delivery (continuous). Abbreviations: DAPs, dialkyl phosphates; CI, 
confidence interval.
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
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Women and men are universally exposed to a broad range of chemicals present in consumer 
products.1,2 Phthalates and bisphenols are synthetic compounds which exist in numerous 
products such as cosmetics and food packaging materials.1,3,4 Organophosphate (OP) 
pesticides are insecticides that are commonly used for crop protection, and exposure occurs 
readily through the diet.3-5 Because these non-persistent chemicals may occur in many 
different combinations and concentrations in a variety of products, all men and women, 
including pregnant women, are exposed to a complex chemical mixture. The fetal brain 
can be exposed to these chemicals as they have the ability to surpass the placenta and 
blood–brain barrier.6,7 Animal studies have linked low-dose exposure to these chemicals 
during pregnancy to adverse effects on the neurodevelopment of the offspring. In some 
cases, the few epidemiological studies investigating fetal exposure to these chemical groups 
are suggestive of an effect on neurodevelopment but are overall inconclusive.
The present thesis examined the relationship between prenatal exposure to phthalates, 
bisphenols, and OP pesticides and neurodevelopment in children by studying (i) the 
determinants of exposure to non-persistent chemicals during pregnancy, (ii) exploring the 
association of prenatal exposure to non-persistent chemicals with neurodevelopment in 
children, and (iii) investigating the effect of exposure to these non-persistent chemicals on 
the potential mediators—such as thyroid function, brain structure, and fetal growth—of 
the association with neurodevelopment. These aims were explored using data from the 
Generation R Study, that is advantageous by having a large sample size; detailed follow-up 
information of prenatal and postnatal development of the fetus and child, respectively; 
multiple measurements (early, mid-, and late pregnancy) of exposure to non-persistent 
chemicals across gestation; and availability of detailed demographic information. In this 
general discussion, the main findings per chapter are presented in brief before discussing 
the methodological considerations. Then, the implications of this research, future directions 
for the field, and the conclusion are presented.
Main findings
Determinants of  exposure to non-persistent chemicals
The identification of the potential sources and routes of exposure to non-persistent chemicals 
is particularly useful for future health risk management strategies and intervention studies 
aimed at reducing exposure. Moreover, identifying potential determinants of exposure 
to non-persistent chemicals helps to understand which possible confounders may exist 




Phthalate and bisphenol concentrations were frequently determined in maternal urinary 
samples. The concentrations observed in the Generation R Study participants were similar 
to those observed in other Western studies from the same time period.8 However, OP 
pesticide concentrations were 2–3 fold higher than those in most other studies previously 
conducted (Chapter 2). The relatively high OP pesticide exposure in our study may 
be related to the high consumption of fruits and the intense farming practices in the 
Netherlands. The fruit and vegetable intake of our study sample in the Dutch population 
(median of 295 g/day) was higher as compared to that of nationally representative 
women of reproductive age from the United States (median of 167 g/day) where most 
other studies were conducted.9,10 Furthermore, approximately 50% of the surface area 
of the Netherlands is used for agricultural purposes, and more pesticides and fertilizers 
per km2 of farmland are applied compared with most other OECD countries such as 
the United States.11 Whether dietary patterns and intense farming activities increase the 
level of OP pesticide exposure through the consumption of food products cannot be 
confirmed. However, between 1998 and 2008, approximately one-third of all insecticides 
used in the Netherlands were OP pesticides12, and detectable OP pesticide residues were 
found on a large proportion of fruits and vegetables tested between 2004 and 2006 in 
the Netherlands.13
Lifestyle- and socioeconomic status (SES)-related factors were associated with phthalate, 
bisphenol, and OP pesticide exposure concentrations in pregnant women, and the 
direction of the effect differed per chemical class.8 For example, a body mass index (BMI) 
of >30 kg/m2 and no folic acid supplement intake were predictive of higher phthalate 
and bisphenol concentrations, and a lower educational level was predictive of higher 
phthalate and bisphenol concentrations. In contrast, protective lifestyle and higher 
SES characteristics, such as having a healthy BMI, being married, being a non-smoker 
during pregnancy, and having a high education level and high income, were associated 
with higher OP pesticide exposure levels. It is conceivable that these associations with 
lifestyle and SES factors are driven by their relationship with the use of consumer goods 
and a healthier diet. SES is associated with food-purchasing patterns14,15 and higher SES 
is predictive of higher consumption of fruit and vegetables16-18, an important source of 
OP pesticide exposure.5 Moreover, pregnant women with low SES may consume more 
canned and packaged products, which results in higher phthalate and bisphenol exposure 
levels through contact with food packaging materials19 because fresh products with a 
short expiration are often more expensive. Additionally, fat-rich diets are predictive of 
high concentrations of phthalates20,21, which may explain why women with overweight 
had higher phthalate concentrations.
Furthermore, the intake of several dietary products was weakly associated with phthalate 
and bisphenol concentrations. For example, women who showed the highest 10% of soft 
Chapter 11
390
drink consumption had higher phthalate concentrations, but these associations were not 
observed after multiple testing correction. However, we found that higher dietary intake 
of fruits was a strong predictor of higher OP pesticide concentrations. This is consistent 
with the observation that OP pesticide residues have frequently been detected on and in 
fruits, which are, therefore, an important source of exposure.5,13
The present study provides useful insights into the potential determinants of exposure 
to non-persistent chemicals and may help to identify the potential sources and routes of 
exposure to non-persistent chemicals. However, the study could have been strengthened 
by the collection of data on factors such personal care product use, vinyl flooring in 
households, and the consumption of packaged versus non-packaged food items. Regarding 
OP pesticides, the exposure generally occurs through the consumption of food. However, 
information on the use of pest control items and the consumption of organic versus 
non-organic food items are such informative factors. These data would be useful in the 
detection of more potential sources and routes of exposure to non-persistent chemicals 
and potentially help in the development of targeted interventions aimed to reduce the 
exposure levels.
Taken all together, these findings demonstrate not only that non-persistent chemicals 
are frequently detected among pregnant women in the Netherlands but also that OP 
pesticide metabolite concentrations in this population were higher than those reported 
in most other birth cohort studies. Furthermore, this research shows that several lifestyle 
and SES factors are associated with exposure concentrations and that the direction of the 
association varies for the chemical classes. Moreover, this work strengthens the hypothesis 
that dietary intake is predictive of OP pesticide exposure among women living in an 
urban environment. The next subsections will describe the potential effects of prenatal 
exposure to phthalates, bisphenols, and OP pesticides on offspring neurodevelopment.
Exposure to non-persistent chemicals and neurodevelopment in children
As a second aim, we explored the association between prenatal exposure to non-persistent 
chemicals and neurodevelopment in children. Chapters 3 (phthalates and bisphenols) and 
4 (OP pesticides) explored the association between prenatal exposure to non-persistent 
chemicals and cognition as measured by the Snijders-Oomen non-verbal intelligence 
test–revise score. Chapter 5 investigated whether OP pesticide exposure is associated 
with autistic traits and attention-deficit hyperactivity disorder (ADHD) in children. 
The results from this study make several important contributions to the existing body of 
literature on environmental exposure and neurodevelopment.
First, a 10-fold higher phthalate exposure during early pregnancy was consistently associated 




observed in this study for exposure in late pregnancy and mean exposure across pregnancy. 
These results are important because all other previous studies assessing prenatal phthalate 
exposure during pregnancy and IQ have examined the exposure during mid- or late 
pregnancy and, therefore, may explain why these studies have reported diverse findings.22-26
Similarly, we found that only the late-pregnancy concentrations of the metabolite 
mono(3-carboxypropyl) phthalate were predictive of lower non-verbal IQ and observed 
no association between non-verbal IQ and other mid- and late-pregnancy phthalate 
metabolite concentrations. Although the critical window(s) of fetal neurotoxicity of 
phthalates is uncertain and future studies should confirm these findings, our findings 
propose that early pregnancy is a susceptible period.
Second, the present study is one of the first to explore the cognitive effects of prenatal 
exposure to bisphenol A and its substitutes bisphenol F and bisphenol S. Only one previous 
study has examined the effects of early-gestational exposure to a mixture of chemicals 
with endocrine disrupting properties such as bisphenols and identified bisphenol F as 
an important driver of the overall mixture effect on reduced IQ.27 Industries exploring 
alternatives for bisphenol A owing to political and consumer pressure use other bisphenols 
to produce bisphenol A-free products.28 Studies have shown that bisphenol F and bisphenol 
S also have endocrine-disrupting effects,29,30 and studies have revealed that prenatal 
bisphenol S has the potential to generate hypothalamic neurogenesis.31 Though, our 
study did not observe an association between bisphenol exposure during pregnancy and 
non-verbal IQ. More research is needed to confirm these null findings, especially because 
the exposure to bisphenol S and F included in this study occurred in 2004–2006; health 
concerns associated with bisphenol A have been growing since and have resulted in an 
increased use of bisphenol S and F as substitutes.32
Third, we found that a 10-fold higher OP pesticide exposure during late-pregnancy 
was associated with 4.3-point decrease in non-verbal IQ. Exposure in early and mid-
pregnancy and mean exposure across pregnancy were not associated with non-verbal 
IQ. A similar association was observed among 7-year-old children living in the Salinas 
Valley of Monterey County, California (CHAMACOS cohort). A log10 increase in OP 
pesticide concentrations measured in late pregnancy was predictive of 3.5-point lower IQ 
score in this study.33 This suggests that late pregnancy is a potential susceptible window 
for neurotoxic effects of OP pesticide exposure. However, more studies are needed to 
replicate these results.
Fourth, despite a large body of literature from both animal and epidemiological studies 
linking prenatal OP exposure to various behavioral outcomes, we found that OP pesticide 
exposure was not associated with ADHD or autistic traits in children. In this research, we 
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used the Child Behavior Checklist (CBCL) to measure children’s ADHD symptoms at 3 
years, 6 years, and 10 years of age. At the child age of 6 years, the Social Responsiveness 
Scale (SRS) was used to assess autistic traits. These null findings are important because 
of the extensive follow-up of behavior problems of children in this study, the fairly high 
background exposure levels of OP pesticides during gestation, and the large size of the 
study sample.
The observed inverse associations between phthalate and OP pesticide exposure during 
pregnancy and non-verbal IQ were different in different time windows of exposure. A 
potential mechanism that may explain the inverse association between early-pregnancy 
exposure to phthalates and non-verbal IQ is the disturbance of the thyroid hormone 
system.34 Thyroid hormones are crucial for normal fetal brain development.35 Notably, 
the earliest stages of brain development are the most susceptible to a disturbed supply of 
thyroid hormones.36 During this period, the fetus is unable to produce thyroid hormones 
by itself and depends entirely on the maternal thyroid hormones crossing the placental 
barrier.37,38 Indeed, studies have shown that prenatal exposure to phthalates— including 
that in early pregnancy—is related to alterations in circulating thyroid hormone levels and 
reduced thyroid function,39-42 which are well-known determinants of the neurodevelopment 
of the offspring.43 For instance, a previous study using data from the Generation R Study 
observed an association between early pregnancy maternal thyroid function and offspring 
neurodevelopment.44 The investigation of the potential effects of phthalate and bisphenol 
exposure on thyroid function using data from the Generation R Study is underway. Future 
studies should investigate the potential mediating role of thyroid function in the association 
between prenatal phthalate exposure and offspring IQ. Regarding OP pesticides, the 
present study found late-pregnancy exposure to be associated with non-verbal IQ. Robust 
literature from animal studies suggests that OP pesticide exposure during development 
at fairly low-dose levels has neurotoxic effects.45,46 The third trimester is a crucial period 
for normal brain development; during this timeframe, the brain increases four times in 
size, resulting in a significant increase in brain surface area with the formation of tertiary 
sulci and gyri.47 Many biological processes such as neuronal organisation48,49 occur 
during this period, and interference by chemical insults such as OP pesticides during 
this developmental phase may result in adverse neurodevelopmental outcomes. Further 
research should be carried out to confirm the observation that late-pregnancy exposure 
to OP pesticides is associated with cognition, especially because some other studies do 
not report an inverse association with IQ.50,51
In summary, we observed that phthalate and OP pesticide exposure during pregnancy 
were predictive of non-verbal IQ and that these inverse associations varied with the time 




with child non-verbal IQ. Furthermore, high gestational OP pesticide exposure was not 
associated with ADHD or autistic traits.
Exposure to non-persistent chemicals and brain structure, thyroid 
function, and fetal growth.
Because considerable uncertainty exists about which mechanisms underlie the observed 
associations between exposure to non-persistent chemicals and neurodevelopment, we 
explored whether prenatal exposure to these chemicals are associated with two important 
determinants of neurodevelopment and a direct assessment of neurodevelopment: thyroid 
function, brain structure, and fetal growth.
Thyroid function
Phthalates, bisphenols, and OP pesticides are endocrine-disrupting chemicals. Animal 
studies suggest that prenatal exposure to these chemicals affects thyroid function, but 
few studies have investigated these associations in humans.
As described above, exposure during pregnancy is particularly interesting because thyroid 
hormones are crucial for brain development during gestation. These chemicals have the 
ability to surpass the placental and blood–brain barrier and may disturb the thyroid 
hormone metabolism and thereby impact fetal development processes regulated by 
these hormones. This work investigated the association between prenatal OP pesticide 
exposure with first-trimester maternal and cord blood thyroid hormone concentrations 
(Chapter 6). In maternal and cord blood the free thyroxine (FT4) and thyroid-stimulating 
hormone (TSH) were determined. Further, first trimester maternal TPO antibodies 
(TPOAbs) and total thyroxine (TT4) were also measured. We found that prenatal OP 
pesticide exposure was not related to first-trimester maternal FT4, TSH, TPOAb, and 
TT4 concentrations. The onset of thyroid function in the human fetus occurs around 
16–20 weeks of gestation.37,52 Thus, during this early period of gestation, the fetus is 
dependent on the active transport of maternal thyroid hormone across the placenta. The 
absence of an association between prenatal OP pesticide exposure and first-trimester 
maternal thyroid concentrations may, therefore, indicate that first-trimester maternal 
thyroid function does not mediate the association between early-pregnancy OP pesticide 
exposure and neurodevelopment. Indeed, no association was observed between early-
pregnancy OP pesticide exposure and non-verbal IQ, ADHD, and autistic traits. Similar 
to maternal thyroid concentrations, cord blood concentrations of TSH and FT4 showed 
no association with prenatal OP pesticide exposure. These results do not provide evidence 
for mediation by fetal thyroid function in the effect of prenatal OP pesticide exposure 
on offspring neurodevelopment and indicate that other mechanisms play a role in the 
observed association between late-pregnancy OP pesticide exposure and non-verbal IQ. 
As stated previously, studies investigating the potential effects of phthalate and bisphenol 
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exposure on thyroid function using data from the Generation R Study are ongoing. An 
additional study should be carried out to explore the mediating role of thyroid function 
in the association between prenatal phthalate exposure and offspring IQ.
Brain structure
Rauh and Margolis emphasize in their seminal research review that we lack an understanding 
of the brain alterations underlying the associations between prenatal exposure to 
environmental chemicals and neurodevelopment.53 This review expressed the need for 
direct assessments of brain measurements via neuroimaging in environmental exposure 
studies to investigate such potential brain alterations. The Generation R Study performed 
magnetic resonance imaging in 9–12-year-old children to obtain T1-weighted images to 
estimate brain volume and surface-based cortical thickness and surface area and diffusion 
tensor images to measure white matter microstructure. We investigated whether prenatal 
exposure to phthalates (chapter 7) and OP pesticides (chapter 8) was associated with 
these brain measures.
Higher maternal urinary concentrations of the metabolite monoethyl phthalate was 
associated with lower total gray matter volume and that higher mono-isobutyl phthalate 
concentrations were associated with higher thalamic volume. Furthermore, higher 
maternal urinary concentrations of the metabolites monobenzyl phthalate and mCPP 
were predictive of thicker inferior parietal and mediolateral temporal cortices in the 
left hemisphere. There was no association between phthalate exposure and measures of 
white matter microstructure. Moreover, a higher mean exposure to OP pesticides across 
pregnancy was associated with lower white matter microstructure, and these associations 
were mainly driven by the early- and mid-pregnancy exposure. No associations were 
observed with structural brain morphology, including brain volume, cortical thickness, 
or cortical surface area. Notably, research to investigate the association between prenatal 
bisphenol exposure and brain morphology and white matter microstructure using data 
from the Generation R Study is currently in progress.
These findings suggest that phthalates and OP pesticides, at standard doses of exposure, 
contribute to altered brain development in children. However, further studies on brain 
imaging are warranted to test the reproducibility of these results, especially because the 
effect size for phthalate exposure was generally small and, as a consequence of having a 
broad range of metabolites and multiple brain structural outcomes, the number of tests 
performed were high. However, multiple testing correction may reveal whether some of 
these results are false positive (i.e., type 1 error). Furthermore, future work will investigate 
the mediating role of structural brain alterations (measured at 9 years) in the effect of 




(measured at 13 years). This work will be performed when the IQ data of the children 
collected at 13 years of age are ready to use.
Fetal growth
Finally, we investigated whether exposure to non-persistent chemicals was associated 
with fetal growth. Altered growth during fetal development might be related to poor 
health in childhood and throughout the lifespan, including poor neurodevelopmental 
outcomes.54,55 We found that prenatal exposure to OP pesticides was predictive of lower 
fetal length and weight measured during mid-pregnancy, though no association was 
observed at birth (chapter 9). These results were confirmed by our follow-up study in 
which we assessed the association between prenatal exposure to a mixture of phthalates, 
bisphenols, and OP pesticides and measures of fetal growth (chapter 10). The results 
indicated that prenatal exposure to this mixture was predictive of lower fetal size, as 
assessed by length and weight measures. Analyses of individual chemical classes revealed 
that the phthalate and OP pesticide mixtures drove the association of the overall mixture. 
Associations were non-linear, and the nature of the non-linearity differed when weight 
measurements were considered. For estimated fetal weight measured by ultrasound at 
18–25 weeks, the largest difference was observed in the lower exposure range (i.e., going 
from only the first to the second quartile). A similar pattern was observed for weight at 
>25 weeks. For birth weight, however, the largest difference was observed in the higher 
overall exposure range (i.e., going from the third to the fourth quartile). Fetal growth 
changes during specific periods of pregnancy may differentially impact childhood health 
outcomes and may also exhibit differences in susceptibility to environmental chemical 
exposure. Decreased fetal development in early gestation might be critical for health 
consequences in childhood. For example, early pregnancy restricted fetal growth is linked 
to accelerated weight gain and poorer cardiovascular outcomes in children.56,57 On the 
other hand, differences in birth weight were only apparent at high levels of exposure. 
Lower birth weight is associated with numerous health outcomes.58,59 The observation that 
only high levels of exposure were associated with lower birth weight may indicate that fat 
mass gain from late pregnancy until birth is not as susceptible to the effect of exposure to 
non-persistent chemicals as weight gain during the first and second trimester. However, 
future studies including gestational fetal growth parameters are warranted to confirm 
our observations, especially because most previous studies of exposure to non-persistent 
chemicals and fetal growth have used growth parameters at birth only, whereas our study 
also included ultrasound measures in pregnancy and found effects of a chemical mixture 
on gestational fetal weight.
Taken together, these results demonstrate that prenatal exposure to phthalates and OP 
pesticides is associated with brain structural alterations and reduced fetal weight, which 
occur in different periods of pregnancy. As these exposures may be modifiable, these 
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findings have implications for preventing potential brain alterations in children and 
growth restriction in pregnancy. However, further research is needed to confirm our results.
Methodological considerations
The strengths and limitations of each study included in this thesis have been described in 
detail in the previous chapters. In this section, we will discuss the general methodological 
considerations regarding the measurement error inherent in the exposure biomarkers 
used in this work, timing of the measurement and periods of heightened susceptibility, 
analyses of repeated exposure measures, and the paradigm shift in risk assessment from 
the individual substance approach to the chemical mixture approach. These are important 
issues and should be considered in existing and future population studies regarding the 
association of prenatal exposure to non-persistent chemicals and child health outcomes.
Measurement error
To estimate the potential health impact of phthalates, bisphenols, and OP pesticides, 
an precise assessment of an exposure during a meaningful time window is required.60 
Most studies investigating the neurodevelopmental effects of exposure to non-persistent 
chemicals during pregnancy have depended on exposure concentrations measured in 
1 or 2 spot urine samples. However, these chemicals are characterized by a brief half-
life and are excreted in urine after only 1 or 2 days. This indicates that the biomarker 
concentrations might differ from day to day within each individual as a consequence 
of variable contact with exposure sources (e.g., variable diet patterns or use of different 
consumer goods) and result in high (within-subject) temporal variability5,61-63 Thus, studies 
depending on one or few biospecimens may have inaccurately characterized the average 
exposure over a certain time period (e.g., a trimester or the whole pregnancy period) and 
have suffered from classical-type measurement error. Classical-type measurement error 
arises if the measured exposure concentrations fluctuates around the true unmeasured 
concentration (e.g., average exposure concentration during a trimester) in such a manner 
that the mean of multiple measurements is likely to estimate the correct individual 
exposure concentration.64-66 Classical-type measurement error is anticipated to result into 
attenuation bias in dose–response associations, less precise effect estimates, and reduced 
statistical power.64,67,68
To increase accuracy, carrying out several repeated exposure measurements on each 
individual is a relevant possibility. However, most studies on the health effects of exposure 
to non-persistent chemicals have used only one or two biomarkers because collecting 
multiple urine specimens over time results in increased sample collection, storage, and 




subject, the bias in the exposure concentration can be reduced by applying a posteriori 
disattenuation (dividing regression coefficient by the intraclass correlation coefficient 
of the corresponding exposure) or use measurement error statistics.64,69-71 Simulation 
extrapolation and regression calibration ar such examples.64,69-71 Both measurement error 
models make use of several biospecimens per subject to correct the dose-response function 
for attenuation bias. Indeed, as observed in Chapter 5 and Chapter 7, correcting regression 
estimates by using measurement error models resulted in stronger effect estimates (i.e., 
further away from the null) than the estimates presented in the main model. However, 
the significance level was essentially the same and the standard errors were increased (i.e., 
more imprecise), which is a trade-off of the measurement error model application64 and 
an important limitation.
One alternative method that provides the benefit of repeated exposure information 
without increasing analytical costs is to increase subject burden and collect more urine 
samples and perform within-subject biospecimen pooling.69,72,73 In this approach, several 
urine samples during a relevant time window are collected and then pooled for each 
individual before analyzing the chemical of interest (within-subject pooling). Indeed, as 
theoretically validated69 for chemicals with a known intraclass correlation (ICC) of 0.2 
(which would be similar to some ICCs that we reported for the non-persistent chemicals 
tested in the present study), the reliance on a single urine measurement to asses exposure 
in a sample of 1000 participants (which approximate our study sample) will result in 
an attenuation bias (i.e., bias towards the null) of 79% with 13% power. By increasing 
the number of biospecimens to 10 per subject, the attenuation bias would be 29% with 
36% power. Another approach to increase power and slightly reduce attenuation bias 
would be to increase sample size. If the sample size is increased to 2000 participants 
with five biospecimens per subject, the attenuation bias would be 44% with 54% power. 
Additionally, Vernet et al. (2019) carried out a validation study of the within-individual 
biospecimen pooling method to reduce exposure misclassification. Vernet et al. (2019) 
compared two innovative pooling approaches (protocol 1 and protocol 2) to estimate 
the chemical exposure during pregnancy with three classical approaches including the 
approach that was used in our work: three random spot samples were collected during 
pregnancy. Protocol 1 consist of collecting and within-subject pooling of complete daily 
spot samples during 3 weeks of pregnancy (15 ± 2, 24 ± 2, and 32 ± 1 gestational weeks). 
These three separate weekly pooled urine samples are then pooled again to obtain within-
subject pregnancy pools for each participant. Protocol 2 followed the same approach; 
however, instead of collecting complete daily spot samples, three randomly selected day 
samples were used. They concluded that protocol 2 provided similar accurate estimate 
exposure averages as compared to protocol 1. When mean pregnancy exposure levels of 
protocol 1 were compared to those of the approach in which three random spot samples 
are collected during pregnancy (used in our work), they showed a relatively high correlation 
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(r = 0.6–0.9) for most chemicals and fair agreement. However, similar to Perrier et al. 
(2016), they also noted that relying on one or few biomarkers per subject for chemicals 
with high (within-subject) temporal variability (such as bisphenol biomarkers) results in a 
poor estimate of the mean exposure and leads to attenuation bias. To limit the attenuation 
bias below 10%, 4–6 samples across pregnancy are needed for chemicals with a relatively 
high ICC (0.6) such as some phthalate metabolites, whereas 18–35 samples are needed 
for chemicals with a relatively low ICC (0.2) such as bisphenol A.69,72,73 Alternatively, 
attenuation bias could be limited by considerably increasing sample sizes in combination 
with the application of a posteriori disattenuation.69
Overall, without increased analytical biomarker expenses, a pooling approach allows 
to use exposure data from multiple biospecimens to estimate mean exposure values 
and reduce attenuation bias in dose–response associations. Recently, the within-subject 
pooling approach has been applied in approximately 500 pregnant women from the 
SEPAGES birth cohort study in France74 and in a sample (n = 157) of the HELIX 
exposome project75 in which both studies showed the possibility of executing such an 
approach. However, it may not always be achievable to collect a few dozen spot urine 
samples per participants (here pregnant women) of large population-based studies such 
as the Generation R Study, especially because the participant burden is already high. For 
example, during each visit in the Generation R Study, a broad range of biospecimens are 
already collected and multiple measurements are taken by several research teams. Unless 
it is a main priority of the principal investigators involved, additionally collecting a few 
dozen spot urine samples may not be achievable. Furthermore, pooling all urine samples 
collected during pregnancy to estimate pregnancy exposure may potentially result in 
diluted effects because of the existence of specific susceptible periods within pregnancy.
Timing of  the measurement and periods of  heightened susceptibility
The timing of the exposure measurement is essential in studies of gestational exposure to 
chemicals because the exposure during susceptible periods (i.e., critical windows) of fetal 
growth may have permanent effects throughout the life course.76,77 Susceptible periods 
are developmental phases through which chemical exposure results in a larger effect on 
health than the exposure to the identical chemical during another period.78 Investigating 
susceptible periods might be useful for studies examining chemical exposures and the 
health effects in children.78 Hypothesized on prior knowledge on underlying developmental 
processes, researchers might compare associations of exposures measured at different 
time intervals to explain the potential mechanisms. Moreover, presenting associations of 
exposures measured at different time intervals with an outcome may help future studies 
to choose a potentially susceptible period. Finally, knowing the susceptible windows can 
provide valuable information for targeted exposure interventions in order to increase the 




The existence of susceptible periods to chemical exposure may result in diluted estimations 
of the exposure-effect associations if studies investigating the effect of such chemicals 
mistime the data collection. Ideally, studies should measure the exposure during that 
exact time window to observe the strongest association.79 This can be difficult because 
the existence, beginning, and duration of the susceptible period to a specific exposure is 
often unknown. Therefore, the absence of an association between exposure to a chemical 
and offspring health might occur because the exposure was not measured during the 
relevant window.79 Furthermore, the identification of susceptible windows requires many 
repeated measurements of the exposure throughout development. However, most studies 
related to prenatal exposure to non-persistent chemicals and neurodevelopment have 
relied on a single biospecimen collected during pregnancy. It is likely that many of these 
studies may have missed the susceptible period. The present study included three repeated 
measures of exposure during early, mid-, and late pregnancy and found some evidence 
for potential susceptible periods to chemical exposure (e.g., early-pregnancy phthalate 
exposure). Although it is more frequent than most other studies, it is conceivable that 
potential windows of susceptibility were missed, and more measurements are required 
to observe the strongest association.
Collecting multiple biospecimens during several potential windows of susceptibility helps 
to identify the susceptible time window but can be logistically difficult. Frequently, for 
convenience, biological materials are sampled at time periods determined by logistics 
(e.g., routine visits at the center) rather than the expected susceptible periods. This may 
increase exposure misclassification and result in poor effect estimation.79 Next, studies 
often investigate the health effects of prenatal chemical exposure; however, the effects of 
exposure to chemicals are not confined to the fetal period and may affect health throughout 
the developmental period. It is likely that other periods of susceptibility exist for that 
chemical. For example, recent studies suggest that chemical exposure disturbs oocytes 
or sperm, which may consequently affect offspring health via epigenetics80,81 Moreover, 
susceptible periods may also be present during childhood. For example, higher lead 
concentrations measured in early childhood is predictive of reduced cognition82 and 
bisphenol A concentrations measured during childhood was associated with behavior 
problems.83
The timing of the outcome measure in identifying susceptible periods to chemical 
exposure is equally important. Neurodevelopment from fetal life onwards is a complex 
and dynamic process. Understanding the trajectory of neurodevelopment and timing of 
neurodevelopmental events is essential for determining how environmental disturbances 
during specific developmental time windows can affect certain structures and functions. 
Repeated outcome measurements throughout the developmental period are needed to 
estimate the neurodevelopmental trajectory and onset of neurodevelopmental disorders. 
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Using a single outcome measurement at one point during childhood may result in an 
imprecise estimate of the neurodevelopmental disorder status. For example, it is conceivable 
that studies assessing the outcome in a single time point during early childhood may have 
suffered from potential outcome misclassification owing to late onset of symptoms as a 
consequence of neurodevelopmental disorders or a measurement problem of applying 
the assessment at a younger age than appropriate for a certain test (e.g., IQ test at < 4 
years). Moreover, studies using a single outcome measurement may also have suffered 
from outcome misclassification because the developing brain may be able to adapt to 
chemical exposure because of its plasticity and associations between prenatal exposure and 
child neurodevelopment may recover as children age.84 The present study was able to use 
repeated measurements for ADHD traits in children at 3, 6, and 10 years of age, which is a 
major strength. However, more repeated measurements from multiple neurodevelopmental 
outcomes would strengthen this work and help to investigate more accurately the effect of 
prenatal chemical exposure on neurodevelopment. Neurodevelopmental data, including 
brain morphology data, from the Generation R participants will be soon be available, which 
will allow us to perform advanced mediation analyses (e.g., to investigate whether brain 
morphology at 10 years is a mediator in the association of prenatal phthalate exposure 
and child IQ at 13 years).
Overall, this discussion highlights the importance of assessing the exposure and outcome 
at multiple time points during preconception (including biospecimens of the father), 
gestation, infancy, childhood, and adolescence. Such studies will help determine the 
potential windows of susceptibility to chemical exposure and help understand the trajectory 
of neurodevelopment and the timing of neurodevelopmental events. A continuation 
of studies investigating developmental processes and susceptible periods will improve 
future epidemiological work. Moreover, the identification of susceptible windows in 
epidemiological studies can inform experimental studies investigating the underlying 
mechanisms of increased susceptibility. However, as described above, it may not be 
achievable to collect a few dozen urine samples from the same women during pregnancy. 
Alternatively, when a certain period is suspected to be a potential window of susceptibility 
to chemical exposure, a design with random exposure assessments during that potential 
susceptible window in different women would be a possibility.
Statistical approaches to handle repeated exposure measurements
As described in the previous two sections, the few studies with multiple exposure measures 
over time most often used the mean value to reduce measurement error.85,86 Although this 
strategy is helpful in summarizing the exposure data measured across time and reducing 
measurement error, studies with repeated exposure data are also interested in exploring 




A frequently used method is to apply linear regression models for each time point of the 
exposure separately and compare the estimates of each separate model with one another. 
However, this method has several notable limitations. First, this approach is not able to 
directly test the differences in effects across time windows. Second, the existence of missing 
observations in exposure data at varying time points may result in different sample sizes 
across the regression models if not imputed. Finally, because the same outcome is used in 
each regression model, the hypotheses tested are not independent.87,88 Alternatively, some 
studies fitted a mutually adjusted regression model in which all exposure windows are 
included in a single regression model. This strategy has the benefit that the independent 
effect of exposure for each time period can be estimated.89,90 However, models may 
be reduced in sample size owing to missingness in exposure measurement at different 
time windows and correlated exposures may introduce multi-collinearity problems.87,88 
Furthermore, the interpretation of the effect differs with timing of exposure. For example, 
when early-, mid-, and late-pregnancy exposures are included in the model, the direct 
effect of early-pregnancy exposure not mediated through mid- and late-pregnancy exposure 
is estimated. For late-pregnancy exposure, only the effect not confounded by early- and 
mid-pregnancy exposure (equal to the direct effect) is estimated.
Several methods have been proposed as alternatives to analyze repeated exposure data and 
explore potential windows of susceptibility. One method regularly applied in chemical 
exposure studies,25,91-93 including ours,94 is the multiple informant method (MIM). This 
method was initially developed to model data from different informants or sources which 
are related to the same inherent construct.95,96 However, it can also be applied in settings 
in which multiple measures of the exposure of the same individual are present.87 The 
MIM is advantageous because it can jointly estimate separate regressions for each time 
period of exposure and formally test whether the effect of exposure differs across time 
periods. However, the MIM is not appropriate for highly correlated data, not robust to 
misclassification of the exposure, and has low power.87
Further, two-stage mixed effect models might be applied to model repeated exposure 
measures and a single outcome.87,88 In this approach, the first step is to model the 
longitudinally time-varying exposure as a function of time (using random slopes 
and intercepts) to obtain subject-specific slopes and intercepts. The second step is to 
simultaneously fit the subject-specific slopes and intercepts as continuous predictors into 
the linear model with the outcome of interest.87,88 The advantages of this method are 
the flexibility of modeling the participants exposure pattern across time and handling of 
missing exposure data at different time points. However, the interpretation of the effect 
estimates is not straightforward anymore.
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Finally, recent novel methodological approaches have been developed to model chemical 
mixture exposures. Several of these approaches are able to account for repeated measurements 
of exposure. These methods are able to allow the effect of the exposure on the outcome 
to differ over time, allowing for non-linear and non-additive effects, and able to include 
interactions among different exposures and within exposures over time. These methods 
will be discussed in the next section.
From the individual substance approach to analyses of  chemical mixtures
Exposure to non-persistent chemicals is universal and multisource.97,98 Biomonitoring 
research have revealed that the background exposure of pregnant women and fetuses 
is continuous and comprises several chemicals concurrently as opposed to separate 
chemicals.77,99,100 For example, in the present study, biomarker concentrations of phthalates, 
bisphenols, and OP pesticides were frequently detected among the same individuals. 
However, the majority of epidemiological studies on non-persistent chemicals have focused 
on the health consequences of separate chemical exposures.101 This approach may not 
be ideal to the study of chemicals that can act additively, synergistically, antagonistically, 
or inertly in relation to a given outcome.102,103 Furthermore, single-chemical models 
can bias effect estimates in the presence of co-pollutant confounders and increase false-
positives when correlated exposures are modeled separately.104 However, studies of separate 
pollutants who observed no associations may also have considerably underestimated the 
health effects of exposure.103 For example, via a common mechanism, multiple agents 
can interact at smaller exposure levels to reach a similar health effect than the exposure 
level that is needed for every pollutant separately.105-110
Therefore, many researchers have stated the necessity for epidemiological research to progress 
from the study of adverse health outcomes of separate pollutants into the investigation 
of mixtures.79,101,103,104,111,112 However, the estimation of the individual and aggregate 
health effects of chemical mixture exposure remains analytically challenging, and the 
development of statistical methods to analyze mixture effects on health and environment 
is an area of active and ongoing research.101,104,113-115 Examples of statistical challenges are 
the presence of highly correlated chemicals from similar exposure sources, which may 
result in inflated standard errors and instable estimates; the possibility that one chemical 
can be a mediator or effect modifier in the association between another chemical and a 
health outcome; and the lack of power to determine small associations in the occurrence 
of measurement error, small sample sizes, non-linearity, and effect modification.101,113,114
Epidemiological data on a variety of chemicals enable researchers to address different 
research questions pertaining to chemical mixtures. Several statistical methods that are 
suited for different questions in datasets with chemical mixtures have emerged. A recent 




applied in research of gestational exposure to chemical mixtures101, such as identifying 
the most potent compound within the mixture.116,117 In this discussion, I will elaborate 
on two novel methods that are able to determine the joint effect of chemical exposure 
on health outcomes.
One innovative method for the analyses of health effects of exposure to mixtures is the 
Bayesian kernel machine regression (BKMR). This method is able to handle time-varying 
exposures to multi-pollutant mixture and allows for hierarchical individual chemical and 
chemical group selection.118,119 This method simultaneously estimates the importance 
of chemical classes with high within group correlations in addition to the estimation of 
the effect of separate chemicals within a chemical class on a given outcome. BKMR is 
able to approximates the mixture exposure–response association by producing a single 
effect estimate of the overall mixture effect. The effect estimate of the overall mixture 
is than interpreted as the health effect that is related with all chemical concentrations 
at a specific quantile versus the median.118 This method is increasingly being applied in 
environmental epidemiology. For example, a study from Kupsco et al. (2019) used this 
method to estimate the mixture effects and interaction effects of prenatal exposure to 
metals on childhood cardiometabolic risk.120 Another Bayesian technique based on the 
kernel machine regression (KMR) framework is called lagged kernel machine regression 
(LKMR), which was designed to detect susceptible exposure windows of chemical mixtures 
on health.78 This method is able to model non-linear effects of a mixture at any given 
exposure window and able to deal with interaction effects among and within exposures.78 
Notably, LKMR is most well adapted for the investigation of chemical mixtures in which 
the exposure is measured during few time periods.78,121 A recent study used this method to 
analyze the association between exposure to four ambient pollutants and birth weight.122 
Wilson et al. (2019) aimed to simultaneously identify the windows of susceptibility to 
exposures and estimate the complex effects of multiple pollutants.
Another recently developed method that is able to determine the joint effect of chemical 
exposure on health outcomes is called the quantile g-computation method and has 
already been applied in several studies.123,124 We used this method to investigate the 
joint effect of prenatal exposure to OP pesticides, phthalates, and bisphenols on fetal 
growth. Quantile g-computation approximates the difference in a certain outcome by 
applying a joint intervention on all chemical exposures simultaneously, while adjusting 
for relevant confounders.120 Quantile g-computation specifically approximates the joint 
effect of increasing every chemical concentrations within the mixture by one quantile.120 
Furthermore, this method provides the opportunity to estimate the joint effect of a specific 
mixture (e.g., phthalate metabolites) while keeping the other chemicals (bisphenols and 
DAP metabolites) as a constant. Quantile g-computation is also able to deal with highly 
correlated exposures and does not assume directional homogeneity (i.e., the assumption 
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that the mutually adjusted association for every separate chemical concentration in the 
model with a given outcome have the same direction). Further, this method is able to 
account for non-linearity and non-additivity by including polynomial features, splines, 
and interaction terms.
Research on prenatal chemical exposure on children’s health is currently moving from 
the study of adverse health outcomes of separate pollutants into the investigation of 
mixtures. Daily exposure to non-persistent chemicals such as phthalates, bisphenols 
and OP pesticides does not occur in isolation but as exposure to a complex mixture of 
chemicals that originate from similar sources. We described two novel methods that 
aim to determine the joint effect of chemical exposure on health outcomes. We believe 
that the investigation of the joint effect of chemical mixture exposure (both the whole 
mixture and the mixture within a chemical group) is important because it provides 
effect estimates that more closely correspond to real-world exposures to chemicals that 
initiate from similar sources; moreover, it offers easiness of inference and may directly 
inform potential public health interventions. For example, using such models, one can 
estimate the health benefits of reducing all chemical exposures or the health benefits of 
eliminating only low-molecular-weight phthalate exposure while other exposures (e.g., 
high-molecular-weight phthalates, bisphenols, and OP pesticides) are continued.
General implications
Studies included in the present thesis have important public health consequences and may 
help to inform public health institutions. We know that the exposure to OP pesticides, 
phthalates, and bisphenols is ubiquitous and occurs as exposure to mixtures. In addition, 
OP pesticide concentrations were 2–3 fold higher than those in most other previous 
studies. Furthermore, we found evidence for an association between prenatal exposure 
to OP pesticides and phthalates and child cognition. Depending on the timing of the 
exposure and the chemical, we found higher chemical exposure to be associated with a 
2–4 points lower IQ score in children.
A higher IQ score during childhood is predictive of healthier behavior and lifestyle-factors 
later in life such as higher educational attainment, improved SES, and improved access 
to health services.125,126 Multiple studies have investigated the economic consequences of 
exposure to chemicals by relating it to IQ loss. These studies concluded that the burden 
and cost of chemical exposures are high.127 For example, in the United States each IQ 
point that is lost from the mean IQ of the general population is predicted to have an 




Finally, our results suggest that prenatal exposure to OP pesticides and phthalates are 
associated with altered fetal growth and brain development in children. These results need 
to be replicated by future studies, but public health institutions and clinicians should be 
aware of the potential neurodevelopmental effects of prenatal exposure to these chemicals. 
Interventions and guidelines may help to inform the general public and clinicians about 
the potential harmful effects of prenatal exposure to these chemicals. This could, for 
example, be comparable to the public health guidelines circulated by the European Food 
Safety Authority on fish consumption to reduce mercury exposure for pregnant women. 
Notably, several studies have demonstrated relatively easy interventions that are effective 
in lowering the exposure to these chemicals during pregnancy. For example, Lu et al. 
(2008) clearly demonstrated that switching to an organic diet provides a remarkable 
and immediate protective effect against exposure to OP pesticides, which are commonly 
used in agricultural production. These findings were confirmed in a recent intervention 
study, which found that organic diet was associated with a significant reduction in urinary 
excretion of several pesticide metabolites and parent compounds.129 Dietary interventions 
have also been successful in lowering the exposure to phthalates and bisphenols.19 Rudel 
et al. (2011) demonstrated that bisphenol and phthalate levels substantially decreased by 
more than half when participants changed their diet from canned and packaged foods 
to a fresh food diet. Furthermore, a study demonstrated that methods accessible to the 
general population, such as selecting cosmetics that are labelled to be without phthalates, 
can reduce personal exposure to these chemicals.130
Future directions
Based on the findings in this thesis, several directions for future research can be formulated. 
We found that early-pregnancy phthalate exposure and late-pregnancy OP pesticide 
exposure were particularly associated with IQ. It is of importance to improve these studies 
by increasing the number of biospecimens collected throughout pregnancy. This will 
help to reduce measurement error and facilitate a more detailed detection of potential 
windows of susceptibility. Second, we found evidence that the exposure to non-persistent 
chemicals is associated with altered fetal growth and brain development. These findings 
need to be validated by replication studies. In parallel, future studies should be carried 
out to investigate the potential mediating role of fetal growth and brain development in 
the association between chemical exposure and neurodevelopment. Third, most studies 
examining maternal exposure to these chemicals in the etiology of child health have 
been restricted to single-exposure models rather than models based on real-life mixture 
combinations. Currently, the field of environmental exposure and health is moving from the 
study of adverse health outcomes of separate pollutants into the investigation of mixtures. 
New techniques have emerged, which allow for modeling the effects of repeated chemical 
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mixture exposure on health and identifying potential periods of susceptibility. Future 
studies should use these techniques and investigate whether real-life prenatal chemical 
mixture exposure is associated with child neurodevelopment. These techniques may also 
assist in other research beyond the field of chemical mixtures and their health effects, 
for example, research on the exposome, which is defined as “the cumulative measure of 
environmental influences and associated biological responses throughout the lifespan, 
including exposures from the environment, behavior, diet, and endogenous processes.”131 
Fourth, intervention studies to reduce non-persistent chemical concentrations are needed 
to detect potential sources of exposure and to provide health risk management strategies 
that may help to reduce personal or societal exposure. Finally, for epidemiological studies 
investigating the effect of environmental and chemical exposures on neurodevelopment, 
it is almost never possible to perform randomized controlled trials (RCTs) owing to 
ethical reasons.132 Therefore, the research in this field depends on observational studies. 
Furthermore, using RCTs to prove causality of non-persistent chemicals is often problematic 
because these chemicals are omnipresent in humans; each person has a certain level of 
exposure, and the exposure itself is constant.132 However, several recent inventive studies 
have used natural experiments to match RCTs.132 For example, a study utilized the 
random assignment of dormitories to undergrad students at Harvard University to study 
the causal relationship between exposure to high temperatures during a heatwave and 
cognitive functioning in students.133 Another study aiming to infer causality of dibutyl 
phthalate exposure on semen quality took advantage of the fact that certain mesalamine 
medications prescribed for inflammatory bowel disease contain phthalates in the coating 
though other medications do not.134 Therefore, being exposed or not exposed (i.e., 
receiving versus not receiving the medication with dibutyl phthalate) relies primarily on 
the prescribing doctor and not on further confounders. Inventiveness in taking advantages 
in these random circumstances may be an extremely valuable strategy to tackle the current 
causal issues in epidemiological studies on the association between environmental and 
chemical exposures with neurodevelopment.132
Practical implications
To reduce personal exposure to OP pesticides, phthalates, and bisphenols, the following 
general suggestions should be considered. First, using organic products in one’s general diet 
(or replacing some food products with organic products) has been shown to substantially 
reduce the urine levels of OP pesticides. Furthermore, reducing the exposure to phthalates 
can be achieved by replacing packaged food products by fresh foods and using phthalate-
free personal care products. Exposure can be further reduced by choosing shower and 
window curtains made from PVC-free alternatives such as linen, cotton, or bamboo instead 




instead of vinyl flooring. Finally, a broad range of potentially phthalate-containing 
general products used by young children—such as teething toys and teethers, soft plastic 
bath toys, and baby shampoo—could easily be replaced by safe products made from 
wood, 100% natural rubber, or cotton. Regarding bisphenols, diet is the main route of 
exposure, and the level of exposure can be considerably reduced by avoiding canned food 
and beverages. Furthermore, bisphenols are present in thermal paper used for a variety 
of products such as ATM receipts, supermarket receipts, boarding passes, and movie 
tickets. A recent study tested 170 thermal paper cash register receipts from 62 different 
retailers such as supermarkets, fast food diners, gas stations, and banks for the presence 
of bisphenols.135 They found that almost all receipts (n = 168) had detectable bisphenol 
concentrations. An easy approach to avoid such exposure to bisphenols is declining the 
receipt from the cashier; when possible, it is better to ask for a digital receipt, purchase 
digital movie tickets, and use an online boarding pass.
Conclusion
In summary, the findings presented in this thesis suggest that prenatal exposure to non-
persistent chemicals is negatively associated with child neurodevelopment. Politicians, 
industries, and public health institutions should not ignore the potential risk of prenatal 
exposure to chemicals such as OP pesticides and phthalates, which are likely associated 
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During pregnancy, women are universally exposed to a broad range of chemicals such 
as phthalates, bisphenols, and organophosphate (OP) pesticides, commonly present in 
consumer products. Animal studies have linked low-dose exposure to these chemicals 
during pregnancy to adverse effects on the neurodevelopment of the offspring. In some 
cases, the few epidemiological studies investigating fetal exposure to these chemicals 
are suggestive of an effect on neurodevelopment but are overall inconclusive. Further, 
considerable uncertainty exists about which mechanisms underlie the observed associations 
between exposure to non-persistent chemicals and neurodevelopment. The present thesis 
examined the relationship between prenatal exposure to the nonpersistent chemicals 
phthalates, bisphenols, and OP pesticides and neurodevelopment in children by:
(i) studying the determinants of exposure to non-persistent chemicals during pregnancy
(ii) exploring the association of prenatal exposure to non-persistent chemicals with 
neurodevelopment in children
(iii) investigating the effect of exposure to these non-persistent chemicals on the potential 
mediators—such as thyroid function, brain structure, and fetal growth—of the 
association with neurodevelopment.
These aims were explored using data from the Generation R Study, which is characterized by 
a large sample size; detailed follow-up information of prenatal and postnatal development 
of the fetus and child, respectively; repeated measurements (early, mid-, and late-pregnancy) 
of exposure to non-persistent chemicals; and availability of detailed demographic 
information. The results of this thesis are summarized below.
In Part II we explored the determinants of exposure to non-persistent chemicals during 
pregnancy. Chapter 2 presents the potential determinants of prenatal exposure to OP 
pesticides. In this chapter OP pesticide concentrations were frequently detected in urine 
samples collected during early-, mid-, and late-pregnancy and these concentrations were 
2–3 times higher than those in most other studies previously conducted. Adverse maternal 
lifestyle- and socioeconomic status (SES)-related factors were associated with lower OP 
pesticide exposure concentrations and fruit intake was the main dietary source of exposure 
to OP pesticides. This chapter provides useful insights into the potential determinants of 
exposure to OP pesticides and strengthens the hypothesis that dietary intake is predictive 
of OP pesticide exposure among pregnant women living in an urban environment. The 
potential determinants of phthalate and bisphenol exposure has been examined by an 





Part III examines the association between prenatal exposure to non-persistent chemicals 
and neurodevelopment in children. Chapter 3 explores the association between prenatal 
exposure to phthalates and bisphenols and offspring non-verbal intelligence quotient 
(IQ). Phthalate exposure during early pregnancy was consistently associated with lower 
non-verbal IQ score in children. Fewer inverse associations were observed for exposure 
in late pregnancy and mean exposure across pregnancy. Bisphenol exposure during 
pregnancy was not associated with non-verbal IQ. These results are important because 
all other previous studies assessing the association between prenatal phthalate exposure 
and IQ have examined the exposure during mid- or late-pregnancy and, therefore, 
may explain why these studies have reported diverse findings. These results therefore 
suggest that early pregnancy is a susceptible period. Chapter 4 expands on this study 
by investigating the association between OP pesticide exposure during pregnancy and 
offspring non-verbal IQ. In this study we found that higher late pregnancy OP pesticide 
exposure was associated with lower non-verbal IQ score in children. Early and mid-
pregnancy OP pesticide exposure was not associated with non-verbal IQ. These results 
suggest that late pregnancy is a potential susceptible window for neurotoxic effects of OP 
pesticide exposure. Beside cognition, non-persistent chemical exposure may be associated 
with neurobehavioral problems. Chapter 5 explored whether OP pesticide exposure is 
associated with attention-deficit hyperactivity disorder (ADHD) and autistic traits in 
children. Despite a large body of literature from both animal and epidemiological studies 
linking prenatal OP exposure to various behavioral outcomes, no association between 
OP pesticide exposure and ADHD or autistic traits was observed. These null findings 
are important because of the extensive follow-up measurements of behavior problems of 
children in this study, the relatively high background exposure levels during gestation, 
and large sample size.
Part IV investigates the effect of exposure to non-persistent chemicals on the potential 
mediators—such as thyroid function, brain structure, and fetal growth—of the association 
with neurodevelopment. Chapter 6 presents the results of prenatal OP pesticide exposure 
and first-trimester maternal or cord blood thyroid hormone concentrations. We found no 
association between prenatal OP pesticide exposure and first-trimester maternal thyroid 
function or fetal thyroid function. These results may indicate that first-trimester maternal 
thyroid function does not mediate the association between early pregnancy OP pesticide 
exposure and neurodevelopment. Further, these results do not support mediation by fetal 
thyroid function in the effect of prenatal OP pesticide exposure on child neurodevelopment. 
Other mechanisms may therefore play a role in the observed association between late 
pregnancy OP pesticide exposure and non-verbal IQ. In Chapter 7 we investigated another 
potential mediator and explored whether prenatal exposure to phthalates was associated 
with brain morphology and white matter microstructure in children. Maternal urinary 
concentrations of monoethyl phthalate metabolite concentrations were associated with 
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lower total gray matter volume and monobutyl phthalate with larger thalamus volumes. 
There was no association between phthalate exposure and measures of white matter 
microstructure. These findings suggest that phthalates exposure contributes to altered 
brain development in children. Chapter 8 expands on this by investigating the association 
between OP pesticide exposure during pregnancy and offspring brain morphology and 
white matter microstructure. Higher mean exposure to OP pesticides across pregnancy 
was associated with lower white matter microstructure, and these associations were 
mainly driven by the early and mid-pregnancy exposure. No associations were observed 
between prenatal OP pesticide exposure and structural brain morphology, including 
brain volume, cortical thickness, or cortical surface area. This study provides the first 
evidence that OP pesticides may alter normal white matter microstructure in children, 
which could have consequences for normal neurodevelopment. Besides thyroid function 
and brain morphology, fetal growth may also be a potential mediator in the association 
between prenatal exposure to non-persistent chemicals and neurodevelopment. Chapter 
9 therefore investigated whether exposure to non-persistent chemicals was associated with 
fetal growth. We found that prenatal exposure to OP pesticides was predictive of lower 
fetal weight and length measured during mid-pregnancy, but not at delivery. These results 
were confirmed by our follow-up study presented in Chapter 10 in which we assessed 
the association between prenatal exposure to a mixture of phthalates, bisphenols, and 
OP pesticides and measures of fetal growth. The results indicated that prenatal exposure 
to this mixture was predictive of lower fetal size, as indicated by length and weight 
measurements. Analyses of individual chemical classes revealed that the phthalate and 
OP pesticide mixtures drove the association of the overall mixture.
Finally, in Chapter 11 we first discussed the main findings of this thesis. We then discussed 
the general methodological considerations, the implications of this study, and provide 
future directions and recommendations. We finalize this chapter by providing general 






Tijdens de zwangerschap worden vrouwen universeel blootgesteld aan een breed scala van 
chemicaliën zoals ftalaten, bisfenolen en organofosfaat (OP) pesticiden. Deze chemische 
stoffen komen voornamelijk voor in consumentenproducten. Dierstudies hebben 
een verband aangetoond tussen de prenatale blootstelling van een lage dosis aan deze 
chemicaliën en nadelige effecten op de neurologische ontwikkeling van het nageslacht. 
In sommige gevallen suggereren de enkele epidemiologische studies dat de blootstelling 
van de foetus aan deze chemicaliën een effect heeft op de neurologische ontwikkeling. 
Echter, zijn deze epidemiologische studies over het algemeen niet doorslaggevend. Verder 
bestaat er onzekerheid over welke mechanismen ten grondslag liggen aan de waargenomen 
associaties tussen de blootstelling aan niet-persistente chemicaliën en de neurologische 
ontwikkeling. Dit proefschrift onderzocht de relatie tussen prenatale blootstelling aan de 
niet-persistente chemicaliën ftalaten, bisfenolen en OP pesticiden en de neurologische 
ontwikkeling van kinderen door:
i) het onderzoeken van mogelijke determinanten van blootstelling aan niet-persistente 
chemicaliën tijdens de zwangerschap
(ii) het onderzoeken van de associatie tussen prenatale blootstelling aan niet-persistente 
chemicaliën en neurologische ontwikkeling van kinderen
(iii) het onderzoeken van het effect van blootstelling aan deze niet-persistente chemicaliën 
op potentiële mediatoren—zoals schildklierfunctie, hersenstructuur en foetale groei—
van de associatie met neurologische ontwikkeling.
Deze doelen werden onderzocht met behulp van gegevens uit de Generation R Studie, die 
wordt gekenmerkt door een grote steekproefomvang; gedetailleerde follow-up informatie 
van de prenatale en postnatale ontwikkeling van respectievelijk de foetus en het kind; 
herhaalde metingen (vroege, midden- en late zwangerschap) van blootstelling aan niet-
persistente chemicaliën; en beschikbaarheid van gedetailleerde demografische informatie. 
De resultaten van dit proefschrift worden hieronder samengevat.
In deel II werden de determinanten van blootstelling aan niet-persistente chemicaliën 
tijdens de zwangerschap onderzocht. In Hoofdstuk 2 onderzochten wij de mogelijke 
determinanten van prenatale blootstelling aan OP pesticiden. In dit hoofdstuk werden 
OP pesticiden concentraties veelvuldig aangetroffen in urinemonsters verzameld tijdens 
de vroege, midden en late zwangerschap. Deze concentraties waren 2-3 keer hoger dan 
de concentraties gevonden in de meeste eerder uitgevoerde onderzoeken. Ongunstige 
levensstijl- en sociaaleconomisch status-gerelateerde factoren waren geassocieerd met 
lagere concentraties van OP-pesticiden. Daarnaast was de consumptie van fruit tijdens 
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de zwangerschap de belangrijkste voedselbron van blootstelling aan OP-pesticiden. Dit 
hoofdstuk biedt inzichten in de potentiële determinanten van blootstelling aan OP 
pesticiden en versterkt de hypothese dat de consumptie van voedsel voorspellend is voor 
blootstelling aan OP-pesticiden bij zwangere vrouwen die in een stedelijke omgeving 
wonen. De mogelijke determinanten van ftalaten en bisfenolen blootstelling zijn onderzocht 
door een eerdere studie met behulp van gegevens van het Generation R Study-cohort. 
Deze resultaten worden besproken in hoofdstuk 11.
Deel III onderzocht de associatie tussen prenatale blootstelling aan niet-persistente 
chemicaliën en neurologische ontwikkeling bij kinderen. In Hoofdstuk 3 keken wij 
naar de associatie tussen prenatale blootstelling aan ftalaten en bisfenolen en het non-
verbale intelligentiequotiënt (IQ) van het nageslacht. Blootstelling aan ftalaten tijdens de 
vroege zwangerschap was consistent geassocieerd met een lagere non-verbale IQ-score bij 
kinderen. Er werden minder negatieve associaties waargenomen voor blootstelling tijdens 
de late zwangerschap en voor gemiddelde blootstelling gedurende de zwangerschap. 
Blootstelling aan bisfenolen tijdens de zwangerschap was niet geassocieerd met non-
verbale IQ. Deze resultaten zijn belangrijk omdat alle eerdere studies die de associatie 
tussen prenatale ftalaten blootstelling en IQ onderzochten, de blootstelling tijdens het 
midden of laat in de zwangerschap hebben gemeten. Dit verklaart mogelijk waarom deze 
onderzoeken geen consistente resultaten hebben gevonden. Deze resultaten suggereren 
daarom dat vroege zwangerschap een gevoelige periode is voor de neurotoxische effecten 
van blootstelling aan ftalaten. Hoofdstuk 4 is een uitbreiding op deze studie waarin we 
het verband onderzochten tussen blootstelling aan OP pesticiden tijdens de zwangerschap 
en het non-verbale IQ van het kind. In deze studie vonden wij dat een hogere blootstelling 
aan OP-pesticiden in de late zwangerschap geassocieerd was met een lagere non-verbale 
IQ-score bij kinderen. Blootstelling aan OP-pesticiden in het begin en midden van de 
zwangerschap was niet geassocieerd met non-verbale IQ. Deze resultaten suggereren dat 
de late zwangerschap een potentieel gevoelig periode is voor de neurotoxische effecten 
van blootstelling aan OP-pesticiden. Naast cognitie keken wij ook naar het verband met 
neurologische gedragsproblemen. In Hoofdstuk 5 bestudeerden wij of blootstelling aan 
OP pesticiden geassocieerd is met symptomen van ADHD en autisme bij kinderen. 
Ondanks dat zowel dierstudies als eerdere epidemiologische studies associaties vonden, 
werd er in onze studie geen verband waargenomen tussen blootstelling aan OP-pesticiden 
en symptomen van ADHD of autisme. Deze nulresultaten zijn belangrijk vanwege de 
uitgebreide follow-upmetingen van gedragsproblemen van kinderen, de relatief hoge 
achtergrondblootstellingsniveaus tijdens de zwangerschap en de grote steekproefomvang.
Deel IV presenteert het onderzochte effect van blootstelling aan niet-persistente chemicaliën 
op potentiële mediatoren van de associatie met neurologische ontwikkeling. In Hoofdstuk 




schildklierhormoon concentraties. Er werd geen verband gevonden tussen blootstelling 
aan OP-pesticiden tijdens de zwangerschap en de schildklierhormoon concentraties 
van de moeder gemeten in het eerste trimester en de schildklierhormoon concentraties 
gemeten in het navelstrengbloed. Deze resultaten suggereren dat de schildklierfunctie van 
de moeder in het eerste trimester en foetale schildklierfunctie niet het verband medieert 
tussen blootstelling aan OP-pesticiden tijdens zwangerschap en neurologische ontwikkeling. 
Andere mechanismen spelen daarom mogelijk een rol in de associatie tussen blootstelling 
aan OP-pesticiden tijdens de late zwangerschap en non-verbale IQ. In Hoofdstuk 7 werd 
er gekeken naar een andere mediator en onderzocht of prenatale blootstelling aan ftalaten 
geassocieerd was met de hersenstructuur en de witte stof microstructuur. Maternale 
mono-ethyl ftalaat metaboliet concentraties waren geassocieerd met een kleiner volume 
van de totale grijze stof, en monobutyl ftalaat metaboliet concentraties waren geassocieerd 
met een groter volume van de thalamus. Er was geen verband tussen blootstelling aan 
ftalaten en metingen van de witte stof microstructuur. Deze bevindingen suggereren dat 
blootstelling aan ftalaten hersenontwikkeling bij kinderen beïnvloed. Hoofdstuk 8 is 
een uitbreiding op deze studie waarin we de associatie onderzochten tussen blootstelling 
aan OP pesticiden tijdens de zwangerschap en de hersenstructuur en de witte stof 
microstructuur van kinderen. Een hogere gemiddelde blootstelling aan OP-pesticiden 
tijdens de zwangerschap was geassocieerd met een lagere microstructuur van witte stof, 
en deze associaties werden voornamelijk veroorzaakt door blootstelling aan het begin en 
midden van de zwangerschap. Er werden geen associaties waargenomen tussen prenatale 
blootstelling aan OP-pesticiden en structurele breinstructuur, inclusief hersenvolume, 
corticale dikte en corticale oppervlakte. Deze studie levert het eerste bewijs dat blootstelling 
aan OP-pesticiden de normale microstructuur van witte stof bij kinderen kunnen 
beïnvloeden, wat gevolgen kan hebben voor de normale neurologische ontwikkeling. 
Naast de schildklierfunctie en de morfologie van de hersenen, kan de groei van de foetus 
ook een potentiële mediator zijn in het verband tussen prenatale blootstelling aan niet-
persistente chemicaliën en neurologische ontwikkeling. Hoofdstuk 9 onderzochten wij 
daarom of de blootstelling aan niet-persistente chemicaliën geassocieerd was met foetale 
groei. We ontdekten dat prenatale blootstelling aan OP-pesticiden voorspellend was voor 
een lager foetaal gewicht en lengte gemeten halverwege de zwangerschap, maar niet bij 
de bevalling. Deze resultaten werden bevestigd door onze vervolgstudie gepresenteerd 
in Hoofdstuk 10 waarin we de associatie tussen prenatale blootstelling aan een mix van 
ftalaten, bisfenolen en OP pesticiden en foetale groei hebben onderzocht. De resultaten 
gaven aan dat prenatale blootstelling aan deze mix voorspellend was voor een kleinere 
foetale grootte. Ten slotte hebben wij in Hoofdstuk 11 de belangrijkste bevindingen 
van dit proefschrift besproken. Vervolgens hebben we de algemene methodologische 
overwegingen en de implicaties van deze studie besproken en toekomstige aanwijzingen 
en aanbevelingen gepresenteerd. We ronden dit hoofdstuk af met algemene suggesties 
Chapter 12
426











Publications not part of  this thesis
Portfolio





The work presented in this thesis was conducted at the Erasmus MC, University Medical 
Center Rotterdam, Department of Child and Adolescent Psychiatry and The Generation R 
Study Group, Rotterdam, 3015 CN, the Netherlands. The Generation R Study is conducted 
by the Erasmus Medical Center, Rotterdam, in close collaboration with the Faculty of Social 
Sciences of the Erasmus University Rotterdam, the Municipal Health Service, Rotterdam 
Homecare Foundation and Stichting Trombosedienst & Artsenlaboratorium Rijnmond. 
The authors thankfully acknowledge the contribution of the participating parents and their 
children, general practitioners, hospitals, midwives, and pharmacies in Rotterdam. The 
general design of the Generation R Study is supported by the Erasmus Medical Center-
Rotterdam, the Erasmus University Rotterdam, the Netherlands Organization for Health 
Research and Development (ZonMw), Netherlands Organization for Scientific Research 
(NOW), and the Ministry of Health, Welfare and Sport, the Municipal Health Service 
Rotterdam area, and the Stichting Trombosedienst and Artsenlaboratorium Rijnmond. 
The research described in the thesis received financial support from the intramural research 
program of the National Institute of Environmental Health Sciences, National Institutes 
of Health (Grant# HHSN273201500003C and ZIAES101575). Further, this research 
received financial support from the National Institute of Health grant R01ES022972 
and the National institute of health grant R01ES029779. The printing of this thesis 





Erasmus MC, University Medical Center Rotterdam, Department of Child and Adolescent 
Psychiatry, Rotterdam, 3015 CN, the Netherlands
Michiel A. van den Dries, Hanan El Marroun, Tessa A. Mulder, Henning Tiemeier, Tonya 
White
Erasmus MC, University Medical Center Rotterdam, The Generation R Study Group, 
Rotterdam, 3015 CN, the Netherlands
Michiel A. van den Dries, Romy Gaillard, Vincent W. V. Jaddoe, Sander Lamballais, Tessa 
A. Mulder, Elise Philips, Susana Santos, Trudy Voortman
Erasmus MC, University Medical Center Rotterdam, Department of Epidemiology, 
Rotterdam, 3015 CN, the Netherlands
Sander Lamballais, Trudy Voortman
Erasmus MC, University Medical Center Rotterdam, Department of Radiology and 
Nuclear Medicine, Rotterdam, 3015 CN, the Netherlands
Tonya White
Erasmus MC, University Medical Center Rotterdam, Department of Clinical Genetics, 
Rotterdam, 3015 CN, the Netherlands
Sander Lamballais
Erasmus MC, University Medical Center Rotterdam, Department of Internal Medicine, 
Academic Center for Thyroid Diseases, Rotterdam, 3015 CN, the Netherlands
Tim I. M. Korevaar, Tessa A. Mulder, Robin P. Peeters
Erasmus MC, University Medical Center Rotterdam, Department of Pediatrics, Rotterdam, 
3015 CN, the Netherlands
Hanan El Marroun, Romy Gaillard, Vincent W. V. Jaddoe, Elise Philips, Susana Santos
Department of Psychology, Education and Child Studies, Erasmus School of Social and 
Behavioral Sciences, Erasmus University Rotterdam, 3062 PA, the Netherlands
Hanan El Marroun
Department of Risk Analysis for Products in Development, TNO, Utrecht, 3584 CB, 
the Netherlands
Anjoeka Pronk, Suzanne Spaan
Appendix
433
Department of Social and Behavioral Sciences, Harvard T. H. Chan School of Public 
Health, Boston, MA, 02115, USA
Henning Tiemeier
Epidemiology Branch, National Institute of Environmental Health Sciences, National 
Institutes of Health, Department of Health and Human Services, Durham, North 
Carolina, NC, 27709, USA
Kelly K. Ferguson
Department of Epidemiology, Gilling School of Global Public Health, University of 
North Carolina Chapel Hill, Chapel Hill, NC
Stephanie M. Engel, Alexander P. Keil
Ramboll, Raleigh, North Carolina, NC, 27612, USA
Matthew P. Longnecker
Department of Pediatrics, New York University School of Medicine, New York, New 
York, USA.
Akhgar Ghassabian, Leonardo Trasande
Department of Environmental Medicine, New York University School of Medicine, New 
York, New York, USA.
Akhgar Ghassabian, Leonardo Trasande
Department of Population Health, New York University School of Medicine, New York, 
New York, USA.
Akhgar Ghassabian, Kurunthachalam Kannan, Leonardo Trasande
New York University Wagner School of Public Service, New York, New York, USA.
Leonardo Trasande
New York University College of Global Public Health, New York, New York, USA.
Leonardo Trasande
Department of Public Health Sciences, University of Rochester School of Medicine and 




Department of Environmental Medicine, University of Rochester School of Medicine 
and Dentistry, Rochester, New York, USA.
Todd A. Jusko
Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Maria-Pilar Martinez-Moral
Department of Biostatistics and Epidemiology, Perelman School of Medicine, University 
of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pamela A. Shaw
ISGlobal, Barcelona, 08003, Spain
Mònica Guxens
Pompeu Fabra University, Barcelona, 08002, Spain
Mònica Guxens
Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), 
Instituto de Salud Carlos III, 28029, Spain
Mònica Guxens





List of  publications not part of  this thesis
Koopman-Verhoeff, M. E., van den Dries, M. A., van Seters, J. J., Luijk, M., Tiemeier, 
H., & Luik, A. I. (2019). Association of Sleep Problems and Melatonin Use in School-
aged Children. JAMA pediatrics, 173(9), 883–885.
de Lijster, J. M., van den Dries, M. A., van der Ende, J., Utens, E., Jaddoe, V. W., 
Dieleman, G. C., Hillegers, M., Tiemeier, H., & Legerstee, J. S. (2019). Developmental 
Trajectories of Anxiety and Depression Symptoms from Early to Middle Childhood: a 
Population-Based Cohort Study in the Netherlands. Journal of abnormal child psychology, 
47(11), 1785–1798.
Rodriguez-Ayllon, M., Derks, I., van den Dries, M. A., Esteban-Cornejo, I., Labrecque, 
J. A., Yang-Huang, J., Raat, H., Vernooij, M. W., White, T., Ortega, F. B., Tiemeier, H., 
& Muetzel, R. L. (2020). Associations of physical activity and screen time with white 




Name PhD student:  Michiel Arjen van den Dries
Erasmus MC Department:  Child & Adolescent Psychiatry/Psychology
PhD period:  Feb 2016 – Jun 2020
Promotor:  Prof. dr. H. Tiemeier,
Copromotors:  Dr. M. Guxens
 Dr. ir. A. Pronk
1. PhD training Year ECTS
Courses
Advanced Causal Inference 2017 1.3
Causal Mediation Analysis, Erasmus MC 2018 1.4
Advances in Clinical Epidemiology, Erasmus MC 2018 0.7
Erasmus Summer Lectures, Erasmus MC 2018 0.4
Masterclass: Advances in Genomics Research, Erasmus MC 2018 0.4
Child Psychiatric Epidemiology, Erasmus MC 2019 0.9
Skills courses
Radiation protection expertise level 5R 2016 1.0
Research Integrity, Erasmus MC 2018 0.3
International conferences
ISES, Utrecht, the Netherlands (poster presentation) 2016 1.0
EDCEH, Rennes, France 2018 1.0
ISEE, Utrecht, the Netherlands (oral & poster presentation) 2019 1.4
Symposia, meetings & workshops
Generation R Behavioral Group Meetings, Rotterdam, the Netherlands (oral 
presentation)
2016-2020 1.0
Generation R Research Meetings, Rotterdam, the Netherlands (oral presentati-
on)
2016-2020 1.0
ACTION meeting, Amsterdam, the Netherlands 2017 0.3
EEARN meeting, Rotterdam, the Netherlands 2018 0.3
NYU Langone Health, Department of Pediatrics, New York, USA (oral presen-
tation)
2019 1.0
NIEHS reproductive Lunch Meetings 2019 0.3
NIEHS mixtures Working Group Meetings (oral presentation) 2019 1.0
NIEHS Summer Internship Program Poster Session 2019 0.3
11th Annual NIEHS Epidemiology Branch Science day, Durham, USA. (presen-
tation judge)
2019 0.3





Biostatistical methods I, SPSS/R (research assistance) 2016 1.7
Clinical trials and diagnostic tests (research assistance) 2017 0.6
Biostatistical methods I, SPSS/R (research assistance) 2017 0.6
Supervision Master thesis
Judith van Seters (Medical Sciences, Erasmus Medical Center).
Association of sleep problems and melatonin use in school-aged children
2017-2018 3.0
Duifje M.B. Wurzer, (Clinical Psychology, Erasmus University Rotterdam).
Prenatal Organophosphate Pesticide Exposure and Academic Achievement in 
Preadolescence: A Population-based Cohort Study in the Netherlands
2018-2019 3.0
Gelitza Croes (Clinical Psychology, Erasmus University Rotterdam).
The Association of Prenatal Organophosphate Pesticides Exposure with Neuromotor 
Development in Young Children
2018-2019 3.0
3. Other activities
Generation R general tasks (360 dayparts of data-collection) 2016-2019
Peer review Neurotoxicology (two reviews) 2016-2017 1.2
Peer review Environment International (three reviews) 2018 1.8
Peer review Environmental Epidemiology (two reviews) 2019-2020 1.2
Three months research visit at the National Institute of Environmental Health 
Sciences (NIEHS)
2019
4. Grants and prices 
KNAW Ter Meulen Grant 2019
LifeCycle Project Grant 2019
1 ECTS (European Credit Transfer System) is equal to a workload of 28 hours
Appendix
438
Words of  gratitude / Dankwoord
“Je gaat het pas zien als je het door hebt.”
– Johan Cruijff
Graag zou ik als eerste alle moeders, vaders en kinderen die deelnemen aan het Generation 
R onderzoek willen bedanken. Dit onderzoek zou onmogelijk geweest zijn zonder jullie 
hulp en trouwe participatie. Dankzij jullie bijdragen is de wetenschappelijke kennis 
wederom gegroeid.
Ook wil ik graag alle personen bedanken die zich elke dag inspannen om het Generation 
R onderzoek in goede banen te leiden. Jullie zijn essentieel en onmisbaar. Beste Vincent 
en het MT, dank voor alle inzet en leiderschap. Beste Janine, dank voor het managen 
van data-veiligheid en privacy. Beste Ronald en alle medewerkers van het focuscentrum, 
ik waardeer enorm met hoeveel passie en kwaliteit jullie de dataverzameling uitvoeren. 
Daarnaast wil ik graag Claudia en Marjolein bedanken. Ik heb veel respect voor het 
werk wat jullie verrichten als datamanagers. Patricia en Sunayna, dank voor alle hulp en 
ondersteuning.
Dank aan mijn promotor, Henning Tiemeier. Beste Henning. Je epidemiologische 
kennis en scherpzinnig denkvermogen zijn excellent en ik heb veel van je geleerd tijdens 
dit project. Waar ik veel bewondering voor heb is je passie voor de wetenschap en je 
vermogen om tot in detail betrokken te zijn bij zoveel verschillende onderzoeksprojecten. 
Ik heb veel waardering voor je begeleiding en de vrijheid die je me gaf om zelfstandig 
wetenschappelijke vragen binnen het onderzoeksproject te beantwoorden. Met veel plezier 
kijk ik terug naar je bezoek aan het NIEHS. Onder het genot van een classic Southern 
meal, was het mooi om nieuwe samenwerkingen te zien ontstaan.
I would like to thank my co-promoters. I was lucky to have such outstanding and involved 
co-promotors with whom I had lots of great meetings. Dear Mònica, thank you for all 
your help during this project and the grant applications. It is amazing how talented you 
are and I have learned so much from you. I especially admire your critical thinking in 
research and your incredible work in the field of environmental exposures and child’s 
health. I am grateful that we continue to work together. Beste Anjoeka, dank voor alle 
hulp tijdens mijn promotie, ik ben dankbaar voor al jouw goede adviezen. Met veel plezier 
kijk ik terug naar onze vele meetings bij TNO. Je enthousiasme en betrokkenheid in 
dit project waardeer ik enorm en ik heb veel geleerd van je deskundigheid op het gebied 
blootstelling aan omgevingsfactoren. Je expertise wordt wederom erkent met het behalen 
van het uitdagende exposome project.
Appendix
439
Beste Prof. dr. ir. Alex Burdorf, het is een eer dat je de secretaris van mijn kleine commissie 
wilt zijn. Dear Prof. dr. Stephanie Engel and Prof. dr. ir. Roel Vermeulen thank you very 
much for being part of the thesis evaluation and defence committee. Prof. dr. Brenda 
Eskenazi, Prof. dr. Majorie van Duursen, and Dr. Tonya White, I am very thankful that 
you are willing to be part of the opposition committee.
Dear Matt, I would like to thank you for all your help and advice in this project. I was 
very fortunate to be able to work with such a specialist in the field of environmental 
epidemiology. It was great meeting you in person in North Carolina and I really appreciate 
you showing me around Durham. Dear Kelly, I really enjoy our collaboration. You are 
truly one of the most talented researchers I know. I really appreciate the fact that I was 
able to visit NIEHS to work with you on a new exciting research project. I am thankful 
that you and Chris showed me around in Carrboro, especially Al’s burger shack and 
beer study, and I will never forget the fourth of July, USA! Suzanne, graag wil ik jou ook 
bedanken voor alle hulp en betrokkenheid bij dit project. Ik kan me nog goed herinneren 
hoe wij samen dikke pesticiden boeken hebben doorgespit. Tijdens dit traject heb je me 
altijd goed advies gegeven en mijn bewondering voor jouw kennis is groot.
Many thanks also to my co-authors. I appreciate our collaboration on many great projects 
and I am thankful for your wise and helpful contributions. Dear Akhgar Ghassabian 
and Leonardo Trasande, it was great meeting you and presenting at your department in 
New York. It is an honour to work with such great specialists in the field of endocrine 
disrupting chemicals. Dear Todd Jusko, thank you for your all your help in this project 
and numerous great meetings. Beste Vincent Jaddoe, hartelijk dank voor alle hulp en 
waardevolle input tijdens dit project.
Beste collega’s van de gedragsgroep en andere Generation R onderzoekers, ik zei altijd 
als grap “The best thing in Rotterdam, is the train to Amsterdam”, maar eigenlijk zijn 
jullie dat! Ivonne, wel of geen vertraging, we hadden altijd een hoop plezier. Ik ben 
dankbaar dat wij zowel wetenschappelijke als persoonlijke verhalen konden delen. Rosa, 
Desi, het super duo. Dank voor zowel de wetenschappelijke discussies als alle lol in het 
kippenhok. Koen, Elize en Clair, ik ben dankbaar voor de buitengewone hummus & 
avocado lunches en borrelavonturen. Alex, Andrea, Annemarie, Arash, Cees, Charlotte, 
Deborah, Elisabet, Fadilah, Fer, Hanan, Jasmijn, Jeremy, Lisa, Lisanne, Lorenza, Louk, 
Lizzie, Maria, Mannan, Monica, Nathalie, Nienke, Pauline, Philip, Runyu, Ryan, Sander, 




Dear colleagues from ISGlobal, Alba, Albert, Anne-Claire, Esmee, Gosia, Laura, Lucia, 
Michelle. It was great seeing you in person for one month and meeting you virtually for 
the past year. I look forward to seeing you in Barcelona and working with you in 2021.
Dear Yllza, what a fun we had during the countless trips to the coffee corner, learning you 
amazing Dutch songs, and afterwork drinks. I am grateful for your friendship, all your 
and Tiki’s help and contribution during this project, and your endless mental support. 
Thank you for standing by my side as my paranymph.
Bob, Erik, Guillaume, Jeroen, Joost, Koen, Philip en Sanne, alles goed? Met mij wel. Wat 
ken ik jullie al lang zeg, netjes. Wanneer we samen zijn is het immer een mooi avontuur. 
Jullie vriendschap is mij dierbaar. Laten we nog heel lang voor goud gaan.
Casa-crewers, 9-5ers, roze-br’s, bedankt voor jullie vriendschap en steun. Roasts, sinterklaas, 
bokhutten, foodfights en altijd die eeuwige vraag: “is het proefschrift al af?” Anouk, 
Chung, Esther, Eva, Iris, Isabelle, Juan, Koen, Lisa, Marieke, Norman, Pedro, Pelle, Pim, 
PJ, Rawand, Robert, Sophie, Teo, Wendy, en Zita, wat moet ik Carcassonne-der jullie.
Spartanen van Arsenal. Strijders van het eerste uur. Zes jaar geleden begonnen we met een 
missie. Naast het kampioenschap, het winnen van de eerste, tweede, en derde helft, de 
teamuitjes en de boetepot, geniet ik van de vriendschappen die wij hebben opgebouwd 
in de afgelopen jaren. Bas, David, Dayen, Feddo, Gerrit, Henk, Jeroen, Jerry, Jori, Lars, 
Luc, Luuk, Maik, Marijn, Nico, Otto, Remco, Remy, Robert, Sanne, Stefan, Vladan, 
Zeno, Zeno en de nieuwe talenten, bedankt.
Bussumers, Cees, Bas, Hannah, Jazz, Julian, Lieke, Maan, Marieke, Steef, Tessa, Yannick, 
Yves, bedankt dat jullie in mijn leven zijn.
Maurice, bedankt voor de vriendschap.
Hessel en Nicole, het superstel. Ik ben blij om jullie als vrienden te hebben. Hessel, naast 
de wereldbeschouwing en de humor, delen wij ook het plezier in epidemiologie. Nicole, 
jouw gezelligheid, humor en warmte is top. Ik kijk altijd uit naar het kindermenu.
Paul en Ina, wat heb ik veel van jullie geleerd. Ik ben dankbaar voor jullie zorg, de wijze 
lessen, de spelletjes, en de humor! Tine, Marc, Roel, Linda, Julia, Wim, Menno, Marianne, 
Michel en Ina, dank voor jullie betrokkenheid. Dat is mij dierbaar. Pauline en Harry, 
dank voor al het plezier dat we beleven tijdens sinterklaas. Herman, Anne, Lea en Lucie, 
ik geniet altijd van onze gesprekken en jullie gastvrijheid, merci beaucoup! Vincent en 
Appendix
441
Ruben, zover als mijn brein terug kan reizen, zijn jullie onderdeel van mijn leven. Risk, 
schaken, kerstvieringen en voetballen op straat. Dank voor al het plezier.
Schoonfamieleden, Olga, Jacques, Styn, Eric, Lonieke, Elisabeth en Sina, bedankt dat ik 
me altijd thuis kan voelen bij jullie, zowel met als zonder kaasplank. Elisabeth, bedankt 
voor het cover design! Anders had ik het moeten doen met de paintversie.
Jos, Petra, Mathijs, Jelle, Guus, Marlies, Sam, Emma, Izzie, Gemma. Van je familie moet 
je het hebben... Maar dan heb je ook wat! Ooms en tantes dank voor alle hulp. Neefjes 
en nichtje, wij hebben altijd veel plezier en ik hoop met jullie nog veel nieuwe avonturen 
te beleven. Dank aan mijn opa en oma voor alle steun en warmte.
Dank aan mijn vader Adrie, in wiens voetstappen ik verder ga.
Lieve Anne, wat ben ik trots op jou. Een medische topper! Het is hardwerken op de IC, 
maar ik weet zeker dat iedereen je heel dankbaar is dat jij daar staat. Je bent een van de 
warmste personen die ik ken en ik mag van geluk spreken met zo’n super zusje! Dank 
voor alle steun!
Lieve moeder, jouw betrokkenheid en steun is ontzettend belangrijk voor me. Ik heb 
bewondering voor wat jij doet en bereikt hebt in het leven tot nu toe. Ik ben trots dat 
wij dezelfde levensvisie delen. Voor mij ben je een heldin! Dankjewel voor alles.
“Ach de liefde… dáár zouden ze eens een liedje over moeten maken!”
– Theo Maassen
Lieve Jeanne, wat heb ik toch een geluk dat jij mijn nummer vroeg, nu alweer meer dan 8 
jaar geleden. Ons leven samen is een groot avontuur en elke dag hebben wij het grootste 
plezier. Ik voel me erg gelukkig met jou. Ik hou van je. 
Appendix
442
About the author 
Michiel Arjen van den Dries was born in Bilthoven, the Netherlands. After his bachelor 
program in Health Sciences at the VU University of Amsterdam, Michiel started two 
masters: a two-year research master in Epidemiology with the specialization Occupational 
and Environmental Epidemiology at the University of Utrecht, and a two-year research 
master in Management, Policy‐Analysis and Entrepreneurship in Health and Life Sciences 
with the specialization in International Public Health at the VU University of Amsterdam. 
During his masters, the interests in scientific research developed and in 2016 he started a 
PhD program supervised by Prof. dr. Henning Tiemeier, Dr. Mònica Guxens, and Dr. ir. 
Anjoeka Pronk at the Department of Child and Adolescent Psychiatry, and the Generation 
R Study Group at the Erasmus MC in Rotterdam, from which the results are presented in 
this thesis. During his PhD he was invited as a visiting scientist at the National Institute 
of Environmental Health Sciences (NIEHS), Durham, NC, United States, to perform 
a research project. In 2020 Michiel van den Dries is working at ISGlobal, Barcelona, 
Spain, as a postdoctoral researcher. He is working on a project about prenatal exposure 
to non-persistent chemical mixtures and neurodevelopment in children which is funded 
by two research grants he received: The LifeCycle project fellowship, and The Academy 
Ter Meulen grant. Michiel will pursue his scientific career as a postdoctoral researcher 
in the field of environmental exposures and children’s health at ISGlobal and hopes to 


















Prenatal exposure to non-persistent 
chemicals and child neurodevelopment: 
an epidemiological study
Michiel Arjen van den Dries
UITNODIGING
Voor het volgen van de openbare 
verdediging van het proefschrift
 
Prenatal exposure to non-
persistent chemicals and 
child neurodevelopment:  
an epidemiological study 
Dinsdag 02-02-2021  
15:30 uur 
U kunt de openbare verdediging 
volgen via een livestream.  
De link voor de livestream 
ontvangt u via e-mail.  
Michiel van den Dries 
Generaal Vetterstraat 2-H  
1059BV Amsterdam  
michielvddries@gmail.com 
Paranimfen 
Jeanne Leerssen  
Yllza Xerxa  
michielsparanimfen@gmail.com
